RELEASE HISTORY


Protein Atlas version 16


Release date: 2016.12.04
Ensembl version: 83.38
  • Sixteenth major release of the Human Protein Atlas with more than 25,000 antibodies, targeting proteins from more than 17,000 human genes (~86% of the human protein-coding genes).
  • A new Cell Atlas is released with spatial location of more than 12,000 genes to 30 different organelles and cellular structures. The data is described on knowledge pages for the Subcellular proteomes (organelle proteome, cell cycle dependent proteome, cell line transcriptome, and multilocalizing proteome), and the Organelle proteomes.
  • The Tissue Atlas is complemented with CAGE data from FANTOM5 and extended with antibody staining on the following tissues: extended brain samples, mouse brain, eye, lactating breast, hair, extended skin samples, and full section adrenal gland.
  • The antibody validation information has been complemented with formal validations based on the pillars presented in A proposal for validation of antibodies by Uhlen et al (2016).
    Tissue atlas
  • CAB000135 (keratin 15, type I) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA000414 (palmitoyl-protein thioesterase 2) has been omitted due to inconsistency with RNA-seq data.
  • CAB000462 (galanin/GMAP prepropeptide) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
  • HPA000549 (arylsulfatase F) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA000555 (discs and large homolog 5 (Drosophila)) has been omitted due to inconsistency with RNA-seq data.
  • HPA000564 (interleukin 1 receptor accessory protein-like 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA000567 (makorin ring finger protein 1) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA000644 (CLOCK-interacting pacemaker) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA000645 (cyclin K) has been omitted due to inconsistency with RNA-seq data.
  • HPA000688 (regulator of G-protein signaling 7) has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA000734 (guanylate cyclase 2F, retinal) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA000760 (FERM and RhoGEF (ARHGEF) and pleckstrin domain protein 1 (chondrocyte-derived)) has been omitted due to inconsistency with RNA-seq data.
  • HPA000815 (l(3)mbt-like 2 (Drosophila)) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA000837 (transcobalamin II) has been omitted due to inconsistency with RNA-seq data.
  • HPA000850 (NOP9 nucleolar protein) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA000853 (coiled-coil domain containing 116) has been omitted due to inconsistency with RNA-seq data.
  • HPA000880 (autophagy related 2B) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
  • HPA000884 (membrane protein, palmitoylated 1 and 55kDa) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA000924 (interleukin-1 receptor-associated kinase 4) has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA000932 (low density lipoprotein receptor-related protein 10) has been omitted due to inconsistency with RNA-seq data.
  • HPA000988 (kelch-like family member 28) has been omitted due to inconsistency with RNA-seq data.
  • HPA001008 (interleukin 13 receptor, alpha 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA001039 (SLIT and NTRK-like family, member 4) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
  • HPA001045 (malignant T cell amplified sequence 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA001149 (chromosome 22 open reading frame 23) has been omitted due to inconsistency with RNA-seq data.
  • HPA001206 (family with sequence similarity 71 and member D) has been omitted due to inconsistency with RNA-seq data.
  • HPA001256 (sushi-repeat containing protein and X-linked) has been omitted due to inconsistency with RNA-seq data.
  • HPA001271 (apoptosis-inducing factor, mitochondrion-associated, 3) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA001299 (methyltransferase like 3) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA001394 (syntrophin, beta 2 (dystrophin-associated protein A1, 59kDa, basic component 2)) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA001407 (RAB guanine nucleotide exchange factor (GEF) 1) has been omitted due to inconsistency with other antibody targeting the same gene.
  • HPA001438 (hes-related family bHLH transcription factor with YRPW motif-like) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA001502 (connector enhancer of kinase suppressor of Ras 2) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA001546 (ankyrin repeat and SOCS box containing 2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA001587 (interleukin 13 receptor, alpha 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA001669 (solute carrier family 8 (sodium/calcium exchanger) and member 3) has been omitted due to inconsistency with RNA-seq data.
  • HPA001741 (potassium channel regulator) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA001821 (regulator of G-protein signaling 5) has been omitted due to inconsistency with RNA-seq data.
  • HPA001823 (sphingomyelin phosphodiesterase 1 and acid lysosomal) has been omitted due to inconsistency with gene/protein characterization data.
  • CAB001998 (protein kinase C, eta) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA002020 (intercellular adhesion molecule 2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA002103 (transcription factor 12) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA002314 (leucine rich repeat containing 7) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA002354 (HMG box domain containing 3) has been omitted due to inconsistency with RNA-seq data.
  • HPA002385 (CXADR-like membrane protein) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA002386 (deafness, autosomal recessive 31) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA002652 (secreted frizzled-related protein 2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA002704 (mitogen-activated protein kinase 15) has been omitted due to inconsistency with RNA-seq data.
  • CAB002768 (matrix metallopeptidase 23B) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA002871 (zinc finger protein 410) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA002918 (integral membrane protein 2A) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA002942 (transmembrane protein 179) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA002959 (phosphoinositide-3-kinase interacting protein 1) has been omitted due to inconsistency with RNA-seq data.
  • HPA002966 (mitochondrial transcription termination factor 3) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA003098 (EF-hand calcium binding domain 6) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA003099 (tetratricopeptide repeat domain 28) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA003173 (ZNF680, ZNF92) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA003175 (BTB and CNC homology 1, basic leucine zipper transcription factor 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA003266 (synuclein, alpha interacting protein) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA003296 (splA/ryanodine receptor domain and SOCS box containing 1) has been omitted due to inconsistency with RNA-seq data.
  • HPA003346 (phospholipase C, eta 2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA003391 (ribonuclease, RNase A family, 9 (non-active)) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA003421 (microtubule associated monooxygenase, calponin and LIM domain containing 3) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
  • HPA003511 (ribosomal protein L15) has been omitted due to inconsistency with RNA-seq data.
  • HPA003581 (tripartite motif containing 42) has been omitted due to inconsistency with RNA-seq data.
  • HPA003614 (HAUS augmin-like complex, subunit 7) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA003626 (bombesin-like receptor 3) has been omitted due to inconsistency with RNA-seq data.
  • HPA003636 (oxysterol binding protein-like 10) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA003865 (MALT1 paracaspase) has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA003905 (G protein-coupled receptor 173) has been omitted due to inconsistency with RNA-seq data.
  • HPA003962 (ubiquitin-conjugating enzyme E2N) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA003973 (IQ motif and Sec7 domain 2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA004000 (ADAM metallopeptidase domain 9) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA004006 (mitogen-activated protein kinase kinase kinase 15) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA004063 (aryl hydrocarbon receptor interacting protein) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
  • HPA004131 (CD300 molecule-like family member g) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA004178 (ankyrin repeat and SOCS box containing 10) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • CAB004444 (interferon gamma receptor 1) has been omitted due to inconsistency with other antibody targeting the same gene.
  • CAB004533 (protein kinase C, zeta) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • CAB004569 (KIT ligand) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • CAB004675 (triosephosphate isomerase 1) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA004731 (RP11-330H6.5, TLR9) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA004739 (family with sequence similarity 71 and member D) has been omitted due to inconsistency with RNA-seq data.
  • HPA004742 (catenin, beta like 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
  • CAB004755 (nescient helix loop helix 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA004775 (histone deacetylase 7) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA004933 (homeobox A1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • CAB004987 (keratin 83, type II) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
  • CAB005057 (mechanistic target of rapamycin (serine/threonine kinase)) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • CAB005066 (arachidonate 5-lipoxygenase) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
  • HPA005478 (enhancer of zeste 1 polycomb repressive complex 2 subunit) has been omitted due to inconsistency with RNA-seq data and lack of appropriate tissue.
  • HPA005499 (structural maintenance of chromosomes 1A) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
  • HPA005625 (leucine rich repeat containing 7) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA005782 (bromodomain adjacent to zinc finger domain and 2A) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA005894 (protease, serine and 57) has been omitted due to inconsistency with RNA-seq data.
  • HPA005912 (calmodulin-like 6) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA005960 (dopamine beta-hydroxylase (dopamine beta-monooxygenase)) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
  • HPA005967 (HMG box domain containing 3) has been omitted due to inconsistency with RNA-seq data.
  • HPA005972 (B-cell translocation gene 1, anti-proliferative) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA006076 (death associated protein 3) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
  • HPA006105 (GATA zinc finger domain containing 1) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA006123 (BUB1 mitotic checkpoint serine/threonine kinase) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA006201 (lysine (K)-specific demethylase 5A) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA006204 (Ts translation elongation factor, mitochondrial) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA006221 (latent transforming growth factor beta binding protein 1) has been omitted due to inconsistency with RNA-seq data.
  • HPA006237 (ubiquitin specific peptidase 15) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA006298 (nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor-like 1) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA006316 (glypican 3) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA006376 (transforming growth factor beta 1 induced transcript 1) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA006432 (kinesin family member 2C) has been omitted due to inconsistency with RNA-seq data.
  • HPA006433 (myosin VIIA and Rab interacting protein) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA006487 (lysine (K)-specific methyltransferase 2B) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA006687 (zinc fingers and homeoboxes 3) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA006806 (paired box 4) has been omitted due to inconsistency with gene/protein characterization data.
  • CAB006813 (purinergic receptor P2X, ligand gated ion channel, 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • CAB006838 (potassium channel, voltage gated eag related subfamily H, member 2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA006879 (slit guidance ligand 1) has been omitted due to inconsistency with RNA-seq data.
  • CAB006907 (Kv channel interacting protein 3, calsenilin) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA007012 (growth factor independent 1B transcription repressor) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA007037 (transient receptor potential cation channel, subfamily M and member 6) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA007090 (cell migration inducing protein and hyaluronan binding) has been omitted due to inconsistency with RNA-seq data.
  • HPA007158 (adhesion G protein-coupled receptor F4) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA007182 (paired box 4) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA007247 (zinc finger protein 165) has been omitted due to inconsistency with RNA-seq data.
  • HPA007314 (gastrin-releasing peptide) has been omitted due to inconsistency with gene/protein characterization data and lack of appropriate tissue.
  • HPA007322 (CLDN3, CLDN4, CLDN6 and CLDN9) has been omitted due to inconsistency with RNA-seq data.
  • HPA007410 (transmembrane protein 59) has been omitted due to inconsistency with RNA-seq data.
  • HPA007446 (cyclin-dependent kinase-like 3) has been omitted due to inconsistency with RNA-seq data.
  • HPA007461 (mitogen-activated protein kinase 4) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA007538 (malectin) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA007663 (solute carrier family 6 (neutral amino acid transporter), member 17) has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA007703 (seizure related 6 homolog (mouse)) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA007720 (WD repeat domain 20) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA007959 (SAYSVFN motif domain containing 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA007988 (DnaJ (Hsp40) homolog, subfamily C and member 15) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA008192 (T-box 20) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA008252 (interleukin 24) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA008255 (solute carrier family 27 (fatty acid transporter) and member 1) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA008266 (6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA008322 (acyl-CoA synthetase family member 3) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA008323 (acyl-CoA synthetase family member 3) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA008344 (Sad1 and UNC84 domain containing 3) has been omitted due to inconsistency with RNA-seq data.
  • CAB008385 (family with sequence similarity 234, member B) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA008419 (BUB1 mitotic checkpoint serine/threonine kinase B) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA008607 (dedicator of cytokinesis 7) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA008614 (MCF.2 cell line derived transforming sequence-like) has been omitted due to inconsistency with RNA-seq data.
  • CAB008675 (synaptotagmin VI) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA008709 (ring finger protein 13) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA008966 (melanocortin 2 receptor accessory protein 2) has been omitted due to inconsistency with gene/protein characterization data.
  • CAB009013 (toll-like receptor 5) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA009042 (ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2 and6-sialyltransferase 4) has been omitted due to inconsistency with RNA-seq data.
  • CAB009156 (translocase of outer mitochondrial membrane 40 homolog (yeast)) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
  • CAB009190 (NLR family, pyrin domain containing 3) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA009431 (leucine rich repeat neuronal 4) has been omitted due to inconsistency with RNA-seq data.
  • CAB009497 (phosphodiesterase 3B, cGMP-inhibited) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA009641 (mannan-binding lectin serine peptidase 1 (C4/C2 activating component of Ra-reactive factor)) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
  • HPA009673 (keratin 9 and type I) has been omitted due to inconsistency with gene/protein characterization data.
  • CAB009813 (heparanase) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA010016 (G0/G1 switch 2) has been omitted due to inconsistency with RNA-seq data.
  • HPA010132 (KIAA1549-like) has been omitted due to inconsistency with RNA-seq data.
  • HPA010135 (tumor necrosis factor receptor superfamily and member 19) has been omitted due to inconsistency with RNA-seq data.
  • CAB010166 (TTK protein kinase) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • CAB010251 (colony stimulating factor 2 receptor, beta, low-affinity (granulocyte-macrophage)) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • CAB010409 (cholinergic receptor and muscarinic 3) has been omitted due to inconsistency with gene/protein characterization data.
  • CAB010423 (MCF.2 cell line derived transforming sequence) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA010611 (acyl-CoA dehydrogenase, long chain) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA010628 (CD244 molecule, natural killer cell receptor 2B4) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA010647 (coiled-coil domain containing 136) has been omitted due to inconsistency with RNA-seq data.
  • HPA010663 (gap junction protein, beta 1 and 32kDa) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA010803 (family with sequence similarity 234, member B) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA010843 (progestin and adipoQ receptor family member VI) has been omitted due to inconsistency with RNA-seq data.
  • HPA010872 (RAB25, member RAS oncogene family) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • CAB010902 (cholinergic receptor, nicotinic and alpha 1 (muscle)) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA010953 (WAP, follistatin/kazal, immunoglobulin and kunitz and netrin domain containing 2) has been omitted due to inconsistency with RNA-seq data.
  • HPA010967 (major histocompatibility complex, class II and DQ alpha 2) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA011134 (T-cell lymphoma invasion and metastasis 2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
  • HPA011141 (unc-5 netrin receptor B) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA011169 (KIAA0319-like) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA011219 (retinoic acid receptor responder (tazarotene induced) 3) has been omitted due to inconsistency with RNA-seq data.
  • HPA011223 (wingless-type MMTV integration site family and member 9A) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA011310 (roundabout guidance receptor 3) has been omitted due to inconsistency with gene/protein characterization data and lack of appropriate tissue.
  • CAB011488 (forkhead box P2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
  • HPA011561 (WAP, follistatin/kazal, immunoglobulin and kunitz and netrin domain containing 2) has been omitted due to inconsistency with RNA-seq data.
  • HPA011738 (TEK tyrosine kinase, endothelial) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA011747 (AC004754.3, FAM234A) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA011913 (kalirin, RhoGEF kinase) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA011977 (natriuretic peptide receptor 2) has been omitted due to inconsistency with RNA-seq data.
  • HPA011981 (ankyrin repeat domain 30A) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA012000 (polymerase (DNA directed) iota) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA012043 (G protein-coupled receptor 22) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA012084 (tachykinin receptor 2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA012086 (unc-5 netrin receptor C) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA012115 (phytanoyl-CoA dioxygenase domain containing 1) has been omitted due to inconsistency with RNA-seq data.
  • HPA012150 (chromosome 19 open reading frame 38) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA012157 (adherens junctions associated protein 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • CAB012248 (endothelial PAS domain protein 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA012383 (solute carrier family 29 (equilibrative nucleoside transporter), member 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
  • HPA012385 (Sjogren syndrome antigen B (autoantigen La)) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
  • CAB012452 (potassium channel, inwardly rectifying subfamily J, member 6) has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA012613 (son of sevenless homolog 1 (Drosophila)) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
  • HPA012718 (coiled-coil domain containing 141) has been omitted due to inconsistency with RNA-seq data.
  • HPA012801 (carcinoembryonic antigen-related cell adhesion molecule 4) has been omitted due to inconsistency with RNA-seq data.
  • HPA012845 (matrix metallopeptidase 19) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA012890 (spexin hormone) has been omitted due to inconsistency with RNA-seq data.
  • HPA012939 (sodium channel, non voltage gated 1 alpha subunit) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • CAB013009 (SMAD specific E3 ubiquitin protein ligase 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
  • CAB013284 (CDC28 protein kinase regulatory subunit 1B) has been omitted due to inconsistency with RNA-seq data.
  • HPA013332 (CMT1A duplicated region transcript 1) has been omitted due to inconsistency with RNA-seq data.
  • HPA013357 (insulin-like growth factor binding protein 3) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA013572 (zinc finger and CCHC domain containing 14) has been omitted due to inconsistency with RNA-seq data.
  • HPA013573 (adhesion G protein-coupled receptor L2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA013609 (endo/exonuclease (5'-3') and endonuclease G-like) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA013661 (protein phosphatase 1, catalytic subunit and gamma isozyme) has been omitted due to inconsistency with RNA-seq data.
  • HPA013699 (chromosome 17 open reading frame 78) has been omitted due to inconsistency with RNA-seq data.
  • HPA013790 (neuropeptide Y receptor Y5) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA013870 (CKLF-like MARVEL transmembrane domain containing 3) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA013892 (podocan) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA014025 (purinergic receptor P2X, ligand gated ion channel, 2) has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and lack of appropriate tissue.
  • HPA014046 (WAP four-disulfide core domain 10B) has been omitted due to inconsistency with RNA-seq data.
  • HPA014087 (endothelin receptor type A) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA014092 (alkaline ceramidase 2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA014159 (ADAM metallopeptidase domain 29) has been omitted due to inconsistency with RNA-seq data.
  • HPA014350 (transmembrane protein 26) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
  • HPA014374 (CDK5 regulatory subunit associated protein 1-like 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA014421 (ring finger protein 133) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA014468 (adenomatosis polyposis coli down-regulated 1) has been omitted due to inconsistency with RNA-seq data.
  • HPA014526 (V-set and immunoglobulin domain containing 10) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA014541 (leucine rich repeat containing 19) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA014574 (PX domain containing 1) has been omitted due to inconsistency with RNA-seq data.
  • HPA014687 (family with sequence similarity 187 and member B) has been omitted due to inconsistency with RNA-seq data.
  • HPA014700 (ceramide kinase) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA014709 (glutamate receptor, ionotropic and kainate 3) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA014713 (solute carrier family 37, member 3) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA014725 (sidekick cell adhesion molecule 2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA014745 (leucine rich repeat containing 8 family and member D) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA014775 (fatty acid hydroxylase domain containing 2) has been omitted due to inconsistency with RNA-seq data.
  • HPA014785 (transient receptor potential cation channel, subfamily M, member 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
  • HPA014801 (UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase and polypeptide 1) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA014846 (gap junction protein, beta 6, 30kDa) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA014865 (zinc finger and BTB domain containing 38) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA014904 (anthrax toxin receptor-like) has been omitted due to inconsistency with RNA-seq data.
  • HPA014905 (phosphatidylinositol glycan anchor biosynthesis and class O) has been omitted due to inconsistency with RNA-seq data.
  • HPA015050 (ARP2 actin-related protein 2 homolog (yeast)) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA015052 (transmembrane protein 225) has been omitted due to inconsistency with RNA-seq data.
  • HPA015086 (thioredoxin domain containing 12 (endoplasmic reticulum)) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA015102 (GIMAP1-GIMAP5 and GIMAP5) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA015240 (nicotinamide nucleotide adenylyltransferase 2) has been omitted due to inconsistency with RNA-seq data.
  • HPA015272 (tribbles pseudokinase 3) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA015280 (calcium channel flower domain containing 1) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA015297 (IKAROS family zinc finger 5 (Pegasus)) has been omitted due to inconsistency with RNA-seq data.
  • HPA015305 (trinucleotide repeat containing 6A) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA015307 (hydroxysteroid (17-beta) dehydrogenase 3) has been omitted due to inconsistency with RNA-seq data.
  • HPA015567 (pipecolic acid oxidase) has been omitted due to inconsistency with RNA-seq data.
  • HPA015571 (transmembrane (C-terminal) protease and serine 12) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA015573 (toll-like receptor 5) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA015581 (protocadherin 9) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA015613 (cadherin 4, type 1 and R-cadherin (retinal)) has been omitted due to inconsistency with RNA-seq data.
  • HPA015692 (zinc finger protein 451) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA015733 (ring finger protein 152) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA015736 (coproporphyrinogen oxidase) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA015796 (transmembrane protein 125) has been omitted due to inconsistency with RNA-seq data.
  • HPA015816 (zinc finger and MYND-type containing 11) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA015890 (t-SNARE domain containing 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • CAB015941 (tumor necrosis factor receptor superfamily, member 12A) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
  • CAB015944 (stomatin (EPB72)-like 2) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA016040 (vaccinia related kinase 3) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA016418 (MGAT4 family, member C) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA016435 (tetraspanin 4) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA016467 (gamma-aminobutyric acid (GABA) A receptor and rho 2) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA016506 (solute carrier family 39 (zinc transporter), member 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA016507 (progestin and adipoQ receptor family member V) has been omitted due to inconsistency with RNA-seq data.
  • HPA016565 (fem-1 homolog a (C. elegans)) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA016567 (potassium channel, two pore domain subfamily K and member 16) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA016585 (transmembrane protein 179B) has been omitted due to inconsistency with RNA-seq data.
  • HPA016593 (ybeY metallopeptidase (putative)) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA016596 (DDB1 and CUL4 associated factor 12) has been omitted due to inconsistency with RNA-seq data.
  • HPA016811 (leucine rich repeat containing 8 family and member A) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA016826 (vesicular, overexpressed in cancer, prosurvival protein 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA016834 (TTK protein kinase) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA016856 (solute carrier family 18 (vesicular monoamine transporter) and member 2) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA016857 (coiled-coil domain containing 107) has been omitted due to inconsistency with RNA-seq data.
  • HPA016871 (transmembrane protein 140) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA016993 (repulsive guidance molecule family member b) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA017046 (Rho/Rac guanine nucleotide exchange factor (GEF) 2) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA017064 (testis-specific kinase 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • CAB017105 (IKAROS family zinc finger 3 (Aiolos)) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • CAB017123 (fat mass and obesity associated) has been omitted due to inconsistency with gene/protein characterization data.
  • CAB017133 (kallikrein-related peptidase 10) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA017195 (kallikrein-related peptidase 10) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA017288 (SH3 and cysteine rich domain 2) has been omitted due to inconsistency with RNA-seq data.
  • HPA017313 (fms-related tyrosine kinase 3 ligand) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA017337 (arginine vasopressin receptor 1B) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA017344 (nuclear fragile X mental retardation protein interacting protein 2) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA017374 (NLR family, pyrin domain containing 3) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA017434 (methyltransferase like 7A) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • CAB017459 (exocyst complex component 3) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA017571 (peptidase M20 domain containing 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA017587 (NDRG family member 4) has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • CAB017619 (Fc receptor-like 2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA017636 (SLIT and NTRK-like family, member 3) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA017681 (mitochondrial E3 ubiquitin protein ligase 1) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA017740 (embigin) has been omitted due to inconsistency with RNA-seq data.
  • HPA017748 (CD79a molecule, immunoglobulin-associated alpha) has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • CAB017771 (ankyrin repeat domain 30A) has been omitted due to inconsistency with gene/protein characterization data.
  • CAB017792 (T-cell leukemia homeobox 3) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
  • HPA017886 (WD repeat domain 45B) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA017903 (myeloid leukemia factor 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA017914 (protein phosphatase 1 and regulatory subunit 9A) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA017943 (nescient helix loop helix 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA017945 (keratin associated protein 23-1) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA017948 (family with sequence similarity 26 and member F) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA017978 (hippocampus abundant transcript-like 1) has been omitted due to inconsistency with RNA-seq data.
  • HPA017979 (solute carrier family 30 (zinc transporter) and member 2) has been omitted due to inconsistency with RNA-seq data.
  • HPA018028 (sideroflexin 4) has been omitted due to inconsistency with RNA-seq data.
  • HPA018032 (synaptophysin-like 2) has been omitted due to inconsistency with RNA-seq data.
  • HPA018147 (lipase maturation factor 1) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA018209 (casein kinase 1 and gamma 1) has been omitted due to inconsistency with RNA-seq data.
  • HPA018242 (ribonucleic acid export 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA018310 (myelin regulatory factor) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • CAB018335 (RAP1A and member of RAS oncogene family) has been omitted due to inconsistency with gene/protein characterization data.
  • CAB018369 (breast cancer 1, early onset) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
  • HPA018404 (nucleoporin 214kDa) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA018423 (solute carrier family 39 (zinc transporter) and member 5) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA018487 (polycomb group ring finger 3) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA018536 (nudE neurodevelopment protein 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
  • CAB018599 (protein phosphatase 2, regulatory subunit A, alpha) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • CAB018752 (protein phosphatase 1 and regulatory subunit 9A) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA018946 (EF-hand calcium binding domain 6) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA018979 (spermatogenesis and centriole associated 1-like) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA019059 (solute carrier family 23 and member 3) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA019162 (catenin (cadherin-associated protein), alpha 2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA019178 (family with sequence similarity 26 and member D) has been omitted due to inconsistency with RNA-seq data.
  • HPA019239 (oxidative stress induced growth inhibitor 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA019252 (defensin and beta 129) has been omitted due to inconsistency with RNA-seq data.
  • HPA019253 (eukaryotic translation initiation factor 4E family member 2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA019362 (NADPH oxidase, EF-hand calcium binding domain 5) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • CAB019438 (ubiquitin-conjugating enzyme E2R 2) has been omitted due to inconsistency with RNA-seq data.
  • HPA019487 (kallikrein-related peptidase 13) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA019534 (keratin associated protein 15-1) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA019611 (calicin) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA019614 (aryl-hydrocarbon receptor repressor) has been omitted due to inconsistency with RNA-seq data.
  • HPA019637 (breast cancer metastasis suppressor 1) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA019680 (transmembrane protein 57) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA019702 (interferon-related developmental regulator 2) has been omitted due to inconsistency with RNA-seq data.
  • HPA019767 (HEAT repeat containing 4) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA019790 (Leber congenital amaurosis 5-like) has been omitted due to inconsistency with RNA-seq data.
  • HPA019796 (ring finger protein 32) has been omitted due to inconsistency with RNA-seq data.
  • HPA019820 (NDRG family member 3) has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA019823 (family with sequence similarity 20, member C) has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and lack of appropriate tissue.
  • HPA019840 (secreted frizzled-related protein 5) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA019850 (amyloid beta (A4) precursor protein-binding, family A, member 1) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA019860 (ATPase family and AAA domain containing 2) has been omitted due to inconsistency with other antibody targeting the same gene.
  • HPA019946 (BCL2/adenovirus E1B 19kD interacting protein like) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA019965 (DGCR8 microprocessor complex subunit) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA020058 (gamma-secretase activating protein) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA020090 (DEAD (Asp-Glu-Ala-Asp) box helicase 25) has been omitted due to inconsistency with RNA-seq data.
  • HPA020122 (ubinuclein 2) has been omitted due to inconsistency with RNA-seq data.
  • HPA020190 (selenocysteine lyase) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
  • HPA020225 (HMG-box transcription factor 1) has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA020322 (carboxypeptidase A5) has been omitted due to inconsistency with RNA-seq data.
  • HPA020380 (CDKN1A interacting zinc finger protein 1) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA020384 (CDKN1A interacting zinc finger protein 1) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA020435 (potassium channel subfamily M regulatory beta subunit 1) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA020446 (aspartate-rich 1) has been omitted due to inconsistency with RNA-seq data.
  • HPA020472 (ubiquitin-conjugating enzyme E2U (putative)) has been omitted due to inconsistency with RNA-seq data.
  • HPA020481 (DENN/MADD domain containing 1A) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA020521 (calmodulin regulated spectrin-associated protein 1) has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA020529 (calmodulin regulated spectrin-associated protein 1) has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA020621 (IQ motif and ubiquitin domain containing) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA020631 (prostaglandin E synthase 2) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA020636 (family with sequence similarity 71, member F1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • CAB020783 (LY6/PLAUR domain containing 1) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA020891 (DEAD (Asp-Glu-Ala-Asp) box polypeptide 31) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA020930 (MORN repeat containing 5) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA021029 (surfeit 1) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA021068 (contactin 4) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA021127 (ArfGAP with coiled-coil and ankyrin repeat and PH domains 1) has been omitted due to inconsistency with RNA-seq data.
  • HPA021135 (adhesion G protein-coupled receptor G7) has been omitted due to inconsistency with RNA-seq data.
  • HPA021158 (receptor-interacting serine-threonine kinase 4) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA021194 (tripartite motif containing 41) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA021275 (leucine-rich repeats and guanylate kinase domain containing) has been omitted due to inconsistency with RNA-seq data.
  • HPA021310 (chromosome 9 open reading frame 43) has been omitted due to inconsistency with RNA-seq data.
  • HPA021315 (dynein, cytoplasmic 1, intermediate chain 1) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA021371 (family with sequence similarity 131 and member B) has been omitted due to inconsistency with RNA-seq data.
  • HPA021409 (family with sequence similarity 71 and member F1) has been omitted due to inconsistency with RNA-seq data.
  • HPA021426 (keratin 36 and type I) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA021431 (RAS and EF-hand domain containing) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA021459 (family with sequence similarity 104 and member A) has been omitted due to inconsistency with RNA-seq data.
  • HPA021480 (calpain 8) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA021483 (aryl-hydrocarbon receptor repressor) has been omitted due to inconsistency with RNA-seq data.
  • HPA021530 (diacylglycerol O-acyltransferase 2-like 6) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA021539 (Xg blood group) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA021556 (coronin 6) has been omitted due to inconsistency with RNA-seq data.
  • HPA021586 (family with sequence similarity 205 and member A) has been omitted due to inconsistency with RNA-seq data.
  • HPA021660 (ubiquitin-conjugating enzyme E2U (putative)) has been omitted due to inconsistency with RNA-seq data.
  • HPA021661 (RecQ mediated genome instability 1) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA021676 (guanine nucleotide binding protein (G protein), beta polypeptide 2-like 1) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA021795 (PANK1, PANK2, PANK3) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA021802 (chromosome 9 open reading frame 43) has been omitted due to inconsistency with RNA-seq data.
  • HPA021882 (leucine rich repeat containing 46) has been omitted due to inconsistency with RNA-seq data.
  • HPA021913 (tensin 4) has been omitted due to inconsistency with RNA-seq data.
  • HPA021946 (transmembrane and immunoglobulin domain containing 1) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA022029 (chromosome 9 open reading frame 131) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA022145 (aspartoacylase) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
  • CAB022164 (frataxin) has been omitted due to inconsistency with gene/protein characterization data.
  • CAB022187 (TIMP metallopeptidase inhibitor 3) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA022246 (kinesin family member 27) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • CAB022407 (inhibitor of DNA binding 4, dominant negative helix-loop-helix protein) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA022481 (tripartite motif containing 42) has been omitted due to inconsistency with RNA-seq data.
  • HPA022520 (prolyl 3-hydroxylase family member 4 (non-enzymatic)) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
  • HPA022533 (caspase recruitment domain family, member 14) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • CAB022597 (synuclein, alpha interacting protein) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • CAB022658 (syntaxin 2) has been omitted due to inconsistency with gene/protein characterization data.
  • CAB022674 (potassium channel, voltage gated eag related subfamily H, member 6) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA022786 (guanylyl cyclase domain containing 1) has been omitted due to inconsistency with RNA-seq data.
  • HPA022828 (transmembrane protein 99) has been omitted due to inconsistency with RNA-seq data.
  • HPA022836 (F-box and WD repeat domain containing 10) has been omitted due to inconsistency with RNA-seq data.
  • HPA022850 (nucleoredoxin) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA022895 (Rap guanine nucleotide exchange factor (GEF)-like 1) has been omitted due to inconsistency with RNA-seq data.
  • HPA022990 (chromosome 9 open reading frame 114) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA023041 (notum pectinacetylesterase homolog (Drosophila)) has been omitted due to inconsistency with RNA-seq data.
  • HPA023118 (regulator of G-protein signaling 22) has been omitted due to inconsistency with RNA-seq data.
  • HPA023150 (DDHD domain containing 2) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA023260 (tetratricopeptide repeat domain 16) has been omitted due to inconsistency with RNA-seq data.
  • HPA023317 (EF-hand calcium binding domain 3) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA023324 (cyclin N-terminal domain containing 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA023339 (ring finger protein 113B) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA023387 (chromosome 17 open reading frame 104) has been omitted due to inconsistency with RNA-seq data.
  • HPA023388 (caspase recruitment domain family, member 14) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA023435 (tumor protein D52-like 3) has been omitted due to inconsistency with RNA-seq data.
  • HPA023464 (BCL2/adenovirus E1B 19kD interacting protein like) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA023481 (ferric-chelate reductase 1-like) has been omitted due to inconsistency with RNA-seq data.
  • HPA023545 (protein phosphatase, EF-hand calcium binding domain 2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA023560 (tripartite motif containing 8) has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA023679 (nardilysin (N-arginine dibasic convertase)) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA023779 (epoxide hydrolase 2, cytoplasmic) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA023817 (chromosome 7 open reading frame 62) has been omitted due to inconsistency with RNA-seq data.
  • HPA023898 (retinoic acid induced 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA023994 (gamma-secretase activating protein) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA024016 (family with sequence similarity 205 and member A) has been omitted due to inconsistency with RNA-seq data.
  • HPA024109 (leucine rich repeat transmembrane neuronal 3) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA024132 (UFM1-specific peptidase 1 (non-functional)) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA024163 (chromosome 7 open reading frame 62) has been omitted due to inconsistency with RNA-seq data.
  • HPA024170 (S100P binding protein) has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA024220 (S100P binding protein) has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA024349 (coiled-coil domain containing 42) has been omitted due to inconsistency with RNA-seq data.
  • HPA024354 (dynein, axonemal, heavy chain 17) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA024394 (ras homolog family member D) has been omitted due to inconsistency with RNA-seq data.
  • HPA024405 (MYCBP associated protein) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
  • HPA024429 (matrix metallopeptidase 21) has been omitted due to inconsistency with RNA-seq data.
  • HPA024511 (collectin sub-family member 10 (C-type lectin)) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA024516 (Sp6 transcription factor) has been omitted due to inconsistency with RNA-seq data.
  • HPA024562 (transmembrane protein 52) has been omitted due to inconsistency with RNA-seq data.
  • HPA024584 (leucine-rich repeats and guanylate kinase domain containing) has been omitted due to inconsistency with RNA-seq data.
  • HPA024601 (LSM1 homolog and mRNA degradation associated) has been omitted due to inconsistency with RNA-seq data.
  • HPA024626 (Fanconi anemia core complex associated protein 100) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA024658 (KIAA1456) has been omitted due to inconsistency with RNA-seq data.
  • HPA024660 (KIAA1456) has been omitted due to inconsistency with RNA-seq data.
  • HPA024680 (lipocalin 12) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA024708 (RAD52 motif containing 1) has been omitted due to inconsistency with RNA-seq data.
  • HPA024728 (ubiquitin protein ligase E3 component n-recognin 5) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA024794 (RAD52 motif containing 1) has been omitted due to inconsistency with RNA-seq data.
  • HPA024797 (CDC42 effector protein (Rho GTPase binding) 4) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
  • CAB024870 (reticulon 4 receptor-like 2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA025225 (trafficking protein particle complex 9) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA025246 (trafficking protein particle complex 9) has been omitted due to inconsistency with RNA-seq data.
  • CAB025355 (ectonucleoside triphosphate diphosphohydrolase 6 (putative)) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • CAB025453 (kallikrein-related peptidase 13) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • CAB025499 (vascular endothelial growth factor B) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA025706 (smoothelin-like 2) has been omitted due to inconsistency with RNA-seq data.
  • HPA025829 (glutathione peroxidase 7) has been omitted due to inconsistency with RNA-seq data.
  • CAB025868 (mitogen-activated protein kinase 4) has been omitted due to inconsistency with RNA-seq data.
  • HPA026100 (DENN/MADD domain containing 3) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • CAB026176 (solute carrier family 2 (facilitated glucose/fructose transporter), member 5) has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • CAB026377 (MAM domain containing 4) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA026434 (kinesin family member 1B) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA026438 (MRT4 homolog and ribosome maturation factor) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA026482 (zinc finger and C2HC-type containing 1B) has been omitted due to inconsistency with RNA-seq data.
  • HPA026522 (minichromosome maintenance domain containing 2) has been omitted due to inconsistency with RNA-seq data.
  • HPA026559 (tubulin folding cofactor E) has been omitted due to inconsistency with RNA-seq data.
  • HPA026579 (trafficking protein particle complex 9) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA026587 (cell division cycle associated 3) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA026633 (ubiquitin-like with PHD and ring finger domains 2 and E3 ubiquitin protein ligase) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA026637 (coiled-coil domain containing 158) has been omitted due to inconsistency with RNA-seq data.
  • HPA026658 (potassium channel, two pore domain subfamily K, member 3) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA026680 (thyroid stimulating hormone receptor) has been omitted due to inconsistency with RNA-seq data.
  • HPA026697 (ubiquitin-like with PHD and ring finger domains 2 and E3 ubiquitin protein ligase) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA026714 (acyloxyacyl hydrolase (neutrophil)) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA026725 (ankyrin repeat domain 13C) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA026789 (ankyrin repeat and LEM domain containing 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
  • HPA026825 (neuropeptide FF receptor 2) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA026827 (mitochondrial E3 ubiquitin protein ligase 1) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA026845 (thrombospondin, type I, domain containing 4) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA026873 (FXYD domain containing ion transport regulator 1) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA026876 (multiple EGF-like-domains 10) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA026877 (serine-rich single-pass membrane protein 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA026899 (transmembrane protein 190) has been omitted due to inconsistency with RNA-seq data.
  • HPA026906 (family with sequence similarity 134 and member B) has been omitted due to inconsistency with RNA-seq data.
  • HPA027013 (tumor necrosis factor receptor superfamily and member 11b) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA027054 (keratin associated protein 8-1) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA027058 (zinc finger protein 823) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA027085 (tuftelin interacting protein 11) has been omitted due to inconsistency with RNA-seq data and lack of appropriate tissue.
  • HPA027089 (CPX chromosome region and candidate 1) has been omitted due to inconsistency with RNA-seq data.
  • HPA027113 (dehydrogenase/reductase (SDR family) member 7C) has been omitted due to inconsistency with RNA-seq data.
  • HPA027114 (coiled-coil domain containing 170) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA027121 (coiled-coil domain containing 170) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA027122 (opioid growth factor receptor-like 1) has been omitted due to inconsistency with RNA-seq data.
  • HPA027149 (opioid growth factor receptor-like 1) has been omitted due to inconsistency with RNA-seq data.
  • HPA027176 (actin-like 8) has been omitted due to inconsistency with RNA-seq data.
  • HPA027186 (lymphocyte antigen 6 complex and locus E) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA027206 (ERBB receptor feedback inhibitor 1) has been omitted due to inconsistency with RNA-seq data.
  • HPA027235 (collagen, type XVI and alpha 1) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA027237 (collagen, type XVI and alpha 1) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA027348 (stimulated by retinoic acid 13) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA027473 (guanylate cyclase 2F, retinal) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA027491 (lipocalin 8) has been omitted due to inconsistency with RNA-seq data.
  • HPA027496 (von Willebrand factor A domain containing 5B1) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA027516 (polymerase (RNA) III (DNA directed) polypeptide C (62kD)) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA027534 (fatty acid amide hydrolase 2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA027552 (serine palmitoyltransferase, long chain base subunit 2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA027572 (erythropoietin) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
  • HPA027612 (inhibitor of DNA binding 2 and dominant negative helix-loop-helix protein) has been omitted due to inconsistency with RNA-seq data.
  • HPA027646 (thioesterase superfamily member 5) has been omitted due to inconsistency with RNA-seq data.
  • HPA027751 (cyclin-dependent kinase-like 3) has been omitted due to inconsistency with RNA-seq data.
  • HPA027765 (stathmin-like 4) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA027871 (mindbomb E3 ubiquitin protein ligase 2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA027923 (transforming growth factor and beta 3) has been omitted due to inconsistency with RNA-seq data.
  • HPA027977 (protease, serine, 55) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA027985 (tubulin tyrosine ligase-like family member 2) has been omitted due to inconsistency with RNA-seq data.
  • HPA027992 (spermatogenesis associated 32) has been omitted due to inconsistency with RNA-seq data.
  • HPA028045 (antizyme inhibitor 2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA028079 (fibronectin type III domain containing 7) has been omitted due to inconsistency with RNA-seq data.
  • HPA028138 (vav 3 guanine nucleotide exchange factor) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA028146 (vacuolar protein sorting 13 homolog B (yeast)) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA028162 (adaptor-related protein complex 4, beta 1 subunit) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
  • HPA028181 (microtubule associated serine/threonine kinase 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA028197 (ring finger and WD repeat domain 2 and E3 ubiquitin protein ligase) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA028262 (trafficking protein particle complex 9) has been omitted due to inconsistency with RNA-seq data.
  • HPA028264 (ATR serine/threonine kinase) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA028265 (zinc finger and C2HC-type containing 1B) has been omitted due to inconsistency with RNA-seq data.
  • HPA028277 (EBNA1 binding protein 2) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA028280 (zinc finger, CCHC domain containing 17) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA028317 (ADAM-like, decysin 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA028326 (spermatogenesis associated 6) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA028345 (N-acetylneuraminate pyruvate lyase (dihydrodipicolinate synthase)) has been omitted due to inconsistency with RNA-seq data.
  • HPA028352 (protein phosphatase 1 and regulatory subunit 15B) has been omitted due to inconsistency with RNA-seq data.
  • HPA028356 (phosphoprotein enriched in astrocytes 15) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA028358 (family with sequence similarity 63, member A) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA028390 (tudor domain containing 10) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA028399 (adaptor-related protein complex 4, beta 1 subunit) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
  • HPA028403 (coiled-coil domain containing 28B) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
  • HPA028405 (von Willebrand factor A domain containing 5B1) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA028429 (exonuclease 5) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA028432 (phosducin) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
  • HPA028442 (leucine rich repeat containing 71) has been omitted due to inconsistency with RNA-seq data.
  • HPA028480 (chromosome 1 open reading frame 105) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA028509 (adenosine A3 receptor) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA028519 (solute carrier family 25 (mitochondrial carrier; phosphate carrier), member 24) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
  • HPA028527 (antizyme inhibitor 2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA028566 (adenosine A3 receptor) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA028568 (adenosine A3 receptor) has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA028662 (keratinocyte differentiation factor 1) has been omitted due to inconsistency with RNA-seq data.
  • HPA028681 (inhibitor of DNA binding 2 and dominant negative helix-loop-helix protein) has been omitted due to inconsistency with RNA-seq data.
  • HPA028714 (tetratricopeptide repeat domain 16) has been omitted due to inconsistency with RNA-seq data.
  • HPA028838 (zinc finger protein 451) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA028853 (ankyrin repeat and SOCS box containing 15) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA028857 (transmembrane protein 257) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA028868 (thyrotrophic embryonic factor) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA028870 (ankyrin repeat and SOCS box containing 5) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA028878 (like-glycosyltransferase) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA028886 (forkhead box F1) has been omitted due to inconsistency with RNA-seq data.
  • HPA028940 (heat shock factor binding protein 1) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA028947 (transmembrane protease and serine 13) has been omitted due to inconsistency with RNA-seq data.
  • HPA029014 (T-box 18) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA029077 (midline 2) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA029107 (collagen, type XXV, alpha 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA029116 (myelin protein zero-like 3) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA029202 (chromosome 14 open reading frame 105) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA029206 (telomerase-associated protein 1) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA029213 (interferon gamma receptor 1) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA029222 (ERGIC and golgi 2) has been omitted due to inconsistency with RNA-seq data.
  • HPA029266 (ribosomal protein S8) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA029307 (cytochrome c oxidase subunit IV isoform 2 (lung)) has been omitted due to inconsistency with RNA-seq data.
  • HPA029308 (Kruppel-like factor 9) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA029348 (transmembrane protein 156) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA029415 (immunoglobulin-like domain containing receptor 1) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA029487 (mitochondrial ribosomal protein S2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
  • HPA029502 (GRAM domain containing 4) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA029528 (spermidine synthase) has been omitted due to inconsistency with RNA-seq data.
  • HPA029544 (deiodinase, iodothyronine, type II) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA029558 (dehydrogenase/reductase (SDR family) member 7C) has been omitted due to inconsistency with RNA-seq data.
  • HPA029582 (phosphate regulating endopeptidase homolog and X-linked) has been omitted due to lack of appropriate tissue.
  • HPA029767 (RAB44 and member RAS oncogene family) has been omitted due to inconsistency with RNA-seq data.
  • HPA029788 (chromosome 6 open reading frame 118) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA029812 (THO complex 5) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA029814 (oncostatin M) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA029821 (regulatory associated protein of MTOR, complex 1) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA029842 (claudin domain containing 1) has been omitted due to inconsistency with RNA-seq data.
  • HPA029875 (cytochrome P450, family 4, subfamily F and polypeptide 22) has been omitted due to inconsistency with RNA-seq data.
  • HPA029897 (TSSK6 activating co-chaperone) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA029903 (neuropeptide Y receptor Y1) has been omitted due to inconsistency with RNA-seq data.
  • HPA029916 (leucine-rich repeats and WD repeat domain containing 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA029927 (castor zinc finger 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA029950 (lipase and member I) has been omitted due to inconsistency with RNA-seq data.
  • HPA029959 (nuclear fragile X mental retardation protein interacting protein 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
  • HPA029960 (nuclear fragile X mental retardation protein interacting protein 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
  • HPA029975 (forkhead box M1) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA029976 (forkhead box M1) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA029992 (family with sequence similarity 131 and member B) has been omitted due to inconsistency with RNA-seq data.
  • HPA030062 (paired box 8) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA030064 (LINE-1 type transposase domain containing 1) has been omitted due to inconsistency with RNA-seq data.
  • HPA030068 (keratin 40, type I) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA030089 (chromosome 1 open reading frame 168) has been omitted due to inconsistency with RNA-seq data.
  • HPA030110 (sterile alpha motif domain containing 11) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA030116 (tumor suppressor candidate 2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA030179 (solute carrier family 17, member 4) has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA030181 (kelch domain containing 8A) has been omitted due to inconsistency with RNA-seq data.
  • HPA030182 (SH2 domain containing 5) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA030183 (solute carrier family 25 (mitochondrial carrier; citrate transporter) and member 1) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA030185 (potassium channel and voltage gated subfamily A regulatory beta subunit 2) has been omitted due to inconsistency with RNA-seq data.
  • HPA030223 (3-hydroxymethyl-3-methylglutaryl-CoA lyase-like 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA030275 (inositol-trisphosphate 3-kinase B) has been omitted due to inconsistency with other antibody targeting the same gene and lack of positivity.
  • HPA030280 (leucine rich repeat containing 71) has been omitted due to inconsistency with RNA-seq data.
  • HPA030325 (peptidase M20 domain containing 2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
  • HPA030354 (protein disulfide isomerase family A, member 5) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA030356 (protein disulfide isomerase family A and member 5) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA030398 (purinergic receptor P2Y, G-protein coupled and 14) has been omitted due to inconsistency with RNA-seq data.
  • HPA030553 (zinc finger and MYND-type containing 11) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA030561 (sphingomyelin phosphodiesterase, acid-like 3B) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA030562 (cadherin 5, type 2 (vascular endothelium)) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA030620 (testis expressed 14) has been omitted due to inconsistency with RNA-seq data.
  • HPA030721 (leptin) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA030798 (leucine-rich repeats and IQ motif containing 3) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA030801 (leucine-rich repeats and IQ motif containing 3) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA030802 (regulator of G-protein signaling 4) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA030838 (zinc finger protein 546) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA030849 (calcium channel, voltage-dependent, alpha 2/delta subunit 3) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA030850 (calcium channel, voltage-dependent and alpha 2/delta subunit 3) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA030872 (APEX nuclease (apurinic/apyrimidinic endonuclease) 2) has been omitted due to inconsistency with RNA-seq data.
  • HPA030881 (C-type lectin domain family 4 and member F) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA031010 (polymerase (RNA) I polypeptide C, 30kDa) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA031074 (connective tissue growth factor) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA031087 (natriuretic peptide receptor 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA031114 (dual specificity phosphatase 15) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA031147 (keratin associated protein 22-1) has been omitted due to lack of appropriate tissue.
  • HPA031164 (distal-less homeobox 3) has been omitted due to inconsistency with RNA-seq data.
  • HPA031179 (chromosome 1 open reading frame 100) has been omitted due to inconsistency with RNA-seq data.
  • HPA031180 (chromosome 1 open reading frame 100) has been omitted due to inconsistency with RNA-seq data.
  • HPA031190 (squamous cell carcinoma antigen recognized by T cells 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
  • HPA031241 (SEC22 homolog C, vesicle trafficking protein) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA031245 (family with sequence similarity 65 and member B) has been omitted due to inconsistency with RNA-seq data.
  • HPA031325 (keratin associated protein 24-1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
  • HPA031332 (adenosine deaminase, RNA-specific, B2 (non-functional)) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA031409 (glial cells missing homolog 2 (Drosophila)) has been omitted due to inconsistency with RNA-seq data.
  • HPA031446 (glomulin and FKBP associated protein) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA031447 (glomulin and FKBP associated protein) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA031463 (homeobox B9) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA031539 (chondroitin sulfate N-acetylgalactosaminyltransferase 2) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA031548 (IQ motif containing with AAA domain 1) has been omitted due to inconsistency with RNA-seq data.
  • HPA031602 (leucine rich repeat containing 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
  • HPA031604 (leucine rich repeat containing 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
  • HPA031820 (erythroid differentiation regulatory factor 1) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA031877 (ELOVL fatty acid elongase 2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA031878 (ELOVL fatty acid elongase 2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • CAB031933 (anti-Mullerian hormone) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA031953 (synaptojanin 2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
  • HPA032000 (neurotrophin 3) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
  • HPA032079 (spermatogenesis associated 21) has been omitted due to inconsistency with RNA-seq data.
  • HPA032080 (spermatogenesis associated 21) has been omitted due to inconsistency with RNA-seq data.
  • HPA032094 (exocyst complex component 2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA032108 (chromosome 9 open reading frame 84) has been omitted due to inconsistency with RNA-seq data.
  • HPA032151 (diaphanous-related formin 3) has been omitted due to inconsistency with RNA-seq data.
  • HPA032152 (diaphanous-related formin 3) has been omitted due to inconsistency with RNA-seq data.
  • CAB032507 (regulator of G-protein signaling 3) has been omitted due to inconsistency with gene/protein characterization data.
  • CAB032627 (homeobox A5) has been omitted due to inconsistency with gene/protein characterization data.
  • CAB033084 (docking protein 6) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
  • CAB033438 (calpain 3) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • CAB033659 (LUC7-like) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • CAB033749 (glycerol-3-phosphate acyltransferase 3) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • CAB034049 (protein interacting with PRKCA 1) has been omitted due to inconsistency with gene/protein characterization data.
  • CAB034141 (keratin associated protein 24-1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
  • CAB034351 (hes family bHLH transcription factor 6) has been omitted due to inconsistency with RNA-seq data.
  • HPA034495 (RAB3 GTPase activating protein subunit 1 (catalytic)) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
  • HPA034530 (sulfotransferase family, cytosolic, 1C and member 4) has been omitted due to inconsistency with RNA-seq data.
  • HPA034539 (inositol polyphosphate-5-phosphatase J) has been omitted due to inconsistency with RNA-seq data.
  • HPA034551 (transmembrane protein 214) has been omitted due to inconsistency with RNA-seq data.
  • HPA034567 (chromosome 1 open reading frame 111) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA034573 (ATPase, class V and type 10B) has been omitted due to inconsistency with RNA-seq data.
  • HPA034581 (ADAM metallopeptidase with thrombospondin type 1 motif and 7) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA034597 (coiled-coil domain containing 115) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA034605 (ADAM metallopeptidase with thrombospondin type 1 motif, 14) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA034628 (guanine nucleotide binding protein (G protein), beta polypeptide 1-like) has been omitted due to inconsistency with gene/protein characterization data, antibody titration issue and inconsistency with other antibody targeting the same gene.
  • HPA034721 (lysozyme G-like 1) has been omitted due to inconsistency with RNA-seq data.
  • HPA034733 (DnaJ (Hsp40) homolog, subfamily B and member 8) has been omitted due to inconsistency with RNA-seq data.
  • HPA034742 (ADP-ribosylation factor-like 14) has been omitted due to inconsistency with RNA-seq data.
  • HPA034752 (cyclin L1) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA034778 (myotubularin related protein 6) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA034989 (ataxin 7) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA034999 (D site of albumin promoter (albumin D-box) binding protein) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA035019 (NMD3 ribosome export adaptor) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA035036 (HFM1, ATP-dependent DNA helicase homolog) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA035092 (translocation associated membrane protein 2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
  • HPA035108 (scavenger receptor class F, member 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA035182 (kelch-like family member 22) has been omitted due to inconsistency with RNA-seq data.
  • HPA035196 (methylmalonyl CoA epimerase) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA035284 (glycerol-3-phosphate dehydrogenase 1-like) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA035299 (NADPH oxidase 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA035300 (NADPH oxidase 1) has been omitted due to inconsistency with RNA-seq data.
  • HPA035309 (acyl-CoA thioesterase 11) has been omitted due to inconsistency with RNA-seq data.
  • HPA035337 (cannabinoid receptor interacting protein 1) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA035367 (ubiquitin associated and SH3 domain containing A) has been omitted due to inconsistency with RNA-seq data.
  • HPA035382 (von Willebrand factor A domain containing 1) has been omitted due to inconsistency with RNA-seq data.
  • HPA035383 (von Willebrand factor A domain containing 1) has been omitted due to inconsistency with RNA-seq data.
  • HPA035386 (inhibin, beta B) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA035557 (HFM1, ATP-dependent DNA helicase homolog) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA035615 (interleukin 36 and alpha) has been omitted due to inconsistency with RNA-seq data.
  • HPA035616 (transmembrane protein 9) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA035676 (villin-like) has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA035720 (calpain 14) has been omitted due to inconsistency with RNA-seq data.
  • HPA035721 (calpain 14) has been omitted due to inconsistency with RNA-seq data.
  • HPA035744 (cilia and flagella associated protein 47) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA035758 (elongation factor, RNA polymerase II and 2) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA035820 (CDK5 regulatory subunit associated protein 2) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA035824 (SLAIN motif family, member 2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA035825 (NFU1 iron-sulfur cluster scaffold) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA035965 (methyl-CpG binding domain protein 5) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA036030 (family with sequence similarity 102, member A) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA036042 (acid sensing (proton gated) ion channel family member 4) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA036068 (family with sequence similarity 229 and member B) has been omitted due to inconsistency with RNA-seq data.
  • HPA036080 (mutS homolog 3) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA036081 (mutS homolog 3) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA036139 (fibrous sheath interacting protein 2) has been omitted due to inconsistency with RNA-seq data.
  • HPA036184 (secretoglobin, family 2A, member 2) has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA036276 (anoctamin 2, calcium activated chloride channel) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
  • HPA036339 (tetratricopeptide repeat domain 26) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA036403 (oculocutaneous albinism II) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA036418 (zinc finger, SWIM-type containing 2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA036419 (zinc finger, SWIM-type containing 2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA036468 (dedicator of cytokinesis 2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
  • HPA036479 (G protein regulated inducer of neurite outgrowth 1) has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA036516 (solute carrier organic anion transporter family and member 4C1) has been omitted due to inconsistency with RNA-seq data.
  • HPA036549 (KIAA0141) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA036606 (tankyrase and TRF1-interacting ankyrin-related ADP-ribose polymerase 2) has been omitted due to inconsistency with RNA-seq data.
  • HPA036616 (hematopoietic SH2 domain containing) has been omitted due to inconsistency with RNA-seq data.
  • HPA036659 (glutamate receptor, metabotropic 7) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA036660 (endothelial cell-specific molecule 1) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA036680 (solute carrier family 4 (anion exchanger), member 1 and adaptor protein) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA036725 (prostaglandin reductase 1) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA036801 (protein phosphatase 1 and regulatory subunit 36) has been omitted due to inconsistency with RNA-seq data.
  • HPA036815 (DnaJ (Hsp40) homolog, subfamily C and member 27) has been omitted due to inconsistency with RNA-seq data.
  • HPA036820 (cadherin-related family member 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA036869 (protein phosphatase 2C-like domain containing 1) has been omitted due to inconsistency with RNA-seq data.
  • HPA036870 (protein phosphatase 2C-like domain containing 1) has been omitted due to inconsistency with RNA-seq data.
  • HPA036884 (chromosome 10 open reading frame 62) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA036886 (macrophage erythroblast attacher) has been omitted due to inconsistency with RNA-seq data.
  • HPA036931 (TBC1 domain family, member 14) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA036963 (synaptotagmin XIV) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA036977 (DAB2 interacting protein) has been omitted due to inconsistency with RNA-seq data.
  • CAB037029 (general transcription factor IIH and polypeptide 5) has been omitted due to inconsistency with gene/protein characterization data.
  • CAB037042 (general transcription factor IIH and polypeptide 5) has been omitted due to inconsistency with gene/protein characterization data.
  • CAB037055 (mindbomb E3 ubiquitin protein ligase 2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • CAB037223 (sprouty-related and EVH1 domain containing 2) has been omitted due to inconsistency with RNA-seq data.
  • CAB037319 (neuroglobin) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA037398 (major facilitator superfamily domain containing 10) has been omitted due to inconsistency with RNA-seq data.
  • HPA037486 (M-phase phosphoprotein 9) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA037528 (polymerase (RNA) I polypeptide B and 128kDa) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA037529 (polymerase (RNA) I polypeptide B and 128kDa) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA037544 (dedicator of cytokinesis 3) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA037556 (solute carrier family 22 and member 14) has been omitted due to inconsistency with RNA-seq data.
  • HPA037581 (cilia and flagella associated protein 70) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA037583 (pleckstrin homology domain containing and family S member 1) has been omitted due to inconsistency with RNA-seq data.
  • HPA037587 (solute carrier family 16 and member 12) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA037595 (leucine rich repeat containing 27) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA037596 (leucine rich repeat containing 27) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA037653 (family with sequence similarity 175, member A) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
  • HPA037692 (cytochrome P450, family 2, subfamily S and polypeptide 1) has been omitted due to inconsistency with RNA-seq data.
  • HPA037711 (Ras association (RalGDS/AF-6) domain family member 6) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA037742 (allantoicase) has been omitted due to inconsistency with RNA-seq data.
  • HPA037743 (allantoicase) has been omitted due to inconsistency with RNA-seq data.
  • HPA037761 (death domain containing 1) has been omitted due to inconsistency with RNA-seq data.
  • HPA037762 (death domain containing 1) has been omitted due to inconsistency with RNA-seq data.
  • HPA037774 (nucleoporin 155kDa) has been omitted due to inconsistency with RNA-seq data.
  • HPA037798 (spermatogenic leucine zipper 1) has been omitted due to inconsistency with RNA-seq data.
  • HPA037840 (exophilin 5) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA037853 (patatin-like phospholipase domain containing 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA037859 (chromosome 1 open reading frame 186) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA037924 (oligonucleotide/oligosaccharide-binding fold containing 1) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA037925 (oligonucleotide/oligosaccharide-binding fold containing 1) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA037927 (polymerase (RNA) III (DNA directed) polypeptide A, 155kDa) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA037935 (sestrin 3) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA037936 (sestrin 3) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA037943 (shootin 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
  • HPA037955 (coiled-coil domain containing 172) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA037956 (coiled-coil domain containing 172) has been omitted due to inconsistency with RNA-seq data.
  • HPA037985 (feline leukemia virus subgroup C cellular receptor family, member 2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
  • HPA038066 (WD repeat domain 63) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA038167 (family with sequence similarity 60, member A) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA038200 (UbiA prenyltransferase domain containing 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA038203 (transformation/transcription domain-associated protein) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA038255 (DEP domain containing 1B) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA038287 (family with sequence similarity 216, member A) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA038372 (inner mitochondrial membrane peptidase subunit 1) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA038381 (centrosomal protein 126kDa) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA038385 (mitochondrial carrier 2) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA038392 (cytoplasmic polyadenylation element binding protein 4) has been omitted due to inconsistency with RNA-seq data.
  • HPA038399 (centrosomal protein 126kDa) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA038413 (fibronectin type III and ankyrin repeat domains 1) has been omitted due to inconsistency with RNA-seq data.
  • HPA038415 (xylulokinase homolog (H. influenzae)) has been omitted due to inconsistency with other antibody targeting the same gene.
  • HPA038434 (ELMO/CED-12 domain containing 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA038435 (ELMO/CED-12 domain containing 1) has been omitted due to inconsistency with RNA-seq data.
  • HPA038570 (carnosine synthase 1) has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA038615 (nucleosome assembly protein 1-like 5) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA038626 (chromosome 12 open reading frame 10) has been omitted due to inconsistency with RNA-seq data.
  • HPA038630 (NLR family member X1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
  • HPA038682 (RAD9-HUS1-RAD1 interacting nuclear orphan 1) has been omitted due to inconsistency with RNA-seq data.
  • HPA038701 (vacuolar protein sorting 33 homolog A (S. cerevisiae)) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA038702 (vacuolar protein sorting 33 homolog A (S. cerevisiae)) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA038864 (zinc finger CCHC-type and RNA binding motif 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA038889 (heat shock 27kDa protein 2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA038890 (heat shock 27kDa protein 2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA038935 (neuregulin 2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
  • HPA039048 (coiled-coil domain containing 60) has been omitted due to inconsistency with RNA-seq data.
  • HPA039051 (glycosyltransferase 1 domain containing 1) has been omitted due to inconsistency with RNA-seq data.
  • HPA039052 (glycosyltransferase 1 domain containing 1) has been omitted due to inconsistency with RNA-seq data.
  • HPA039112 (ubiquilin-like) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA039115 (peroxisomal biogenesis factor 11 alpha) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA039144 (oxysterol binding protein-like 11) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA039265 (metallophosphoesterase domain containing 2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA039268 (chaperonin containing TCP1 and subunit 8 (theta)-like 2) has been omitted due to inconsistency with RNA-seq data.
  • HPA039294 (chromosome 12 open reading frame 74) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA039300 (coiled-coil domain containing 7) has been omitted due to inconsistency with RNA-seq data.
  • HPA039305 (coiled-coil domain containing 38) has been omitted due to inconsistency with RNA-seq data.
  • HPA039311 (cyclin-dependent kinase inhibitor 3) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA039350 (autophagy related 13) has been omitted due to inconsistency with RNA-seq data.
  • HPA039356 (spindle and kinetochore associated complex subunit 3) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA039386 (zwilch kinetochore protein) has been omitted due to inconsistency with RNA-seq data.
  • HPA039388 (exonuclease 3'-5' domain containing 1) has been omitted due to inconsistency with RNA-seq data.
  • HPA039416 (interactor of little elongation complex ELL subunit 2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA039443 (protein phosphatase 1 and regulatory subunit 12A) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA039474 (X-ray radiation resistance associated 1) has been omitted due to inconsistency with RNA-seq data.
  • HPA039496 (PIH1 domain containing 2) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA039589 (Rho GTPase activating protein 10) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA039630 (leucine rich repeat containing 20) has been omitted due to inconsistency with RNA-seq data.
  • HPA039668 (thymocyte expressed, positive selection associated 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA039691 (adrenomedullin 2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA039707 (coiled-coil domain containing 83) has been omitted due to inconsistency with RNA-seq data.
  • HPA039798 (keratin 86, type II) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
  • HPA039823 (peptidase domain containing associated with muscle regeneration 1) has been omitted due to inconsistency with RNA-seq data.
  • HPA039844 (butyrophilin-like 2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA039882 (coiled-coil domain containing 83) has been omitted due to inconsistency with RNA-seq data.
  • HPA039909 (chromosome 12 open reading frame 42) has been omitted due to inconsistency with RNA-seq data.
  • HPA039921 (chromosome 11 open reading frame 85) has been omitted due to inconsistency with RNA-seq data.
  • HPA039941 (meiotic nuclear divisions 1) has been omitted due to inconsistency with RNA-seq data.
  • HPA039991 (syntaxin binding protein 5 (tomosyn)) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA039997 (lipase, family member N) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA040042 (doublecortin domain containing 1) has been omitted due to inconsistency with RNA-seq data.
  • HPA040049 (chromosome 3 open reading frame 20) has been omitted due to inconsistency with RNA-seq data.
  • HPA040058 (interactor of little elongation complex ELL subunit 2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA040083 (methyltransferase like 21C) has been omitted due to inconsistency with RNA-seq data.
  • HPA040089 (thymus, brain and testes associated) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA040103 (non-SMC condensin I complex, subunit G) has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA040117 (leucine rich repeat containing 10) has been omitted due to inconsistency with RNA-seq data.
  • HPA040159 (leucine rich repeat containing 10) has been omitted due to inconsistency with RNA-seq data.
  • HPA040188 (DENN/MADD domain containing 4B) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA040192 (chromosome 7 open reading frame 34) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA040203 (lemur tyrosine kinase 3) has been omitted due to inconsistency with RNA-seq data.
  • HPA040230 (radial spoke 3 homolog (Chlamydomonas)) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA040264 (smoothelin-like 1) has been omitted due to inconsistency with RNA-seq data.
  • HPA040279 (PCF11 cleavage and polyadenylation factor subunit) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA040284 (chromosome 11 open reading frame 65) has been omitted due to inconsistency with RNA-seq data.
  • HPA040315 (solute carrier family 4 (anion exchanger) and member 3) has been omitted due to inconsistency with RNA-seq data.
  • HPA040330 (keratin 32 and type I) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA040332 (alkylglycerol monooxygenase) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA040336 (ATP-binding cassette, sub-family D (ALD) and member 2) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA040364 (otogelin-like) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA040373 (transaldolase 1) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA040399 (UHRF1 binding protein 1-like) has been omitted due to inconsistency with RNA-seq data.
  • HPA040402 (SDS3 homolog, SIN3A corepressor complex component) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA040455 (testis expressed 26) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA040458 (isochorismatase domain containing 1) has been omitted due to inconsistency with RNA-seq data.
  • HPA040461 (bromo adjacent homology domain containing 1) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA040467 (exostosin-like glycosyltransferase 3) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA040483 (elaC ribonuclease Z 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA040639 (serine/threonine/tyrosine interacting protein) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA040677 (N-acetyltransferase 8-like (GCN5-related and putative)) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA040682 (StAR-related lipid transfer (START) domain containing 5) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA040704 (chromosome 18 open reading frame 54) has been omitted due to inconsistency with RNA-seq data.
  • HPA040724 (protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA040750 (protease, serine, 54) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA040766 (kelch-like family member 22) has been omitted due to inconsistency with RNA-seq data.
  • HPA040782 (keratin 80, type II) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA040783 (potassium channel, voltage gated eag related subfamily H, member 2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA040785 (testis expressed 26) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA040798 (SLAIN motif family and member 1) has been omitted due to inconsistency with RNA-seq data.
  • HPA040814 (tRNA methyltransferase 2 homolog B) has been omitted due to inconsistency with RNA-seq data.
  • HPA040848 (lysine-rich nucleolar protein 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA040852 (phosphomannomutase 2) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA040879 (ADP-ribosyltransferase 4 (Dombrock blood group)) has been omitted due to inconsistency with RNA-seq data.
  • HPA040890 (elastin microfibril interfacer 2) has been omitted due to inconsistency with RNA-seq data.
  • HPA040908 (coiled-coil domain containing 178) has been omitted due to inconsistency with RNA-seq data.
  • HPA040923 (proline-serine-threonine phosphatase interacting protein 2) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA040929 (pancreatic progenitor cell differentiation and proliferation factor) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA040931 (SCP2 sterol-binding domain containing 1) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA041018 (chromosome 16 open reading frame 86) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA041028 (interferon, epsilon) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA041098 (chromosome 18 open reading frame 54) has been omitted due to inconsistency with RNA-seq data.
  • HPA041101 (ring finger protein 138 and E3 ubiquitin protein ligase) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA041152 (metallothionein 1E) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA041159 (family with sequence similarity 45 and member A) has been omitted due to inconsistency with RNA-seq data.
  • HPA041186 (coiled-coil domain containing 78) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA041196 (bromo adjacent homology domain containing 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA041204 (beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA041254 (isopentenyl-diphosphate delta isomerase 2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA041259 (transmembrane 4 L six family member 5) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA041336 (chaperonin containing TCP1 and subunit 8 (theta)-like 2) has been omitted due to inconsistency with RNA-seq data.
  • HPA041340 (family with sequence similarity 45, member A) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA041341 (chromosome 20 open reading frame 195) has been omitted due to inconsistency with RNA-seq data.
  • HPA041373 (ring finger protein 138 and E3 ubiquitin protein ligase) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA041376 (tumor necrosis factor (ligand) superfamily, member 9) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA041383 (FANCD2/FANCI-associated nuclease 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA041384 (coiled-coil domain containing 78) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA041426 (Fc receptor-like 2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA041494 (RIMS binding protein 2) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA041520 (forkhead box N1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA041577 (SIGLEC family like 1) has been omitted due to inconsistency with RNA-seq data.
  • HPA041633 (myosin IA) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA041640 (SRY (sex determining region Y)-box 8) has been omitted due to inconsistency with RNA-seq data.
  • HPA041649 (transglutaminase 5) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA041682 (WW domain containing E3 ubiquitin protein ligase 2) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA041691 (myogenic factor 5) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA041744 (pleckstrin homology domain containing and family G (with RhoGef domain) member 4) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA041765 (coiled-coil domain containing 63) has been omitted due to inconsistency with RNA-seq data.
  • HPA041778 (carbonic anhydrase XI) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA041780 (chromosome 15 open reading frame 43) has been omitted due to inconsistency with RNA-seq data.
  • HPA041789 (chromosome 18 open reading frame 63) has been omitted due to inconsistency with RNA-seq data.
  • HPA041827 (synaptotagmin IX) has been omitted due to inconsistency with RNA-seq data.
  • HPA041894 (cytosolic thiouridylase subunit 2 homolog (S. pombe)) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA041919 (REC114 meiotic recombination protein) has been omitted due to inconsistency with RNA-seq data.
  • HPA041941 (chromosome 15 open reading frame 43) has been omitted due to inconsistency with RNA-seq data.
  • HPA041963 (RAS-like and family 12) has been omitted due to inconsistency with RNA-seq data.
  • HPA041976 (cholecystokinin B receptor) has been omitted due to inconsistency with RNA-seq data.
  • HPA041983 (DCN1, defective in cullin neddylation 1, domain containing 3) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
  • HPA041992 (ATPase, aminophospholipid transporter, class I, type 8B and member 3) has been omitted due to inconsistency with RNA-seq data.
  • HPA042004 (leukocyte receptor cluster (LRC) member 8) has been omitted due to inconsistency with RNA-seq data.
  • HPA042063 (homeobox B6) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA042129 (BIRC8 and XIAP) has been omitted due to inconsistency with RNA-seq data.
  • HPA042137 (PARK2 co-regulated-like) has been omitted due to inconsistency with RNA-seq data.
  • HPA042142 (ATP5E, ATP5EP2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA042150 (chromosome 16 open reading frame 78) has been omitted due to inconsistency with RNA-seq data.
  • HPA042153 (coiled-coil domain containing 79) has been omitted due to inconsistency with RNA-seq data.
  • HPA042161 (meiosis specific with OB domains) has been omitted due to inconsistency with RNA-seq data.
  • HPA042173 (FAM127A, FAM127B and FAM127C) has been omitted due to inconsistency with RNA-seq data.
  • HPA042195 (IZUMO family member 2) has been omitted due to inconsistency with RNA-seq data.
  • HPA042233 (chromosome 18 open reading frame 63) has been omitted due to inconsistency with RNA-seq data.
  • HPA042274 (BTAF1 RNA polymerase II, B-TFIID transcription factor-associated and 170kDa) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA042277 (integrin and beta 7) has been omitted due to inconsistency with RNA-seq data.
  • HPA042293 (testis expressed 29) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA042344 (axin 2) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA042359 (transmembrane protein 127) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA042374 (retinal pigment epithelium-derived rhodopsin homolog) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA042386 (zinc finger and BTB domain containing 40) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA042391 (Kell blood group and metallo-endopeptidase) has been omitted due to inconsistency with RNA-seq data.
  • HPA042421 (interleukin 13) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA042457 (PDZ domain containing 9) has been omitted due to inconsistency with RNA-seq data.
  • HPA042468 (potassium channel tetramerization domain containing 9) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA042474 (gametocyte specific factor 1-like) has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA042479 (deoxynucleotidyltransferase, terminal, interacting protein 1) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA042480 (LRRN4 C-terminal like) has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA042489 (SRSF protein kinase 3) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA042493 (HRAS-like suppressor family and member 5) has been omitted due to inconsistency with RNA-seq data.
  • HPA042501 (cilia and flagella associated protein 221) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA042506 (alkaline ceramidase 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA042520 (family with sequence similarity 228 and member A) has been omitted due to inconsistency with RNA-seq data.
  • HPA042521 (BIRC8, XIAP) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA042547 (meiosis specific with OB domains) has been omitted due to inconsistency with RNA-seq data.
  • HPA042552 (REX1, RNA exonuclease 1 homolog) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
  • HPA042569 (family with sequence similarity 71 and member C) has been omitted due to inconsistency with RNA-seq data.
  • HPA042571 (chromosome 1 open reading frame 185) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA042583 (StAR-related lipid transfer (START) domain containing 6) has been omitted due to inconsistency with RNA-seq data.
  • HPA042605 (inositol polyphosphate-5-phosphatase F) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA042621 (deafness and autosomal recessive 59) has been omitted due to inconsistency with RNA-seq data.
  • HPA042625 (RAD51 associated protein 2) has been omitted due to inconsistency with RNA-seq data.
  • HPA042642 (RABL2A, RABL2B) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA042684 (tudor domain containing 12) has been omitted due to inconsistency with RNA-seq data.
  • HPA042709 (cation channel, sperm associated 2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA042756 (family with sequence similarity 209 and member A) has been omitted due to inconsistency with RNA-seq data.
  • HPA042765 (RABL2A, RABL2B) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA042778 (Bet1 golgi vesicular membrane trafficking protein) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA042793 (zinc finger protein 706) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA042799 (stromal cell-derived factor 2) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA042821 (FAM24A and FAM24B) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA042951 (transmembrane protease and serine 11B) has been omitted due to inconsistency with RNA-seq data.
  • HPA042970 (ring finger protein 166) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA042972 (zinc finger and CCHC domain containing 3) has been omitted due to inconsistency with RNA-seq data.
  • HPA042982 (lipoxygenase homology domains 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA043005 (cytochrome P450, family 4, subfamily Z, polypeptide 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA043007 (maestro heat-like repeat family member 7) has been omitted due to inconsistency with RNA-seq data.
  • HPA043012 (TUBG1 and TUBG2) has been omitted due to inconsistency with RNA-seq data.
  • HPA043022 (chromosome 10 open reading frame 82) has been omitted due to inconsistency with RNA-seq data.
  • HPA043045 (mesoderm induction early response 1 and family member 2) has been omitted due to inconsistency with RNA-seq data.
  • HPA043064 (WD repeat domain 70) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA043073 (zinc finger and RAN-binding domain containing 3) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA043108 (paraneoplastic Ma antigen family-like 2) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA043109 (sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6D) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA043181 (proprotein convertase subtilisin/kexin type 7) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA043248 (zinc finger and CCCH-type with G patch domain) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA043250 (transmembrane protein 203) has been omitted due to inconsistency with RNA-seq data.
  • HPA043262 (family with sequence similarity 71 and member E1) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA043301 (zinc finger and RAN-binding domain containing 3) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA043330 (cadherin-related family member 4) has been omitted due to inconsistency with RNA-seq data.
  • HPA043356 (vacuolar protein sorting 13 homolog C (S. cerevisiae)) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA043363 (family with sequence similarity 205 and member A) has been omitted due to inconsistency with RNA-seq data.
  • HPA043371 (germ cell associated 1) has been omitted due to inconsistency with RNA-seq data.
  • HPA043419 (death effector domain containing 2) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA043429 (butyrophilin-like 9) has been omitted due to inconsistency with RNA-seq data.
  • HPA043486 (TEN1 CST complex subunit) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA043514 (MARVEL domain containing 3) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA043554 (death effector domain containing 2) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA043577 (protein phosphatase, Mg2+/Mn2+ dependent and 1N (putative)) has been omitted due to inconsistency with RNA-seq data.
  • HPA043578 (tektin 5) has been omitted due to inconsistency with RNA-seq data.
  • HPA043582 (ATPase, aminophospholipid transporter, class I, type 8B and member 3) has been omitted due to inconsistency with RNA-seq data.
  • HPA043617 (COX20 cytochrome c oxidase assembly factor) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA043626 (inositol 1,4,5-trisphosphate receptor interacting protein) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA043638 (kinesin family member 19) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA043650 (FTH1 and FTMT) has been omitted due to inconsistency with RNA-seq data.
  • HPA043710 (ubiquitin D) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA043725 (leukocyte specific transcript 1) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA043769 (TXK tyrosine kinase) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA043790 (chromosome 5 open reading frame 56) has been omitted due to inconsistency with RNA-seq data.
  • HPA043794 (testis expressed 43) has been omitted due to inconsistency with RNA-seq data.
  • HPA043797 (transketolase-like 2) has been omitted due to inconsistency with RNA-seq data.
  • HPA043802 (lactate dehydrogenase A-like 6A) has been omitted due to inconsistency with RNA-seq data.
  • HPA043811 (beta-carotene oxygenase 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA043848 (zinc finger and BTB domain containing 22) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA043852 (myotubularin related protein 4) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA043890 (spondin 2, extracellular matrix protein) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA043908 (coiled-coil domain containing 64) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA043926 (hyaluronan-mediated motility receptor (RHAMM)) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA043927 (coiled-coil domain containing 63) has been omitted due to inconsistency with RNA-seq data.
  • HPA043935 (cysteinyl-tRNA synthetase 2, mitochondrial (putative)) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA043960 (outer dense fiber of sperm tails 3-like 1) has been omitted due to inconsistency with RNA-seq data.
  • HPA043963 (tumor protein p53 inducible protein 13) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA043967 (TRIM64, TRIM64B, TRIM64C) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA043993 (serine incorporator 3) has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA043994 (adenosine deaminase domain containing 2) has been omitted due to inconsistency with RNA-seq data.
  • HPA044080 (adenosine deaminase domain containing 1 (testis-specific)) has been omitted due to inconsistency with RNA-seq data.
  • HPA044122 (beta-gamma crystallin domain containing 3) has been omitted due to inconsistency with RNA-seq data.
  • HPA044151 (lymphocyte antigen 6 complex and locus G6C) has been omitted due to inconsistency with RNA-seq data.
  • HPA044152 (protamine 3) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA044166 (transmembrane channel-like 1) has been omitted due to lack of appropriate tissue.
  • HPA044172 (defensin, beta 133) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA044176 (defensin and beta 135) has been omitted due to inconsistency with RNA-seq data.
  • HPA044182 (kelch repeat and BTB (POZ) domain containing 12) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA044195 (mediator complex subunit 26) has been omitted due to inconsistency with RNA-seq data.
  • HPA044281 (ATPase, H+ transporting, lysosomal 21kDa and V0 subunit b) has been omitted due to inconsistency with RNA-seq data.
  • HPA044298 (PR domain containing 8) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA044305 (X-box binding protein 1) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA044344 (chromosome 9 open reading frame 57) has been omitted due to inconsistency with RNA-seq data.
  • HPA044349 (CTS telomere maintenance complex component 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA044395 (coiled-coil domain containing 27) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA044402 (sterile alpha motif domain containing 8) has been omitted due to inconsistency with RNA-seq data.
  • HPA044449 (zyg-11 related and cell cycle regulator) has been omitted due to inconsistency with RNA-seq data.
  • HPA044460 (THAP domain containing, apoptosis associated protein 3) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA044469 (Sp6 transcription factor) has been omitted due to inconsistency with RNA-seq data.
  • HPA044479 (solute carrier family 17 (acidic sugar transporter), member 5) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA044491 (Rho GTPase activating protein 39) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA044493 (G protein-coupled receptor 83) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA044494 (defensin and beta 134) has been omitted due to inconsistency with RNA-seq data.
  • HPA044497 (mitogen-activated protein kinase kinase 3) has been omitted due to inconsistency with RNA-seq data.
  • HPA044523 (zona pellucida glycoprotein 1 (sperm receptor)) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA044586 (heparan sulfate 6-O-sulfotransferase 1) has been omitted due to inconsistency with RNA-seq data.
  • HPA044596 (transcription factor 23) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA044676 (cell migration inducing protein and hyaluronan binding) has been omitted due to inconsistency with RNA-seq data.
  • HPA044714 (deoxyribonuclease I-like 2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA044765 (ribonuclease, RNase A family and 8) has been omitted due to inconsistency with RNA-seq data.
  • HPA044767 (lecithin-cholesterol acyltransferase) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA044812 (DNA-damage regulated autophagy modulator 1) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA044835 (zinc finger and BTB domain containing 8 opposite strand) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA044883 (BMP8A, BMP8B) has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA044900 (ankyrin repeat and MYND domain containing 2) has been omitted due to inconsistency with RNA-seq data.
  • HPA044969 (glycoprotein (transmembrane) nmb) has been omitted due to inconsistency with RNA-seq data.
  • HPA045026 (glycerophosphodiester phosphodiesterase domain containing 2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA045049 (psoriasis susceptibility 1 candidate 1) has been omitted due to inconsistency with RNA-seq data.
  • HPA045070 (SEC61A1 and SEC61A2) has been omitted due to inconsistency with RNA-seq data.
  • HPA045074 (rhomboid domain containing 2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA045086 (keratin associated protein 20-4) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA045128 (ribonuclease P/MRP 38kDa subunit) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA045151 (four and a half LIM domains 5) has been omitted due to inconsistency with RNA-seq data.
  • HPA045207 (cysteine-serine-rich nuclear protein 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA045242 (H2AFV, H2AFZ) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA045260 (solute carrier family 25, member 30) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA045269 (sorting nexin 29) has been omitted due to inconsistency with RNA-seq data.
  • HPA045272 (transmembrane protein 252) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA045282 (ADAM metallopeptidase domain 22) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA045285 (chromosome 16 open reading frame 92) has been omitted due to inconsistency with RNA-seq data.
  • HPA045290 (defensin and beta 121) has been omitted due to inconsistency with RNA-seq data.
  • HPA045293 (crystallin and beta B3) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA045317 (zinc finger and BTB domain containing 8 opposite strand) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA045344 (bone morphogenetic protein 3) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA045377 (melanoma antigen family A11) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA045405 (coiled-coil domain containing 70) has been omitted due to inconsistency with RNA-seq data.
  • HPA045406 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region and candidate 11) has been omitted due to inconsistency with RNA-seq data.
  • HPA045425 (LEM domain containing 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA045434 (testis expressed 10) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA045440 (chaperonin containing TCP1 and subunit 8 (theta)-like 2) has been omitted due to inconsistency with RNA-seq data.
  • HPA045447 (synaptotagmin IX) has been omitted due to inconsistency with RNA-seq data.
  • HPA045494 (DENN/MADD domain containing 1B) has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA045496 (deoxynucleotidyltransferase, terminal, interacting protein 1) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA045523 (RAN binding protein 10) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA045559 (chromosome 9 open reading frame 153) has been omitted due to inconsistency with RNA-seq data.
  • HPA045587 (ring finger protein 148) has been omitted due to inconsistency with RNA-seq data.
  • HPA045614 (casein kinase 1 and alpha 1) has been omitted due to inconsistency with RNA-seq data.
  • HPA045671 (transmembrane protein 114) has been omitted due to inconsistency with RNA-seq data.
  • HPA045695 (developmental pluripotency associated 3) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA045710 (inhibitor of DNA binding 4, dominant negative helix-loop-helix protein) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA045722 (IZUMO family member 3) has been omitted due to inconsistency with RNA-seq data.
  • HPA045723 (four and a half LIM domains 3) has been omitted due to inconsistency with RNA-seq data.
  • HPA045778 (regulation of nuclear pre-mRNA domain containing 2) has been omitted due to inconsistency with RNA-seq data.
  • HPA045805 (chromosome 1 open reading frame 94) has been omitted due to inconsistency with RNA-seq data.
  • HPA045816 (sorting nexin family member 27) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA045819 (primary cilia formation) has been omitted due to inconsistency with RNA-seq data.
  • HPA045820 (vasohibin 2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA045860 (Na+/K+ transporting ATPase interacting 2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA045885 (RNA binding motif protein 11) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA045905 (bifunctional apoptosis regulator) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA045913 (crystallin, beta A2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA045925 (regulator of chromosome condensation (RCC1) and BTB (POZ) domain containing protein 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA045926 (kelch-like family member 30) has been omitted due to inconsistency with RNA-seq data.
  • HPA045935 (coiled-coil and C2 domain containing 2B) has been omitted due to inconsistency with RNA-seq data.
  • CAB046000 (protein kinase, membrane associated tyrosine/threonine 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA046040 (TUBG1 and TUBG2) has been omitted due to inconsistency with RNA-seq data.
  • HPA046113 (Src homology 2 domain containing F) has been omitted due to inconsistency with RNA-seq data.
  • HPA046139 (suppressor of variegation 4-20 homolog 1 (Drosophila)) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA046146 (RWD domain containing 3) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA046156 (t-complex-associated-testis-expressed 3) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA046195 (methyltransferase like 15) has been omitted due to inconsistency with RNA-seq data.
  • HPA046256 (tubby like protein 2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA046274 (tryptophan hydroxylase 2) has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA046286 (PDZ domain containing 9) has been omitted due to inconsistency with RNA-seq data.
  • HPA046308 (phospholipase A2 and group IID) has been omitted due to inconsistency with RNA-seq data.
  • HPA046323 (ZNF585A, ZNF585B) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA046331 (zinc finger and BTB domain containing 8 opposite strand) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA046362 (nucleolar complex associated 4 homolog) has been omitted due to inconsistency with RNA-seq data.
  • HPA046419 (lin-7 homolog B (C. elegans)) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA046538 (regulating synaptic membrane exocytosis 2) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA046644 (delta(4)-desaturase and sphingolipid 2) has been omitted due to inconsistency with RNA-seq data.
  • HPA046682 (lens epithelial protein) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA046773 (transmembrane channel-like 1) has been omitted due to lack of appropriate tissue.
  • HPA046776 (RAD51 associated protein 2) has been omitted due to inconsistency with RNA-seq data.
  • HPA046779 (immunoglobulin lambda-like polypeptide 5) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA046789 (SIGLEC family like 1) has been omitted due to inconsistency with RNA-seq data.
  • HPA046794 (ribosomal protein L7a) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA046820 (speckle-type POZ protein) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA046839 (patched 2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA046844 (thioredoxin domain containing 8 (spermatozoa)) has been omitted due to inconsistency with RNA-seq data.
  • HPA046866 (MOB3A, MOB3B and MOB3C) has been omitted due to inconsistency with RNA-seq data.
  • HPA046896 (protein tyrosine phosphatase and non-receptor type 20) has been omitted due to inconsistency with RNA-seq data.
  • HPA046901 (KRAB box domain containing 1) has been omitted due to inconsistency with RNA-seq data.
  • HPA046905 (COMM domain containing 5) has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA046913 (calsyntenin 3) has been omitted due to inconsistency with RNA-seq data.
  • HPA046944 (solute carrier family 16 (monocarboxylate transporter), member 5) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA046983 (ubiquitin associated and SH3 domain containing A) has been omitted due to inconsistency with RNA-seq data.
  • HPA046989 (COMM domain containing 5) has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA047055 (protein tyrosine phosphatase and non-receptor type 20) has been omitted due to inconsistency with RNA-seq data.
  • HPA047082 (tetratricopeptide repeat domain 9) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA047110 (elongation factor Tu GTP binding domain containing 1) has been omitted due to inconsistency with RNA-seq data.
  • HPA047130 (iroquois homeobox 5) has been omitted due to inconsistency with RNA-seq data.
  • HPA047142 (mannosidase, beta A and lysosomal-like) has been omitted due to inconsistency with RNA-seq data.
  • HPA047240 (glutamine--fructose-6-phosphate transaminase 1) has been omitted due to inconsistency with RNA-seq data.
  • HPA047245 (NOMO1, NOMO2 and NOMO3) has been omitted due to inconsistency with RNA-seq data.
  • HPA047288 (basic leucine zipper and W2 domains 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
  • HPA047440 (KDELR1, KDELR2) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA047457 (CDRT1 and FBXW10) has been omitted due to inconsistency with RNA-seq data.
  • HPA047458 (leucine rich repeat containing 42) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA047472 (testis, prostate and placenta expressed) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA047476 (defensin and beta 127) has been omitted due to inconsistency with RNA-seq data.
  • HPA047481 (family with sequence similarity 150 and member B) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA047490 (chromosome 5 open reading frame 52) has been omitted due to inconsistency with RNA-seq data.
  • HPA047498 (cytohesin 1) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA047500 (ZRSR1 and ZRSR2) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA047538 (MAX dimerization protein 4) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA047593 (kelch-like family member 23) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA047620 (vacuolar protein sorting 39 homolog (S. cerevisiae)) has been omitted due to inconsistency with RNA-seq data.
  • HPA047631 (2,4-dienoyl CoA reductase 2, peroxisomal) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA047680 (transmembrane protein 220) has been omitted due to inconsistency with RNA-seq data.
  • HPA047781 (isochorismatase domain containing 1) has been omitted due to inconsistency with RNA-seq data.
  • HPA047782 (polyamine oxidase (exo-N4-amino)) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA047813 (synaptonemal complex central element protein 3) has been omitted due to inconsistency with RNA-seq data.
  • HPA047832 (AC133551.1, AC136612.1, TP53TG3, TP53TG3B, TP53TG3C, TP53TG3D, TP53TG3E and TP53TG3F) has been omitted due to inconsistency with RNA-seq data.
  • HPA047861 (chromosome 5 open reading frame 67) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA047904 (serine hydrolase-like 2) has been omitted due to inconsistency with RNA-seq data.
  • HPA047905 (AC007325.4, DGCR6, DGCR6L) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA047909 (NIPSNAP3A and NIPSNAP3B) has been omitted due to inconsistency with RNA-seq data.
  • HPA047925 (NIPSNAP3A and NIPSNAP3B) has been omitted due to inconsistency with RNA-seq data.
  • HPA047926 (leukemia NUP98 fusion partner 1) has been omitted due to inconsistency with RNA-seq data.
  • HPA047940 (NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 1 and 7kDa) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA047943 (RNA binding motif and single stranded interacting protein 1) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA047992 (myc target 1) has been omitted due to inconsistency with RNA-seq data.
  • HPA048014 (family with sequence similarity 26 and member D) has been omitted due to inconsistency with RNA-seq data.
  • HPA048111 (family with sequence similarity 71 and member E1) has been omitted due to inconsistency with RNA-seq data.
  • HPA048118 (CDC-like kinase 4) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA048133 (WSC domain containing 2) has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA048223 (MAU2 sister chromatid cohesion factor) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA048253 (Cdk5 and Abl enzyme substrate 2) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA048255 (leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 4) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA048263 (IgLON family member 5) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA048269 (WD repeat domain 87) has been omitted due to inconsistency with RNA-seq data.
  • HPA048299 (coiled-coil alpha-helical rod protein 1) has been omitted due to inconsistency with RNA-seq data.
  • HPA048329 (ring finger protein 185) has been omitted due to inconsistency with RNA-seq data.
  • HPA048464 (zyg-11 related and cell cycle regulator) has been omitted due to inconsistency with RNA-seq data.
  • HPA048469 (LSM10 and U7 small nuclear RNA associated) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA048546 (interleukin 1, alpha) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA048599 (apoptosis enhancing nuclease) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA048621 (inositol 1,4,5-trisphosphate receptor interacting protein-like 2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA048646 (keratin 37 and type I) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA048703 (YTH N(6)-methyladenosine RNA binding protein 3) has been omitted due to inconsistency with RNA-seq data.
  • HPA048716 (chromosome 5 open reading frame 47) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA048727 (family with sequence similarity 19 (chemokine (C-C motif)-like), member A5) has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA048739 (serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin) and member 10) has been omitted due to inconsistency with RNA-seq data.
  • HPA048766 (purine-rich element binding protein B) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA048834 (inhibin, alpha) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
  • HPA048851 (proprotein convertase subtilisin/kexin type 2) has been omitted due to inconsistency with RNA-seq data.
  • HPA048878 (WAP four-disulfide core domain 8) has been omitted due to inconsistency with RNA-seq data.
  • HPA048881 (neuron-derived neurotrophic factor) has been omitted due to inconsistency with RNA-seq data.
  • HPA048898 (sex comb on midleg homolog 1 (Drosophila)) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA048994 (methyltransferase like 15) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA049035 (transmembrane protein 202) has been omitted due to inconsistency with RNA-seq data.
  • HPA049036 (nucleoporin like 2) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA049099 (doublesex and mab-3 related transcription factor 3) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA049122 (TBC1D26 and TBC1D28) has been omitted due to inconsistency with RNA-seq data.
  • HPA049130 (transmembrane protein 247) has been omitted due to inconsistency with RNA-seq data.
  • HPA049215 (porcupine homolog (Drosophila)) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA049256 (NIPSNAP3A and NIPSNAP3B) has been omitted due to inconsistency with RNA-seq data.
  • HPA049280 (matrix metallopeptidase 24 (membrane-inserted)) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA049377 (proteasome subunit alpha 8) has been omitted due to inconsistency with RNA-seq data.
  • HPA049382 (zinc finger protein 395) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA049434 (differentially expressed in FDCP 8 homolog (mouse)) has been omitted due to inconsistency with RNA-seq data.
  • HPA049455 (WD repeat domain 87) has been omitted due to inconsistency with RNA-seq data.
  • HPA049503 (small integral membrane protein 23) has been omitted due to inconsistency with RNA-seq data.
  • HPA049556 (IQ motif containing F5) has been omitted due to inconsistency with RNA-seq data.
  • HPA049564 (chromosome 2 open reading frame 81) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA049571 (protein phosphatase 1 and regulatory subunit 16B) has been omitted due to inconsistency with RNA-seq data.
  • HPA049579 (small integral membrane protein 23) has been omitted due to inconsistency with RNA-seq data.
  • HPA049588 (interferon, alpha-inducible protein 27-like 2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA049597 (adhesion G protein-coupled receptor D2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA049626 (IQ motif and ubiquitin domain containing) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA049847 (PRKAR1A and PRKAR1B) has been omitted due to inconsistency with RNA-seq data.
  • HPA049858 (copine family member IX) has been omitted due to inconsistency with RNA-seq data.
  • HPA049878 (WAP four-disulfide core domain 5) has been omitted due to inconsistency with RNA-seq data.
  • HPA049881 (calcium channel, voltage-dependent and gamma subunit 7) has been omitted due to inconsistency with RNA-seq data.
  • HPA049936 (SET domain containing 9) has been omitted due to inconsistency with RNA-seq data.
  • HPA049946 (keratin 82 and type II) has been omitted due to inconsistency with other antibody targeting the same gene.
  • HPA050011 (arylsulfatase family and member H) has been omitted due to inconsistency with RNA-seq data.
  • HPA050044 (TBC1D26 and TBC1D28) has been omitted due to inconsistency with RNA-seq data.
  • HPA050223 (RAB26, member RAS oncogene family) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA050297 (olfactomedin 3) has been omitted due to inconsistency with RNA-seq data.
  • HPA050337 (5-hydroxymethylcytosine (hmC) binding and ES cell-specific) has been omitted due to inconsistency with RNA-seq data.
  • HPA050370 (primary cilia formation) has been omitted due to inconsistency with RNA-seq data.
  • HPA050410 (isthmin 1, angiogenesis inhibitor) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA050416 (pleckstrin and Sec7 domain containing 2) has been omitted due to inconsistency with RNA-seq data.
  • HPA050419 (chromosome 10 open reading frame 11) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA050447 (ankyrin repeat and MYND domain containing 2) has been omitted due to inconsistency with RNA-seq data.
  • HPA050544 (SPC25 and NDC80 kinetochore complex component) has been omitted due to inconsistency with RNA-seq data.
  • HPA050601 (RNA binding motif protein 46) has been omitted due to inconsistency with RNA-seq data.
  • HPA050625 (ataxin 7-like 3) has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA050682 (guanine monophosphate synthase) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA050784 (aralkylamine N-acetyltransferase) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA050819 (chromosome 11 open reading frame 88) has been omitted due to inconsistency with RNA-seq data.
  • HPA050895 (iroquois homeobox 2) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA050903 (DNA-damage-inducible transcript 4-like) has been omitted due to inconsistency with RNA-seq data.
  • HPA050908 (RUN domain and cysteine-rich domain containing, Beclin 1-interacting protein) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
  • HPA050929 (arrestin domain containing 5) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA051003 (neuron-derived neurotrophic factor) has been omitted due to inconsistency with RNA-seq data.
  • HPA051100 (leucine rich repeat containing 4) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA051163 (epithelial membrane protein 3) has been omitted due to inconsistency with RNA-seq data.
  • HPA051206 (lectin, mannose-binding, 1 like) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA051219 (paired immunoglobin-like type 2 receptor alpha) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA051229 (vanin 2) has been omitted due to inconsistency with RNA-seq data.
  • HPA051249 (deltex 1, E3 ubiquitin ligase) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA051264 (proline rich 29) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA051286 (uridine-cytidine kinase 2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA051292 (FAHD2A and FAHD2B) has been omitted due to inconsistency with other antibody targeting the same gene.
  • HPA051352 (phospholipid scramblase 2) has been omitted due to inconsistency with RNA-seq data.
  • HPA051365 (nuclear receptor subfamily 1, group I and member 3) has been omitted due to inconsistency with RNA-seq data.
  • HPA051399 (ubiquitin-conjugating enzyme E2 and J2) has been omitted due to inconsistency with RNA-seq data.
  • HPA051403 (killer cell lectin-like receptor subfamily G, member 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA051418 (N-terminal asparagine amidase) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA051447 (Rho GTPase activating protein 9) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA051458 (PHD finger protein 19) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA051462 () has been omitted due to inconsistency with RNA-seq data.
  • HPA051466 (lipin 3) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA051499 (RAD51 associated protein 1) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA051582 (chondroitin polymerizing factor 2) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA051592 (RecQ mediated genome instability 1) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA051594 (KIAA1549-like) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA051637 (kelch-like family member 2) has been omitted due to inconsistency with RNA-seq data.
  • HPA051639 (SEC22 homolog A and vesicle trafficking protein) has been omitted due to inconsistency with RNA-seq data.
  • HPA051655 (colipase-like 2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
  • HPA051715 (exostosin glycosyltransferase 2) has been omitted due to inconsistency with RNA-seq data.
  • HPA051812 (prostate tumor overexpressed 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA051825 (mitogen-activated protein kinase 14) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA051847 (SLIT and NTRK-like family and member 2) has been omitted due to inconsistency with RNA-seq data.
  • HPA051858 (RAB37 and member RAS oncogene family) has been omitted due to inconsistency with RNA-seq data.
  • HPA051866 (myelin transcription factor 1-like) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA051907 (BLOC-1 related complex subunit 8) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA051921 (arrestin domain containing 3) has been omitted due to inconsistency with RNA-seq data.
  • HPA051932 (ATPase type 13A4) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA052024 (zinc finger protein 496) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA052041 (Rab interacting lysosomal protein) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA052044 (chromosome 8 open reading frame 46) has been omitted due to inconsistency with RNA-seq data.
  • HPA052048 (defensin and beta 112) has been omitted due to inconsistency with RNA-seq data.
  • HPA052084 (AC007325.1, AC023491.2 and POM121L7) has been omitted due to inconsistency with RNA-seq data.
  • HPA052246 (collagen, type XI and alpha 1) has been omitted due to inconsistency with RNA-seq data.
  • HPA052257 (CTD-2313N18.7 and DEFB131) has been omitted due to inconsistency with RNA-seq data.
  • HPA052282 (WAP four-disulfide core domain 3) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA052327 (defensin and beta 113) has been omitted due to inconsistency with RNA-seq data.
  • HPA052332 (LYZL1 and LYZL2) has been omitted due to inconsistency with RNA-seq data.
  • HPA052392 (methyltransferase like 23) has been omitted due to inconsistency with RNA-seq data.
  • HPA052442 (FGGY carbohydrate kinase domain containing) has been omitted due to inconsistency with RNA-seq data.
  • HPA052491 (CDRT1 and FBXW10) has been omitted due to inconsistency with RNA-seq data.
  • HPA052506 (WAP four-disulfide core domain 9) has been omitted due to inconsistency with RNA-seq data.
  • HPA052511 (retbindin) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA052615 (family with sequence similarity 83 and member A) has been omitted due to inconsistency with RNA-seq data.
  • HPA052633 (zinc finger and BTB domain containing 32) has been omitted due to inconsistency with RNA-seq data.
  • HPA052722 (chromosome 2 open reading frame 54) has been omitted due to inconsistency with RNA-seq data.
  • HPA052760 (transmembrane protein 31) has been omitted due to inconsistency with RNA-seq data.
  • HPA052777 (catsper channel auxiliary subunit gamma) has been omitted due to inconsistency with RNA-seq data.
  • HPA052822 (testis expressed 40) has been omitted due to inconsistency with RNA-seq data.
  • HPA052901 (membrane-associated ring finger (C3HC4) 5) has been omitted due to inconsistency with RNA-seq data.
  • HPA052996 (membrane bound O-acyltransferase domain containing 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA053024 (notum pectinacetylesterase homolog (Drosophila)) has been omitted due to inconsistency with RNA-seq data.
  • HPA053026 (regulator of G-protein signaling 22) has been omitted due to inconsistency with RNA-seq data.
  • HPA053106 (eukaryotic translation initiation factor 4E family member 3) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA053112 (isoamyl acetate-hydrolyzing esterase 1 homolog) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA053209 (vacuolar protein sorting 33 homolog A (S. cerevisiae)) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA053212 (HIG1 hypoxia inducible domain family and member 1B) has been omitted due to inconsistency with RNA-seq data.
  • HPA053237 (family with sequence similarity 32, member A) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
  • HPA053292 (sex comb on midleg homolog 1 (Drosophila)) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA053514 (coiled-coil domain containing 87) has been omitted due to inconsistency with RNA-seq data.
  • HPA053528 (solute carrier family 45, member 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA053643 (epilepsy, progressive myoclonus type 2A and Lafora disease (laforin)) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA053651 (chromosome 8 open reading frame 46) has been omitted due to inconsistency with RNA-seq data.
  • HPA053672 (regulating synaptic membrane exocytosis 2) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA053763 (mesenteric estrogen-dependent adipogenesis) has been omitted due to inconsistency with RNA-seq data.
  • HPA053781 (family with sequence similarity 71 and member E2) has been omitted due to inconsistency with RNA-seq data.
  • HPA053811 (frizzled class receptor 5) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA053826 (transmembrane protein 129, E3 ubiquitin protein ligase) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA053849 (golgin A6 family-like 2) has been omitted due to inconsistency with RNA-seq data.
  • HPA053850 (AC007325.1, AC023491.2 and POM121L7) has been omitted due to inconsistency with RNA-seq data.
  • HPA053860 (signal recognition particle receptor (docking protein)) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA053862 (EEF1A1, EEF1A2) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA053950 (3-oxoacid CoA transferase 2) has been omitted due to inconsistency with RNA-seq data.
  • HPA053976 (mitochondrially encoded ATP synthase 8) has been omitted due to inconsistency with RNA-seq data.
  • HPA053992 (sodium channel, voltage gated and type IV alpha subunit) has been omitted due to inconsistency with RNA-seq data.
  • HPA054014 (zinc finger protein 12) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA054022 (retinoic acid early transcript 1E) has been omitted due to inconsistency with RNA-seq data.
  • HPA054086 (polycomb group ring finger 6) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA054100 (leucine rich repeat containing 52) has been omitted due to inconsistency with RNA-seq data.
  • HPA054139 (ornithine decarboxylase antizyme 2) has been omitted due to inconsistency with RNA-seq data.
  • HPA054379 (zinc finger protein 541) has been omitted due to inconsistency with RNA-seq data.
  • HPA054427 (poly(A) polymerase beta (testis specific)) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA054432 (choline/ethanolamine phosphotransferase 1) has been omitted due to inconsistency with RNA-seq data.
  • HPA054441 (beta-gamma crystallin domain containing 3) has been omitted due to inconsistency with RNA-seq data.
  • HPA054474 (forty-two-three domain containing 1) has been omitted due to inconsistency with RNA-seq data.
  • HPA054478 (crooked neck pre-mRNA splicing factor 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA054513 (EF-hand calcium binding domain 11) has been omitted due to inconsistency with RNA-seq data.
  • HPA054552 (zinc finger and BTB domain containing 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA054625 (pleckstrin and Sec7 domain containing 2) has been omitted due to inconsistency with RNA-seq data.
  • HPA054679 (arrestin domain containing 5) has been omitted due to inconsistency with RNA-seq data.
  • HPA054729 (ceramide synthase 4) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA054754 (shisa family member 3) has been omitted due to inconsistency with RNA-seq data.
  • HPA054762 (zinc finger protein 571) has been omitted due to inconsistency with RNA-seq data.
  • HPA054894 (importin 9) has been omitted due to inconsistency with RNA-seq data.
  • HPA054923 (chromosome 1 open reading frame 168) has been omitted due to inconsistency with RNA-seq data.
  • HPA054971 (FGGY carbohydrate kinase domain containing) has been omitted due to inconsistency with RNA-seq data.
  • HPA055021 (leucine-rich single-pass membrane protein 2) has been omitted due to inconsistency with RNA-seq data.
  • HPA055036 (antioxidant 1 copper chaperone) has been omitted due to inconsistency with RNA-seq data.
  • HPA055043 (protein phosphatase 1 and regulatory (inhibitor) subunit 1C) has been omitted due to inconsistency with RNA-seq data.
  • HPA055044 (carboxypeptidase X (M14 family) and member 1) has been omitted due to inconsistency with RNA-seq data.
  • HPA055054 (ring finger protein 151) has been omitted due to inconsistency with RNA-seq data.
  • HPA055143 (dual specificity phosphatase 5) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA055180 (indolethylamine N-methyltransferase) has been omitted due to inconsistency with RNA-seq data.
  • HPA055187 (WAP four-disulfide core domain 10A) has been omitted due to inconsistency with RNA-seq data.
  • HPA055189 (mitochondrial calcium uniporter regulator 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA055224 (proline and serine rich 3) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA055344 (heparanase) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
  • HPA055404 (tumor protein p63 regulated 1-like) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
  • HPA055411 (transmembrane protein 154) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA055468 (epilepsy, progressive myoclonus type 2A, Lafora disease (laforin)) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA055537 (ADAM metallopeptidase domain 19) has been omitted due to inconsistency with RNA-seq data.
  • HPA055596 (tetratricopeptide repeat domain 27) has been omitted due to inconsistency with RNA-seq data.
  • HPA055670 (leucine-rich repeats and death domain containing 1) has been omitted due to inconsistency with RNA-seq data.
  • HPA055693 (retbindin) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA055795 (ATPase, class II, type 9A) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
  • HPA055834 (zinc finger protein 496) has been omitted due to inconsistency with RNA-seq data.
  • HPA055837 (DNA-damage inducible 1 homolog 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA055931 (RAB40C, member RAS oncogene family) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA055946 (kringle containing transmembrane protein 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA055954 (human immunodeficiency virus type I enhancer binding protein 2) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA055971 (interleukin 34) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA056250 (epithelial membrane protein 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA056274 (EF-hand calcium binding domain 9) has been omitted due to inconsistency with RNA-seq data.
  • HPA056301 (myeloid-associated differentiation marker) has been omitted due to inconsistency with RNA-seq data.
  • HPA056307 (C-type lectin domain family 1 and member A) has been omitted due to inconsistency with RNA-seq data.
  • HPA056344 (ribosomal modification protein rimK-like family member B) has been omitted due to inconsistency with RNA-seq data.
  • HPA056347 (methyltransferase like 9) has been omitted due to inconsistency with RNA-seq data.
  • HPA056362 (olfactomedin-like 3) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA056378 (discs, large (Drosophila) homolog-associated protein 4) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA056533 (delta-like 3 (Drosophila)) has been omitted due to inconsistency with RNA-seq data.
  • HPA056563 (myocyte enhancer factor 2A) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA056584 (potassium channel, voltage gated eag related subfamily H, member 2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA056610 (small integral membrane protein 3) has been omitted due to inconsistency with RNA-seq data.
  • HPA056613 (small EDRK-rich factor 2) has been omitted due to inconsistency with RNA-seq data.
  • HPA056650 (migration and invasion enhancer 1) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA056919 (serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin) and member 5) has been omitted due to inconsistency with RNA-seq data.
  • HPA056928 (partner of NOB1 homolog) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA056934 (NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 6, 14kDa) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA056973 (dual specificity phosphatase 11 (RNA/RNP complex 1-interacting)) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA056985 (glutamate-rich 2) has been omitted due to inconsistency with RNA-seq data.
  • HPA057065 (nucleosome assembly protein 1-like 2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA057194 (discoidin domain receptor tyrosine kinase 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA057230 (WAP four-disulfide core domain 11) has been omitted due to inconsistency with RNA-seq data.
  • HPA057251 (nucleoporin like 2) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA057278 (solute carrier family 24 (sodium/potassium/calcium exchanger), member 2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA057287 (prolyl 3-hydroxylase family member 4 (non-enzymatic)) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
  • HPA057345 (transcription elongation factor A (SII)-like 1) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA057414 (ubiquitin-conjugating enzyme E2Q family-like 1) has been omitted due to inconsistency with RNA-seq data.
  • HPA057569 (limb development membrane protein 1-like) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA057672 (MEF2 activating motif and SAP domain containing transcriptional regulator) has been omitted due to inconsistency with RNA-seq data.
  • HPA057766 (solute carrier family 45, member 1) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA057772 (NACHT and WD repeat domain containing 1) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA057838 (potassium channel, calcium activated large conductance subfamily M alpha, member 1) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA057987 (endothelin 3) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA058038 (minichromosome maintenance domain containing 2) has been omitted due to inconsistency with RNA-seq data.
  • HPA058056 (binder of sperm protein homolog 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA058273 (SLC25A51 and SLC25A52) has been omitted due to inconsistency with RNA-seq data.
  • HPA058285 (chromosome 1 open reading frame 101) has been omitted due to inconsistency with RNA-seq data.
  • HPA058298 (CAP-GLY domain containing linker protein 3) has been omitted due to inconsistency with RNA-seq data.
  • HPA058366 (RNA binding protein with multiple splicing 2) has been omitted due to inconsistency with RNA-seq data.
  • HPA058456 (septin 14) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
  • HPA058503 (vitrin) has been omitted due to inconsistency with RNA-seq data.
  • HPA058981 (phospholipase A1 member A) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA058999 (chromosome 5 open reading frame 46) has been omitted due to inconsistency with RNA-seq data.
  • HPA059000 (tripartite motif containing 36) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA059038 (proline rich 30) has been omitted due to inconsistency with RNA-seq data.
  • HPA059048 (transcription elongation factor A (SII)-like 2) has been omitted due to inconsistency with RNA-seq data.
  • HPA059122 (solute carrier family 9, member C2 (putative)) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA059189 (N(alpha)-acetyltransferase 38 and NatC auxiliary subunit) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA059246 (desumoylating isopeptidase 2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA059365 (V-set and transmembrane domain containing 1) has been omitted due to inconsistency with RNA-seq data.
  • HPA059486 (putative homeodomain transcription factor 1) has been omitted due to inconsistency with RNA-seq data.
  • HPA059513 (sphingosine-1-phosphate receptor 3) has been omitted due to inconsistency with RNA-seq data.
  • HPA059540 (importin 9) has been omitted due to inconsistency with RNA-seq data.
  • HPA059552 (ribosomal modification protein rimK-like family member B) has been omitted due to inconsistency with RNA-seq data.
  • HPA059703 (ribonuclease H2, subunit C) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA059748 (SPT4 homolog and DSIF elongation factor subunit) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA059948 (hexokinase 3 (white cell)) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
  • HPA059966 (zinc finger protein 571) has been omitted due to inconsistency with RNA-seq data.
  • HPA060057 (ras homolog family member F (in filopodia)) has been omitted due to inconsistency with RNA-seq data.
  • HPA060059 (glyceronephosphate O-acyltransferase) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA060266 (COMM domain containing 6) has been omitted due to inconsistency with RNA-seq data.
  • HPA060288 (zinc finger protein 790) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA060334 (transmembrane protein 150B) has been omitted due to inconsistency with RNA-seq data.
  • HPA060355 (cyclic nucleotide gated channel beta 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA060368 (sulfotransferase family, cytosolic, 1C and member 3) has been omitted due to inconsistency with RNA-seq data.
  • HPA060396 (V-set and transmembrane domain containing 1) has been omitted due to inconsistency with RNA-seq data.
  • HPA060475 (interleukin 17D) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA060492 (transmembrane protein 132A) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA060515 (secretoglobin, family 1D, member 4) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA060517 (defensin and beta 110) has been omitted due to inconsistency with RNA-seq data.
  • HPA060601 (sphingosine-1-phosphate receptor 4) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA060665 (SLC25A4, SLC25A5 and SLC25A6) has been omitted due to inconsistency with RNA-seq data.
  • HPA060718 (calcium channel, voltage-dependent, gamma subunit 4) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA060863 (T-box 1) has been omitted due to inconsistency with RNA-seq data.
  • HPA060901 (ZNF836, ZNF841) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA060997 (dephospho-CoA kinase domain containing) has been omitted due to inconsistency with RNA-seq data.
  • HPA061010 (glutamate-rich 2) has been omitted due to inconsistency with RNA-seq data.
  • HPA061206 (chromosome 6 open reading frame 201) has been omitted due to inconsistency with RNA-seq data.
  • HPA061317 (calpain and small subunit 2) has been omitted due to inconsistency with RNA-seq data.
  • HPA061607 (PQ loop repeat containing 3) has been omitted due to inconsistency with RNA-seq data.
  • HPA061929 (C-type lectin domain family 1 and member A) has been omitted due to inconsistency with RNA-seq data.
  • HPA061957 (serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin) and member 5) has been omitted due to inconsistency with RNA-seq data.
  • HPA061966 (leucine-rich single-pass membrane protein 2) has been omitted due to inconsistency with RNA-seq data.
  • HPA062346 (RHOA and RHOC) has been omitted due to inconsistency with RNA-seq data.
  • HPA062493 (dynein, axonemal, heavy chain 3) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA062514 (phospholipid phosphatase 7 (inactive)) has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA062522 (iroquois homeobox 3) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA062538 (family with sequence similarity 83 and member A) has been omitted due to inconsistency with RNA-seq data.
  • HPA062623 (proline/arginine-rich end leucine-rich repeat protein) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA062664 (cytoplasmic linker associated protein 1) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA062822 (selenocysteine lyase) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
  • HPA062893 (musculin) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA064157 (PDLIM1 interacting kinase 1 like) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA064208 (fucose-1-phosphate guanylyltransferase) has been omitted due to inconsistency with RNA-seq data.
  • HPA065435 (zinc finger protein 528) has been omitted due to inconsistency with RNA-seq data.
  • HPA065439 (leucine rich repeat containing 32) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA065587 (chromosome 8 open reading frame 88) has been omitted due to inconsistency with RNA-seq data.
  • HPA065598 (vitrin) has been omitted due to inconsistency with RNA-seq data.
  • HPA065745 (family with sequence similarity 229 and member A) has been omitted due to inconsistency with RNA-seq data.
  • HPA065747 (ankyrin repeat domain 66) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA065863 (RAS guanyl releasing protein 3 (calcium and DAG-regulated)) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA065945 (RAS guanyl releasing protein 3 (calcium and DAG-regulated)) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA066585 (chromodomain helicase DNA binding protein 7) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA066616 (ankyrin repeat domain 66) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA066669 (coiled-coil glutamate-rich protein 1) has been omitted due to inconsistency with RNA-seq data.
  • HPA066750 (actin-like 10) has been omitted due to inconsistency with RNA-seq data.
  • HPA066969 (solute carrier family 22 (organic cation/carnitine transporter), member 5) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA067047 (Down syndrome critical region 8) has been omitted due to inconsistency with RNA-seq data.
  • HPA067655 (tetraspanin 5) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA068290 (alanine and arginine rich domain containing protein) has been omitted due to inconsistency with RNA-seq data.
  • HPA068437 (ectonucleoside triphosphate diphosphohydrolase 3) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA070565 (X-ray repair complementing defective repair in Chinese hamster cells 3) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA070619 (transmembrane epididymal protein 1) has been omitted due to inconsistency with RNA-seq data.
  • HPA071295 (interleukin 10 receptor, alpha) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA071363 (transmembrane epididymal protein 1) has been omitted due to inconsistency with RNA-seq data.
  • CAB000095 (retinoblastoma 1) has been omitted due to inconsistency with gene/protein characterization data.
  • CAB000105 (BCL2-like 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA001522 (lumican) has been omitted due to lack of appropriate tissue.
  • CAB002312 (SMAD family member 4) has been omitted due to inconsistency with gene/protein characterization data.
  • CAB002663 (cell division cycle 25B) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • CAB002682 (glutamate decarboxylase 2 (pancreatic islets and brain, 65kDa)) has been omitted due to inconsistency with gene/protein characterization data.
  • CAB002771 (TIMP metallopeptidase inhibitor 4) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA003642 (HEAT repeat containing 4) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • CAB003690 (testis derived transcript (3 LIM domains)) has been omitted due to inconsistency with other antibody targeting the same gene and inconsistency with RNA-seq data.
  • CAB003709 (angiomotin like 2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • CAB003851 (RAP1 GTPase activating protein) has been omitted due to inconsistency with gene/protein characterization data, other antibody targeting the same gene and inconsistency with RNA-seq data.
  • CAB004560 (ras homolog family member B) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • CAB004649 (FXYD domain containing ion transport regulator 2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • CAB004658 (ribosomal protein L39-like) has been omitted due to inconsistency with RNA-seq data.
  • CAB004780 (neuropeptide FF receptor 2) has been omitted due to inconsistency with gene/protein characterization data.
  • CAB004785 (serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 1) has been omitted due to inconsistency with gene/protein characterization data.
  • CAB004786 (neurofibromin 1) has been omitted due to inconsistency with gene/protein characterization data.
  • CAB004990 (RAB4A, member RAS oncogene family) has been omitted due to inconsistency with gene/protein characterization data.
  • CAB005007 (alkB, alkylation repair homolog 3 (E. coli)) has been omitted due to inconsistency with RNA-seq data.
  • CAB005285 (cyclin-dependent kinase inhibitor 3) has been omitted due to inconsistency with gene/protein characterization data.
  • CAB005373 (tenascin XB) has been omitted due to inconsistency with RNA-seq data.
  • CAB005426 (vascular cell adhesion molecule 1) has been omitted due to inconsistency with gene/protein characterization data.
  • CAB005619 (cholecystokinin A receptor) has been omitted due to inconsistency with gene/protein characterization data.
  • CAB006330 (centromere protein M) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • CAB006887 (ryanodine receptor 3) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA007261 (keratin 9) has been omitted due to lack of appropriate tissue.
  • CAB008649 (ribosomal protein S6 kinase, 90kDa, polypeptide 4) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • CAB009055 (TNF receptor-associated factor 4) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • CAB009249 (frizzled-related protein) has been omitted due to inconsistency with RNA-seq data.
  • HPA009338 (amyloid beta (A4) precursor protein-binding, family A, member 1) has been omitted due to inconsistency with gene/protein characterization data.
  • CAB009474 (protein phosphatase, Mg2+/Mn2+ dependent, 1D) has been omitted due to inconsistency with gene/protein characterization data.
  • CAB009508 (solute carrier family 25, member 27) has been omitted due to inconsistency with gene/protein characterization data.
  • CAB009779 (calcium channel, voltage-dependent, beta 1 subunit) has been omitted due to product no longer available in provider's catalogue.
  • CAB009808 (epoxide hydrolase 2, cytoplasmic) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
  • CAB009850 (chaperonin containing TCP1, subunit 2 (beta)) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • CAB009906 (phosphatidylethanolamine binding protein 1) has been omitted due to inconsistency with other antibody targeting the same gene and inconsistency with RNA-seq data.
  • CAB009948 (tyrosine kinase, non-receptor, 2) has been omitted due to inconsistency with other antibody targeting the same gene and inconsistency with RNA-seq data.
  • CAB010346 (neurotrophic tyrosine kinase, receptor, type 2) has been omitted due to lack of appropriate tissue.
  • CAB010347 (fibroblast growth factor receptor substrate 2) has been omitted due to inconsistency with RNA-seq data.
  • CAB010360 (insulin-like growth factor binding protein 3) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • CAB010381 (RAD51 recombinase) has been omitted due to lack of appropriate tissue.
  • CAB010426 (transcription factor AP-2 beta (activating enhancer binding protein 2 beta)) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
  • CAB010464 (EPH receptor A2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • CAB010908 (transducer of ERBB2, 1) has been omitted due to inconsistency with other antibody targeting the same gene and inconsistency with RNA-seq data.
  • CAB011569 (shugoshin-like 1 (S. pombe)) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • CAB012247 (RecQ mediated genome instability 1) has been omitted due to inconsistency with gene/protein characterization data.
  • CAB012356 (centromere protein I) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA012657 (phospholipase A2 receptor 1, 180kDa) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
  • CAB012900 (S100 calcium binding protein P) has been omitted due to inconsistency with other antibody targeting the same gene and inconsistency with RNA-seq data.
  • CAB013045 (tumor necrosis factor receptor superfamily, member 1B) has been omitted due to inconsistency with gene/protein characterization data.
  • CAB013289 (mitogen-activated protein kinase 8 interacting protein 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • CAB013455 (proteasome (prosome, macropain) subunit, alpha type, 8) has been omitted due to inconsistency with gene/protein characterization data.
  • CAB013471 (presenilin enhancer gamma secretase subunit) has been omitted due to inconsistency with gene/protein characterization data, inconistency with other antibody targeting the same gene and inconsistency with RNA-seq data.
  • HPA014763 (delta(4)-desaturase, sphingolipid 1) has been omitted due to inconsistency with gene/protein characterization data.
  • CAB014884 (engrailed homeobox 1) has been omitted due to inconsistency with gene/protein characterization data, inconistency with other antibody targeting the same gene and inconsistency with RNA-seq data.
  • HPA015607 (KIAA0319) has been omitted due to lack of appropriate tissue.
  • HPA015784 (corepressor interacting with RBPJ, 1) has been omitted due to inconsistency with gene/protein characterization data.
  • CAB015945 (ectodysplasin A2 receptor) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA016004 (carbohydrate (N-acetylgalactosamine 4-0) sulfotransferase 8) has been omitted due to lack of appropriate tissue.
  • CAB016324 (survival of motor neuron 1, telomeric) has been omitted due to inconsistency with other antibody targeting the same gene and inconsistency with RNA-seq data.
  • CAB016339 (Kin17 DNA and RNA binding protein) has been omitted due to inconsistency with gene/protein characterization data.
  • CAB016383 (complement factor D (adipsin)) has been omitted due to inconsistency with gene/protein characterization data.
  • CAB016523 (E2F transcription factor 4, p107/p130-binding) has been omitted due to inconsistency with gene/protein characterization data.
  • CAB016688 (diablo, IAP-binding mitochondrial protein) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
  • CAB016713 (leptin) has been omitted due to inconsistency with gene/protein characterization data.
  • CAB017023 (K(lysine) acetyltransferase 6A) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
  • CAB017039 (slowmo homolog 2 (Drosophila)) has been omitted due to inconsistency with other antibody targeting the same gene and inconsistency with RNA-seq data.
  • CAB017489 (solute carrier family 16 (monocarboxylate transporter), member 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
  • CAB017784 (glypican 3) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • CAB017843 (epidermal growth factor) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • CAB018377 (transforming growth factor, beta 3) has been omitted due to inconsistency with RNA-seq data.
  • CAB018358 (fms-related tyrosine kinase 3) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • CAB018773 (aldo-keto reductase family 1, member B1 (aldose reductase)) has been omitted due to inconsistency with gene/protein characterization data.
  • CAB018966 (sonic hedgehog) has been omitted due to lack of appropriate tissue and inconsistency with gene/protein characterization data.
  • CAB019267 (NCK interacting protein with SH3 domain) has been omitted due to inconsistency with gene/protein characterization data.
  • CAB019281 (nuclear receptor subfamily 2, group F, member 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • CAB020790 (myosin VC) has been omitted due to inconsistency with gene/protein characterization data.
  • CAB022076 (Sec61 alpha 1 subunit (S. cerevisiae)) has been omitted due to inconsistency with gene/protein characterization data.
  • CAB022193 (lumican) has been omitted due to inconsistency with other antibody targeting the same gene.
  • CAB022337 (musashi RNA-binding protein 1) has been omitted due to inconsistency with RNA-seq data.
  • CAB022700 (oxytocin receptor) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • CAB022770 (5-hydroxytryptamine (serotonin) receptor 1D, G protein-coupled) has been omitted due to inconsistency with other antibody targeting the same gene and inconsistency with RNA-seq data.
  • CAB022775 (5-hydroxytryptamine (serotonin) receptor 1D, G protein-coupled) has been omitted due to inconsistency with other antibody targeting the same gene and inconsistency with RNA-seq data.
  • CAB023814 (SATB homeobox 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
  • HPA024342 (phosphodiesterase 3B, cGMP-inhibited) has been omitted due to lack of appropriate tissue.
  • CAB024893 (catenin, beta interacting protein 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • CAB025086 (unc-5 homolog C (C. elegans)) has been omitted due to inconsistency with gene/protein characterization data.
  • CAB025154 (sialic acid binding Ig-like lectin 7) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • CAB025575 (proprotein convertase subtilisin/kexin type 9) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • CAB025621 (WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 2) has been omitted due to inconsistency with RNA-seq data.
  • CAB025665 (wingless-type MMTV integration site family, member 7B) has been omitted due to lack of appropriate tissue and inconsistency with RNA-seq data.
  • CAB025879 (peptidoglycan recognition protein 4) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • CAB026001 (transmembrane protein 123) has been omitted due to inconsistency with gene/protein characterization data.
  • CAB026224 (glycoprotein (transmembrane) nmb) has been omitted due to inconsistency with RNA-seq data.
  • CAB027385 (interleukin 18) has been omitted due to inconsistency with other antibody targeting the same gene.
  • CAB027714 (proline rich 9) has been omitted due to inconsistency with gene/protein characterization data.
  • CAB029997 (N-terminal asparagine amidase) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • CAB030018 (CD274 molecule) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA030899 (leptin receptor) has been omitted due to lack of appropriate tissue.
  • CAB031479 (guanine nucleotide binding protein (G protein), alpha transducing activity polypeptide 2) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA031605 (BEN domain containing 6) has been omitted due to lack of appropriate tissue.
  • CAB031925 (regulator of G-protein signaling 19) has been omitted due to inconsistency with RNA-seq data.
  • CAB032233 (eukaryotic translation initiation factor 2B, subunit 3 gamma, 58kDa) has been omitted due to inconsistency with other antibody targeting the same gene and inconsistency with RNA-seq data.
  • CAB032277 (metallothionein 1H) has been omitted due to inconsistency with RNA-seq data.
  • CAB032529 (acid-sensing (proton-gated) ion channel family member 4) has been omitted due to inconsistency with gene/protein characterization data.
  • CAB032802 (serpin peptidase inhibitor, clade B (ovalbumin), member 12) has been omitted due to inconsistency with RNA-seq data.
  • CAB033205 (ferrochelatase) has been omitted due to inconsistency with gene/protein characterization data, inconsistency with other antibody targeting the same gene and inconsistency with RNA-seq data.
  • CAB033298 (leucine-rich repeats and calponin homology (CH) domain containing 4) has been omitted due to inconsistency with gene/protein characterization data.
  • CAB033531 (hydroxyacylglutathione hydrolase) has been omitted due to inconsistency with gene/protein characterization data.
  • CAB034047 (arrestin, beta 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • CAB034160 (DNA-damage regulated autophagy modulator 1) has been omitted due to inconsistency with gene/protein characterization data.
  • CAB034215 (testis expressed 29) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA035493 (prickle homolog 2 (Drosophila)) has been omitted due to inconsistency with gene/protein characterization data.
  • CAB037025 (baculoviral IAP repeat containing 7) has been omitted due to inconsistency with RNA-seq data.
  • CAB037026 (early B-cell factor 2) has been omitted due to inconsistency with RNA-seq data.
  • CAB037056 (RAB guanine nucleotide exchange factor (GEF) 1) has been omitted due to inconsistency with gene/protein characterization data.
  • CAB037119 (baculoviral IAP repeat containing 7) has been omitted due to inconsistency with RNA-seq data.
  • CAB037199 (uncoupling protein 1 (mitochondrial, proton carrier)) has been omitted due to lack of appropriate tissue.
  • CAB037232 (autophagy related 10) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
  • HPA037991 (MAP6 domain containing 1) has been omitted due to lack of appropriate tissue.
  • HPA039297 (regulating synaptic membrane exocytosis 1) has been omitted due to lack of appropriate tissue.
  • HPA039799 (zinc finger protein 385A) has been omitted due to lack of appropriate tissue.
  • CAB040294 (cell division cycle associated 8) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
  • HPA042028 (IQ motif containing B1) has been omitted due to lack of appropriate tissue.
  • HPA042369 (melanoma inhibitory activity) has been omitted due to lack of appropriate tissue.
  • HPA043698 (calcium binding protein 5) has been omitted due to lack of appropriate tissue.
  • HPA044114 (RIMS binding protein 2) has been omitted due to lack of appropriate tissue.
  • HPA044639 (paired-like homeodomain 3) has been omitted due to lack of appropriate tissue.
  • CAB045968 (deoxynucleotidyltransferase, terminal, interacting protein 1) has been omitted due to inconsistency with other antibody targeting the same gene and inconsistency with RNA-seq data.
  • CAB045996 (NME/NM23 nucleoside diphosphate kinase 4) has been omitted due to inconsistency with gene/protein characterization data.
  • CAB046474 (homeobox C10) has been omitted due to inconsistency with RNA-seq data.
  • HPA046937 (death associated protein-like 1) has been omitted due to lack of appropriate tissue.
  • HPA048450 (fibronectin type III and SPRY domain containing 2) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA049124 (solute carrier family 1 (glutamate transporter), member 7) has been omitted due to lack of appropriate tissue.
  • HPA049791 (regulator of G protein signaling 9 binding protein) has been omitted due to lack of appropriate tissue.
  • HPA053869 (clavesin 1) has been omitted due to lack of appropriate tissue.
  • HPA056970 (proteasome (prosome, macropain) subunit, beta type, 11) has been omitted due to lack of appropriate tissue.
  • HPA059051 (HERV-H LTR-associating 1) has been omitted due to lack of appropriate tissue.
  • HPA060697 (family with sequence similarity 9, member C) has been omitted due to inconsistency with gene/protein characterization data.
  • CAB069411 (SMAD family member 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
  • CAB000073 & HPA015768 (S100 calcium binding protein B) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • CAB000114 (cyclin A2) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • CAB032191 & HPA000505 (transketolase-like 1) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA000556 (cysteine rich transmembrane BMP regulator 1 (chordin-like)) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA001079 (neuronal pentraxin receptor) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA001323 (epididymal protein 3B) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • CAB004307, HPA001399 & HPA023884 (adenosine deaminase) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA001403 (SIX homeobox 6) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA001625 (purine nucleoside phosphorylase) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA001864 (vav 1 guanine nucleotide exchange factor) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • CAB001948 & HPA044496 (protein kinase C, epsilon) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA003298 (RNA binding motif protein 44) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA003314 (Rhox homeobox family, member 2B) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • CAB020794 & HPA003314 (Rhox homeobox family, member 2) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • CAB004608 (tubulin, gamma 1) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • CAB015452 & HPA004622 (melanoma antigen family C1) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA005788 (GRB2-related adaptor protein 2) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA005792 (Purkinje cell protein 4) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA007133 (adhesion G protein-coupled receptor G5) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA008315 (actinin, alpha 2) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA008411 (ELL associated factor 2) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • CAB009564 (brain-derived neurotrophic factor) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA010575 (chitinase 1 (chitotriosidase)) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA015313 (NDRG family member 4) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • CAB017029, HPA043412 & HPA051005 (phenylethanolamine N-methyltransferase) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • CAB017042 & HPA047752 (ELOVL fatty acid elongase 5) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • CAB017615 (interferon induced transmembrane protein 1) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA017742 (dopa decarboxylase (aromatic L-amino acid decarboxylase)) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA020137 (DEAD (Asp-Glu-Ala-Asp) box helicase 25) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA021509 (ectonucleoside triphosphate diphosphohydrolase 8) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA022243 (chromosome 9 open reading frame 9) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • CAB022626 (remodeling and spacing factor 1) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA023257 (MYCBP associated protein) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA023307 (family with sequence similarity 166, member A) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA023899 (stabilizer of axonemal microtubules 1) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA024629 (Kruppel-like factor 17) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • CAB025635 (tumor necrosis factor receptor superfamily, member 10c, decoy without an intracellular domain) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • CAB025749, HPA043355 & HPA048460 (calreticulin 3) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • CAB027391 & HPA026425 (aldo-keto reductase family 1, member B1 (aldose reductase)) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA028597 & HPA028666 (sperm associated antigen 17) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA028894 (tripartite motif containing 69) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA029458 (peripherin 2 (retinal degeneration, slow)) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA030900 (neural cell adhesion molecule 2) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA032001 (neurotrophin 3) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • CAB032495 (BMX non-receptor tyrosine kinase) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA035582 (immunoglobulin superfamily, member 1) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA036338 (tetratricopeptide repeat domain 26) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA036762 & HPA036763 (cone-rod homeobox) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA036807 (mediator complex subunit 12-like) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA036819 (cadherin-related family member 1) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA038464 (beaded filament structural protein 2, phakinin) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA038526 (WD repeat domain 63) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA039795 & HPA039866 (GLI pathogenesis-related 1 like 2) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA039805 (UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA040025 (hyaluronan-mediated motility receptor (RHAMM)) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • CAB040310 (laminin, alpha 2) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA040421 (NUT midline carcinoma, family member 1) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA040671 & HPA056228 (cAMP responsive element binding protein 3-like 3) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA041025 (G protein-coupled receptor 174) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA041646 (POU class 1 homeobox 1) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA041733 (neuropeptide VF precursor) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA042767 (semenogelin II) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA043232 (G antigen 10) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA043232 (G antigen 12J) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA043232 (G antigen 13) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA043232 (G antigen 2E) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA043232 (G antigen 12C) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA043232 (G antigen 12D) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA043232 (G antigen 12E) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA043232 (G antigen 12F) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA043232 (G antigen 12G) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA043232 (G antigen 12H) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA043232 (G antigen 1) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA043232 (G antigen 2A) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA044016 & HPA055352 (calcium-binding protein, spermatid-specific 1) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA044741 (junctional sarcoplasmic reticulum protein 1) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA046068 & HPA055623 (solute carrier family 28 (concentrative nucleoside transporter), member 2) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA051384 (BTB and CNC homology 1, basic leucine zipper transcription factor 2) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA054010 (gamma-aminobutyric acid (GABA) A receptor, gamma 3) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA054126 (solute carrier organic anion transporter family, member 6A1) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA054508 (glutathione synthetase) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA054694 (gametocyte specific factor 1-like) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA055177 (VGF nerve growth factor inducible) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA055194 (keratin 33A, type I) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA055194 (keratin 33B, type I) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA055194 (keratin 34, type I) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA055194 (keratin 31, type I) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA060789 (YjeF N-terminal domain containing 3) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA062468 (chromosome 3 open reading frame 30) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA062866 (cadherin, EGF LAG seven-pass G-type receptor 3) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA019750 has been omitted due to target gene not found in Ensembl.
  • HPA021577 has been omitted due to target gene not found in Ensembl.
  • HPA021912 has been omitted due to target gene not found in Ensembl.
  • HPA023045 has been omitted due to target gene not found in Ensembl.
  • HPA030080 has been omitted due to target gene not found in Ensembl.
  • HPA034756 has been omitted due to target gene not found in Ensembl.
  • HPA037369 has been omitted due to target gene not found in Ensembl.
  • HPA038302 has been omitted due to target gene not found in Ensembl.
  • HPA040195 has been omitted due to target gene not found in Ensembl.
  • HPA041883 has been omitted due to target gene not found in Ensembl.
  • HPA041898 has been omitted due to target gene not found in Ensembl.
  • HPA042431 has been omitted due to target gene not found in Ensembl.
  • HPA043259 has been omitted due to target gene not found in Ensembl.
  • HPA043680 has been omitted due to target gene not found in Ensembl.
  • HPA044422 has been omitted due to target gene not found in Ensembl.
  • HPA044640 has been omitted due to target gene not found in Ensembl.
  • HPA044800 has been omitted due to target gene not found in Ensembl.
  • HPA044806 has been omitted due to target gene not found in Ensembl.
  • HPA044834 has been omitted due to target gene not found in Ensembl.
  • HPA044995 has been omitted due to target gene not found in Ensembl.
  • HPA045553 has been omitted due to target gene not found in Ensembl.
  • HPA045811 has been omitted due to target gene not found in Ensembl.
  • HPA046799 has been omitted due to target gene not found in Ensembl.
  • HPA046873 has been omitted due to target gene not found in Ensembl.
  • HPA047196 has been omitted due to target gene not found in Ensembl.
  • HPA049545 has been omitted due to target gene not found in Ensembl.
  • HPA050106 has been omitted due to target gene not found in Ensembl.
  • HPA050870 has been omitted due to target gene not found in Ensembl.
  • HPA051619 has been omitted due to target gene not found in Ensembl.
  • HPA051774 has been omitted due to target gene not found in Ensembl.
  • HPA052542 has been omitted due to target gene not found in Ensembl.
  • HPA052795 has been omitted due to target gene not found in Ensembl.
  • HPA053911 has been omitted due to target gene not found in Ensembl.
  • HPA053930 has been omitted due to target gene not found in Ensembl.
  • HPA054377 has been omitted due to target gene not found in Ensembl.
  • HPA055347 has been omitted due to target gene not found in Ensembl.
  • HPA055395 has been omitted due to target gene not found in Ensembl.
  • HPA060293 has been omitted due to target gene not found in Ensembl.
  • HPA061034 has been omitted due to target gene not found in Ensembl.
  • HPA061221 has been omitted due to target gene not found in Ensembl.
  • HPA062694 has been omitted due to target gene not found in Ensembl.
  • HPA062836 has been omitted due to target gene not found in Ensembl.
  • HPA065431 has been omitted due to target gene not found in Ensembl.
  • HPA067901 has been omitted due to target gene not found in Ensembl.
  • HPA068791 has been omitted due to target gene not found in Ensembl.
  • HPA069084 has been omitted due to target gene not found in Ensembl.
    Subcell atlas
  • CAB000024 has been omitted due to qualitative reasons. An alternative antibody HPA027802 has been added.
  • CAB000032 has been omitted due to lack of RNA expression in cell line panel. An alternative antibody HPA024684 has been added.
  • CAB000096 has been omitted due to qualitative reasons.
  • CAB000130 has been omitted due to antibody staining not supported by experimental data. An alternative antibody HPA045697 has been added.
  • CAB000132 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • CAB000143 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA000166 has been omitted due to qualitative reasons.
  • HPA000262 has been omitted due to qualitative reasons. An alternative antibody HPA006503 has been added.
  • HPA000298 has been omitted due to qualitative reasons. An alternative antibody HPA001374 has been added.
  • CAB000349 has been omitted due to lack of RNA expression in cell line panel.
  • CAB000376 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA000397 has been omitted due to qualitative reasons.
  • HPA000428 has been omitted due to qualitative reasons.
  • CAB000458 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • CAB000460 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA000522 has been omitted due to qualitative reasons.
  • HPA000527 has been omitted due to antibody staining not supported by experimental data.
  • HPA000554 has been omitted due to antibody staining not supported by experimental data.
  • HPA000817 has been omitted due to antibody staining not supported by experimental data.
  • HPA001042 has been omitted due to qualitative reasons.
  • HPA001115 has been omitted due to qualitative reasons.
  • HPA001136 has been omitted due to qualitative reasons.
  • HPA001206 has been omitted due to lack of RNA expression in cell line panel.
  • HPA001232 has been omitted due to qualitative reasons. An alternative antibody CAB015397 has been added.
  • HPA001383 has been omitted due to qualitative reasons. An alternative antibody HPA001060 has been added.
  • HPA001396 has been omitted due to antibody staining not supported by experimental data.
  • HPA001399 has been omitted due to qualitative reasons.
  • HPA001432 has been omitted due to antibody staining not supported by experimental data.
  • HPA001436 has been omitted due to lack of RNA expression in cell line panel.
  • CAB001447 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA001472 has been omitted due to lack of RNA expression in cell line panel.
  • HPA001499 has been omitted due to qualitative reasons.
  • HPA001508 has been omitted due to lack of RNA expression in cell line panel.
  • HPA001536 has been omitted due to qualitative reasons.
  • HPA001689 has been omitted due to qualitative reasons.
  • HPA001756 has been omitted due to qualitative reasons.
  • HPA001768 has been omitted due to qualitative reasons. An alternative antibody HPA005924 has been added.
  • HPA001804 has been omitted due to qualitative reasons.
  • CAB001809 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA001817 has been omitted due to qualitative reasons. An alternative antibody HPA000951 has been added.
  • HPA001830 has been omitted due to qualitative reasons.
  • HPA001844 has been omitted due to qualitative reasons.
  • HPA001847 has been omitted due to qualitative reasons. An alternative antibody HPA065797 has been added.
  • HPA001852 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA001860 has been omitted due to lack of RNA expression in cell line panel.
  • HPA001908 has been omitted due to qualitative reasons. An alternative antibody HPA001909 has been added.
  • HPA001914 has been omitted due to qualitative reasons.
  • HPA001942 has been omitted due to qualitative reasons.
  • CAB002011 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA002022 has been omitted due to qualitative reasons.
  • HPA002038 has been omitted due to qualitative reasons. An alternative antibody HPA002698 has been added.
  • HPA002111 has been omitted due to qualitative reasons. An alternative antibody HPA000568 has been added.
  • CAB002145 has been omitted due to lack of RNA expression in cell line panel.
  • CAB002148 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • CAB002151 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • CAB002158 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA002188 has been omitted due to qualitative reasons.
  • HPA002198 has been omitted due to antibody staining not supported by experimental data.
  • CAB002222 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • CAB002223 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • CAB002226 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA002270 has been omitted due to lack of RNA expression in cell line panel.
  • CAB002301 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • CAB002302 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA002314 has been omitted due to qualitative reasons.
  • HPA002315 has been omitted due to qualitative reasons.
  • HPA002327 has been omitted due to qualitative reasons.
  • HPA002356 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA002385 has been omitted due to qualitative reasons.
  • CAB002418 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • CAB002424 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • CAB002430 has been omitted due to lack of RNA expression in cell line panel.
  • CAB002489 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • CAB002491 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • CAB002494 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • CAB002496 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • CAB002499 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • CAB002501 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA002549 has been omitted due to qualitative reasons.
  • CAB002601 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • CAB002624 has been omitted due to lack of RNA expression in cell line panel.
  • HPA002642 has been omitted due to qualitative reasons.
  • HPA002655 has been omitted due to lack of RNA expression in cell line panel.
  • CAB002658 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • CAB002661 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • CAB002679 has been omitted due to qualitative reasons.
  • CAB002681 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • CAB002720 has been omitted due to qualitative reasons.
  • HPA002735 has been omitted due to qualitative reasons.
  • CAB002781 has been omitted due to qualitative reasons.
  • HPA002857 has been omitted due to antibody staining not supported by experimental data.
  • HPA002881 has been omitted due to lack of RNA expression in cell line panel.
  • HPA002907 has been omitted due to qualitative reasons. An alternative antibody HPA005835 has been added.
  • HPA002969 has been omitted due to qualitative reasons.
  • HPA002981 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA003010 has been omitted due to antibody staining not supported by experimental data.
  • HPA003020 has been omitted due to qualitative reasons.
  • HPA003056 has been omitted due to antibody staining not supported by experimental data.
  • HPA003184 has been omitted due to qualitative reasons.
  • HPA003214 has been omitted due to qualitative reasons.
  • HPA003228 has been omitted due to qualitative reasons. An alternative antibody HPA070799 has been added.
  • HPA003240 has been omitted due to qualitative reasons. An alternative antibody HPA061783 has been added.
  • HPA003335 has been omitted due to qualitative reasons.
  • HPA003381 has been omitted due to qualitative reasons. An alternative antibody HPA056308 has been added.
  • HPA003413 has been omitted due to qualitative reasons.
  • HPA003418 has been omitted due to lack of RNA expression in cell line panel.
  • HPA003474 has been omitted due to qualitative reasons.
  • HPA003501 has been omitted due to antibody staining not supported by experimental data.
  • HPA003525 has been omitted due to qualitative reasons.
  • HPA003572 has been omitted due to qualitative reasons.
  • HPA003584 has been omitted due to qualitative reasons. An alternative antibody HPA063872 has been added.
  • HPA003595 has been omitted due to lack of RNA expression in cell line panel.
  • HPA003617 has been omitted due to qualitative reasons.
  • HPA003642 has been omitted due to qualitative reasons.
  • HPA003656 has been omitted due to qualitative reasons.
  • CAB003674 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • CAB003690 has been omitted due to qualitative reasons.
  • CAB003695 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • CAB003789 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • CAB003799 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • CAB003809 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines. An alternative antibody HPA067463 has been added.
  • CAB003844 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • CAB003852 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA003883 has been omitted due to lack of RNA expression in cell line panel.
  • HPA003995 has been omitted due to antibody staining not supported by experimental data.
  • CAB004005 has been omitted due to lack of RNA expression in cell line panel.
  • HPA004011 has been omitted due to lack of RNA expression in cell line panel.
  • CAB004022 has been omitted due to qualitative reasons.
  • CAB004025 has been omitted due to antibody staining not supported by experimental data. An alternative antibody HPA049174 has been added.
  • CAB004031 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA004056 has been omitted due to antibody staining not supported by experimental data.
  • HPA004063 has been omitted due to qualitative reasons.
  • CAB004080 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA004102 has been omitted due to qualitative reasons.
  • HPA004184 has been omitted due to qualitative reasons. An alternative antibody HPA063840 has been added.
  • CAB004214 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • CAB004216 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • CAB004229 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • CAB004239 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • CAB004283 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • CAB004288 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • CAB004290 has been omitted due to lack of RNA expression in cell line panel.
  • CAB004307 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • CAB004318 has been omitted due to qualitative reasons.
  • CAB004364 has been omitted due to qualitative reasons.
  • CAB004370 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • CAB004372 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • CAB004395 has been omitted due to antibody staining not supported by experimental data.
  • CAB004458 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • CAB004464 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • CAB004511 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • CAB004580 has been omitted due to antibody staining not supported by experimental data.
  • CAB004581 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • CAB004643 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • CAB004645 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • CAB004646 has been omitted due to qualitative reasons. An alternative antibody HPA041790 has been added.
  • HPA004714 has been omitted due to qualitative reasons.
  • HPA004716 has been omitted due to qualitative reasons.
  • HPA004723 has been omitted due to qualitative reasons.
  • HPA004739 has been omitted due to lack of RNA expression in cell line panel.
  • HPA004789 has been omitted due to qualitative reasons.
  • HPA004812 has been omitted due to qualitative reasons.
  • HPA004820 has been omitted due to qualitative reasons.
  • HPA004842 has been omitted due to qualitative reasons.
  • HPA004896 has been omitted due to qualitative reasons.
  • HPA004917 has been omitted due to qualitative reasons.
  • HPA004940 has been omitted due to qualitative reasons.
  • CAB004998 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • CAB005123 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • CAB005196 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • CAB005227 has been omitted due to qualitative reasons.
  • CAB005268 has been omitted due to qualitative reasons.
  • CAB005272 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • CAB005399 has been omitted due to qualitative reasons.
  • CAB005429 has been omitted due to qualitative reasons.
  • HPA005465 has been omitted due to qualitative reasons. An alternative antibody HPA046786 has been added.
  • HPA005534 has been omitted due to antibody staining not supported by experimental data.
  • CAB005597 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • CAB005605 has been omitted due to qualitative reasons.
  • HPA005625 has been omitted due to qualitative reasons.
  • HPA005680 has been omitted due to qualitative reasons.
  • HPA005688 has been omitted due to qualitative reasons.
  • HPA005696 has been omitted due to qualitative reasons.
  • HPA005751 has been omitted due to qualitative reasons. An alternative antibody HPA071988 has been added.
  • HPA005788 has been omitted due to lack of RNA expression in cell line panel.
  • HPA005841 has been omitted due to qualitative reasons.
  • CAB005872 has been omitted due to qualitative reasons. An alternative antibody HPA062262 has been added.
  • CAB005875 has been omitted due to qualitative reasons.
  • HPA005949 has been omitted due to lack of RNA expression in cell line panel.
  • HPA005953 has been omitted due to qualitative reasons.
  • HPA005987 has been omitted due to qualitative reasons.
  • HPA005990 has been omitted due to lack of RNA expression in cell line panel.
  • HPA006092 has been omitted due to qualitative reasons.
  • HPA006159 has been omitted due to lack of RNA expression in cell line panel.
  • HPA006195 has been omitted due to qualitative reasons.
  • CAB006246 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • CAB006252 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA006280 has been omitted due to qualitative reasons.
  • HPA006281 has been omitted due to qualitative reasons.
  • HPA006293 has been omitted due to qualitative reasons.
  • HPA006298 has been omitted due to qualitative reasons.
  • HPA006302 has been omitted due to qualitative reasons.
  • HPA006353 has been omitted due to qualitative reasons.
  • HPA006367 has been omitted due to qualitative reasons.
  • HPA006401 has been omitted due to qualitative reasons.
  • HPA006426 has been omitted due to antibody staining not supported by experimental data. An alternative antibody HPA075984 has been added.
  • HPA006432 has been omitted due to antibody staining not supported by experimental data. An alternative antibody HPA006219 has been added.
  • HPA006632 has been omitted due to qualitative reasons.
  • HPA006641 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA006657 has been omitted due to antibody staining not supported by experimental data.
  • HPA006660 has been omitted due to qualitative reasons.
  • HPA006669 has been omitted due to qualitative reasons. An alternative antibody HPA006484 has been added.
  • HPA006769 has been omitted due to qualitative reasons.
  • HPA006779 has been omitted due to qualitative reasons.
  • HPA006874 has been omitted due to qualitative reasons.
  • HPA006885 has been omitted due to qualitative reasons.
  • HPA006996 has been omitted due to qualitative reasons.
  • HPA007005 has been omitted due to antibody staining not supported by experimental data.
  • CAB007057 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines. An alternative antibody HPA052386 has been added.
  • HPA007072 has been omitted due to qualitative reasons.
  • HPA007105 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA007272 has been omitted due to qualitative reasons.
  • HPA007318 has been omitted due to lack of RNA expression in cell line panel.
  • HPA007319 has been omitted due to lack of RNA expression in cell line panel.
  • HPA007326 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA007329 has been omitted due to antibody staining not supported by experimental data.
  • HPA007401 has been omitted due to qualitative reasons. An alternative antibody HPA067453 has been added.
  • HPA007446 has been omitted due to lack of RNA expression in cell line panel.
  • HPA007455 has been omitted due to qualitative reasons.
  • HPA007459 has been omitted due to qualitative reasons.
  • HPA007570 has been omitted due to antibody staining not supported by experimental data.
  • HPA007669 has been omitted due to qualitative reasons.
  • CAB007744 has been omitted due to qualitative reasons. An alternative antibody HPA031134 has been added.
  • CAB007751 has been omitted due to qualitative reasons. An alternative antibody HPA060074 has been added.
  • CAB007766 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • CAB007783 has been omitted due to qualitative reasons.
  • CAB007793 has been omitted due to qualitative reasons.
  • HPA007847 has been omitted due to qualitative reasons.
  • HPA007865 has been omitted due to antibody staining not supported by experimental data.
  • HPA007904 has been omitted due to qualitative reasons.
  • HPA007932 has been omitted due to qualitative reasons.
  • HPA007982 has been omitted due to lack of RNA expression in cell line panel.
  • HPA007987 has been omitted due to lack of RNA expression in cell line panel.
  • HPA008065 has been omitted due to qualitative reasons.
  • HPA008119 has been omitted due to qualitative reasons.
  • HPA008206 has been omitted due to lack of RNA expression in cell line panel.
  • HPA008241 has been omitted due to qualitative reasons.
  • HPA008252 has been omitted due to qualitative reasons.
  • HPA008304 has been omitted due to antibody staining not supported by experimental data.
  • HPA008320 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA008335 has been omitted due to qualitative reasons. An alternative antibody HPA070756 has been added.
  • HPA008405 has been omitted due to qualitative reasons.
  • HPA008411 has been omitted due to qualitative reasons.
  • HPA008587 has been omitted due to qualitative reasons.
  • CAB008594 antibody has been omitted due to target gene not found in Ensembl.
  • HPA008622 has been omitted due to qualitative reasons.
  • CAB008625 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • CAB008640 has been omitted due to qualitative reasons. An alternative antibody HPA052504 has been added.
  • HPA008703 has been omitted due to qualitative reasons.
  • HPA008718 has been omitted due to qualitative reasons.
  • HPA008736 has been omitted due to qualitative reasons. An alternative antibody HPA008797 has been added.
  • HPA008877 has been omitted due to qualitative reasons. An alternative antibody HPA016894 has been added.
  • HPA008928 has been omitted due to lack of RNA expression in cell line panel.
  • CAB008980 has been omitted due to antibody staining not supported by experimental data. An alternative antibody HPA064763 has been added.
  • HPA008994 has been omitted due to qualitative reasons.
  • CAB009008 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA009079 has been omitted due to lack of RNA expression in cell line panel.
  • HPA009132 has been omitted due to antibody staining not supported by experimental data.
  • HPA009177 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA009269 has been omitted due to qualitative reasons.
  • HPA009285 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • CAB009344 has been omitted due to antibody staining not supported by experimental data.
  • CAB009372 has been omitted due to qualitative reasons.
  • HPA009420 has been omitted due to lack of RNA expression in cell line panel.
  • CAB009469 has been omitted due to qualitative reasons.
  • CAB009587 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA009647 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA009705 has been omitted due to qualitative reasons.
  • CAB009751 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • CAB009803 has been omitted due to qualitative reasons. An alternative antibody CAB005044 has been added.
  • CAB009805 has been omitted due to qualitative reasons.
  • CAB009845 has been omitted due to qualitative reasons.
  • CAB009893 has been omitted due to qualitative reasons.
  • CAB009936 has been omitted due to qualitative reasons. An alternative antibody HPA059131 has been added.
  • CAB009960 has been omitted due to antibody staining not supported by experimental data.
  • HPA010132 has been omitted due to qualitative reasons. An alternative antibody HPA051594 has been added.
  • CAB010142 has been omitted due to qualitative reasons.
  • CAB010207 has been omitted due to qualitative reasons. An alternative antibody HPA069684 has been added.
  • CAB010224 has been omitted due to qualitative reasons. An alternative antibody HPA068337 has been added.
  • CAB010309 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • CAB010494 has been omitted due to antibody staining not supported by experimental data.
  • HPA010533 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA010551 has been omitted due to qualitative reasons.
  • HPA010568 has been omitted due to qualitative reasons. An alternative antibody HPA010093 has been added.
  • HPA010592 has been omitted due to antibody staining not supported by experimental data.
  • HPA010630 has been omitted due to qualitative reasons.
  • HPA010644 has been omitted due to qualitative reasons.
  • HPA010691 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA010785 has been omitted due to qualitative reasons.
  • HPA010800 has been omitted due to qualitative reasons.
  • HPA010871 has been omitted due to antibody staining not supported by experimental data.
  • HPA010921 has been omitted due to qualitative reasons.
  • HPA010926 has been omitted due to qualitative reasons.
  • HPA010950 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA010973 has been omitted due to qualitative reasons.
  • HPA011026 has been omitted due to qualitative reasons.
  • HPA011115 has been omitted due to lack of RNA expression in cell line panel.
  • HPA011157 has been omitted due to antibody staining not supported by experimental data.
  • HPA011284 has been omitted due to qualitative reasons.
  • CAB011458 has been omitted due to qualitative reasons.
  • CAB011482 has been omitted due to antibody staining not supported by experimental data. An alternative antibody HPA071396 has been added.
  • CAB011487 has been omitted due to qualitative reasons.
  • CAB011532 has been omitted due to qualitative reasons.
  • CAB011576 has been omitted due to qualitative reasons.
  • CAB011626 has been omitted due to qualitative reasons.
  • CAB011690 has been omitted due to qualitative reasons. An alternative antibody HPA068286 has been added.
  • HPA011862 has been omitted due to antibody staining not supported by experimental data.
  • HPA011933 has been omitted due to lack of RNA expression in cell line panel.
  • HPA011977 has been omitted due to antibody staining not supported by experimental data.
  • HPA012014 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA012069 has been omitted due to lack of RNA expression in cell line panel.
  • HPA012078 has been omitted due to qualitative reasons.
  • HPA012086 has been omitted due to qualitative reasons.
  • HPA012099 has been omitted due to antibody staining not supported by experimental data.
  • HPA012132 has been omitted due to qualitative reasons.
  • CAB012237 has been omitted due to lack of RNA expression in cell line panel.
  • CAB012249 has been omitted due to antibody staining not supported by experimental data.
  • CAB012272 has been omitted due to qualitative reasons.
  • CAB012275 has been omitted due to qualitative reasons.
  • HPA012383 has been omitted due to qualitative reasons.
  • HPA012384 has been omitted due to antibody staining not supported by experimental data.
  • HPA012385 has been omitted due to qualitative reasons.
  • CAB012459 has been omitted due to qualitative reasons.
  • HPA012500 has been omitted due to qualitative reasons.
  • HPA012501 has been omitted due to qualitative reasons.
  • HPA012601 has been omitted due to qualitative reasons.
  • HPA012692 has been omitted due to lack of RNA expression in cell line panel.
  • HPA012693 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA012769 has been omitted due to lack of RNA expression in cell line panel.
  • HPA012800 has been omitted due to qualitative reasons.
  • HPA012863 has been omitted due to qualitative reasons. An alternative antibody HPA064700 has been added.
  • HPA012892 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA012893 has been omitted due to antibody staining not supported by experimental data.
  • CAB012978 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • CAB013075 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • CAB013087 has been omitted due to antibody staining not supported by experimental data.
  • CAB013108 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA013159 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA013191 has been omitted due to qualitative reasons.
  • CAB013260 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • CAB013305 has been omitted due to lack of RNA expression in cell line panel.
  • HPA013316 has been omitted due to qualitative reasons.
  • HPA013397 has been omitted due to qualitative reasons.
  • CAB013511 has been omitted due to qualitative reasons.
  • CAB013535 has been omitted due to antibody staining not supported by experimental data.
  • HPA013659 has been omitted due to lack of RNA expression in cell line panel.
  • HPA013750 has been omitted due to qualitative reasons.
  • HPA013774 has been omitted due to antibody staining not supported by experimental data.
  • HPA013967 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA013995 has been omitted due to qualitative reasons.
  • HPA014044 has been omitted due to lack of RNA expression in cell line panel.
  • HPA014087 has been omitted due to antibody staining not supported by experimental data.
  • HPA014388 has been omitted due to qualitative reasons.
  • HPA014405 has been omitted due to qualitative reasons. An alternative antibody HPA065785 has been added.
  • HPA014474 has been omitted due to qualitative reasons.
  • HPA014499 has been omitted due to qualitative reasons.
  • HPA014520 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA014562 has been omitted due to antibody staining not supported by experimental data. An alternative antibody HPA038631 has been added.
  • HPA014563 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA014569 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA014719 has been omitted due to qualitative reasons.
  • HPA014741 has been omitted due to qualitative reasons.
  • HPA014811 has been omitted due to lack of RNA expression in cell line panel.
  • CAB014880 has been omitted due to lack of RNA expression in cell line panel.
  • HPA014967 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA015083 has been omitted due to qualitative reasons.
  • HPA015085 has been omitted due to antibody staining not supported by experimental data.
  • CAB015220 has been omitted due to qualitative reasons. An alternative antibody HPA005436 has been added.
  • HPA015243 has been omitted due to qualitative reasons.
  • HPA015272 has been omitted due to qualitative reasons.
  • HPA015283 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • CAB015386 has been omitted due to qualitative reasons.
  • CAB015392 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • CAB015444 has been omitted due to qualitative reasons. An alternative antibody HPA058182 has been added.
  • CAB015449 has been omitted due to antibody staining not supported by experimental data.
  • CAB015454 has been omitted due to qualitative reasons.
  • HPA015497 has been omitted due to qualitative reasons.
  • HPA015525 has been omitted due to lack of RNA expression in cell line panel.
  • HPA015590 has been omitted due to antibody staining not supported by experimental data.
  • HPA015603 has been omitted due to antibody staining not supported by experimental data.
  • HPA015636 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA015637 has been omitted due to lack of RNA expression in cell line panel.
  • HPA015639 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA015716 has been omitted due to qualitative reasons.
  • HPA015819 has been omitted due to qualitative reasons. An alternative antibody HPA015329 has been added.
  • HPA015830 has been omitted due to qualitative reasons.
  • HPA015858 has been omitted due to qualitative reasons. An alternative antibody HPA029579 has been added.
  • CAB015941 has been omitted due to antibody staining not supported by experimental data.
  • CAB016132 has been omitted due to qualitative reasons.
  • CAB016135 has been omitted due to antibody staining not supported by experimental data.
  • CAB016169 has been omitted due to qualitative reasons.
  • CAB016231 has been omitted due to qualitative reasons. An alternative antibody HPA067481 has been added.
  • CAB016252 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • CAB016253 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • CAB016271 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • CAB016290 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • CAB016348 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • CAB016416 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA016419 has been omitted due to qualitative reasons.
  • HPA016424 has been omitted due to qualitative reasons. An alternative antibody HPA058562 has been added.
  • HPA016431 has been omitted due to qualitative reasons.
  • HPA016450 has been omitted due to qualitative reasons.
  • HPA016484 has been omitted due to qualitative reasons.
  • HPA016493 has been omitted due to qualitative reasons.
  • HPA016560 has been omitted due to qualitative reasons.
  • HPA016599 has been omitted due to qualitative reasons.
  • HPA016633 has been omitted due to lack of RNA expression in cell line panel.
  • CAB016729 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • CAB016734 has been omitted due to qualitative reasons.
  • HPA016744 has been omitted due to qualitative reasons.
  • HPA016811 has been omitted due to antibody staining not supported by experimental data.
  • HPA016960 has been omitted due to qualitative reasons.
  • HPA017019 has been omitted due to qualitative reasons.
  • CAB017040 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA017046 has been omitted due to antibody staining not supported by experimental data.
  • HPA017061 has been omitted due to qualitative reasons.
  • HPA017074 has been omitted due to antibody staining not supported by experimental data.
  • CAB017133 has been omitted due to qualitative reasons.
  • CAB017193 has been omitted due to qualitative reasons.
  • HPA017210 has been omitted due to qualitative reasons.
  • HPA017291 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA017313 has been omitted due to qualitative reasons.
  • CAB017441 has been omitted due to qualitative reasons.
  • CAB017452 has been omitted due to qualitative reasons. An alternative antibody HPA052504 has been added.
  • CAB017486 has been omitted due to qualitative reasons.
  • CAB017490 has been omitted due to qualitative reasons.
  • CAB017562 has been omitted due to qualitative reasons.
  • HPA017572 has been omitted due to antibody staining not supported by experimental data.
  • HPA017600 has been omitted due to qualitative reasons.
  • HPA017602 has been omitted due to antibody staining not supported by experimental data.
  • CAB017617 has been omitted due to qualitative reasons. An alternative antibody HPA010093 has been added.
  • CAB017634 has been omitted due to antibody staining not supported by experimental data.
  • HPA017646 has been omitted due to antibody staining not supported by experimental data.
  • HPA017653 has been omitted due to qualitative reasons.
  • HPA017681 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • CAB017712 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA017722 has been omitted due to qualitative reasons.
  • HPA017737 has been omitted due to qualitative reasons. An alternative antibody CAB009449 has been added.
  • HPA017749 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA017765 has been omitted due to qualitative reasons.
  • CAB017779 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • CAB017804 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • CAB017826 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA017851 has been omitted due to qualitative reasons.
  • HPA017891 has been omitted due to qualitative reasons. An alternative antibody HPA062067 has been added.
  • HPA017903 has been omitted due to qualitative reasons. An alternative antibody HPA069479 has been added.
  • HPA017948 has been omitted due to antibody staining not supported by experimental data.
  • HPA018003 has been omitted due to lack of RNA expression in cell line panel.
  • HPA018107 has been omitted due to qualitative reasons.
  • HPA018148 has been omitted due to qualitative reasons.
  • HPA018207 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA018216 has been omitted due to qualitative reasons. An alternative antibody HPA019173 has been added.
  • HPA018303 has been omitted due to lack of RNA expression in cell line panel.
  • HPA018325 has been omitted due to antibody staining not supported by experimental data.
  • CAB018389 has been omitted due to qualitative reasons.
  • HPA018410 has been omitted due to qualitative reasons.
  • HPA018459 has been omitted due to antibody staining not supported by experimental data.
  • HPA018517 has been omitted due to qualitative reasons.
  • CAB018611 has been omitted due to qualitative reasons.
  • CAB018641 has been omitted due to qualitative reasons.
  • HPA018673 has been omitted due to qualitative reasons.
  • HPA018674 has been omitted due to antibody staining not supported by experimental data.
  • CAB018719 has been omitted due to qualitative reasons.
  • CAB018737 has been omitted due to qualitative reasons. An alternative antibody CAB018383 has been added.
  • HPA018859 has been omitted due to qualitative reasons.
  • HPA018885 has been omitted due to qualitative reasons.
  • HPA018951 has been omitted due to qualitative reasons.
  • CAB018957 has been omitted due to qualitative reasons.
  • HPA018995 has been omitted due to qualitative reasons.
  • HPA019055 has been omitted due to qualitative reasons. An alternative antibody CAB034170 has been added.
  • HPA019097 has been omitted due to antibody staining not supported by experimental data.
  • HPA019125 has been omitted due to qualitative reasons.
  • HPA019127 has been omitted due to qualitative reasons.
  • HPA019155 has been omitted due to qualitative reasons.
  • HPA019184 has been omitted due to qualitative reasons.
  • HPA019194 has been omitted due to qualitative reasons.
  • HPA019215 has been omitted due to qualitative reasons.
  • HPA019231 has been omitted due to lack of RNA expression in cell line panel.
  • HPA019254 has been omitted due to qualitative reasons.
  • HPA019259 has been omitted due to lack of RNA expression in cell line panel.
  • CAB019284 has been omitted due to antibody staining not supported by experimental data. An alternative antibody HPA004799 has been added.
  • CAB019296 has been omitted due to qualitative reasons.
  • CAB019321 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA019340 has been omitted due to qualitative reasons.
  • CAB019381 has been omitted due to qualitative reasons.
  • CAB019394 has been omitted due to qualitative reasons.
  • CAB019400 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA019487 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA019497 has been omitted due to antibody staining not supported by experimental data.
  • HPA019511 has been omitted due to qualitative reasons.
  • HPA019527 has been omitted due to qualitative reasons.
  • HPA019593 has been omitted due to lack of RNA expression in cell line panel.
  • HPA019627 has been omitted due to antibody staining not supported by experimental data.
  • HPA019639 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA019652 has been omitted due to lack of RNA expression in cell line panel.
  • HPA019675 has been omitted due to qualitative reasons.
  • HPA019702 has been omitted due to qualitative reasons. An alternative antibody HPA068560 has been added.
  • HPA019767 has been omitted due to qualitative reasons.
  • HPA019772 has been omitted due to qualitative reasons.
  • HPA019777 has been omitted due to lack of RNA expression in cell line panel.
  • HPA019848 has been omitted due to qualitative reasons.
  • HPA019862 has been omitted due to qualitative reasons. An alternative antibody HPA047843 has been added.
  • HPA019878 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA019946 has been omitted due to qualitative reasons.
  • HPA019948 has been omitted due to qualitative reasons.
  • HPA019957 has been omitted due to qualitative reasons.
  • HPA019965 has been omitted due to antibody staining not supported by experimental data.
  • HPA020046 has been omitted due to lack of RNA expression in cell line panel.
  • HPA020080 has been omitted due to qualitative reasons.
  • HPA020124 has been omitted due to qualitative reasons.
  • CAB020308 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA020339 has been omitted due to qualitative reasons.
  • HPA020342 has been omitted due to qualitative reasons.
  • HPA020457 has been omitted due to qualitative reasons. An alternative antibody HPA000887 has been added.
  • HPA020615 has been omitted due to qualitative reasons.
  • HPA020735 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • CAB020827 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA020870 has been omitted due to qualitative reasons. An alternative antibody CAB010890 has been added.
  • HPA020896 has been omitted due to qualitative reasons.
  • HPA021004 has been omitted due to lack of RNA expression in cell line panel.
  • HPA021011 has been omitted due to qualitative reasons.
  • HPA021019 has been omitted due to qualitative reasons.
  • HPA021121 has been omitted due to antibody staining not supported by experimental data.
  • HPA021136 has been omitted due to qualitative reasons.
  • HPA021146 has been omitted due to qualitative reasons.
  • HPA021194 has been omitted due to qualitative reasons.
  • HPA021261 has been omitted due to lack of RNA expression in cell line panel.
  • HPA021275 has been omitted due to lack of RNA expression in cell line panel.
  • HPA021305 has been omitted due to qualitative reasons.
  • HPA021317 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA021325 has been omitted due to lack of RNA expression in cell line panel.
  • HPA021466 has been omitted due to antibody staining not supported by experimental data.
  • HPA021564 has been omitted due to antibody staining not supported by experimental data.
  • HPA021565 has been omitted due to antibody staining not supported by experimental data.
  • HPA021566 has been omitted due to qualitative reasons.
  • HPA021579 has been omitted due to antibody staining not supported by experimental data.
  • HPA021586 has been omitted due to lack of RNA expression in cell line panel.
  • HPA021612 has been omitted due to qualitative reasons.
  • HPA021624 has been omitted due to lack of RNA expression in cell line panel.
  • HPA021633 has been omitted due to qualitative reasons.
  • HPA021649 has been omitted due to lack of RNA expression in cell line panel.
  • HPA021652 has been omitted due to antibody staining not supported by experimental data.
  • HPA021662 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA021773 has been omitted due to qualitative reasons.
  • HPA021815 has been omitted due to qualitative reasons.
  • HPA021831 has been omitted due to qualitative reasons.
  • HPA021843 has been omitted due to lack of RNA expression in cell line panel.
  • HPA021854 has been omitted due to qualitative reasons.
  • HPA021875 has been omitted due to qualitative reasons.
  • CAB021888 has been omitted due to qualitative reasons.
  • CAB021929 has been omitted due to lack of RNA expression in cell line panel.
  • HPA022008 has been omitted due to antibody staining not supported by experimental data.
  • CAB022069 has been omitted due to qualitative reasons.
  • CAB022073 has been omitted due to lack of RNA expression in cell line panel.
  • HPA022138 has been omitted due to qualitative reasons. An alternative antibody CAB007760 has been added.
  • CAB022161 has been omitted due to antibody staining not supported by experimental data.
  • CAB022187 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • CAB022226 has been omitted due to qualitative reasons.
  • HPA022271 has been omitted due to antibody staining not supported by experimental data. An alternative antibody HPA004799 has been added.
  • CAB022343 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • CAB022390 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA022479 has been omitted due to antibody staining not supported by experimental data.
  • HPA022538 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA022817 has been omitted due to qualitative reasons. An alternative antibody HPA041810 has been added.
  • HPA022818 has been omitted due to antibody staining not supported by experimental data.
  • HPA022842 has been omitted due to qualitative reasons.
  • HPA022882 has been omitted due to qualitative reasons.
  • HPA022924 has been omitted due to antibody staining not supported by experimental data.
  • HPA022957 has been omitted due to qualitative reasons.
  • HPA022959 has been omitted due to qualitative reasons.
  • HPA022963 has been omitted due to qualitative reasons.
  • HPA022988 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA023031 has been omitted due to antibody staining not supported by experimental data.
  • HPA023064 has been omitted due to qualitative reasons. An alternative antibody HPA022532 has been added.
  • HPA023092 has been omitted due to qualitative reasons.
  • HPA023128 has been omitted due to lack of RNA expression in cell line panel.
  • HPA023139 has been omitted due to antibody staining not supported by experimental data.
  • HPA023201 has been omitted due to qualitative reasons.
  • HPA023249 has been omitted due to qualitative reasons.
  • HPA023261 has been omitted due to qualitative reasons.
  • HPA023265 has been omitted due to qualitative reasons.
  • HPA023292 has been omitted due to antibody staining not supported by experimental data.
  • HPA023300 has been omitted due to qualitative reasons.
  • HPA023311 has been omitted due to lack of RNA expression in cell line panel.
  • HPA023312 has been omitted due to qualitative reasons.
  • HPA023313 has been omitted due to lack of RNA expression in cell line panel.
  • HPA023389 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA023394 has been omitted due to qualitative reasons. An alternative antibody HPA076992 has been added.
  • HPA023446 has been omitted due to lack of RNA expression in cell line panel.
  • HPA023454 has been omitted due to lack of RNA expression in cell line panel.
  • HPA023464 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA023501 has been omitted due to qualitative reasons.
  • HPA023526 has been omitted due to lack of RNA expression in cell line panel.
  • HPA023580 has been omitted due to qualitative reasons.
  • HPA023597 has been omitted due to qualitative reasons.
  • HPA023636 has been omitted due to qualitative reasons.
  • HPA023648 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA023778 has been omitted due to qualitative reasons.
  • HPA023818 has been omitted due to qualitative reasons. An alternative antibody HPA050794 has been added.
  • HPA023820 has been omitted due to qualitative reasons.
  • HPA023844 has been omitted due to qualitative reasons.
  • HPA023873 has been omitted due to qualitative reasons.
  • HPA023884 has been omitted due to qualitative reasons.
  • HPA023900 has been omitted due to qualitative reasons.
  • HPA023911 has been omitted due to qualitative reasons.
  • HPA023920 has been omitted due to qualitative reasons. An alternative antibody HPA067106 has been added.
  • HPA023974 has been omitted due to qualitative reasons.
  • HPA024006 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA024016 has been omitted due to lack of RNA expression in cell line panel.
  • HPA024037 has been omitted due to qualitative reasons.
  • HPA024132 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA024207 has been omitted due to lack of RNA expression in cell line panel.
  • HPA024227 has been omitted due to qualitative reasons. An alternative antibody CAB007760 has been added.
  • HPA024292 has been omitted due to lack of RNA expression in cell line panel.
  • HPA024294 has been omitted due to qualitative reasons.
  • HPA024295 has been omitted due to lack of RNA expression in cell line panel.
  • HPA024313 has been omitted due to lack of RNA expression in cell line panel.
  • HPA024343 has been omitted due to lack of RNA expression in cell line panel.
  • HPA024353 has been omitted due to qualitative reasons.
  • HPA024356 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA024369 has been omitted due to antibody staining not supported by experimental data. An alternative antibody HPA008789 has been added.
  • HPA024424 has been omitted due to antibody staining not supported by experimental data.
  • HPA024426 has been omitted due to qualitative reasons. An alternative antibody HPA052386 has been added.
  • HPA024430 has been omitted due to qualitative reasons.
  • HPA024452 has been omitted due to antibody staining not supported by experimental data.
  • HPA024460 has been omitted due to antibody staining not supported by experimental data.
  • HPA024544 has been omitted due to lack of RNA expression in cell line panel.
  • HPA024549 has been omitted due to qualitative reasons.
  • HPA024574 has been omitted due to antibody staining not supported by experimental data.
  • HPA024602 has been omitted due to qualitative reasons.
  • HPA024621 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA024629 has been omitted due to lack of RNA expression in cell line panel.
  • HPA024654 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA024662 has been omitted due to qualitative reasons.
  • HPA024676 has been omitted due to qualitative reasons.
  • HPA024677 has been omitted due to qualitative reasons.
  • HPA024688 has been omitted due to antibody staining not supported by experimental data.
  • HPA024729 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA024745 has been omitted due to antibody staining not supported by experimental data.
  • HPA024817 has been omitted due to qualitative reasons. An alternative antibody HPA024730 has been added.
  • HPA024821 has been omitted due to qualitative reasons.
  • HPA024824 has been omitted due to lack of RNA expression in cell line panel.
  • CAB024847 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • CAB024865 has been omitted due to lack of RNA expression in cell line panel.
  • CAB024949 has been omitted due to qualitative reasons.
  • CAB024961 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA025018 has been omitted due to qualitative reasons.
  • HPA025060 has been omitted due to qualitative reasons.
  • HPA025061 has been omitted due to antibody staining not supported by experimental data. An alternative antibody HPA073626 has been added.
  • HPA025068 has been omitted due to qualitative reasons.
  • HPA025072 has been omitted due to qualitative reasons.
  • CAB025086 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • CAB025183 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA025226 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA025230 has been omitted due to antibody staining not supported by experimental data.
  • HPA025244 has been omitted due to qualitative reasons.
  • CAB025361 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • CAB025453 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • CAB025487 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines. An alternative antibody HPA062452 has been added.
  • CAB025503 has been omitted due to qualitative reasons.
  • CAB025538 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines. An alternative antibody HPA062452 has been added.
  • CAB025567 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA025696 has been omitted due to qualitative reasons. An alternative antibody HPA061444 has been added.
  • HPA025706 has been omitted due to qualitative reasons.
  • CAB025746 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA025764 has been omitted due to qualitative reasons.
  • CAB025872 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • CAB025882 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • CAB025905 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • CAB025918 has been omitted due to qualitative reasons.
  • CAB025972 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • CAB026051 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA026078 has been omitted due to qualitative reasons.
  • HPA026088 has been omitted due to lack of RNA expression in cell line panel.
  • HPA026091 has been omitted due to qualitative reasons.
  • CAB026130 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • CAB026150 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • CAB026151 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • CAB026182 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • CAB026243 has been omitted due to qualitative reasons.
  • HPA026272 has been omitted due to qualitative reasons.
  • HPA026276 has been omitted due to qualitative reasons.
  • HPA026320 has been omitted due to antibody staining not supported by experimental data. An alternative antibody HPA072229 has been added.
  • CAB026383 has been omitted due to qualitative reasons.
  • CAB026403 has been omitted due to qualitative reasons.
  • HPA026438 has been omitted due to antibody staining not supported by experimental data.
  • HPA026439 has been omitted due to qualitative reasons.
  • HPA026441 has been omitted due to qualitative reasons.
  • HPA026448 has been omitted due to qualitative reasons.
  • CAB026456 has been omitted due to antibody staining not supported by experimental data.
  • CAB026461 has been omitted due to lack of RNA expression in cell line panel.
  • HPA026509 has been omitted due to qualitative reasons. An alternative antibody HPA025059 has been added.
  • HPA026517 has been omitted due to qualitative reasons.
  • HPA026561 has been omitted due to lack of RNA expression in cell line panel.
  • HPA026562 has been omitted due to qualitative reasons. An alternative antibody HPA052429 has been added.
  • HPA026581 has been omitted due to qualitative reasons.
  • HPA026656 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA026682 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA026693 has been omitted due to lack of RNA expression in cell line panel.
  • HPA026721 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA026747 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA026756 has been omitted due to qualitative reasons.
  • HPA026761 has been omitted due to antibody staining not supported by experimental data. An alternative antibody HPA067463 has been added.
  • HPA026773 has been omitted due to qualitative reasons.
  • HPA026816 has been omitted due to qualitative reasons. An alternative antibody HPA047533 has been added.
  • HPA026842 has been omitted due to qualitative reasons.
  • HPA026843 has been omitted due to qualitative reasons.
  • HPA026846 has been omitted due to antibody staining not supported by experimental data.
  • HPA026851 has been omitted due to antibody staining not supported by experimental data.
  • HPA026878 has been omitted due to lack of RNA expression in cell line panel.
  • HPA026895 has been omitted due to antibody staining not supported by experimental data.
  • HPA026900 has been omitted due to lack of RNA expression in cell line panel.
  • HPA026905 has been omitted due to qualitative reasons.
  • HPA026918 has been omitted due to qualitative reasons.
  • HPA026966 has been omitted due to antibody staining not supported by experimental data. An alternative antibody HPA063538 has been added.
  • HPA027099 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA027124 has been omitted due to qualitative reasons.
  • HPA027134 has been omitted due to lack of RNA expression in cell line panel.
  • HPA027150 has been omitted due to lack of RNA expression in cell line panel.
  • HPA027158 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA027172 has been omitted due to antibody staining not supported by experimental data.
  • HPA027273 has been omitted due to antibody staining not supported by experimental data.
  • HPA027279 has been omitted due to qualitative reasons.
  • HPA027281 has been omitted due to qualitative reasons.
  • HPA027299 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA027312 has been omitted due to qualitative reasons.
  • HPA027322 has been omitted due to antibody staining not supported by experimental data.
  • HPA027331 has been omitted due to qualitative reasons. An alternative antibody HPA067113 has been added.
  • HPA027337 has been omitted due to antibody staining not supported by experimental data.
  • HPA027345 has been omitted due to qualitative reasons.
  • HPA027369 has been omitted due to antibody staining not supported by experimental data.
  • HPA027377 has been omitted due to qualitative reasons. An alternative antibody HPA029801 has been added.
  • HPA027381 has been omitted due to qualitative reasons.
  • HPA027431 has been omitted due to qualitative reasons.
  • HPA027461 has been omitted due to antibody staining not supported by experimental data.
  • HPA027494 has been omitted due to qualitative reasons.
  • HPA027515 has been omitted due to qualitative reasons.
  • HPA027519 has been omitted due to qualitative reasons.
  • HPA027529 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA027534 has been omitted due to qualitative reasons.
  • HPA027587 has been omitted due to qualitative reasons.
  • HPA027597 has been omitted due to antibody staining not supported by experimental data.
  • HPA027598 has been omitted due to qualitative reasons.
  • HPA027608 has been omitted due to lack of RNA expression in cell line panel.
  • HPA027609 has been omitted due to qualitative reasons.
  • HPA027614 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA027657 has been omitted due to qualitative reasons.
  • HPA027708 has been omitted due to antibody staining not supported by experimental data.
  • HPA027718 has been omitted due to qualitative reasons. An alternative antibody HPA028545 has been added.
  • HPA027734 has been omitted due to qualitative reasons.
  • HPA027762 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA027801 has been omitted due to qualitative reasons. An alternative antibody HPA027802 has been added.
  • HPA027808 has been omitted due to qualitative reasons.
  • HPA027814 has been omitted due to qualitative reasons.
  • HPA027869 has been omitted due to qualitative reasons.
  • HPA027976 has been omitted due to qualitative reasons. An alternative antibody HPA029801 has been added.
  • HPA027983 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA027992 has been omitted due to lack of RNA expression in cell line panel.
  • HPA028016 has been omitted due to qualitative reasons.
  • HPA028049 has been omitted due to lack of RNA expression in cell line panel.
  • HPA028064 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA028083 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA028084 has been omitted due to qualitative reasons. An alternative antibody HPA029801 has been added.
  • HPA028122 has been omitted due to antibody staining not supported by experimental data. An alternative antibody HPA052427 has been added.
  • HPA028134 has been omitted due to qualitative reasons. An alternative antibody HPA067137 has been added.
  • HPA028176 has been omitted due to lack of RNA expression in cell line panel.
  • HPA028197 has been omitted due to qualitative reasons.
  • HPA028251 has been omitted due to qualitative reasons.
  • HPA028255 has been omitted due to qualitative reasons. An alternative antibody HPA041673 has been added.
  • HPA028258 has been omitted due to qualitative reasons.
  • HPA028285 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA028327 has been omitted due to antibody staining not supported by experimental data.
  • HPA028357 has been omitted due to qualitative reasons.
  • HPA028377 has been omitted due to qualitative reasons.
  • HPA028392 has been omitted due to qualitative reasons.
  • HPA028423 has been omitted due to qualitative reasons.
  • HPA028432 has been omitted due to lack of RNA expression in cell line panel.
  • HPA028441 has been omitted due to qualitative reasons.
  • HPA028443 has been omitted due to qualitative reasons.
  • HPA028446 has been omitted due to qualitative reasons.
  • HPA028470 has been omitted due to qualitative reasons.
  • HPA028472 has been omitted due to qualitative reasons.
  • HPA028500 has been omitted due to antibody staining not supported by experimental data.
  • HPA028518 has been omitted due to qualitative reasons. An alternative antibody HPA028308 has been added.
  • HPA028523 has been omitted due to qualitative reasons.
  • HPA028526 has been omitted due to qualitative reasons.
  • HPA028528 has been omitted due to qualitative reasons.
  • HPA028549 has been omitted due to qualitative reasons. An alternative antibody HPA052504 has been added.
  • HPA028550 has been omitted due to lack of RNA expression in cell line panel.
  • CAB028574 has been omitted due to qualitative reasons.
  • HPA028628 has been omitted due to lack of RNA expression in cell line panel.
  • HPA028639 has been omitted due to qualitative reasons. An alternative antibody HPA068312 has been added.
  • HPA028642 has been omitted due to qualitative reasons.
  • HPA028662 has been omitted due to qualitative reasons. An alternative antibody HPA068312 has been added.
  • HPA028676 has been omitted due to qualitative reasons.
  • HPA028692 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA028758 has been omitted due to qualitative reasons.
  • HPA028783 has been omitted due to qualitative reasons.
  • HPA028894 has been omitted due to lack of RNA expression in cell line panel.
  • HPA028895 has been omitted due to lack of RNA expression in cell line panel.
  • HPA028921 has been omitted due to qualitative reasons.
  • HPA028941 has been omitted due to antibody staining not supported by experimental data.
  • HPA028979 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA029005 has been omitted due to antibody staining not supported by experimental data.
  • HPA029014 has been omitted due to qualitative reasons.
  • HPA029025 has been omitted due to qualitative reasons.
  • HPA029058 has been omitted due to qualitative reasons.
  • HPA029082 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA029092 has been omitted due to qualitative reasons.
  • HPA029100 has been omitted due to antibody staining not supported by experimental data.
  • HPA029103 has been omitted due to qualitative reasons.
  • HPA029131 has been omitted due to qualitative reasons.
  • HPA029254 has been omitted due to antibody staining not supported by experimental data.
  • HPA029272 has been omitted due to antibody staining not supported by experimental data.
  • HPA029282 has been omitted due to qualitative reasons.
  • HPA029289 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA029314 has been omitted due to qualitative reasons.
  • HPA029384 has been omitted due to qualitative reasons. An alternative antibody HPA028557 has been added.
  • HPA029397 has been omitted due to qualitative reasons.
  • HPA029412 has been omitted due to qualitative reasons. An alternative antibody HPA069480 has been added.
  • HPA029415 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA029418 has been omitted due to lack of RNA expression in cell line panel.
  • HPA029468 has been omitted due to qualitative reasons.
  • HPA029505 has been omitted due to lack of RNA expression in cell line panel.
  • HPA029506 has been omitted due to lack of RNA expression in cell line panel.
  • HPA029569 has been omitted due to qualitative reasons.
  • HPA029600 has been omitted due to antibody staining not supported by experimental data.
  • HPA029631 has been omitted due to qualitative reasons.
  • HPA029694 has been omitted due to lack of RNA expression in cell line panel.
  • HPA029695 has been omitted due to lack of RNA expression in cell line panel.
  • HPA029719 has been omitted due to qualitative reasons.
  • HPA029720 has been omitted due to qualitative reasons.
  • HPA029724 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA029759 has been omitted due to qualitative reasons.
  • HPA029774 has been omitted due to qualitative reasons. An alternative antibody HPA078220 has been added.
  • HPA029797 has been omitted due to lack of RNA expression in cell line panel.
  • HPA029798 has been omitted due to lack of RNA expression in cell line panel.
  • HPA029799 has been omitted due to qualitative reasons.
  • HPA029830 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA029831 has been omitted due to lack of RNA expression in cell line panel.
  • HPA029832 has been omitted due to lack of RNA expression in cell line panel.
  • HPA029842 has been omitted due to qualitative reasons.
  • HPA029849 has been omitted due to qualitative reasons.
  • HPA029853 has been omitted due to qualitative reasons.
  • HPA029859 has been omitted due to lack of RNA expression in cell line panel.
  • HPA029871 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA029910 has been omitted due to qualitative reasons.
  • HPA029914 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA029944 has been omitted due to qualitative reasons.
  • HPA029960 has been omitted due to qualitative reasons.
  • HPA029974 has been omitted due to qualitative reasons.
  • HPA029975 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA029976 has been omitted due to qualitative reasons.
  • CAB030012 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines. An alternative antibody HPA067463 has been added.
  • HPA030061 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA030069 has been omitted due to antibody staining not supported by experimental data.
  • HPA030076 has been omitted due to lack of RNA expression in cell line panel.
  • HPA030085 has been omitted due to qualitative reasons.
  • HPA030090 has been omitted due to qualitative reasons.
  • HPA030095 has been omitted due to qualitative reasons.
  • HPA030096 has been omitted due to qualitative reasons.
  • HPA030103 has been omitted due to qualitative reasons.
  • HPA030118 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA030162 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA030170 has been omitted due to qualitative reasons. An alternative antibody HPA030173 has been added.
  • HPA030175 has been omitted due to qualitative reasons.
  • HPA030176 has been omitted due to antibody staining not supported by experimental data.
  • HPA030202 has been omitted due to qualitative reasons. An alternative antibody CAB037133 has been added.
  • HPA030218 has been omitted due to qualitative reasons.
  • HPA030226 has been omitted due to qualitative reasons.
  • HPA030247 has been omitted due to qualitative reasons.
  • HPA030251 has been omitted due to qualitative reasons.
  • HPA030252 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA030270 has been omitted due to lack of RNA expression in cell line panel.
  • HPA030271 has been omitted due to lack of RNA expression in cell line panel.
  • HPA030301 has been omitted due to qualitative reasons.
  • HPA030356 has been omitted due to qualitative reasons.
  • HPA030388 has been omitted due to qualitative reasons.
  • HPA030436 has been omitted due to qualitative reasons. An alternative antibody HPA063533 has been added.
  • HPA030458 has been omitted due to qualitative reasons.
  • HPA030506 has been omitted due to qualitative reasons.
  • HPA030523 has been omitted due to qualitative reasons.
  • HPA030560 has been omitted due to qualitative reasons.
  • HPA030712 has been omitted due to antibody staining not supported by experimental data.
  • HPA030728 has been omitted due to qualitative reasons. An alternative antibody HPA066901 has been added.
  • HPA030746 has been omitted due to antibody staining not supported by experimental data.
  • HPA030757 has been omitted due to antibody staining not supported by experimental data.
  • HPA030817 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA030893 has been omitted due to qualitative reasons. An alternative antibody CAB004028 has been added.
  • HPA030968 has been omitted due to qualitative reasons. An alternative antibody HPA030969 has been added.
  • HPA030997 has been omitted due to qualitative reasons.
  • HPA031021 has been omitted due to qualitative reasons. An alternative antibody HPA061394 has been added.
  • HPA031032 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA031033 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA031037 has been omitted due to qualitative reasons. An alternative antibody HPA069654 has been added.
  • HPA031053 has been omitted due to antibody staining not supported by experimental data.
  • HPA031066 has been omitted due to antibody staining not supported by experimental data.
  • HPA031079 has been omitted due to qualitative reasons.
  • HPA031092 has been omitted due to qualitative reasons.
  • HPA031152 has been omitted due to antibody staining not supported by experimental data. An alternative antibody HPA066330 has been added.
  • HPA031168 has been omitted due to qualitative reasons.
  • HPA031169 has been omitted due to qualitative reasons.
  • HPA031179 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA031180 has been omitted due to lack of RNA expression in cell line panel.
  • HPA031184 has been omitted due to qualitative reasons.
  • HPA031213 has been omitted due to qualitative reasons. An alternative antibody HPA031212 has been added.
  • HPA031215 has been omitted due to qualitative reasons.
  • HPA031256 has been omitted due to qualitative reasons.
  • HPA031262 has been omitted due to qualitative reasons.
  • HPA031273 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA031325 has been omitted due to lack of RNA expression in cell line panel.
  • HPA031326 has been omitted due to lack of RNA expression in cell line panel.
  • HPA031380 has been omitted due to qualitative reasons.
  • HPA031381 has been omitted due to qualitative reasons.
  • HPA031402 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines. An alternative antibody HPA068554 has been added.
  • HPA031404 has been omitted due to qualitative reasons. An alternative antibody HPA068554 has been added.
  • HPA031415 has been omitted due to qualitative reasons.
  • HPA031417 has been omitted due to antibody staining not supported by experimental data.
  • HPA031464 has been omitted due to antibody staining not supported by experimental data.
  • CAB031489 has been omitted due to qualitative reasons. An alternative antibody HPA067188 has been added.
  • HPA031525 has been omitted due to qualitative reasons. An alternative antibody HPA068560 has been added.
  • HPA031605 has been omitted due to qualitative reasons. An alternative antibody HPA052973 has been added.
  • HPA031641 has been omitted due to qualitative reasons. An alternative antibody HPA076526 has been added.
  • HPA031657 has been omitted due to qualitative reasons.
  • HPA031659 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA031660 has been omitted due to antibody staining not supported by experimental data.
  • HPA031661 has been omitted due to qualitative reasons.
  • HPA031686 has been omitted due to antibody staining not supported by experimental data.
  • HPA031720 has been omitted due to qualitative reasons.
  • HPA031725 has been omitted due to qualitative reasons.
  • HPA031769 has been omitted due to qualitative reasons.
  • HPA031777 has been omitted due to qualitative reasons. An alternative antibody HPA068568 has been added.
  • HPA031790 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA031953 has been omitted due to antibody staining not supported by experimental data.
  • HPA031958 has been omitted due to lack of RNA expression in cell line panel.
  • HPA032000 has been omitted due to qualitative reasons.
  • HPA032032 has been omitted due to qualitative reasons.
  • HPA032052 has been omitted due to antibody staining not supported by experimental data. An alternative antibody HPA032053 has been added.
  • HPA032069 has been omitted due to qualitative reasons. An alternative antibody HPA032068 has been added.
  • HPA032078 has been omitted due to qualitative reasons.
  • HPA032096 has been omitted due to qualitative reasons.
  • HPA032130 has been omitted due to qualitative reasons.
  • HPA032134 has been omitted due to qualitative reasons. An alternative antibody HPA069678 has been added.
  • HPA032145 has been omitted due to antibody staining not supported by experimental data.
  • HPA032146 has been omitted due to antibody staining not supported by experimental data.
  • HPA032148 has been omitted due to qualitative reasons.
  • CAB032815 has been omitted due to qualitative reasons. An alternative antibody HPA052504 has been added.
  • CAB032907 has been omitted due to qualitative reasons.
  • CAB033237 has been omitted due to lack of RNA expression in cell line panel. An alternative antibody HPA072319 has been added.
  • CAB033276 has been omitted due to qualitative reasons.
  • CAB033911 has been omitted due to qualitative reasons.
  • CAB034128 has been omitted due to qualitative reasons.
  • CAB034319 has been omitted due to qualitative reasons.
  • CAB034342 has been omitted due to lack of RNA expression in cell line panel. An alternative antibody HPA028867 has been added.
  • HPA034515 has been omitted due to qualitative reasons.
  • HPA034525 has been omitted due to antibody staining not supported by experimental data.
  • HPA034535 has been omitted due to qualitative reasons.
  • HPA034585 has been omitted due to qualitative reasons. An alternative antibody HPA065172 has been added.
  • HPA034597 has been omitted due to antibody staining not supported by experimental data. An alternative antibody HPA034598 has been added.
  • HPA034621 has been omitted due to qualitative reasons.
  • HPA034683 has been omitted due to qualitative reasons. An alternative antibody HPA062942 has been added.
  • HPA034715 has been omitted due to qualitative reasons. An alternative antibody HPA064945 has been added.
  • HPA034752 has been omitted due to qualitative reasons.
  • HPA034779 has been omitted due to antibody staining not supported by experimental data.
  • HPA034792 has been omitted due to antibody staining not supported by experimental data. An alternative antibody HPA060655 has been added.
  • HPA034804 has been omitted due to antibody staining not supported by experimental data.
  • HPA034805 has been omitted due to qualitative reasons.
  • HPA034807 has been omitted due to qualitative reasons. An alternative antibody HPA034808 has been added.
  • HPA034809 has been omitted due to lack of RNA expression in cell line panel.
  • HPA034845 has been omitted due to qualitative reasons.
  • HPA034861 has been omitted due to qualitative reasons.
  • HPA034958 has been omitted due to qualitative reasons.
  • HPA034980 has been omitted due to qualitative reasons.
  • HPA035026 has been omitted due to qualitative reasons. An alternative antibody HPA017327 has been added.
  • HPA035063 has been omitted due to qualitative reasons.
  • HPA035069 has been omitted due to antibody staining not supported by experimental data.
  • HPA035089 has been omitted due to qualitative reasons.
  • HPA035116 has been omitted due to qualitative reasons. An alternative antibody HPA069684 has been added.
  • HPA035117 has been omitted due to qualitative reasons.
  • HPA035199 has been omitted due to qualitative reasons. An alternative antibody HPA068961 has been added.
  • HPA035297 has been omitted due to antibody staining not supported by experimental data.
  • HPA035305 has been omitted due to qualitative reasons.
  • HPA035326 has been omitted due to lack of RNA expression in cell line panel.
  • HPA035434 has been omitted due to qualitative reasons.
  • HPA035481 has been omitted due to qualitative reasons.
  • HPA035501 has been omitted due to qualitative reasons.
  • HPA035528 has been omitted due to qualitative reasons.
  • HPA035630 has been omitted due to antibody staining not supported by experimental data.
  • HPA035672 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA035676 has been omitted due to qualitative reasons.
  • HPA035720 has been omitted due to lack of RNA expression in cell line panel.
  • HPA035721 has been omitted due to lack of RNA expression in cell line panel.
  • HPA035758 has been omitted due to qualitative reasons. An alternative antibody HPA013569 has been added.
  • HPA035759 has been omitted due to qualitative reasons. An alternative antibody HPA013569 has been added.
  • HPA035814 has been omitted due to qualitative reasons.
  • HPA035869 has been omitted due to qualitative reasons.
  • HPA035876 has been omitted due to qualitative reasons.
  • HPA035877 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA035878 has been omitted due to antibody staining not supported by experimental data.
  • HPA035901 has been omitted due to qualitative reasons.
  • HPA035970 has been omitted due to antibody staining not supported by experimental data.
  • CAB035999 has been omitted due to qualitative reasons.
  • HPA036016 has been omitted due to antibody staining not supported by experimental data.
  • HPA036070 has been omitted due to qualitative reasons. An alternative antibody HPA036071 has been added.
  • HPA036145 has been omitted due to qualitative reasons.
  • HPA036166 has been omitted due to antibody staining not supported by experimental data.
  • HPA036174 has been omitted due to qualitative reasons. An alternative antibody HPA038153 has been added.
  • HPA036175 has been omitted due to qualitative reasons. An alternative antibody HPA038153 has been added.
  • HPA036205 has been omitted due to qualitative reasons.
  • HPA036292 has been omitted due to qualitative reasons.
  • HPA036314 has been omitted due to qualitative reasons.
  • HPA036337 has been omitted due to qualitative reasons.
  • HPA036390 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA036391 has been omitted due to lack of RNA expression in cell line panel.
  • HPA036398 has been omitted due to antibody staining not supported by experimental data. An alternative antibody HPA044860 has been added.
  • HPA036443 has been omitted due to qualitative reasons.
  • HPA036468 has been omitted due to qualitative reasons.
  • HPA036469 has been omitted due to antibody staining not supported by experimental data.
  • HPA036480 has been omitted due to qualitative reasons.
  • HPA036626 has been omitted due to qualitative reasons.
  • HPA036664 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA036665 has been omitted due to lack of RNA expression in cell line panel.
  • HPA036680 has been omitted due to qualitative reasons.
  • HPA036697 has been omitted due to antibody staining not supported by experimental data.
  • HPA036705 has been omitted due to qualitative reasons.
  • HPA036715 has been omitted due to qualitative reasons. An alternative antibody HPA036714 has been added.
  • HPA036734 has been omitted due to lack of RNA expression in cell line panel.
  • HPA036735 has been omitted due to lack of RNA expression in cell line panel.
  • HPA036749 has been omitted due to qualitative reasons.
  • HPA036750 has been omitted due to qualitative reasons.
  • HPA036767 has been omitted due to qualitative reasons.
  • HPA036838 has been omitted due to qualitative reasons.
  • HPA036853 has been omitted due to qualitative reasons.
  • HPA036863 has been omitted due to qualitative reasons.
  • HPA036864 has been omitted due to antibody staining not supported by experimental data.
  • HPA036885 has been omitted due to qualitative reasons. An alternative antibody HPA058185 has been added.
  • HPA036894 has been omitted due to qualitative reasons.
  • HPA036909 has been omitted due to qualitative reasons.
  • HPA036912 has been omitted due to qualitative reasons. An alternative antibody HPA036911 has been added.
  • HPA036934 has been omitted due to qualitative reasons. An alternative antibody CAB011596 has been added.
  • HPA036991 has been omitted due to antibody staining not supported by experimental data. An alternative antibody HPA066081 has been added.
  • HPA036992 has been omitted due to qualitative reasons. An alternative antibody HPA066081 has been added.
  • HPA037369 antibody has been omitted due to target gene not found in Ensembl.
  • HPA037398 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA037429 has been omitted due to qualitative reasons.
  • HPA037430 has been omitted due to qualitative reasons.
  • HPA037465 has been omitted due to lack of RNA expression in cell line panel.
  • HPA037469 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA037470 has been omitted due to qualitative reasons.
  • HPA037481 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA037556 has been omitted due to lack of RNA expression in cell line panel.
  • HPA037587 has been omitted due to qualitative reasons.
  • HPA037596 has been omitted due to qualitative reasons.
  • HPA037694 has been omitted due to lack of RNA expression in cell line panel.
  • HPA037757 has been omitted due to qualitative reasons.
  • HPA037772 has been omitted due to qualitative reasons. An alternative antibody HPA037773 has been added.
  • HPA037795 has been omitted due to qualitative reasons.
  • HPA037824 has been omitted due to lack of RNA expression in cell line panel.
  • HPA037828 has been omitted due to antibody staining not supported by experimental data.
  • HPA037829 has been omitted due to antibody staining not supported by experimental data.
  • HPA037857 has been omitted due to antibody staining not supported by experimental data.
  • HPA037858 has been omitted due to antibody staining not supported by experimental data.
  • HPA037874 has been omitted due to antibody staining not supported by experimental data.
  • HPA037875 has been omitted due to antibody staining not supported by experimental data.
  • HPA037881 has been omitted due to qualitative reasons.
  • HPA037929 has been omitted due to qualitative reasons.
  • HPA037930 has been omitted due to qualitative reasons.
  • HPA037938 has been omitted due to qualitative reasons. An alternative antibody HPA037937 has been added.
  • HPA037959 has been omitted due to qualitative reasons. An alternative antibody HPA061506 has been added.
  • HPA037997 has been omitted due to qualitative reasons.
  • HPA037998 has been omitted due to qualitative reasons.
  • HPA038015 has been omitted due to qualitative reasons.
  • HPA038030 has been omitted due to qualitative reasons.
  • HPA038052 has been omitted due to qualitative reasons.
  • HPA038053 has been omitted due to antibody staining not supported by experimental data.
  • HPA038080 has been omitted due to lack of RNA expression in cell line panel.
  • HPA038081 has been omitted due to lack of RNA expression in cell line panel.
  • HPA038093 has been omitted due to qualitative reasons. An alternative antibody HPA028336 has been added.
  • HPA038115 has been omitted due to antibody staining not supported by experimental data.
  • HPA038231 has been omitted due to qualitative reasons.
  • HPA038248 has been omitted due to qualitative reasons. An alternative antibody HPA077591 has been added.
  • HPA038249 has been omitted due to qualitative reasons. An alternative antibody HPA077591 has been added.
  • HPA038258 has been omitted due to qualitative reasons.
  • HPA038259 has been omitted due to antibody staining not supported by experimental data.
  • HPA038287 has been omitted due to qualitative reasons.
  • HPA038296 has been omitted due to lack of RNA expression in cell line panel.
  • HPA038297 has been omitted due to qualitative reasons.
  • HPA038302 antibody has been omitted due to target gene not found in Ensembl.
  • HPA038396 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA038446 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA038475 has been omitted due to qualitative reasons.
  • HPA038486 has been omitted due to qualitative reasons. An alternative antibody HPA003311 has been added.
  • HPA038520 has been omitted due to qualitative reasons. An alternative antibody HPA057573 has been added.
  • HPA038525 has been omitted due to antibody staining not supported by experimental data.
  • HPA038533 has been omitted due to antibody staining not supported by experimental data.
  • HPA038548 has been omitted due to qualitative reasons.
  • HPA038577 has been omitted due to qualitative reasons.
  • HPA038591 has been omitted due to new images pending.
  • HPA038599 has been omitted due to qualitative reasons.
  • HPA038615 has been omitted due to qualitative reasons. An alternative antibody HPA058227 has been added.
  • HPA038624 has been omitted due to antibody staining not supported by experimental data.
  • HPA038653 has been omitted due to lack of RNA expression in cell line panel.
  • HPA038654 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA038675 has been omitted due to qualitative reasons. An alternative antibody HPA045912 has been added.
  • HPA038686 has been omitted due to antibody staining not supported by experimental data.
  • HPA038725 has been omitted due to qualitative reasons.
  • HPA038787 has been omitted due to qualitative reasons.
  • HPA038875 has been omitted due to qualitative reasons.
  • HPA038915 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines. An alternative antibody HPA038922 has been added.
  • HPA038928 has been omitted due to antibody staining not supported by experimental data.
  • HPA038929 has been omitted due to antibody staining not supported by experimental data.
  • HPA039043 has been omitted due to qualitative reasons. An alternative antibody HPA064572 has been added.
  • HPA039044 has been omitted due to qualitative reasons. An alternative antibody HPA064572 has been added.
  • HPA039064 has been omitted due to qualitative reasons. An alternative antibody HPA066488 has been added.
  • HPA039076 has been omitted due to qualitative reasons.
  • HPA039105 has been omitted due to qualitative reasons.
  • HPA039138 has been omitted due to qualitative reasons.
  • HPA039162 has been omitted due to qualitative reasons.
  • HPA039169 has been omitted due to antibody staining not supported by experimental data.
  • HPA039190 has been omitted due to qualitative reasons.
  • HPA039208 has been omitted due to lack of RNA expression in cell line panel.
  • HPA039232 has been omitted due to qualitative reasons.
  • CAB039239 has been omitted due to qualitative reasons.
  • HPA039253 has been omitted due to antibody staining not supported by experimental data. An alternative antibody HPA069055 has been added.
  • HPA039330 has been omitted due to antibody staining not supported by experimental data.
  • HPA039342 has been omitted due to antibody staining not supported by experimental data.
  • HPA039372 has been omitted due to qualitative reasons.
  • HPA039403 has been omitted due to qualitative reasons.
  • HPA039407 has been omitted due to antibody staining not supported by experimental data. An alternative antibody HPA070737 has been added.
  • HPA039416 has been omitted due to antibody staining not supported by experimental data.
  • HPA039451 has been omitted due to qualitative reasons.
  • HPA039461 has been omitted due to antibody staining not supported by experimental data.
  • HPA039467 has been omitted due to qualitative reasons.
  • HPA039480 has been omitted due to qualitative reasons.
  • HPA039533 has been omitted due to antibody staining not supported by experimental data.
  • HPA039543 has been omitted due to antibody staining not supported by experimental data.
  • HPA039562 has been omitted due to qualitative reasons.
  • HPA039566 has been omitted due to qualitative reasons.
  • HPA039588 has been omitted due to antibody staining not supported by experimental data.
  • HPA039613 has been omitted due to antibody staining not supported by experimental data.
  • HPA039617 has been omitted due to qualitative reasons.
  • HPA039627 has been omitted due to qualitative reasons.
  • HPA039671 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA039681 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA039691 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA039698 has been omitted due to qualitative reasons. An alternative antibody HPA040267 has been added.
  • HPA039704 has been omitted due to qualitative reasons.
  • HPA039736 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA039738 has been omitted due to qualitative reasons.
  • HPA039778 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA039780 has been omitted due to qualitative reasons.
  • HPA039825 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA039860 has been omitted due to lack of RNA expression in cell line panel.
  • HPA039908 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA039928 has been omitted due to qualitative reasons.
  • HPA039951 has been omitted due to qualitative reasons.
  • HPA040005 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA040028 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA040051 has been omitted due to qualitative reasons.
  • HPA040057 has been omitted due to antibody staining not supported by experimental data. An alternative antibody HPA070737 has been added.
  • HPA040096 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA040103 has been omitted due to antibody staining not supported by experimental data.
  • HPA040109 has been omitted due to antibody staining not supported by experimental data.
  • HPA040117 has been omitted due to lack of RNA expression in cell line panel.
  • HPA040143 has been omitted due to lack of RNA expression in cell line panel.
  • HPA040155 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA040159 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA040172 has been omitted due to antibody staining not supported by experimental data.
  • HPA040229 has been omitted due to qualitative reasons.
  • HPA040293 has been omitted due to qualitative reasons.
  • HPA040301 has been omitted due to qualitative reasons.
  • HPA040315 has been omitted due to qualitative reasons. An alternative antibody HPA063498 has been added.
  • HPA040336 has been omitted due to qualitative reasons.
  • HPA040355 has been omitted due to antibody staining not supported by experimental data.
  • HPA040386 has been omitted due to antibody staining not supported by experimental data.
  • HPA040390 has been omitted due to qualitative reasons.
  • HPA040391 has been omitted due to qualitative reasons.
  • HPA040410 has been omitted due to qualitative reasons.
  • HPA040411 has been omitted due to qualitative reasons.
  • HPA040419 has been omitted due to qualitative reasons.
  • HPA040439 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA040450 has been omitted due to qualitative reasons.
  • HPA040511 has been omitted due to qualitative reasons.
  • CAB040552 has been omitted due to qualitative reasons.
  • HPA040593 has been omitted due to qualitative reasons. An alternative antibody HPA069773 has been added.
  • HPA040595 has been omitted due to qualitative reasons.
  • HPA040650 has been omitted due to qualitative reasons.
  • HPA040661 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA040675 has been omitted due to qualitative reasons.
  • HPA040679 has been omitted due to qualitative reasons.
  • HPA040691 has been omitted due to qualitative reasons.
  • HPA040695 has been omitted due to lack of RNA expression in cell line panel.
  • HPA040726 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines. An alternative antibody HPA038922 has been added.
  • HPA040735 has been omitted due to qualitative reasons.
  • HPA040750 has been omitted due to qualitative reasons.
  • HPA040753 has been omitted due to qualitative reasons.
  • HPA040774 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA040803 has been omitted due to qualitative reasons. An alternative antibody HPA074173 has been added.
  • HPA040816 has been omitted due to antibody staining not supported by experimental data.
  • HPA040848 has been omitted due to qualitative reasons. An alternative antibody HPA066169 has been added.
  • HPA040855 has been omitted due to qualitative reasons.
  • HPA040868 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA040887 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA040891 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA040902 has been omitted due to qualitative reasons. An alternative antibody HPA069773 has been added.
  • HPA040915 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA040942 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA040959 has been omitted due to antibody staining not supported by experimental data.
  • HPA040967 has been omitted due to qualitative reasons. An alternative antibody HPA041553 has been added.
  • HPA040988 has been omitted due to qualitative reasons.
  • HPA040991 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA041005 has been omitted due to qualitative reasons.
  • HPA041016 has been omitted due to qualitative reasons.
  • HPA041023 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA041028 has been omitted due to qualitative reasons.
  • HPA041060 has been omitted due to qualitative reasons.
  • HPA041071 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA041072 has been omitted due to lack of RNA expression in cell line panel.
  • HPA041076 has been omitted due to qualitative reasons. An alternative antibody HPA048213 has been added.
  • HPA041131 has been omitted due to qualitative reasons.
  • HPA041222 has been omitted due to qualitative reasons.
  • HPA041228 has been omitted due to qualitative reasons.
  • HPA041343 has been omitted due to antibody staining not supported by experimental data.
  • HPA041412 has been omitted due to qualitative reasons. An alternative antibody HPA043503 has been added.
  • HPA041428 has been omitted due to qualitative reasons.
  • HPA041452 has been omitted due to qualitative reasons.
  • HPA041549 has been omitted due to qualitative reasons.
  • HPA041550 has been omitted due to antibody staining not supported by experimental data.
  • HPA041576 has been omitted due to lack of RNA expression in cell line panel.
  • HPA041592 has been omitted due to qualitative reasons. An alternative antibody HPA007200 has been added.
  • HPA041622 has been omitted due to qualitative reasons. An alternative antibody HPA064827 has been added.
  • HPA041646 has been omitted due to lack of RNA expression in cell line panel.
  • HPA041683 has been omitted due to qualitative reasons.
  • HPA041689 has been omitted due to qualitative reasons. An alternative antibody HPA061560 has been added.
  • HPA041699 has been omitted due to qualitative reasons.
  • HPA041719 has been omitted due to qualitative reasons.
  • HPA041749 has been omitted due to qualitative reasons.
  • HPA041811 has been omitted due to qualitative reasons.
  • HPA041824 has been omitted due to qualitative reasons. An alternative antibody HPA064645 has been added.
  • HPA041867 has been omitted due to qualitative reasons.
  • HPA041891 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA041925 has been omitted due to qualitative reasons. An alternative antibody HPA043219 has been added.
  • HPA041938 has been omitted due to qualitative reasons.
  • HPA041944 has been omitted due to qualitative reasons.
  • HPA041948 has been omitted due to antibody staining not supported by experimental data.
  • HPA041966 has been omitted due to qualitative reasons.
  • HPA041967 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA041992 has been omitted due to antibody staining not supported by experimental data.
  • HPA042001 has been omitted due to qualitative reasons.
  • HPA042005 has been omitted due to antibody staining not supported by experimental data.
  • HPA042009 has been omitted due to lack of RNA expression in cell line panel.
  • HPA042014 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA042026 has been omitted due to qualitative reasons.
  • HPA042058 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA042068 has been omitted due to qualitative reasons.
  • HPA042096 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA042098 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA042109 has been omitted due to antibody staining not supported by experimental data.
  • HPA042137 has been omitted due to qualitative reasons.
  • HPA042182 has been omitted due to qualitative reasons.
  • HPA042193 has been omitted due to qualitative reasons. An alternative antibody HPA061805 has been added.
  • HPA042231 has been omitted due to qualitative reasons.
  • HPA042275 has been omitted due to qualitative reasons. An alternative antibody HPA067433 has been added.
  • HPA042282 has been omitted due to qualitative reasons.
  • HPA042344 has been omitted due to antibody staining not supported by experimental data.
  • HPA042360 has been omitted due to qualitative reasons.
  • HPA042455 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA042481 has been omitted due to qualitative reasons. An alternative antibody HPA066764 has been added.
  • HPA042504 has been omitted due to qualitative reasons.
  • HPA042546 has been omitted due to qualitative reasons.
  • HPA042567 has been omitted due to qualitative reasons. An alternative antibody HPA048658 has been added.
  • HPA042598 has been omitted due to qualitative reasons.
  • HPA042601 has been omitted due to qualitative reasons. An alternative antibody HPA035157 has been added.
  • HPA042603 has been omitted due to qualitative reasons. An alternative antibody HPA057952 has been added.
  • HPA042613 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA042631 has been omitted due to lack of RNA expression in cell line panel.
  • HPA042654 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA042658 has been omitted due to qualitative reasons. An alternative antibody HPA041427 has been added.
  • HPA042685 has been omitted due to antibody staining not supported by experimental data.
  • HPA042709 has been omitted due to antibody staining not supported by experimental data.
  • HPA042779 has been omitted due to qualitative reasons.
  • HPA042813 has been omitted due to qualitative reasons. An alternative antibody HPA042759 has been added.
  • HPA042839 has been omitted due to qualitative reasons.
  • HPA042844 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA042910 has been omitted due to qualitative reasons.
  • HPA042975 has been omitted due to qualitative reasons.
  • HPA043004 has been omitted due to lack of RNA expression in cell line panel.
  • HPA043047 has been omitted due to qualitative reasons.
  • HPA043066 has been omitted due to qualitative reasons.
  • HPA043121 has been omitted due to lack of RNA expression in cell line panel.
  • HPA043140 has been omitted due to qualitative reasons.
  • HPA043198 has been omitted due to qualitative reasons. An alternative antibody HPA017327 has been added.
  • HPA043208 has been omitted due to qualitative reasons.
  • HPA043237 has been omitted due to qualitative reasons. An alternative antibody HPA056980 has been added.
  • HPA043260 has been omitted due to antibody staining not supported by experimental data.
  • HPA043266 has been omitted due to qualitative reasons. An alternative antibody HPA060174 has been added.
  • HPA043270 has been omitted due to qualitative reasons.
  • HPA043358 has been omitted due to antibody staining not supported by experimental data.
  • HPA043368 has been omitted due to antibody staining not supported by experimental data. An alternative antibody HPA076524 has been added.
  • HPA043437 has been omitted due to antibody staining not supported by experimental data.
  • HPA043470 has been omitted due to qualitative reasons.
  • HPA043478 has been omitted due to qualitative reasons. An alternative antibody HPA060158 has been added.
  • HPA043582 has been omitted due to antibody staining not supported by experimental data.
  • HPA043606 has been omitted due to qualitative reasons.
  • HPA043613 has been omitted due to qualitative reasons.
  • HPA043665 has been omitted due to antibody staining not supported by experimental data.
  • HPA043680 antibody has been omitted due to target gene not found in Ensembl.
  • HPA043701 has been omitted due to qualitative reasons.
  • HPA043737 has been omitted due to antibody staining not supported by experimental data.
  • HPA043741 has been omitted due to qualitative reasons. An alternative antibody HPA061441 has been added.
  • HPA043810 has been omitted due to qualitative reasons. An alternative antibody HPA053554 has been added.
  • HPA043833 has been omitted due to qualitative reasons.
  • HPA043839 has been omitted due to qualitative reasons. An alternative antibody HPA066490 has been added.
  • HPA043847 has been omitted due to antibody staining not supported by experimental data.
  • HPA043852 has been omitted due to antibody staining not supported by experimental data.
  • HPA043915 has been omitted due to qualitative reasons.
  • HPA044004 has been omitted due to new images pending.
  • HPA044113 has been omitted due to qualitative reasons. An alternative antibody HPA040396 has been added.
  • HPA044133 has been omitted due to qualitative reasons.
  • HPA044145 has been omitted due to lack of RNA expression in cell line panel.
  • HPA044201 has been omitted due to qualitative reasons.
  • HPA044231 has been omitted due to qualitative reasons.
  • HPA044232 has been omitted due to qualitative reasons.
  • HPA044322 has been omitted due to antibody staining not supported by experimental data.
  • HPA044378 has been omitted due to qualitative reasons.
  • HPA044440 has been omitted due to qualitative reasons.
  • HPA044460 has been omitted due to qualitative reasons.
  • HPA044550 has been omitted due to lack of RNA expression in cell line panel.
  • HPA044581 has been omitted due to qualitative reasons. An alternative antibody HPA057498 has been added.
  • HPA044592 has been omitted due to antibody staining not supported by experimental data.
  • HPA044676 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA044731 antibody has been omitted due to target gene not found in Ensembl.
  • HPA044736 has been omitted due to qualitative reasons.
  • HPA044806 antibody has been omitted due to target gene not found in Ensembl.
  • HPA044834 antibody has been omitted due to target gene not found in Ensembl.
  • HPA044858 has been omitted due to qualitative reasons. An alternative antibody HPA034609 has been added.
  • HPA044867 has been omitted due to qualitative reasons. An alternative antibody HPA035957 has been added.
  • HPA044875 has been omitted due to qualitative reasons.
  • HPA044885 has been omitted due to lack of RNA expression in cell line panel. An alternative antibody HPA051925 has been added.
  • HPA044978 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA044982 has been omitted due to qualitative reasons.
  • HPA045018 has been omitted due to qualitative reasons.
  • HPA045056 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA045165 has been omitted due to qualitative reasons. An alternative antibody HPA071709 has been added.
  • HPA045224 has been omitted due to antibody staining not supported by experimental data.
  • HPA045282 has been omitted due to antibody staining not supported by experimental data. An alternative antibody HPA050325 has been added.
  • HPA045377 has been omitted due to qualitative reasons.
  • HPA045473 has been omitted due to qualitative reasons.
  • HPA045549 has been omitted due to qualitative reasons.
  • HPA045579 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA045663 has been omitted due to qualitative reasons. An alternative antibody HPA050553 has been added.
  • HPA045753 has been omitted due to qualitative reasons. An alternative antibody HPA054396 has been added.
  • HPA045781 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA045827 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA045899 has been omitted due to qualitative reasons.
  • HPA045909 has been omitted due to qualitative reasons.
  • HPA046076 has been omitted due to antibody staining not supported by experimental data.
  • HPA046094 has been omitted due to qualitative reasons. An alternative antibody HPA040427 has been added.
  • HPA046223 has been omitted due to qualitative reasons.
  • HPA046300 has been omitted due to qualitative reasons.
  • HPA046398 has been omitted due to qualitative reasons. An alternative antibody HPA042759 has been added.
  • HPA046440 has been omitted due to qualitative reasons.
  • HPA046546 has been omitted due to qualitative reasons. An alternative antibody CAB005337 has been added.
  • HPA046570 has been omitted due to qualitative reasons.
  • HPA046571 has been omitted due to qualitative reasons.
  • HPA046628 has been omitted due to qualitative reasons. An alternative antibody HPA028957 has been added.
  • HPA046679 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines. An alternative antibody HPA030843 has been added.
  • HPA046724 has been omitted due to qualitative reasons.
  • HPA046751 has been omitted due to qualitative reasons.
  • HPA046756 has been omitted due to antibody staining not supported by experimental data.
  • HPA046784 has been omitted due to qualitative reasons. An alternative antibody HPA072371 has been added.
  • HPA046791 has been omitted due to qualitative reasons.
  • HPA046795 has been omitted due to qualitative reasons.
  • HPA046797 has been omitted due to qualitative reasons.
  • HPA046880 has been omitted due to lack of RNA expression in cell line panel.
  • HPA046888 has been omitted due to qualitative reasons.
  • HPA046909 has been omitted due to antibody staining not supported by experimental data.
  • HPA047036 has been omitted due to qualitative reasons. An alternative antibody HPA058554 has been added.
  • HPA047037 has been omitted due to qualitative reasons. An alternative antibody HPA064515 has been added.
  • HPA047117 has been omitted due to qualitative reasons. An alternative antibody HPA060198 has been added.
  • HPA047126 has been omitted due to qualitative reasons.
  • HPA047148 has been omitted due to antibody staining not supported by experimental data.
  • HPA047151 has been omitted due to antibody staining not supported by experimental data.
  • HPA047207 has been omitted due to qualitative reasons.
  • HPA047213 has been omitted due to qualitative reasons.
  • HPA047228 has been omitted due to qualitative reasons.
  • HPA047290 has been omitted due to qualitative reasons.
  • CAB047318 has been omitted due to qualitative reasons.
  • CAB047327 has been omitted due to qualitative reasons.
  • CAB047339 has been omitted due to qualitative reasons.
  • CAB047340 has been omitted due to qualitative reasons.
  • HPA047368 has been omitted due to qualitative reasons.
  • HPA047546 has been omitted due to antibody staining not supported by experimental data.
  • HPA047554 has been omitted due to qualitative reasons. An alternative antibody HPA074408 has been added.
  • HPA047562 has been omitted due to antibody staining not supported by experimental data.
  • HPA047605 has been omitted due to antibody staining not supported by experimental data. An alternative antibody HPA039601 has been added.
  • HPA047793 has been omitted due to qualitative reasons.
  • HPA047798 has been omitted due to qualitative reasons.
  • HPA047859 has been omitted due to antibody staining not supported by experimental data.
  • HPA047862 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA047903 has been omitted due to qualitative reasons.
  • HPA047904 has been omitted due to qualitative reasons.
  • HPA047922 has been omitted due to qualitative reasons.
  • HPA048121 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA048253 has been omitted due to qualitative reasons.
  • HPA048306 has been omitted due to antibody staining not supported by experimental data.
  • HPA048332 has been omitted due to qualitative reasons.
  • HPA048340 has been omitted due to qualitative reasons.
  • HPA048440 has been omitted due to qualitative reasons.
  • HPA048472 has been omitted due to qualitative reasons.
  • HPA048494 has been omitted due to qualitative reasons.
  • HPA048531 has been omitted due to qualitative reasons. An alternative antibody HPA066469 has been added.
  • HPA048549 has been omitted due to qualitative reasons. An alternative antibody HPA074132 has been added.
  • HPA048566 has been omitted due to qualitative reasons.
  • HPA048582 has been omitted due to lack of RNA expression in cell line panel.
  • HPA048635 has been omitted due to lack of RNA expression in cell line panel.
  • HPA048801 has been omitted due to qualitative reasons.
  • HPA048808 has been omitted due to qualitative reasons. An alternative antibody HPA072587 has been added.
  • HPA048818 has been omitted due to antibody staining not supported by experimental data.
  • HPA048866 has been omitted due to qualitative reasons.
  • HPA048871 has been omitted due to qualitative reasons.
  • HPA048939 has been omitted due to qualitative reasons. An alternative antibody HPA057749 has been added.
  • HPA049079 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA049081 has been omitted due to qualitative reasons.
  • HPA049101 has been omitted due to antibody staining not supported by experimental data. An alternative antibody HPA027530 has been added.
  • HPA049105 has been omitted due to qualitative reasons.
  • HPA049143 has been omitted due to qualitative reasons. An alternative antibody HPA070386 has been added.
  • HPA049272 has been omitted due to qualitative reasons.
  • HPA049277 has been omitted due to qualitative reasons. An alternative antibody HPA063895 has been added.
  • HPA049361 has been omitted due to qualitative reasons. An alternative antibody HPA067487 has been added.
  • HPA049447 has been omitted due to qualitative reasons.
  • HPA049549 has been omitted due to antibody staining not supported by experimental data.
  • HPA049560 has been omitted due to antibody staining not supported by experimental data. An alternative antibody HPA066330 has been added.
  • HPA049564 has been omitted due to qualitative reasons.
  • HPA049622 has been omitted due to antibody staining not supported by experimental data.
  • HPA049634 has been omitted due to qualitative reasons.
  • HPA049651 has been omitted due to qualitative reasons. An alternative antibody CAB037133 has been added.
  • HPA049655 has been omitted due to antibody staining not supported by experimental data.
  • HPA049657 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA049678 has been omitted due to antibody staining not supported by experimental data.
  • HPA049777 has been omitted due to qualitative reasons.
  • HPA049809 has been omitted due to antibody staining not supported by experimental data.
  • HPA049811 has been omitted due to qualitative reasons. An alternative antibody HPA065052 has been added.
  • HPA049815 has been omitted due to qualitative reasons. An alternative antibody HPA070386 has been added.
  • HPA049832 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA049974 has been omitted due to qualitative reasons.
  • HPA050270 has been omitted due to qualitative reasons. An alternative antibody HPA067491 has been added.
  • HPA050344 has been omitted due to qualitative reasons.
  • HPA050359 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA050414 has been omitted due to qualitative reasons.
  • HPA050480 has been omitted due to qualitative reasons.
  • HPA050528 has been omitted due to antibody staining not supported by experimental data. An alternative antibody HPA063577 has been added.
  • HPA050541 has been omitted due to lack of RNA expression in cell line panel.
  • HPA050560 has been omitted due to qualitative reasons.
  • HPA050593 has been omitted due to qualitative reasons.
  • HPA050647 has been omitted due to qualitative reasons.
  • HPA050796 has been omitted due to qualitative reasons.
  • HPA051061 has been omitted due to qualitative reasons. An alternative antibody HPA018945 has been added.
  • HPA051105 has been omitted due to qualitative reasons.
  • HPA051123 has been omitted due to qualitative reasons.
  • HPA051208 has been omitted due to qualitative reasons. An alternative antibody HPA060565 has been added.
  • HPA051384 has been omitted due to antibody staining not supported by experimental data. An alternative antibody HPA058384 has been added.
  • HPA051397 has been omitted due to qualitative reasons.
  • HPA051421 has been omitted due to qualitative reasons.
  • HPA051427 has been omitted due to qualitative reasons. An alternative antibody HPA059960 has been added.
  • HPA051487 has been omitted due to qualitative reasons. An alternative antibody HPA060238 has been added.
  • HPA051492 has been omitted due to qualitative reasons. An alternative antibody HPA059518 has been added.
  • HPA051582 has been omitted due to qualitative reasons.
  • HPA051592 has been omitted due to qualitative reasons. An alternative antibody HPA021661 has been added.
  • HPA051606 has been omitted due to qualitative reasons.
  • HPA051620 has been omitted due to qualitative reasons.
  • HPA051627 has been omitted due to antibody staining not supported by experimental data.
  • HPA051638 has been omitted due to antibody staining not supported by experimental data.
  • HPA051639 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA051677 has been omitted due to qualitative reasons.
  • HPA051748 has been omitted due to qualitative reasons. An alternative antibody CAB016326 has been added.
  • HPA051749 has been omitted due to antibody staining not supported by experimental data.
  • HPA051885 has been omitted due to qualitative reasons. An alternative antibody HPA062852 has been added.
  • HPA051900 has been omitted due to qualitative reasons. An alternative antibody HPA060251 has been added.
  • HPA051912 has been omitted due to qualitative reasons. An alternative antibody HPA063283 has been added.
  • HPA051948 has been omitted due to qualitative reasons.
  • HPA051998 has been omitted due to qualitative reasons.
  • HPA052061 has been omitted due to qualitative reasons.
  • HPA052147 has been omitted due to lack of RNA expression in cell line panel.
  • HPA052154 has been omitted due to antibody staining not supported by experimental data.
  • HPA052157 has been omitted due to qualitative reasons. An alternative antibody HPA044383 has been added.
  • HPA052170 has been omitted due to qualitative reasons. An alternative antibody HPA016812 has been added.
  • HPA052205 has been omitted due to qualitative reasons. An alternative antibody HPA042932 has been added.
  • HPA052242 has been omitted due to qualitative reasons.
  • HPA052246 has been omitted due to antibody staining not supported by experimental data. An alternative antibody HPA058335 has been added.
  • HPA052278 has been omitted due to qualitative reasons.
  • HPA052329 has been omitted due to lack of RNA expression in cell line panel.
  • HPA052458 has been omitted due to qualitative reasons. An alternative antibody HPA046189 has been added.
  • HPA052461 has been omitted due to antibody staining not supported by experimental data.
  • HPA052542 antibody has been omitted due to target gene not found in Ensembl.
  • HPA052596 has been omitted due to qualitative reasons.
  • HPA052603 has been omitted due to qualitative reasons.
  • HPA052663 has been omitted due to qualitative reasons. An alternative antibody HPA048174 has been added.
  • HPA052690 has been omitted due to qualitative reasons.
  • HPA052751 has been omitted due to qualitative reasons.
  • HPA052758 has been omitted due to antibody staining not supported by experimental data.
  • HPA052776 has been omitted due to qualitative reasons. An alternative antibody HPA074408 has been added.
  • HPA052782 has been omitted due to qualitative reasons.
  • HPA052862 has been omitted due to qualitative reasons.
  • HPA052977 has been omitted due to antibody staining not supported by experimental data. An alternative antibody HPA046537 has been added.
  • HPA053037 has been omitted due to antibody staining not supported by experimental data. An alternative antibody HPA044383 has been added.
  • HPA053038 has been omitted due to qualitative reasons.
  • HPA053047 has been omitted due to qualitative reasons.
  • HPA053051 has been omitted due to qualitative reasons.
  • HPA053052 has been omitted due to qualitative reasons. An alternative antibody HPA023948 has been added.
  • HPA053097 has been omitted due to antibody staining not supported by experimental data.
  • HPA053136 has been omitted due to antibody staining not supported by experimental data.
  • HPA053141 has been omitted due to antibody staining not supported by experimental data. An alternative antibody HPA072532 has been added.
  • HPA053162 has been omitted due to qualitative reasons.
  • HPA053177 has been omitted due to antibody staining not supported by experimental data. An alternative antibody HPA072399 has been added.
  • HPA053233 has been omitted due to qualitative reasons.
  • HPA053237 has been omitted due to qualitative reasons.
  • HPA053280 has been omitted due to qualitative reasons.
  • HPA053290 has been omitted due to qualitative reasons. An alternative antibody HPA049852 has been added.
  • HPA053299 has been omitted due to antibody staining not supported by experimental data.
  • HPA053367 has been omitted due to qualitative reasons.
  • HPA053383 has been omitted due to antibody staining not supported by experimental data.
  • HPA053389 has been omitted due to qualitative reasons. An alternative antibody HPA043930 has been added.
  • HPA053413 has been omitted due to qualitative reasons.
  • HPA053419 has been omitted due to antibody staining not supported by experimental data.
  • HPA053444 has been omitted due to lack of RNA expression in cell line panel.
  • HPA053515 has been omitted due to antibody staining not supported by experimental data.
  • HPA053523 has been omitted due to qualitative reasons. An alternative antibody HPA065052 has been added.
  • HPA053533 has been omitted due to qualitative reasons. An alternative antibody HPA069684 has been added.
  • HPA053616 has been omitted due to qualitative reasons. An alternative antibody HPA063157 has been added.
  • HPA053651 has been omitted due to qualitative reasons. An alternative antibody HPA075134 has been added.
  • HPA053656 has been omitted due to qualitative reasons.
  • HPA053686 has been omitted due to qualitative reasons.
  • HPA053702 has been omitted due to antibody staining not supported by experimental data.
  • HPA053703 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA053815 has been omitted due to qualitative reasons. An alternative antibody HPA063982 has been added.
  • HPA053841 has been omitted due to antibody staining not supported by experimental data.
  • HPA053893 has been omitted due to qualitative reasons.
  • HPA053905 has been omitted due to antibody staining not supported by experimental data.
  • HPA053976 has been omitted due to antibody staining not supported by experimental data.
  • HPA054041 has been omitted due to qualitative reasons. An alternative antibody HPA011318 has been added.
  • HPA054132 has been omitted due to antibody staining not supported by experimental data.
  • HPA054236 has been omitted due to qualitative reasons.
  • HPA054237 has been omitted due to qualitative reasons.
  • HPA054272 has been omitted due to qualitative reasons. An alternative antibody HPA074011 has been added.
  • HPA054290 has been omitted due to qualitative reasons.
  • HPA054302 has been omitted due to qualitative reasons.
  • HPA054309 has been omitted due to antibody staining not supported by experimental data.
  • HPA054330 has been omitted due to qualitative reasons.
  • HPA054371 has been omitted due to qualitative reasons.
  • HPA054419 has been omitted due to qualitative reasons.
  • HPA054444 has been omitted due to qualitative reasons.
  • HPA054464 has been omitted due to qualitative reasons.
  • HPA054479 has been omitted due to qualitative reasons.
  • HPA054562 has been omitted due to qualitative reasons.
  • HPA054601 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA054743 has been omitted due to antibody staining not supported by experimental data.
  • HPA054746 has been omitted due to qualitative reasons.
  • HPA054755 has been omitted due to qualitative reasons.
  • HPA054759 has been omitted due to qualitative reasons. An alternative antibody HPA051823 has been added.
  • HPA054836 antibody has been omitted due to target gene not found in Ensembl.
  • HPA054857 has been omitted due to qualitative reasons. An alternative antibody HPA070550 has been added.
  • HPA054895 has been omitted due to qualitative reasons.
  • HPA054916 has been omitted due to antibody staining not supported by experimental data. An alternative antibody HPA067881 has been added.
  • HPA054917 has been omitted due to qualitative reasons.
  • HPA054936 has been omitted due to qualitative reasons.
  • HPA054960 has been omitted due to qualitative reasons.
  • HPA055002 has been omitted due to lack of RNA expression in cell line panel.
  • HPA055116 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA055160 has been omitted due to qualitative reasons. An alternative antibody HPA071396 has been added.
  • HPA055288 has been omitted due to antibody staining not supported by experimental data.
  • HPA055297 has been omitted due to qualitative reasons. An alternative antibody HPA015794 has been added.
  • HPA055361 has been omitted due to antibody staining not supported by experimental data.
  • HPA055372 has been omitted due to qualitative reasons. An alternative antibody HPA078659 has been added.
  • HPA055444 has been omitted due to qualitative reasons. An alternative antibody HPA047929 has been added.
  • HPA055483 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA055536 has been omitted due to antibody staining not supported by experimental data.
  • HPA055550 has been omitted due to antibody staining not supported by experimental data.
  • HPA055579 has been omitted due to antibody staining not supported by experimental data. An alternative antibody HPA030288 has been added.
  • HPA055599 has been omitted due to qualitative reasons. An alternative antibody HPA063472 has been added.
  • HPA055664 has been omitted due to antibody staining not supported by experimental data.
  • HPA055678 has been omitted due to qualitative reasons. An alternative antibody HPA043275 has been added.
  • HPA055693 has been omitted due to qualitative reasons.
  • HPA055757 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA055795 has been omitted due to antibody staining not supported by experimental data.
  • HPA055847 has been omitted due to qualitative reasons. An alternative antibody HPA072469 has been added.
  • HPA055904 has been omitted due to new images pending.
  • HPA056046 has been omitted due to qualitative reasons.
  • HPA056056 has been omitted due to qualitative reasons.
  • HPA056112 has been omitted due to qualitative reasons.
  • HPA056125 has been omitted due to qualitative reasons.
  • HPA056297 has been omitted due to qualitative reasons. An alternative antibody HPA049933 has been added.
  • HPA056304 has been omitted due to qualitative reasons. An alternative antibody HPA047860 has been added.
  • HPA056393 has been omitted due to lack of RNA expression in cell line panel.
  • HPA056449 has been omitted due to qualitative reasons.
  • HPA056509 has been omitted due to antibody staining not supported by experimental data.
  • HPA056548 has been omitted due to qualitative reasons.
  • HPA056563 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA056574 has been omitted due to antibody staining not supported by experimental data.
  • HPA056609 has been omitted due to qualitative reasons.
  • HPA056650 has been omitted due to antibody staining not supported by experimental data.
  • HPA056782 has been omitted due to qualitative reasons.
  • HPA056862 has been omitted due to antibody staining not supported by experimental data.
  • HPA056911 has been omitted due to qualitative reasons. An alternative antibody HPA069214 has been added.
  • HPA056920 has been omitted due to qualitative reasons.
  • HPA056933 has been omitted due to qualitative reasons.
  • HPA056951 has been omitted due to antibody staining not supported by experimental data.
  • HPA056990 has been omitted due to qualitative reasons. An alternative antibody CAB034019 has been added.
  • HPA057135 has been omitted due to qualitative reasons.
  • HPA057165 has been omitted due to qualitative reasons.
  • HPA057168 has been omitted due to qualitative reasons.
  • HPA057275 has been omitted due to qualitative reasons. An alternative antibody HPA021166 has been added.
  • HPA057276 has been omitted due to qualitative reasons. An alternative antibody HPA066190 has been added.
  • HPA057284 has been omitted due to qualitative reasons. An alternative antibody HPA052217 has been added.
  • HPA057293 has been omitted due to qualitative reasons.
  • HPA057300 has been omitted due to qualitative reasons.
  • HPA057315 has been omitted due to qualitative reasons.
  • HPA057469 has been omitted due to qualitative reasons.
  • HPA057480 has been omitted due to qualitative reasons. An alternative antibody HPA068537 has been added.
  • HPA057489 has been omitted due to qualitative reasons.
  • HPA057518 has been omitted due to qualitative reasons.
  • HPA057540 has been omitted due to qualitative reasons.
  • HPA057541 has been omitted due to qualitative reasons.
  • HPA057578 has been omitted due to qualitative reasons.
  • HPA057607 has been omitted due to qualitative reasons.
  • HPA057793 has been omitted due to qualitative reasons.
  • HPA057913 has been omitted due to qualitative reasons.
  • HPA057939 has been omitted due to qualitative reasons.
  • HPA058060 has been omitted due to qualitative reasons. An alternative antibody HPA067575 has been added.
  • HPA058149 has been omitted due to qualitative reasons.
  • HPA058159 has been omitted due to qualitative reasons. An alternative antibody HPA036283 has been added.
  • HPA058193 has been omitted due to qualitative reasons.
  • HPA058198 has been omitted due to antibody staining not supported by experimental data.
  • HPA058279 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA058375 has been omitted due to antibody staining not supported by experimental data. An alternative antibody HPA001400 has been added.
  • HPA058376 has been omitted due to qualitative reasons.
  • HPA058473 has been omitted due to qualitative reasons.
  • HPA058561 has been omitted due to qualitative reasons.
  • HPA058573 has been omitted due to antibody staining not supported by experimental data.
  • HPA058611 has been omitted due to qualitative reasons.
  • HPA058659 has been omitted due to qualitative reasons.
  • HPA058745 has been omitted due to qualitative reasons.
  • HPA058842 has been omitted due to antibody staining not supported by experimental data.
  • HPA058848 has been omitted due to qualitative reasons.
  • HPA058854 has been omitted due to antibody staining not supported by experimental data.
  • HPA058875 has been omitted due to antibody staining not supported by experimental data.
  • HPA059000 has been omitted due to qualitative reasons. An alternative antibody HPA061321 has been added.
  • HPA059005 has been omitted due to qualitative reasons. An alternative antibody HPA022432 has been added.
  • HPA059014 has been omitted due to qualitative reasons. An alternative antibody HPA029311 has been added.
  • HPA059057 has been omitted due to qualitative reasons. An alternative antibody HPA070326 has been added.
  • HPA059202 has been omitted due to qualitative reasons.
  • HPA059247 has been omitted due to qualitative reasons. An alternative antibody HPA067042 has been added.
  • HPA059318 has been omitted due to antibody staining not supported by experimental data.
  • HPA059333 has been omitted due to qualitative reasons.
  • HPA059359 has been omitted due to qualitative reasons.
  • HPA059460 has been omitted due to qualitative reasons. An alternative antibody HPA071287 has been added.
  • HPA059476 has been omitted due to antibody staining not supported by experimental data. An alternative antibody HPA067071 has been added.
  • HPA059607 has been omitted due to qualitative reasons.
  • HPA059734 has been omitted due to qualitative reasons. An alternative antibody HPA076168 has been added.
  • HPA059851 has been omitted due to qualitative reasons.
  • HPA059881 has been omitted due to qualitative reasons.
  • HPA059970 has been omitted due to qualitative reasons. An alternative antibody HPA068156 has been added.
  • HPA060132 has been omitted due to qualitative reasons.
  • HPA060215 has been omitted due to qualitative reasons.
  • HPA060360 has been omitted due to qualitative reasons.
  • HPA060475 has been omitted due to qualitative reasons.
  • HPA060554 has been omitted due to antibody staining not supported by experimental data.
  • HPA060559 has been omitted due to qualitative reasons.
  • HPA060614 has been omitted due to qualitative reasons. An alternative antibody HPA072319 has been added.
  • HPA060685 has been omitted due to qualitative reasons. An alternative antibody HPA068337 has been added.
  • HPA060806 has been omitted due to qualitative reasons.
  • HPA061073 has been omitted due to qualitative reasons.
  • HPA061075 has been omitted due to qualitative reasons.
  • HPA061140 has been omitted due to qualitative reasons.
  • HPA061191 has been omitted due to qualitative reasons. An alternative antibody HPA048142 has been added.
  • HPA061243 has been omitted due to qualitative reasons. An alternative antibody HPA071252 has been added.
  • HPA061332 has been omitted due to qualitative reasons.
  • HPA061344 has been omitted due to antibody staining not supported by experimental data.
  • HPA061413 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA061434 has been omitted due to qualitative reasons.
  • HPA061533 has been omitted due to antibody staining not supported by experimental data.
  • HPA061570 has been omitted due to qualitative reasons.
  • HPA061761 has been omitted due to antibody staining not supported by experimental data.
  • HPA061793 has been omitted due to qualitative reasons. An alternative antibody HPA020626 has been added.
  • HPA061812 has been omitted due to qualitative reasons.
  • HPA061845 has been omitted due to antibody staining not supported by experimental data.
  • HPA061854 has been omitted due to qualitative reasons.
  • HPA061923 has been omitted due to antibody staining not supported by experimental data. An alternative antibody HPA077474 has been added.
  • HPA062047 has been omitted due to qualitative reasons. An alternative antibody HPA072587 has been added.
  • HPA062249 has been omitted due to antibody staining not supported by experimental data.
  • HPA062365 has been omitted due to qualitative reasons.
  • HPA062439 has been omitted due to qualitative reasons. An alternative antibody HPA066670 has been added.
  • HPA062620 has been omitted due to qualitative reasons.
  • HPA062644 has been omitted due to antibody staining not supported by experimental data.
  • HPA062723 has been omitted due to antibody staining not supported by experimental data.
  • HPA062735 has been omitted due to qualitative reasons.
  • HPA062915 has been omitted due to lack of RNA expression in cell line panel.
  • HPA062933 has been omitted due to qualitative reasons.
  • HPA062936 has been omitted due to antibody staining not supported by experimental data.
  • HPA062987 has been omitted due to qualitative reasons. An alternative antibody CAB011596 has been added.
  • HPA063019 has been omitted due to qualitative reasons.
  • HPA063020 has been omitted due to qualitative reasons. An alternative antibody HPA036739 has been added.
  • HPA063069 has been omitted due to qualitative reasons.
  • HPA063073 has been omitted due to qualitative reasons. An alternative antibody HPA045646 has been added.
  • HPA063102 has been omitted due to qualitative reasons. An alternative antibody HPA072291 has been added.
  • HPA063258 has been omitted due to qualitative reasons. An alternative antibody HPA046428 has been added.
  • HPA063478 has been omitted due to antibody staining not supported by experimental data.
  • HPA063512 has been omitted due to qualitative reasons.
  • HPA063861 has been omitted due to qualitative reasons.
  • HPA063899 has been omitted due to qualitative reasons.
  • HPA063918 has been omitted due to qualitative reasons.
  • HPA063976 has been omitted due to qualitative reasons. An alternative antibody HPA069750 has been added.
  • HPA063991 has been omitted due to qualitative reasons.
  • HPA064147 has been omitted due to qualitative reasons.
  • HPA064166 has been omitted due to qualitative reasons.
  • HPA064211 has been omitted due to qualitative reasons. An alternative antibody HPA069119 has been added.
  • HPA064429 has been omitted due to qualitative reasons.
  • HPA064441 has been omitted due to qualitative reasons.
  • HPA064527 has been omitted due to antibody staining not supported by experimental data.
  • HPA064560 has been omitted due to qualitative reasons.
  • HPA064566 has been omitted due to antibody staining not supported by experimental data. An alternative antibody HPA036739 has been added.
  • HPA064746 has been omitted due to qualitative reasons.
  • HPA064837 has been omitted due to qualitative reasons. An alternative antibody HPA040427 has been added.
  • HPA064854 has been omitted due to qualitative reasons. An alternative antibody HPA069752 has been added.
  • HPA064857 has been omitted due to qualitative reasons.
  • HPA065223 has been omitted due to qualitative reasons. An alternative antibody HPA055132 has been added.
  • HPA065278 has been omitted due to qualitative reasons. An alternative antibody HPA026305 has been added.
  • HPA065391 has been omitted due to qualitative reasons. An alternative antibody HPA056308 has been added.
  • HPA065459 has been omitted due to qualitative reasons.
  • HPA065682 has been omitted due to qualitative reasons. An alternative antibody HPA068819 has been added.
  • HPA065734 has been omitted due to qualitative reasons.
  • HPA065758 has been omitted due to qualitative reasons.
  • HPA065777 has been omitted due to qualitative reasons. An alternative antibody HPA069119 has been added.
  • HPA065832 has been omitted due to qualitative reasons.
  • HPA065870 has been omitted due to antibody staining not supported by experimental data. An alternative antibody HPA058870 has been added.
  • HPA066008 has been omitted due to qualitative reasons. An alternative antibody HPA059495 has been added.
  • HPA066144 has been omitted due to qualitative reasons.
  • HPA066188 has been omitted due to antibody staining not supported by experimental data.
  • HPA066326 has been omitted due to qualitative reasons.
  • HPA066374 has been omitted due to qualitative reasons. An alternative antibody HPA058532 has been added.
  • HPA066466 has been omitted due to antibody staining not supported by experimental data.
  • HPA066618 has been omitted due to qualitative reasons.
  • HPA066721 has been omitted due to qualitative reasons.
  • HPA066797 has been omitted due to qualitative reasons.
  • HPA066888 has been omitted due to antibody staining not supported by experimental data.
  • HPA066926 has been omitted due to antibody staining not supported by experimental data.
  • HPA067377 has been omitted due to qualitative reasons. An alternative antibody HPA072229 has been added.
  • HPA067471 has been omitted due to qualitative reasons.
  • HPA067558 has been omitted due to qualitative reasons. An alternative antibody HPA039601 has been added.
  • HPA067579 has been omitted due to qualitative reasons. An alternative antibody HPA060537 has been added.
  • HPA067596 has been omitted due to qualitative reasons. An alternative antibody HPA060593 has been added.
  • HPA067671 has been omitted due to antibody staining not supported by experimental data.
  • HPA067895 has been omitted due to qualitative reasons.
  • HPA067913 has been omitted due to antibody staining not supported by experimental data.
  • HPA068036 has been omitted due to antibody staining not supported by experimental data.
  • HPA068463 has been omitted due to antibody staining not supported by experimental data. An alternative antibody CAB015186 has been added.
  • HPA068473 has been omitted due to antibody staining not supported by experimental data.
  • HPA068671 has been omitted due to qualitative reasons. An alternative antibody HPA061017 has been added.
  • HPA069105 has been omitted due to qualitative reasons.
  • HPA069252 has been omitted due to qualitative reasons.
  • HPA069346 has been omitted due to antibody staining not supported by experimental data. An alternative antibody HPA057484 has been added.
  • HPA069517 has been omitted due to antibody staining not supported by experimental data.
  • HPA070119 antibody has been omitted due to target gene not found in Ensembl.
  • HPA071268 has been omitted due to qualitative reasons. An alternative antibody HPA065332 has been added.
  • HPA071327 has been omitted due to qualitative reasons. An alternative antibody HPA053275 has been added.
  • HPA071536 has been omitted due to qualitative reasons. An alternative antibody HPA073875 has been added.
  • HPA071556 has been omitted due to qualitative reasons. An alternative antibody HPA074736 has been added.
  • HPA071662 has been omitted due to qualitative reasons. An alternative antibody HPA028917 has been added.
  • HPA072377 has been omitted due to qualitative reasons. An alternative antibody HPA037773 has been added.
  • CAB072802 has been omitted due to qualitative reasons.
  • CAB072824 has been omitted due to qualitative reasons.
  • CAB072847 has been omitted due to antibody staining not supported by experimental data. An alternative antibody HPA028957 has been added.
  • CAB072848 has been omitted due to qualitative reasons. An alternative antibody HPA028957 has been added.
  • HPA073454 has been omitted due to qualitative reasons.
  • HPA073653 has been omitted due to qualitative reasons. An alternative antibody HPA076187 has been added.
  • HPA073710 has been omitted due to qualitative reasons. An alternative antibody HPA065620 has been added.

Protein Atlas version 15


Release date: 2016.04.11
Ensembl version: 78.38
  • Fifteenth release of the Human Protein Atlas.
  • RNA-seq data from the Genotype-Tissue Expression (GTEx) consortium from 28 different tissues with a corresponding tissue in the Human Protein Atlas have been included, to allow for direct comparison with in-house generated RNA-seq data.
  • The summary page of the Tissue Atlas has been redesigned, with a new display view for comparisons of human tissue profiles on both the RNA and protein level.
  • Version 14 of the Human Protein Atlas can be accessed using v14.proteinatlas.org.

Protein Atlas version 14


Release date: 2015.10.16
Ensembl version: 78.38
  • Fourteenth major release of the Human Protein Atlas with more than 25,000 antibodies, targeting proteins from more than 17,000 human genes (~86% of the human protein-coding genes). A new mouse brain atlas is introduced that includes 88 genes and 129 brain regions.

    More than 7000 genes have been updated with a knowledge-based annotation in the tissue atlas. In addition to this, co-localization of a fluorescent protein with the target protein has been introduced for antibody characterization and now complements the previously introduced gene silencing (siRNA) technique. In total, 100 genes have been analyzed using co-localization, 256 genes have been silenced and analyzed using immunocytochemistry, and 190 genes have been silenced and analyzed using western blot. New in this version is also the Human Protein Atlas blog.

    As of version 13 of the Human Protein Atlas, the site can be reached using the url structure "vXX.proteinatlas.org" where XX is the version number. For example, version 13 of the Human Protein Atlas has the url "v13.proteinatlas.org".

    On 2015-11-19 the data reliability description in the tissue atlas was updated for 3726 proteins that mistakenly had information on antibodies targeting proteins from multiple genes.
    Tissue atlas
  • CAB000140 (myosin, heavy chain 13, skeletal muscle) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA000510 (transient receptor potential cation channel, subfamily C, member 5) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA000696 (cylicin and basic protein of sperm head cytoskeleton 1) has been omitted due to inconsistency with RNA-seq data.
  • HPA000978 (Rho-related BTB domain containing 3) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA001099 (pyridoxal (pyridoxine, vitamin B6) phosphatase) has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA001141 (alpha 1 and4-galactosyltransferase) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA001662 (sex comb on midleg-like 2 (Drosophila)) has been omitted due to inconsistency with gene/protein characterization data.
  • CAB002011 (MPL proto-oncogene, thrombopoietin receptor) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • CAB002049 (checkpoint kinase 1) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA002084 (single-minded family bHLH transcription factor 1) has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • CAB002159 (matrix metallopeptidase 10 (stromelysin 2)) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • CAB002311 (DCC netrin 1 receptor) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • CAB002423 (tumor necrosis factor receptor superfamily and member 9) has been omitted due to inconsistency with gene/protein characterization data.
  • CAB002511 (myogenic differentiation 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA002831 (ubiquitin-conjugating enzyme E2T (putative)) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA002955 (methyltransferase like 17) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA003105 (T-box 22) has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and lack of appropriate tissue.
  • HPA003133 (5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA003186 (DEAD (Asp-Glu-Ala-Asp) box polypeptide 53) has been omitted due to inconsistency with RNA-seq data.
  • HPA003270 (potassium inwardly-rectifying channel, subfamily J, member 4) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA003959 (SRY) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA003994 (pleckstrin homology-like domain, family A, member 2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA004149 (melanin-concentrating hormone receptor 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA004153 (SPARC related modular calcium binding 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • CAB004303 (actinin, alpha 1) has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • CAB004357 (cell division cycle 27) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
  • CAB004498 (ATP-binding cassette, sub-family B (MDR/TAP), member 4) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • CAB004556 (reelin) has been omitted due to inconsistency with gene/protein characterization data.
  • CAB004596 (TGFB-induced factor homeobox 1) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA004773 (cancer/testis antigen 83) has been omitted due to inconsistency with RNA-seq data.
  • HPA004826 (coagulation factor VII (serum prothrombin conversion accelerator)) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA004915 (myotubularin related protein 7) has been omitted due to inconsistency with RNA-seq data.
  • HPA004937 (formin 2) has been omitted due to inconsistency with RNA-seq data.
  • CAB005598 (ATPase, H+/K+ exchanging and beta polypeptide) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA005623 (mesoderm specific transcript) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA005634 (kallikrein B and plasma (Fletcher factor) 1) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA005799 (T-box 3) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA005845 (zinc finger protein 645) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA005858 (MORN repeat containing 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • CAB005865 (HSPA (heat shock 70kDa) binding protein and cytoplasmic cochaperone 1) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA005896 (secretory carrier membrane protein 3) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA005988 (AC013412.1, AMELX, AMELY) has been omitted due to inconsistency with gene/protein characterization data and lack of appropriate tissue.
  • HPA006239 (membrane-bound transcription factor peptidase, site 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • CAB006834 (ryanodine receptor 2 (cardiac)) has been omitted due to inconsistency with RNA-seq data.
  • CAB006857 (5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA007329 (actin filament associated protein 1-like 1) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA007619 (MPL proto-oncogene and thrombopoietin receptor) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA007919 (peroxidasin homolog (Drosophila)-like) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA007993 (insulin-like growth factor 2) has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA008065 (flavin containing monooxygenase 3) has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA008798 (Lipid phosphate phosphatase-related protein type 4 ) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA008802 (AC136616.1 and SLC6A8) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA008847 (macrophage receptor with collagenous structure) has been omitted due to inconsistency with RNA-seq data.
  • HPA009169 (solute carrier family 7 (cationic amino acid transporter, y+ system), member 2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • CAB009211 (indian hedgehog) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA009298 (kelch-like family member 31) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • CAB009347 (activity-regulated cytoskeleton-associated protein) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • CAB009628 (myosin light chain kinase) has been omitted due to inconsistency with gene/protein characterization data.
  • CAB009725 (six transmembrane epithelial antigen of the prostate 1) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • CAB009726 (dickkopf WNT signaling pathway inhibitor 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • CAB009912 (bone gamma-carboxyglutamate (gla) protein) has been omitted due to inconsistency with gene/protein characterization data and lack of appropriate tissue.
  • CAB010313 (fibroblast growth factor 5) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA010505 (hepatitis A virus cellular receptor 2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA010535 (mixed lineage kinase domain-like) has been omitted due to inconsistency with RNA-seq data.
  • HPA010549 (Wilms tumor 1 associated protein) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
  • HPA010569 (tumor necrosis factor receptor superfamily, member 17) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA010688 (synaptotagmin V) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • CAB010771 (uncoupling protein 3 (mitochondrial, proton carrier)) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA010785 (polypeptide N-acetylgalactosaminyltransferase 14) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA010808 (cadherin 7, type 2) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA010828 (cystatin 8 (cystatin-related epididymal specific)) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA010992 (transmembrane protease, serine 5) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA011093 (melanocortin 2 receptor accessory protein) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA011126 (butyrophilin, subfamily 1, member A1) has been omitted due to lack of appropriate tissue.
  • HPA011388 (mitogen-activated protein kinase kinase kinase 19) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • CAB011435 (Fas ligand (TNF superfamily, member 6)) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • CAB011628 (sarcolipin) has been omitted due to inconsistency with RNA-seq data.
  • HPA011812 (endogenous retrovirus group FRD, member 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA011922 (sarcoglycan and gamma (35kDa dystrophin-associated glycoprotein)) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA012099 (actin filament associated protein 1-like 1) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA012158 (UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6 (core 3 synthase)) has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • CAB012279 (T-box, brain, 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • CAB012344 (ELKS/RAB6-interacting/CAST family member 2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA012381 (HEPACAM family member 2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • CAB012443 (reticulon 4 receptor) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA012502 (beta-1 and3-N-acetylgalactosaminyltransferase 2) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA012577 (autophagy related 16-like 1 (S. cerevisiae)) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA012585 (sodium channel, voltage-gated, type II, beta subunit) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • CAB012644 (ectodysplasin A) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA012659 (Cas scaffolding protein family member 4) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • CAB012971 (lectin, galactoside-binding, soluble, 12) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA013196 (interleukin 5 receptor, alpha) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • CAB013247 (gap junction protein, alpha 4, 37kDa) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • CAB013291 (thioredoxin interacting protein) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA013313 (carbohydrate (N-acetylglucosamine-6-O) sulfotransferase 2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA013351 (diacylglycerol O-acyltransferase 2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA013739 (ring finger protein, transmembrane 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA013752 (CH507-396I9.6, KCNE1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • CAB013793 (F-box and WD repeat domain containing 7 and E3 ubiquitin protein ligase) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA013842 (receptor (chemosensory) transporter protein 3) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA013965 (neuropeptide Y receptor Y2) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA014045 (phospholipase B1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA014096 (glutamate receptor, metabotropic 5) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA014261 (gamma-aminobutyric acid (GABA) A receptor, alpha 2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA014365 (cadherin 18, type 2) has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA014420 (epithelial mitogen) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA014472 (hemochromatosis type 2 (juvenile)) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA014563 (tudor domain containing 5) has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA014668 (protocadherin beta 16) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA014719 (CKLF-like MARVEL transmembrane domain containing 2) has been omitted due to inconsistency with RNA-seq data.
  • HPA014741 (CKLF-like MARVEL transmembrane domain containing 2) has been omitted due to inconsistency with RNA-seq data.
  • HPA014805 (glycine receptor and alpha 3) has been omitted due to inconsistency with RNA-seq data.
  • HPA014839 (FXYD domain containing ion transport regulator 4) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • CAB015153 (cyclin-dependent kinase 4) has been omitted due to lack of appropriate tissue.
  • HPA015315 (Wolf-Hirschhorn syndrome candidate 1) has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA015543 (chromodomain helicase DNA binding protein 6) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA015800 (DEP domain containing 7) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA015809 (chromodomain helicase DNA binding protein 5) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA015963 (brain-specific angiogenesis inhibitor 3) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • CAB016053 (parathyroid hormone 1 receptor) has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • CAB016139 (matrix metallopeptidase 3 (stromelysin 1, progelatinase)) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • CAB016141 (lipase, hepatic) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • CAB016409 (formimidoyltransferase cyclodeaminase) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA016440 (heat shock transcription factor family member 5) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA016456 (xylosyltransferase II) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA016475 (protocadherin beta 16) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA016503 (protein Z, vitamin K-dependent plasma glycoprotein) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA016563 (xenotropic and polytropic retrovirus receptor 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA016586 (potassium voltage-gated channel, subfamily H (eag-related) and member 8) has been omitted due to inconsistency with gene/protein characterization data.
  • CAB016676 (inter-alpha-trypsin inhibitor heavy chain family, member 4) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA016697 (ryanodine receptor 2 (cardiac)) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • CAB017098 (wingless-type MMTV integration site family member 2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA017323 (leucine rich repeat transmembrane neuronal 2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA017383 (leucine rich repeat and fibronectin type III domain containing 1) has been omitted due to inconsistency with RNA-seq data.
  • HPA017424 (mannosyl (alpha-1,6-)-glycoprotein beta-1,6-N-acetyl-glucosaminyltransferase, isozyme B) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • CAB017524 (coilin) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA017674 (purinergic receptor P2Y, G-protein coupled, 1) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA018192 (nemo-like kinase) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA018217 (aarF domain containing kinase 3) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA018253 (Fas (TNFRSF6) associated factor 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
  • HPA018312 (host cell factor C1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA018539 (metallothionein-like 5, testis-specific (tesmin)) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA018995 (dickkopf WNT signaling pathway inhibitor 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA019008 (Fas (TNFRSF6) associated factor 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
  • CAB019298 (glutathione S-transferase pi 1) has been omitted due to product no longer available in provider's catalogue.
  • CAB019300 (immediate early response 3) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA019501 (mitochondrial elongation factor 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA019704 (acetylcholinesterase (Yt blood group)) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA019772 (interleukin 20 receptor beta) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA019964 (PDCD2L, RP11-618P17.4) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA020052 (RFPL3 antisense) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA020104 (solute carrier family 46, member 2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA020385 (stimulated by retinoic acid 8) has been omitted due to inconsistency with gene/protein characterization data.
  • CAB020771 (G protein-coupled receptor, class C, group 5, member A) has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • CAB020805 (hematopoietic prostaglandin D synthase) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
  • CAB020806 (Wilms tumor 1 associated protein) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
  • HPA020920 (wingless-type MMTV integration site family member 2) has been omitted due to inconsistency with gene/protein characterization data.
  • CAB020943 (NME/NM23 family member 9) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • CAB021340 (inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase complex-associated protein) has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA021465 (bromodomain containing 9) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA021776 (zinc finger protein 804B) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA021788 (peptidylprolyl isomerase G (cyclophilin G)) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA022009 (scinderin) has been omitted due to inconsistency with other antibody targeting the same gene.
  • HPA022022 (matrix metallopeptidase 26) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA022023 (spermatogenesis associated 20) has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • CAB022437 (inositol 1,4,5-trisphosphate receptor and type 2) has been omitted due to inconsistency with gene/protein characterization data.
  • CAB022505 (solute carrier family 12 (sodium/chloride transporter), member 3) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
  • CAB022544 (estrogen receptor 2 (ER beta)) has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • CAB022604 (RNA binding motif, single stranded interacting protein 3) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
  • CAB022612 (pancreas specific transcription factor and 1a) has been omitted due to inconsistency with gene/protein characterization data.
  • CAB022623 (non-SMC condensin II complex, subunit D3) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • CAB022636 (potassium inwardly-rectifying channel, subfamily J, member 10) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • CAB022690 (glucagon-like peptide 2 receptor) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA022862 (Kv channel interacting protein 4) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA022892 (zinc finger and HIT-type containing 3) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA023120 (arachidonate lipoxygenase 3) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA023122 (tripartite motif containing 72, E3 ubiquitin protein ligase) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA023316 (membrane-associated ring finger (C3HC4) 10, E3 ubiquitin protein ligase) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA023327 (transmembrane protein 175) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
  • HPA023454 (coiled-coil domain containing 182) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA023499 (phosphatidylinositol glycan anchor biosynthesis and class W) has been omitted due to inconsistency with gene/protein characterization data.
  • CAB023519 (amphiregulin) has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA023562 (cilia and flagella associated protein 52) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA023653 (tubulin tyrosine ligase-like family, member 6) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA023654 (centrosomal protein 95kDa) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
  • HPA023809 (calcium/calmodulin-dependent protein kinase IG) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA024053 (endogenous retrovirus group MER34, member 1) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA024082 (transmembrane protein 45A) has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA024117 (transient receptor potential cation channel, subfamily M, member 8) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA024207 (gasdermin A) has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA024385 (single-minded family bHLH transcription factor 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA024544 (actin-like 7A) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA024826 (leucine-rich repeat LGI family, member 3) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • CAB024999 (insulin-like growth factor 2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • CAB025171 (annexin A10) has been omitted due to inconsistency with gene/protein characterization data and antibody titration issue.
  • CAB025506 (glypican 5) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
  • CAB025540 (Down syndrome cell adhesion molecule like 1) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • CAB025543 (family with sequence similarity 19 (chemokine (C-C motif)-like) and member A2) has been omitted due to inconsistency with RNA-seq data.
  • CAB025582 (protein phosphatase 1, regulatory (inhibitor) subunit 2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA025693 (NK3 homeobox 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA026075 (nucleosome assembly protein 1-like 3) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • CAB026474 (protein tyrosine phosphatase, receptor type, D) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA026543 (ubiquitin specific peptidase 44) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA026707 (zinc finger protein 804B) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA026924 (NPIP, NPIPB11, NPIPB15, NPIPB3, NPIPB4, NPIPB5, NPIPB6, NPIPB7, NPIPB8, NPIPB9, RP11-166B2.1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
  • HPA026958 (junctophilin 3) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA026976 (cornichon family AMPA receptor auxiliary protein 2) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA026998 (neuronal differentiation 4) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
  • HPA027248 (tektin 2 (testicular)) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
  • HPA027327 (KIAA1107) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA027537 (solute carrier organic anion transporter family, member 1A2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA027823 (butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA027989 (chromosome 1 open reading frame 61) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA028062 (calcium/calmodulin-dependent protein kinase kinase 1, alpha) has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA028117 (mutS homolog 4) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA028149 (TSSK6 activating co-chaperone) has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA028232 (maelstrom spermatogenic transposon silencer) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA028724 (crystallin, alpha B) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA029082 (carboxypeptidase Z) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA029083 (carboxypeptidase Z) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA029417 (HERV-H LTR-associating 2) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA029542 (transient receptor potential cation channel, subfamily M, member 8) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA029592 (angiotensin II receptor and type 2) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA029599 (MYST/Esa1-associated factor 6) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA029600 (MYST/Esa1-associated factor 6) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA029645 (adenosine deaminase, RNA-specific and B1) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA029774 (homeobox A2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA029790 (solute carrier family 5 (sodium/myo-inositol cotransporter), member 3) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA029791 (solute carrier family 5 (sodium/myo-inositol cotransporter), member 3) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA029830 (cancer antigen 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA029831 (cancer antigen 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA029892 (cytochrome P450, family 39, subfamily A, polypeptide 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA029935 (DENN/MADD domain containing 2C) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA030108 (dynein, axonemal, heavy chain 8) has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA030218 (protein interacting with cyclin A1) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA030372 (synaptotagmin II) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
  • HPA030476 (tRNA methyltransferase 11 homolog (S. cerevisiae)) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA030726 (ectodermal-neural cortex 1 (with BTB domain)) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA030974 (transient receptor potential cation channel, subfamily M, member 2) has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA031140 (maelstrom spermatogenic transposon silencer) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA031240 (PRICKLE4) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA031299 (keratin associated protein 19-4) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA031309 (G protein-coupled receptor 62) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA031507 (solute carrier family 39 (zinc transporter) and member 4) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA031652 (WNK lysine deficient protein kinase 3) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA031683 (C-type lectin domain family 17, member A) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA031819 (gametogenetin) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA032036 (copine IV) has been omitted due to inconsistency with RNA-seq data.
  • HPA032084 (doublecortin domain containing 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • CAB032863 (Epstein-Barr virus induced 3) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • CAB033351 (cytoplasmic polyadenylation element binding protein 1) has been omitted due to inconsistency with gene/protein characterization data and lack of appropriate tissue.
  • CAB033628 (ATPase, Na+/K+ transporting and alpha 4 polypeptide) has been omitted due to inconsistency with RNA-seq data.
  • CAB034091 (non-SMC condensin II complex, subunit D3) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • CAB034206 (Cas scaffolding protein family member 4) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • CAB034284 (SCAN domain containing 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • CAB034457 (spermatogenesis associated 25) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA034686 (sodium channel, voltage-gated, type I, alpha subunit) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA034704 (sialidase 2 (cytosolic sialidase)) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA035146 (pleckstrin homology-like domain, family B, member 2) has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA035212 (potassium voltage-gated channel, KQT-like subfamily, member 3) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA035397 (sodium channel, voltage-gated, type III, alpha subunit) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA035682 (family with sequence similarity 81, member B) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA035708 (ARV1 homolog (S. cerevisiae)) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA036147 (transmembrane protein 52B) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA036263 (chromosome 6 open reading frame 58) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA036306 (immunoglobulin superfamily, member 3) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA036351 (KIAA1244) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA036390 (dynein, axonemal, heavy chain 6) has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA036621 (solute carrier family 4 (sodium bicarbonate cotransporter), member 5) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA036719 (chromosome 10 open reading frame 128) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA036734 (KIAA2012) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA036903 (solute carrier family 22 (organic cation/carnitine transporter) and member 16) has been omitted due to inconsistency with gene/protein characterization data.
  • CAB037133 (CNKSR family member 3) has been omitted due to inconsistency with gene/protein characterization data.
  • CAB037185 (kinesin family member 17) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • CAB037203 (calsequestrin 2 (cardiac muscle)) has been omitted due to inconsistency with gene/protein characterization data.
  • CAB037299 (ATP-binding cassette, sub-family G (WHITE), member 2 (Junior blood group)) has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA037387 (cardiomyopathy associated 5) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA037515 (testis-specific serine kinase 3) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA037651 (ring finger protein 212) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA037769 (tripartite motif family-like 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA037787 (signal sequence receptor, beta (translocon-associated protein beta)) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA037868 (enamelin) has been omitted due to lack of appropriate tissue.
  • HPA037910 (Hermansky-Pudlak syndrome 5) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA038028 (ankyrin repeat domain 31) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA038083 (spermatogenesis associated 7) has been omitted due to inconsistency with other antibody targeting the same gene.
  • HPA038120 (tudor domain containing 9) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA038269 (glutamate receptor, ionotropic and N-methyl D-aspartate 2D) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA038423 (collagen, type XXIV, alpha 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA038475 (coiled-coil domain containing 110) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA038490 (fasciculation and elongation protein zeta 1 (zygin I)) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA038660 (exportin and tRNA) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA038676 (chromosome 10 open reading frame 120) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA038743 (CNIH2 and CNIH3) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA038785 (brain-specific angiogenesis inhibitor 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA038910 (solute carrier family 38, member 4) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA038968 (nudix (nucleoside diphosphate linked moiety X)-type motif 15) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA039059 (short chain dehydrogenase/reductase family 9C, member 7) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA039071 (distal-less homeobox 2) has been omitted due to inconsistency with gene/protein characterization data and lack of appropriate tissue.
  • HPA039135 (profilin family, member 4) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA039216 (cleavage stimulation factor, 3' pre-RNA, subunit 2, 64kDa, tau variant) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA039476 (solute carrier family 6 (neurotransmitter transporter) and member 5) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA039489 (phospholipase A2 and group IVD (cytosolic)) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA039547 (mediator complex subunit 24) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA039582 (axonemal dynein light chain domain containing 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA039612 (chromosome 11 open reading frame 63) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA039653 (ATP/GTP binding protein-like 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA039655 (cilia and flagella associated 54) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA039726 (coiled-coil domain containing 38) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA039914 (ATP-binding cassette, sub-family A (ABC1), member 13) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA039942 (Fc receptor-like 5) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA039945 (MYC binding protein 2, E3 ubiquitin protein ligase) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA039998 (Fc receptor-like 5) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA040012 (DnaJ (Hsp40) homolog, subfamily C and member 22) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA040069 (chromosome 12 open reading frame 50) has been omitted due to inconsistency with RNA-seq data.
  • HPA040138 (G protein-coupled receptor kinase 7) has been omitted due to inconsistency with RNA-seq data.
  • HPA040323 (carboxypeptidase N and polypeptide 1) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA040383 (calpain 6) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA040482 (PDZ domain containing 3) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA040731 (intraflagellar transport 88) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA040962 (translin-associated factor X interacting protein 1) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA040963 (discs, large (Drosophila) homolog-associated protein 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA041066 (clusterin-like 1 (retinal)) has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA041128 (septin 12) has been omitted due to inconsistency with RNA-seq data.
  • HPA041171 (angiopoietin-like 6) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA041338 (signal-regulatory protein delta) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA041429 (CAP-GLY domain containing linker protein 3) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA041624 (placental growth factor) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA041631 (transcobalamin I (vitamin B12 binding protein and R binder family)) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA041666 (glutamate receptor, ionotropic, N-methyl D-aspartate 2C) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA041719 (testis expressed 35) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA041929 (RAS guanyl releasing protein 4) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA041957 (solute carrier family 26 (anion exchanger), member 2) has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA042224 (BEX1, BEX2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
  • HPA042300 (protein tyrosine phosphatase, receptor type and H) has been omitted due to inconsistency with RNA-seq data.
  • HPA042482 (KRTAP9-2, KRTAP9-3, KRTAP9-4, KRTAP9-6, KRTAP9-7, KRTAP9-8 and KRTAP9-9) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA042515 (calcium channel, voltage-dependent, R type, alpha 1E subunit) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA042518 (sodium channel, voltage-gated, type III, beta subunit) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA042578 (theg spermatid protein) has been omitted due to inconsistency with RNA-seq data.
  • HPA042639 (chromosome 2 open reading frame 80) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA042721 (guanine nucleotide binding protein (G protein), gamma transducing activity polypeptide 1) has been omitted due to lack of appropriate tissue.
  • HPA042787 (IQ motif containing G) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA042795 (mediator complex subunit 10) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA042864 (Spi-C transcription factor (Spi-1/PU.1 related)) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA043003 (EIF1 and EIF1B) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA043180 (protocadherin alpha 4) has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA043185 (filaggrin family member 2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
  • HPA043194 (ATP-binding cassette, sub-family A (ABC1) and member 12) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA043323 (spermatogenesis associated 12) has been omitted due to inconsistency with RNA-seq data.
  • HPA043370 (spectrin, beta, non-erythrocytic 4) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA043489 (ankyrin repeat domain 7) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA043573 (nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor and delta) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA043713 (ras homolog family member V) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA043742 (chromosome 20 open reading frame 78) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA044031 (keratin 73) has been omitted due to lack of appropriate tissue.
  • HPA044049 (AQP7, RP11-407P15.2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA044128 (ATPase, Na+/K+ transporting and beta 4 polypeptide) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA044169 (transmembrane protein 249) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA044184 (coiled-coil domain containing 151) has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA044194 (DNA nucleotidylexotransferase) has been omitted due to inconsistency with RNA-seq data.
  • HPA044431 (LAS1-like (S. cerevisiae)) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
  • HPA044474 (5-methyltetrahydrofolate-homocysteine methyltransferase) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA044507 (prepronociceptin) has been omitted due to lack of appropriate tissue.
  • HPA044628 (ankyrin repeat and sterile alpha motif domain containing 1B) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA044853 (solute carrier family 9, subfamily C (Na+-transporting carboxylic acid decarboxylase), member 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA045001 (chromosome 14 open reading frame 180) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA045032 (P antigen family and member 3 (prostate associated)) has been omitted due to inconsistency with RNA-seq data.
  • HPA045185 (CDP-diacylglycerol--inositol 3-phosphatidyltransferase) has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA045227 (glutamate receptor, metabotropic 3) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA045397 (GOLGA8H, GOLGA8J, GOLGA8K, GOLGA8M, GOLGA8N, GOLGA8O, GOLGA8Q, GOLGA8R, GOLGA8S and GOLGA8T) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA045427 (trafficking protein particle complex 11) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
  • HPA045654 (mitogen-activated protein kinase 9) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA045709 (solute carrier family 25 (mitochondrial carrier; phosphate carrier), member 3) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA045733 (poly-U binding splicing factor 60KDa) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
  • HPA045773 (hydroxyacid oxidase 2 (long chain)) has been omitted due to inconsistency with RNA-seq data.
  • HPA045808 (ornithine decarboxylase antizyme 3) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA045950 (chromosome 5 open reading frame 64) has been omitted due to inconsistency with RNA-seq data.
  • HPA046105 (solute carrier family 5 (sodium/choline cotransporter), member 7) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA046282 (HYDIN, axonemal central pair apparatus protein) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA046427 (TGIF2LX, TGIF2LY) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA046654 (muscular LMNA-interacting protein) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA046665 (solute carrier family 4, sodium bicarbonate cotransporter and member 8) has been omitted due to inconsistency with RNA-seq data.
  • HPA046740 (nucleolar protein 4) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA046840 (RAB43, member RAS oncogene family) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
  • HPA046932 (late cornified envelope-like proline-rich 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA047180 (TIMM23, TIMM23B) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA047234 (profilin 3) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA047242 (HHIP-like 1) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA047243 (zinc finger protein 215) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA047366 (chromosome 2 open reading frame 61) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA047432 (S100 calcium binding protein Z) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA047627 (complexin 4) has been omitted due to inconsistency with gene/protein characterization data and lack of appropriate tissue.
  • HPA047639 (NOBOX oogenesis homeobox) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA047699 (nuclear receptor subfamily 1, group H, member 4) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA047772 (TRIM16 and TRIM16L) has been omitted due to inconsistency with RNA-seq data.
  • HPA047868 (mucin 3A, cell surface associated) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
  • HPA048100 (transmembrane protein 38A) has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA048106 (AQP7, RP11-407P15.2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA048249 (potassium voltage-gated channel, Shaw-related subfamily, member 1) has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA048336 (block of proliferation 1) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA048369 (RPP21, TRIM39-RPP21) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA048714 (monocyte to macrophage differentiation-associated 2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA048899 (AT rich interactive domain 4A (RBP1-like)) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA048931 (polymerase (DNA directed) and theta) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA049046 (5-hydroxytryptamine (serotonin) receptor 1B, G protein-coupled) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA049097 (sortilin-related VPS10 domain containing receptor 3) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA049128 (solute carrier family 6, member 16) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA049150 (keratin 38) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA049320 (fibrinogen-like 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA049389 (RPP21, TRIM39-RPP21) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA049404 (keratin 71) has been omitted due to lack of appropriate tissue.
  • HPA049462 (sterol O-acyltransferase 2) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA049660 (t-complex 10) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA049909 (nicotinamide riboside kinase 2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA049912 (ER membrane protein complex subunit 9) has been omitted due to inconsistency with RNA-seq data.
  • HPA050069 (solute carrier family 14 (urea transporter), member 2) has been omitted due to lack of appropriate tissue.
  • HPA050122 (cochlin) has been omitted due to lack of appropriate tissue.
  • HPA050164 (DIRAS family, GTP-binding RAS-like 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA050263 (solute carrier family 5 (sodium/sugar cotransporter), member 9) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA050798 (oxidized low density lipoprotein (lectin-like) receptor 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA050823 (family with sequence similarity 124B) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA050901 (protein tyrosine phosphatase-like (proline instead of catalytic arginine), member A) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA051067 (family with sequence similarity 46, member A) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA051083 (sosondowah ankyrin repeat domain family member C) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA051212 (GIPC PDZ domain containing family and member 2) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA051232 (solute carrier family 36 and member 3) has been omitted due to inconsistency with RNA-seq data.
  • HPA051362 (myogenic differentiation 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA051513 (heparan sulfate 6-O-sulfotransferase 3) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA051570 (tetraspanin 12) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA051589 (DBF4 zinc finger) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA051609 (potassium inwardly-rectifying channel, subfamily J, member 13) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA051862 (N-acylsphingosine amidohydrolase (non-lysosomal ceramidase) 2B) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA052055 (zinc finger protein 280B) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA052448 (oncoprotein induced transcript 3) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA052626 (CERS1, GDF1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA052786 (zinc finger protein 446) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA052974 (tumor protein p53 inducible nuclear protein 2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA053125 (nudix (nucleoside diphosphate linked moiety X)-type motif 19) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA053177 (shisa family member 9) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA053199 (claudin 15) has been omitted due to inconsistency with RNA-seq data.
  • HPA053268 (collagen, type X and alpha 1) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA053354 (proline-rich basic protein 1) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA053525 (glycine receptor, alpha 2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA053754 (lipase, family member K) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA053974 (Rho GDP dissociation inhibitor (GDI) gamma) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA054029 (HHIP-like 2) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA054153 (calcium channel, voltage-dependent and gamma subunit 1) has been omitted due to inconsistency with RNA-seq data.
  • HPA054182 (ganglioside induced differentiation associated protein 1-like 1) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA054368 (triggering receptor expressed on myeloid cells-like 2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA054373 (epiregulin) has been omitted due to inconsistency with RNA-seq data.
  • HPA054482 (leucine-rich, glioma inactivated 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA054554 (syndecan binding protein (syntenin) 2) has been omitted due to inconsistency with RNA-seq data and lack of positivity.
  • HPA054606 (receptor-interacting serine-threonine kinase 3) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA054686 (SCP2 sterol-binding domain containing 1) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA054847 (phosphatase and actin regulator 3) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA055038 (Myb/SANT-like DNA-binding domain containing 1) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA055193 (keratin 26) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA055323 (NDUFA4, NDUFA4L2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA055372 (UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA055654 (transmembrane protein 145) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA057478 (glucokinase (hexokinase 4) regulator) has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA057690 (KRTAP2-1, KRTAP2-2, KRTAP2-3, KRTAP2-4) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
  • HPA057722 (nicotinamide phosphoribosyltransferase) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA057756 (gamma-aminobutyric acid (GABA) A receptor, alpha 4) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA058167 (glutamyl-tRNA(Gln) amidotransferase, subunit B) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA058496 (ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d2) has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA059256 (egl-9 family hypoxia-inducible factor 3) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA059308 (mitochondrial ribosomal protein S21) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA059619 (deoxyribose-phosphate aldolase (putative)) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA060297 (F-box and leucine-rich repeat protein 3) has been omitted due to inconsistency with RNA-seq data.
  • HPA060308 (histocompatibility (minor) HB-1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA060457 (neuronal differentiation 2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA060526 (glycine receptor, alpha 2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA060894 (cholinergic receptor, nicotinic and beta 2 (neuronal)) has been omitted due to inconsistency with RNA-seq data.
  • HPA060919 (cholinergic receptor, nicotinic and alpha 10 (neuronal)) has been omitted due to inconsistency with RNA-seq data.
  • HPA061586 (CPEB1 and RP11-152F13.10) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA061909 (olfactory receptor, family 5, subfamily T, member 2) has been omitted due to inconsistency with RNA-seq data and lack of appropriate tissue.
  • HPA061943 (WAP four-disulfide core domain 3) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • HPA062112 (solute carrier family 47 (multidrug and toxin extrusion), member 2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA062464 (synaptonemal complex central element protein 1-like) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA062520 (dendrocyte expressed seven transmembrane protein) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA062599 (olfactory receptor, family 5, subfamily T and member 2) has been omitted due to lack of appropriate tissue.
  • HPA063144 (peroxisomal biogenesis factor 11 gamma) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA063464 (chromosome 17 open reading frame 50) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA064998 (tumor necrosis factor) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • HPA065328 (keratin associated protein 22-2) has been omitted due to inconsistency with gene/protein characterization data.
  • HPA066032 (forkhead box Q1) has been omitted due to inconsistency with RNA-seq data.
  • HPA068284 (ENO1, ENO2 and ENO3) has been omitted due to inconsistency with other antibody targeting the same gene.
  • CAB070430 (recombination activating gene 2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • CAB072767 (SATB homeobox 2) has been omitted due to product no longer available in provider's catalogue.
  • CAB000003 (B-cell CLL/lymphoma 2) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • CAB000011 (CD4 molecule) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • CAB000013 (membrane metallo-endopeptidase) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • CAB000018 (CD34 molecule) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • CAB000027 (keratin 5) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • CAB000029 (keratin 17) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • CAB000036 (mucin 1, cell surface associated) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • CAB000057 (melan-A) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • CAB000058 & HPA001164 (marker of proliferation Ki-67) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • CAB000064 (cyclin-dependent kinase inhibitor 1A (p21, Cip1)) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • CAB000066 & HPA048982 (CD68 molecule) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • CAB000087 & HPA004812 (cadherin 1, type 1, E-cadherin (epithelial)) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • CAB000096 & HPA011862 (endoglin) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • CAB000151 (microtubule-associated protein tau) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA000397 (synapsin I) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA000440 (protein tyrosine phosphatase, receptor type, C) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA000694 (dicer 1, ribonuclease type III) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA001238 (matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase)) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA001352 & HPA002549 (apolipoprotein A-IV) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA001671 (signal transducer and activator of transcription 3 (acute-phase response factor)) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • CAB022456 & HPA001758 (SRY (sex determining region Y)-box 9) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA001815 & HPA002082 (von Willebrand factor) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA001936 (paraneoplastic Ma antigen 2) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • CAB001964 (gamma-aminobutyric acid (GABA) A receptor, beta 2) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA002064 (Rho GTPase activating protein 36) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • CAB025091 & HPA002274 (integrin, alpha M (complement component 3 receptor 3 subunit)) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • CAB002500 & CAB010893 (beta-1,3-glucuronyltransferase 1) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA002657 (carboxypeptidase M) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA002868 (succinate dehydrogenase complex, subunit B, iron sulfur (Ip)) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA002924 (cyclin-dependent kinase inhibitor 1C (p57, Kip2)) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • CAB003022 (tumor protein p73) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA003140 (Uncharacterized protein {ECO:0000313|Ensembl:ENSP00000417050}; cDNA FLJ59144, highly similar to Tetraspanin-7 {ECO:0000313|EMBL:BAG64683.1} ) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA003140 (tetraspanin 7) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA003733 (Thy-1 cell surface antigen) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA003948 (inter-alpha-trypsin inhibitor heavy chain family, member 4) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA004114 & HPA045134 (mannose receptor, C type 1) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • CAB004298 (signal transducer and activator of transcription 5B) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • CAB004598 (tumor necrosis factor, alpha-induced protein 2) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA004705 (zinc finger protein 75D) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA004776 (A kinase (PRKA) anchor protein 8) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA004838 (growth arrest-specific 7) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA004847 (megakaryocyte-associated tyrosine kinase) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • CAB005192, CAB015417 & HPA006461 (fatty acid synthase) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • CAB005269 (lamin B1) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA005533 (myocyte enhancer factor 2C) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA005690 (ribonuclease, RNase A family, 7) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • CAB035991 & HPA005723 (fascin actin-bundling protein 1) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • CAB005920 (dynamin 1) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA006026 (protein tyrosine phosphatase, receptor type, J) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA006204 (Ts translation elongation factor, mitochondrial) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA006880 (secretogranin III) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA007292 (solute carrier family 27 (fatty acid transporter), member 5) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA007354 (microfibrillar-associated protein 2) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA007476 (sarcoglycan, gamma (35kDa dystrophin-associated glycoprotein)) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA007489 (neuropeptide S receptor 1) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA007928 (G protein-coupled receptor, class C, group 5, member A) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA008019 (chloride intracellular channel 4) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • CAB008363 (apolipoprotein E) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA008427 (integrin, alpha 7) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA008533 (solute carrier family 51, beta subunit) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA008720 (amphiregulin) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • CAB009111 (calcium/calmodulin-dependent protein kinase kinase 1, alpha) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • CAB009492 (cytochrome b-245, alpha polypeptide) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • CAB010648 (SRY (sex determining region Y)-box 2) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA010932 & HPA015104 (metadherin) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • CAB011201 (cyclin-dependent kinase inhibitor 2D (p19, inhibits CDK4)) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA012023 (carboxylesterase 1) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA012066 (Tyrosine-protein kinase SgK223 ) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA012612 (cell adhesion molecule 4) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA012636 (nudix (nucleoside diphosphate linked moiety X)-type motif 1) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA012867 (5-hydroxytryptamine (serotonin) receptor 2B, G protein-coupled) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA013998 & HPA014144 (N-terminal EF-hand calcium binding protein 2) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA014431 (KIAA0513) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • CAB014893 (Fanconi anemia, complementation group E) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA014924 (aquaporin 3 (Gill blood group)) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA015801 (Wolf-Hirschhorn syndrome candidate 1) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • CAB016241 (mitochondrially encoded cytochrome c oxidase I) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA017282 (chondrolectin) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA017770 (lymphocyte antigen 6 complex, locus K) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA018106 (mucolipin 3) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • CAB018697 (troponin I type 2 (skeletal, fast)) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA018897 (carboxylesterase 2) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA019029 (chromosome 20 open reading frame 144) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA019036 (X-linked Kx blood group) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA019077 (deleted in lung and esophageal cancer 1) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA019367 (keratin 75) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA019730 (origin recognition complex, subunit 5) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA020098 (solute carrier family 46, member 2) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • CAB020697 (ATPase, Na+/K+ transporting, beta 3 polypeptide) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA021057 (fibrillin 1) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA021238 (nucleus accumbens associated 1, BEN and BTB (POZ) domain containing) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA021241 & HPA024031 (phosphoglycerate dehydrogenase) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA021286 (chromosome 7 open reading frame 57) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA021330 (bile acid CoA:amino acid N-acyltransferase) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA021474 & HPA021786 (chromosome 9 open reading frame 117) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA022261 (cytochrome P450, family 24, subfamily A, polypeptide 1) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA023247 (cilia and flagella associated protein 52) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA023307 (family with sequence similarity 166, member A) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA023313 (gasdermin A) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA023314 (serine hydroxymethyltransferase 1 (soluble)) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA023322 (membrane-associated ring finger (C3HC4) 10, E3 ubiquitin protein ligase) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA023527 (EF-hand calcium binding domain 1) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA023629 & HPA025963 (N-terminal EF-hand calcium binding protein 1) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA023778 (chromosome 1 open reading frame 112) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA024216 (KIAA1107) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA024253 (SPATA31 subfamily E, member 1) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • CAB025136 & CAB025269 (X-prolyl aminopeptidase (aminopeptidase P) 2, membrane-bound) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA027179 (lysine (K)-specific demethylase 5B) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA028407 (phenylalanine hydroxylase) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA029185 (nucleolar protein 7, 27kDa) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA029543 (SATB homeobox 2) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA029773 (excision repair cross-complementation group 1) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA030780 (voltage-dependent anion channel 1) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA030866, HPA030867 & HPA030868 (ADAM metallopeptidase domain 12) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA031115 (kynurenine 3-monooxygenase (kynurenine 3-hydroxylase)) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA031567 & HPA031568 (CD40 molecule, TNF receptor superfamily member 5) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA032096 (kazrin, periplakin interacting protein) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA032119 (family with sequence similarity 161, member A) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • CAB032896 (barrier to autointegration factor 1) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • CAB034349 (nicotinamide phosphoribosyltransferase) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA034489 (chromosome 6 open reading frame 106) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA034871 (myosin, heavy chain 15) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA034873 (ubiquitin-like modifier activating enzyme 3) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA035024 (polo-like kinase 5) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA035565 (NIMA-related kinase 5) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA036236 (ELOVL fatty acid elongase 3) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA036283 (PHD finger protein 7) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA036523 (MGAT4 family, member D) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA036655 (HtrA serine peptidase 1) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA036814 (neurocan) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA036978 & HPA036979 (phosphoglycerate mutase family member 5) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • CAB037266 (cell adhesion molecule 1) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA037991 (MAP6 domain containing 1) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA038438 (G protein-coupled receptor 110) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA038440 (sperm associated antigen 6) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA038515 (proteoglycan 2, bone marrow (natural killer cell activator, eosinophil granule major basic protein)) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA038515 (Uncharacterized protein {ECO:0000313|Ensembl:ENSP00000431536} ) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA038585 (chromosome 11 open reading frame 70) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA038686 (calcium release activated channel regulator 2A) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA039103 (G protein-coupled receptor 63) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA039158 (DEAQ box RNA-dependent ATPase 1) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA039256 (leucine rich repeat containing 18) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA039662 (cancer susceptibility candidate 1) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA039744 & HPA039876 (neurexophilin and PC-esterase domain family, member 2) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA039897 (cilia and flagella associated 54) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA040487 (family with sequence similarity 154, member B) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA040809 (RNA binding protein, fox-1 homolog (C. elegans) 1) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA041022 (family with sequence similarity 92, member B) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA041139 (cirrhosis, autosomal recessive 1A (cirhin)) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA041387 (RAS-like, estrogen-regulated, growth inhibitor) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA041398 (chromosome 10 open reading frame 107) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA042635 (barrier to autointegration factor 2) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA042663 (signal-regulatory protein delta) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA043383 (chromosome 4 open reading frame 22) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA043787 (DDB1 and CUL4 associated factor 8-like 1) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA044256 & HPA050341 (epididymal sperm binding protein 1) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA044751 (tumor protein p63 regulated 1) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA044818 (ciliogenesis associated TTC17 interacting protein) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA045064 (prostaglandin E synthase) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA045703 (regulatory subunit of type II PKA R-subunit (RIIa) domain containing 1) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA045904 (cilia and flagella associated protein 126) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA046698 (leucine rich repeat containing 73) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA048260 (phosducin-like 2) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA048458 (family with sequence similarity 184, member B) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA050463 (transmembrane protein 38A) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA050786 (sperm flagellar 1) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA051507 (transcription elongation factor A (SII)-like 7) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA052363 (glycine receptor, beta) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA053793 (mesenchyme homeobox 2) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • HPA062748 (acyl-CoA wax alcohol acyltransferase 2) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • CAB005317 has been omitted due to target gene not found in Ensembl.
  • CAB016275 has been omitted due to target gene not found in Ensembl.
  • HPA001458 has been omitted due to target gene not found in Ensembl.
  • HPA003353 has been omitted due to target gene not found in Ensembl.
  • HPA003446 has been omitted due to target gene not found in Ensembl.
  • HPA006197 has been omitted due to target gene not found in Ensembl.
  • HPA006766 has been omitted due to target gene not found in Ensembl.
  • HPA006776 has been omitted due to target gene not found in Ensembl.
  • HPA011085 has been omitted due to target gene not found in Ensembl.
  • HPA011229 has been omitted due to target gene not found in Ensembl.
  • HPA012540 has been omitted due to target gene not found in Ensembl.
  • HPA014375 has been omitted due to target gene not found in Ensembl.
  • HPA014540 has been omitted due to target gene not found in Ensembl.
  • HPA016617 has been omitted due to target gene not found in Ensembl.
  • HPA017390 has been omitted due to target gene not found in Ensembl.
  • HPA017592 has been omitted due to target gene not found in Ensembl.
  • HPA017941 has been omitted due to target gene not found in Ensembl.
  • HPA018008 has been omitted due to target gene not found in Ensembl.
  • HPA018834 has been omitted due to target gene not found in Ensembl.
  • HPA019464 has been omitted due to target gene not found in Ensembl.
  • HPA019632 has been omitted due to target gene not found in Ensembl.
  • HPA021156 has been omitted due to target gene not found in Ensembl.
  • HPA021614 has been omitted due to target gene not found in Ensembl.
  • HPA021817 has been omitted due to target gene not found in Ensembl.
  • HPA022135 has been omitted due to target gene not found in Ensembl.
  • HPA022847 has been omitted due to target gene not found in Ensembl.
  • HPA023009 has been omitted due to target gene not found in Ensembl.
  • HPA023377 has been omitted due to target gene not found in Ensembl.
  • HPA023460 has been omitted due to target gene not found in Ensembl.
  • HPA023993 has been omitted due to target gene not found in Ensembl.
  • HPA024162 has been omitted due to target gene not found in Ensembl.
  • HPA024419 has been omitted due to target gene not found in Ensembl.
  • HPA024445 has been omitted due to target gene not found in Ensembl.
  • HPA024842 has been omitted due to target gene not found in Ensembl.
  • HPA026741 has been omitted due to target gene not found in Ensembl.
  • HPA027216 has been omitted due to target gene not found in Ensembl.
  • HPA027410 has been omitted due to target gene not found in Ensembl.
  • HPA027600 has been omitted due to target gene not found in Ensembl.
  • HPA027719 has been omitted due to target gene not found in Ensembl.
  • HPA027912 has been omitted due to target gene not found in Ensembl.
  • HPA027918 has been omitted due to target gene not found in Ensembl.
  • HPA028624 has been omitted due to target gene not found in Ensembl.
  • HPA028633 has been omitted due to target gene not found in Ensembl.
  • HPA028638 has been omitted due to target gene not found in Ensembl.
  • HPA028784 has been omitted due to target gene not found in Ensembl.
  • HPA028830 has been omitted due to target gene not found in Ensembl.
  • HPA028990 has been omitted due to target gene not found in Ensembl.
  • HPA028991 has been omitted due to target gene not found in Ensembl.
  • HPA029161 has been omitted due to target gene not found in Ensembl.
  • HPA029610 has been omitted due to target gene not found in Ensembl.
  • HPA030077 has been omitted due to target gene not found in Ensembl.
  • HPA030424 has been omitted due to target gene not found in Ensembl.
  • HPA030434 has been omitted due to target gene not found in Ensembl.
  • HPA031128 has been omitted due to target gene not found in Ensembl.
  • HPA031305 has been omitted due to target gene not found in Ensembl.
  • HPA031407 has been omitted due to target gene not found in Ensembl.
  • HPA031886 has been omitted due to target gene not found in Ensembl.
  • HPA035423 has been omitted due to target gene not found in Ensembl.
  • HPA035442 has been omitted due to target gene not found in Ensembl.
  • HPA036291 has been omitted due to target gene not found in Ensembl.
  • HPA037484 has been omitted due to target gene not found in Ensembl.
  • HPA037933 has been omitted due to target gene not found in Ensembl.
  • HPA038184 has been omitted due to target gene not found in Ensembl.
  • HPA038214 has been omitted due to target gene not found in Ensembl.
  • HPA038219 has been omitted due to target gene not found in Ensembl.
  • HPA038276 has been omitted due to target gene not found in Ensembl.
  • HPA038363 has been omitted due to target gene not found in Ensembl.
  • HPA038930 has been omitted due to target gene not found in Ensembl.
  • HPA039168 has been omitted due to target gene not found in Ensembl.
  • HPA039552 has been omitted due to target gene not found in Ensembl.
  • HPA039591 has been omitted due to target gene not found in Ensembl.
  • HPA039651 has been omitted due to target gene not found in Ensembl.
  • HPA039787 has been omitted due to target gene not found in Ensembl.
  • HPA040129 has been omitted due to target gene not found in Ensembl.
  • HPA040133 has been omitted due to target gene not found in Ensembl.
  • HPA040451 has been omitted due to target gene not found in Ensembl.
  • HPA040646 has been omitted due to target gene not found in Ensembl.
  • HPA040994 has been omitted due to target gene not found in Ensembl.
  • HPA041029 has been omitted due to target gene not found in Ensembl.
  • HPA041190 has been omitted due to target gene not found in Ensembl.
  • HPA041238 has been omitted due to target gene not found in Ensembl.
  • HPA041305 has been omitted due to target gene not found in Ensembl.
  • HPA041844 has been omitted due to target gene not found in Ensembl.
  • HPA042085 has been omitted due to target gene not found in Ensembl.
  • HPA042208 has been omitted due to target gene not found in Ensembl.
  • HPA042217 has been omitted due to target gene not found in Ensembl.
  • HPA042219 has been omitted due to target gene not found in Ensembl.
  • HPA042279 has been omitted due to target gene not found in Ensembl.
  • HPA042458 has been omitted due to target gene not found in Ensembl.
  • HPA042541 has been omitted due to target gene not found in Ensembl.
  • HPA042565 has been omitted due to target gene not found in Ensembl.
  • HPA042587 has been omitted due to target gene not found in Ensembl.
  • HPA042673 has been omitted due to target gene not found in Ensembl.
  • HPA042718 has been omitted due to target gene not found in Ensembl.
  • HPA042783 has been omitted due to target gene not found in Ensembl.
  • HPA042885 has been omitted due to target gene not found in Ensembl.
  • HPA043128 has been omitted due to target gene not found in Ensembl.
  • HPA043159 has been omitted due to target gene not found in Ensembl.
  • HPA043565 has been omitted due to target gene not found in Ensembl.
  • HPA043581 has been omitted due to target gene not found in Ensembl.
  • HPA043655 has been omitted due to target gene not found in Ensembl.
  • HPA043657 has been omitted due to target gene not found in Ensembl.
  • HPA043676 has been omitted due to target gene not found in Ensembl.
  • HPA043694 has been omitted due to target gene not found in Ensembl.
  • HPA043697 has been omitted due to target gene not found in Ensembl.
  • HPA043793 has been omitted due to target gene not found in Ensembl.
  • HPA043982 has been omitted due to target gene not found in Ensembl.
  • HPA044013 has been omitted due to target gene not found in Ensembl.
  • HPA044021 has been omitted due to target gene not found in Ensembl.
  • HPA044173 has been omitted due to target gene not found in Ensembl.
  • HPA044178 has been omitted due to target gene not found in Ensembl.
  • HPA044261 has been omitted due to target gene not found in Ensembl.
  • HPA044687 has been omitted due to target gene not found in Ensembl.
  • HPA044744 has been omitted due to target gene not found in Ensembl.
  • HPA044825 has been omitted due to target gene not found in Ensembl.
  • HPA044964 has been omitted due to target gene not found in Ensembl.
  • HPA045011 has been omitted due to target gene not found in Ensembl.
  • HPA045014 has been omitted due to target gene not found in Ensembl.
  • HPA045076 has been omitted due to target gene not found in Ensembl.
  • HPA045111 has been omitted due to target gene not found in Ensembl.
  • HPA045181 has been omitted due to target gene not found in Ensembl.
  • HPA045264 has been omitted due to target gene not found in Ensembl.
  • HPA045411 has been omitted due to target gene not found in Ensembl.
  • HPA045527 has been omitted due to target gene not found in Ensembl.
  • HPA045651 has been omitted due to target gene not found in Ensembl.
  • HPA045670 has been omitted due to target gene not found in Ensembl.
  • HPA045829 has been omitted due to target gene not found in Ensembl.
  • HPA046221 has been omitted due to target gene not found in Ensembl.
  • HPA046232 has been omitted due to target gene not found in Ensembl.
  • HPA046251 has been omitted due to target gene not found in Ensembl.
  • HPA046382 has been omitted due to target gene not found in Ensembl.
  • HPA046589 has been omitted due to target gene not found in Ensembl.
  • HPA046868 has been omitted due to target gene not found in Ensembl.
  • HPA047537 has been omitted due to target gene not found in Ensembl.
  • HPA047656 has been omitted due to target gene not found in Ensembl.
  • HPA047669 has been omitted due to target gene not found in Ensembl.
  • HPA047670 has been omitted due to target gene not found in Ensembl.
  • HPA047695 has been omitted due to target gene not found in Ensembl.
  • HPA047702 has been omitted due to target gene not found in Ensembl.
  • HPA047727 has been omitted due to target gene not found in Ensembl.
  • HPA047900 has been omitted due to target gene not found in Ensembl.
  • HPA047935 has been omitted due to target gene not found in Ensembl.
  • HPA048278 has been omitted due to target gene not found in Ensembl.
  • HPA048297 has been omitted due to target gene not found in Ensembl.
  • HPA048397 has been omitted due to target gene not found in Ensembl.
  • HPA048463 has been omitted due to target gene not found in Ensembl.
  • HPA048610 has been omitted due to target gene not found in Ensembl.
  • HPA048686 has been omitted due to target gene not found in Ensembl.
  • HPA048689 has been omitted due to target gene not found in Ensembl.
  • HPA048721 has been omitted due to target gene not found in Ensembl.
  • HPA048913 has been omitted due to target gene not found in Ensembl.
  • HPA048915 has been omitted due to target gene not found in Ensembl.
  • HPA048927 has been omitted due to target gene not found in Ensembl.
  • HPA049089 has been omitted due to target gene not found in Ensembl.
  • HPA049125 has been omitted due to target gene not found in Ensembl.
  • HPA049142 has been omitted due to target gene not found in Ensembl.
  • HPA049262 has been omitted due to target gene not found in Ensembl.
  • HPA049322 has been omitted due to target gene not found in Ensembl.
  • HPA049339 has been omitted due to target gene not found in Ensembl.
  • HPA049344 has been omitted due to target gene not found in Ensembl.
  • HPA049371 has been omitted due to target gene not found in Ensembl.
  • HPA049460 has been omitted due to target gene not found in Ensembl.
  • HPA049561 has been omitted due to target gene not found in Ensembl.
  • HPA049572 has been omitted due to target gene not found in Ensembl.
  • HPA049607 has been omitted due to target gene not found in Ensembl.
  • HPA049756 has been omitted due to target gene not found in Ensembl.
  • HPA050067 has been omitted due to target gene not found in Ensembl.
  • HPA050514 has been omitted due to target gene not found in Ensembl.
  • HPA050629 has been omitted due to target gene not found in Ensembl.
  • HPA050836 has been omitted due to target gene not found in Ensembl.
  • HPA050858 has been omitted due to target gene not found in Ensembl.
  • HPA050881 has been omitted due to target gene not found in Ensembl.
  • HPA051023 has been omitted due to target gene not found in Ensembl.
  • HPA051070 has been omitted due to target gene not found in Ensembl.
  • HPA051093 has been omitted due to target gene not found in Ensembl.
  • HPA051125 has been omitted due to target gene not found in Ensembl.
  • HPA051211 has been omitted due to target gene not found in Ensembl.
  • HPA051670 has been omitted due to target gene not found in Ensembl.
  • HPA051747 has been omitted due to target gene not found in Ensembl.
  • HPA052040 has been omitted due to target gene not found in Ensembl.
  • HPA052086 has been omitted due to target gene not found in Ensembl.
  • HPA052431 has been omitted due to target gene not found in Ensembl.
  • HPA052539 has been omitted due to target gene not found in Ensembl.
  • HPA052748 has been omitted due to target gene not found in Ensembl.
  • HPA052925 has been omitted due to target gene not found in Ensembl.
  • HPA052955 has been omitted due to target gene not found in Ensembl.
  • HPA053257 has been omitted due to target gene not found in Ensembl.
  • HPA053350 has been omitted due to target gene not found in Ensembl.
  • HPA053460 has been omitted due to target gene not found in Ensembl.
  • HPA053606 has been omitted due to target gene not found in Ensembl.
  • HPA053619 has been omitted due to target gene not found in Ensembl.
  • HPA053751 has been omitted due to target gene not found in Ensembl.
  • HPA053773 has been omitted due to target gene not found in Ensembl.
  • HPA053798 has been omitted due to target gene not found in Ensembl.
  • HPA053819 has been omitted due to target gene not found in Ensembl.
  • HPA053827 has been omitted due to target gene not found in Ensembl.
  • HPA054090 has been omitted due to target gene not found in Ensembl.
  • HPA054416 has been omitted due to target gene not found in Ensembl.
  • HPA054718 has been omitted due to target gene not found in Ensembl.
  • HPA055055 has been omitted due to target gene not found in Ensembl.
  • HPA055075 has been omitted due to target gene not found in Ensembl.
  • HPA055742 has been omitted due to target gene not found in Ensembl.
  • HPA055865 has been omitted due to target gene not found in Ensembl.
  • HPA055986 has been omitted due to target gene not found in Ensembl.
  • HPA056284 has been omitted due to target gene not found in Ensembl.
  • HPA056291 has been omitted due to target gene not found in Ensembl.
  • HPA056432 has been omitted due to target gene not found in Ensembl.
  • HPA056677 has been omitted due to target gene not found in Ensembl.
  • HPA057435 has been omitted due to target gene not found in Ensembl.
  • HPA057742 has been omitted due to target gene not found in Ensembl.
  • HPA058294 has been omitted due to target gene not found in Ensembl.
  • HPA058883 has been omitted due to target gene not found in Ensembl.
  • HPA059028 has been omitted due to target gene not found in Ensembl.
  • HPA059176 has been omitted due to target gene not found in Ensembl.
  • HPA059232 has been omitted due to target gene not found in Ensembl.
  • HPA059277 has been omitted due to target gene not found in Ensembl.
  • HPA059395 has been omitted due to target gene not found in Ensembl.
  • HPA059471 has been omitted due to target gene not found in Ensembl.
  • HPA059792 has been omitted due to target gene not found in Ensembl.
  • HPA059909 has been omitted due to target gene not found in Ensembl.
  • HPA060079 has been omitted due to target gene not found in Ensembl.
  • HPA060271 has been omitted due to target gene not found in Ensembl.
  • HPA060291 has been omitted due to target gene not found in Ensembl.
  • HPA060387 has been omitted due to target gene not found in Ensembl.
  • HPA060572 has been omitted due to target gene not found in Ensembl.
  • HPA060840 has been omitted due to target gene not found in Ensembl.
  • HPA060976 has been omitted due to target gene not found in Ensembl.
  • HPA061182 has been omitted due to target gene not found in Ensembl.
  • HPA061289 has been omitted due to target gene not found in Ensembl.
  • HPA061319 has been omitted due to target gene not found in Ensembl.
  • HPA061322 has been omitted due to target gene not found in Ensembl.
  • HPA061968 has been omitted due to target gene not found in Ensembl.
  • HPA062825 has been omitted due to target gene not found in Ensembl.
  • HPA063994 has been omitted due to target gene not found in Ensembl.
  • HPA064034 has been omitted due to target gene not found in Ensembl.
  • HPA065220 has been omitted due to target gene not found in Ensembl.
  • HPA065588 has been omitted due to target gene not found in Ensembl.
  • HPA065669 has been omitted due to target gene not found in Ensembl.
  • HPA066613 has been omitted due to target gene not found in Ensembl.
  • HPA066634 has been omitted due to target gene not found in Ensembl.
  • HPA067183 has been omitted due to target gene not found in Ensembl.
  • HPA067341 has been omitted due to target gene not found in Ensembl.
  • HPA068744 has been omitted due to target gene not found in Ensembl.
    Subcell atlas
  • CAB000146 has been omitted due to qualitative reasons.
  • HPA000337 has been omitted due to qualitative reasons.
  • CAB000348 has been omitted due to antibody staining not supported by experimental data.
  • HPA000440 has been omitted due to lack of RNA expression in cell line panel.
  • CAB000445 has been omitted due to qualitative reasons.
  • HPA000878 has been omitted due to qualitative reasons.
  • HPA000884 has been omitted due to qualitative reasons. An alternative antibody HPA000167 has been added.
  • HPA001100 has been omitted due to qualitative reasons. An alternative antibody HPA000532 has been added.
  • HPA001239 has been omitted due to qualitative reasons.
  • HPA001275 has been omitted due to qualitative reasons.
  • HPA001587 has been omitted due to qualitative reasons. An alternative antibody HPA001795 has been added.
  • HPA001609 has been omitted due to antibody staining not supported by experimental data. An alternative antibody HPA005812 has been added.
  • HPA001612 has been omitted due to qualitative reasons. An alternative antibody CAB068187 has been added.
  • HPA001613 has been omitted due to qualitative reasons. An alternative antibody CAB068187 has been added.
  • HPA001733 has been omitted due to qualitative reasons.
  • HPA001800 has been omitted due to qualitative reasons. An alternative antibody HPA001592 has been added.
  • HPA001815 has been omitted due to qualitative reasons.
  • HPA002190 has been omitted due to antibody staining not supported by experimental data.
  • HPA002265 has been omitted due to qualitative reasons.
  • HPA002835 has been omitted due to qualitative reasons.
  • HPA002855 has been omitted due to qualitative reasons.
  • HPA002867 has been omitted due to qualitative reasons. An alternative antibody HPA002868 has been added.
  • HPA002933 has been omitted due to antibody staining not supported by experimental data.
  • HPA003156 has been omitted due to antibody staining not supported by experimental data.
  • HPA003165 has been omitted due to qualitative reasons.
  • HPA003175 has been omitted due to qualitative reasons.
  • HPA003193 has been omitted due to qualitative reasons.
  • HPA003353 antibody has been omitted due to target gene not found in Ensembl.
  • HPA003426 has been omitted due to qualitative reasons. An alternative antibody HPA004167 has been added.
  • HPA003484 has been omitted due to qualitative reasons. An alternative antibody HPA004475 has been added.
  • HPA003511 has been omitted due to antibody staining not supported by experimental data.
  • HPA003543 has been omitted due to qualitative reasons.
  • CAB003710 has been omitted due to qualitative reasons.
  • HPA003934 has been omitted due to qualitative reasons. An alternative antibody HPA024222 has been added.
  • HPA003940 has been omitted due to qualitative reasons.
  • CAB004083 has been omitted due to qualitative reasons.
  • CAB004242 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines. An alternative antibody HPA051531 has been added.
  • CAB004350 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • CAB004393 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines. An alternative antibody CAB068187 has been added.
  • HPA004426 has been omitted due to qualitative reasons.
  • CAB004592 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA004734 has been omitted due to qualitative reasons.
  • HPA004823 has been omitted due to qualitative reasons.
  • HPA004922 has been omitted due to qualitative reasons. An alternative antibody HPA031053 has been added.
  • HPA004924 has been omitted due to qualitative reasons. An alternative antibody HPA064737 has been added.
  • CAB005375 has been omitted due to qualitative reasons.
  • HPA005673 has been omitted due to qualitative reasons.
  • CAB005870 has been omitted due to qualitative reasons.
  • HPA006026 has been omitted due to qualitative reasons.
  • HPA006035 has been omitted due to qualitative reasons.
  • HPA006554 has been omitted due to antibody staining not supported by experimental data.
  • HPA006716 has been omitted due to qualitative reasons. An alternative antibody HPA006724 has been added.
  • HPA006776 antibody has been omitted due to target gene not found in Ensembl.
  • HPA006916 has been omitted due to qualitative reasons.
  • HPA007007 has been omitted due to qualitative reasons. An alternative antibody HPA006286 has been added.
  • HPA007187 has been omitted due to qualitative reasons. An alternative antibody HPA007594 has been added.
  • HPA007227 has been omitted due to qualitative reasons. An alternative antibody HPA054523 has been added.
  • CAB007772 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA007919 has been omitted due to qualitative reasons.
  • HPA008228 has been omitted due to qualitative reasons. An alternative antibody HPA012021 has been added.
  • HPA008312 has been omitted due to qualitative reasons.
  • HPA008315 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA008547 has been omitted due to lack of RNA expression in cell line panel.
  • HPA008556 has been omitted due to qualitative reasons.
  • CAB008630 has been omitted due to qualitative reasons. An alternative antibody HPA058546 has been added.
  • HPA008691 has been omitted due to qualitative reasons. An alternative antibody HPA008620 has been added.
  • HPA008797 has been omitted due to qualitative reasons. An alternative antibody HPA008736 has been added.
  • HPA008802 has been omitted due to antibody staining not supported by experimental data.
  • HPA008846 has been omitted due to qualitative reasons.
  • CAB009055 has been omitted due to qualitative reasons.
  • CAB009233 has been omitted due to qualitative reasons. An alternative antibody HPA027484 has been added.
  • CAB009312 has been omitted due to qualitative reasons. An alternative antibody HPA021611 has been added.
  • CAB009577 has been omitted due to antibody staining not supported by experimental data.
  • CAB009846 has been omitted due to qualitative reasons.
  • CAB009886 has been omitted due to qualitative reasons.
  • CAB010223 has been omitted due to qualitative reasons.
  • CAB010307 has been omitted due to qualitative reasons. An alternative antibody HPA055893 has been added.
  • CAB010337 has been omitted due to antibody staining not supported by experimental data.
  • CAB010434 has been omitted due to qualitative reasons.
  • CAB010454 has been omitted due to antibody staining not supported by experimental data.
  • CAB010469 has been omitted due to qualitative reasons. An alternative antibody HPA001863 has been added.
  • HPA010611 has been omitted due to qualitative reasons.
  • HPA011169 has been omitted due to qualitative reasons. An alternative antibody HPA072692 has been added.
  • HPA011170 has been omitted due to qualitative reasons. An alternative antibody HPA011844 has been added.
  • CAB011203 has been omitted due to qualitative reasons.
  • CAB011571 has been omitted due to qualitative reasons.
  • CAB011596 has been omitted due to qualitative reasons. An alternative antibody HPA062987 has been added.
  • CAB011618 has been omitted due to qualitative reasons.
  • CAB011671 has been omitted due to qualitative reasons.
  • HPA011893 has been omitted due to qualitative reasons.
  • HPA011990 has been omitted due to antibody staining not supported by experimental data.
  • CAB012179 has been omitted due to antibody staining not supported by experimental data.
  • CAB012190 has been omitted due to qualitative reasons.
  • CAB012200 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • CAB012340 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA012716 has been omitted due to qualitative reasons.
  • HPA012748 has been omitted due to antibody staining not supported by experimental data.
  • CAB013284 has been omitted due to qualitative reasons.
  • CAB013294 has been omitted due to qualitative reasons. An alternative antibody HPA060714 has been added.
  • HPA013349 has been omitted due to qualitative reasons.
  • CAB013478 has been omitted due to qualitative reasons. An alternative antibody HPA057961 has been added.
  • HPA014002 has been omitted due to qualitative reasons.
  • HPA014048 has been omitted due to qualitative reasons.
  • HPA014144 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA014418 has been omitted due to qualitative reasons. An alternative antibody HPA073461 has been added.
  • HPA014539 has been omitted due to antibody staining not supported by experimental data.
  • HPA014540 antibody has been omitted due to target gene not found in Ensembl.
  • HPA014848 has been omitted due to qualitative reasons.
  • HPA014862 antibody has been omitted due to target gene not found in Ensembl.
  • CAB014895 has been omitted due to qualitative reasons. An alternative antibody HPA059851 has been added.
  • HPA014996 has been omitted due to antibody staining not supported by experimental data.
  • CAB015124 has been omitted due to qualitative reasons.
  • HPA015134 has been omitted due to qualitative reasons.
  • CAB015221 has been omitted due to qualitative reasons.
  • CAB015412 has been omitted due to qualitative reasons. An alternative antibody HPA064370 has been added.
  • HPA015535 has been omitted due to qualitative reasons.
  • HPA015641 has been omitted due to qualitative reasons.
  • HPA015788 has been omitted due to qualitative reasons.
  • CAB016061 has been omitted due to qualitative reasons. An alternative antibody HPA055179 has been added.
  • CAB016079 has been omitted due to qualitative reasons. An alternative antibody HPA055179 has been added.
  • CAB016120 has been omitted due to qualitative reasons. An alternative antibody HPA029095 has been added.
  • CAB016327 has been omitted due to qualitative reasons. An alternative antibody HPA061593 has been added.
  • HPA016434 has been omitted due to antibody staining not supported by experimental data.
  • CAB016535 has been omitted due to qualitative reasons.
  • HPA016617 antibody has been omitted due to target gene not found in Ensembl.
  • CAB016673 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA016867 has been omitted due to qualitative reasons. An alternative antibody HPA061071 has been added.
  • HPA016871 has been omitted due to qualitative reasons.
  • HPA016885 has been omitted due to qualitative reasons.
  • CAB017185 has been omitted due to qualitative reasons.
  • HPA017254 has been omitted due to qualitative reasons.
  • HPA017344 has been omitted due to qualitative reasons. An alternative antibody HPA067443 has been added.
  • HPA017369 has been omitted due to qualitative reasons.
  • CAB017566 has been omitted due to qualitative reasons. An alternative antibody HPA053188 has been added.
  • HPA017592 antibody has been omitted due to target gene not found in Ensembl.
  • HPA017759 has been omitted due to qualitative reasons. An alternative antibody HPA021057 has been added.
  • HPA017770 has been omitted due to qualitative reasons.
  • CAB017773 has been omitted due to qualitative reasons.
  • CAB017849 has been omitted due to qualitative reasons.
  • HPA017869 has been omitted due to qualitative reasons.
  • HPA017916 has been omitted due to antibody staining not supported by experimental data.
  • HPA017941 antibody has been omitted due to target gene not found in Ensembl.
  • HPA018008 antibody has been omitted due to target gene not found in Ensembl.
  • HPA018122 has been omitted due to antibody staining not supported by experimental data.
  • HPA018152 has been omitted due to qualitative reasons.
  • HPA018155 has been omitted due to qualitative reasons.
  • HPA018226 has been omitted due to qualitative reasons. An alternative antibody HPA063559 has been added.
  • CAB018346 has been omitted due to qualitative reasons.
  • CAB018371 has been omitted due to qualitative reasons.
  • HPA018406 has been omitted due to qualitative reasons.
  • HPA018447 has been omitted due to antibody staining not supported by experimental data. An alternative antibody HPA031518 has been added.
  • HPA018520 has been omitted due to qualitative reasons. An alternative antibody HPA021051 has been added.
  • HPA018523 has been omitted due to antibody staining not supported by experimental data.
  • CAB018782 has been omitted due to qualitative reasons.
  • HPA018871 has been omitted due to antibody staining not supported by experimental data.
  • HPA018977 has been omitted due to antibody staining not supported by experimental data. An alternative antibody HPA064535 has been added.
  • HPA019008 has been omitted due to qualitative reasons. An alternative antibody CAB072814 has been added.
  • HPA019016 has been omitted due to lack of RNA expression in cell line panel. An alternative antibody HPA042715 has been added.
  • HPA019049 has been omitted due to qualitative reasons.
  • HPA019198 has been omitted due to antibody staining not supported by experimental data.
  • HPA019228 has been omitted due to qualitative reasons.
  • HPA019232 has been omitted due to qualitative reasons.
  • CAB019308 has been omitted due to qualitative reasons. An alternative antibody CAB000329 has been added.
  • HPA019445 has been omitted due to qualitative reasons.
  • HPA019646 has been omitted due to qualitative reasons.
  • HPA019653 has been omitted due to qualitative reasons. An alternative antibody HPA067444 has been added.
  • HPA019704 has been omitted due to qualitative reasons.
  • HPA019779 has been omitted due to qualitative reasons.
  • HPA019840 has been omitted due to qualitative reasons.
  • HPA019937 has been omitted due to lack of RNA expression in cell line panel.
  • HPA019940 has been omitted due to lack of RNA expression in cell line panel.
  • HPA020086 has been omitted due to qualitative reasons.
  • HPA020111 has been omitted due to qualitative reasons.
  • HPA020432 has been omitted due to qualitative reasons.
  • HPA020512 has been omitted due to qualitative reasons. An alternative antibody HPA061066 has been added.
  • HPA020643 has been omitted due to antibody staining not supported by experimental data.
  • HPA020960 has been omitted due to antibody staining not supported by experimental data.
  • HPA020989 has been omitted due to qualitative reasons. An alternative antibody HPA063592 has been added.
  • HPA021002 has been omitted due to antibody staining not supported by experimental data.
  • HPA021153 has been omitted due to qualitative reasons. An alternative antibody CAB072810 has been added.
  • HPA021154 has been omitted due to qualitative reasons. An alternative antibody CAB072810 has been added.
  • HPA021158 has been omitted due to antibody staining not supported by experimental data.
  • HPA021187 has been omitted due to antibody staining not supported by experimental data. An alternative antibody HPA063810 has been added.
  • HPA021193 has been omitted due to qualitative reasons.
  • HPA021421 has been omitted due to antibody staining not supported by experimental data. An alternative antibody HPA061073 has been added.
  • HPA021444 has been omitted due to qualitative reasons.
  • HPA021497 has been omitted due to qualitative reasons.
  • HPA021587 has been omitted due to qualitative reasons. An alternative antibody HPA022905 has been added.
  • HPA021669 has been omitted due to qualitative reasons. An alternative antibody HPA065815 has been added.
  • HPA021817 antibody has been omitted due to target gene not found in Ensembl.
  • CAB022068 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • CAB022337 has been omitted due to qualitative reasons. An alternative antibody HPA064401 has been added.
  • HPA023072 has been omitted due to qualitative reasons.
  • HPA023106 has been omitted due to qualitative reasons.
  • HPA023149 has been omitted due to qualitative reasons.
  • HPA023240 has been omitted due to qualitative reasons. An alternative antibody HPA067108 has been added.
  • HPA023290 has been omitted due to qualitative reasons.
  • HPA023377 antibody has been omitted due to target gene not found in Ensembl.
  • HPA023386 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA023534 has been omitted due to antibody staining not supported by experimental data.
  • HPA023614 has been omitted due to qualitative reasons. An alternative antibody HPA026556 has been added.
  • HPA023690 has been omitted due to qualitative reasons. An alternative antibody HPA029634 has been added.
  • HPA023738 has been omitted due to qualitative reasons.
  • HPA023742 has been omitted due to qualitative reasons.
  • HPA023964 has been omitted due to qualitative reasons. An alternative antibody HPA036304 has been added.
  • HPA024075 has been omitted due to antibody staining not supported by experimental data.
  • HPA024110 has been omitted due to qualitative reasons.
  • HPA024241 has been omitted due to qualitative reasons. An alternative antibody HPA064304 has been added.
  • HPA024258 has been omitted due to qualitative reasons.
  • HPA024482 has been omitted due to qualitative reasons. An alternative antibody HPA065839 has been added.
  • HPA024525 has been omitted due to qualitative reasons.
  • HPA024573 has been omitted due to qualitative reasons.
  • HPA024607 has been omitted due to qualitative reasons. An alternative antibody HPA067108 has been added.
  • HPA024630 has been omitted due to qualitative reasons. An alternative antibody HPA066512 has been added.
  • CAB024999 has been omitted due to antibody staining not supported by experimental data. An alternative antibody HPA007993 has been added.
  • CAB025100 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • CAB025115 has been omitted due to qualitative reasons. An alternative antibody HPA007398 has been added.
  • HPA025235 has been omitted due to qualitative reasons. An alternative antibody CAB076375 has been added.
  • CAB025488 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • CAB025646 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA025695 has been omitted due to antibody staining not supported by experimental data.
  • HPA025715 has been omitted due to antibody staining not supported by experimental data.
  • HPA025754 has been omitted due to antibody staining not supported by experimental data.
  • HPA025755 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA025924 has been omitted due to antibody staining not supported by experimental data.
  • CAB026025 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • CAB026212 has been omitted due to qualitative reasons.
  • CAB026335 has been omitted due to qualitative reasons.
  • CAB026374 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA026442 has been omitted due to qualitative reasons.
  • HPA026488 has been omitted due to qualitative reasons.
  • HPA026552 has been omitted due to qualitative reasons.
  • HPA026557 has been omitted due to qualitative reasons.
  • HPA026579 has been omitted due to qualitative reasons.
  • HPA026580 has been omitted due to qualitative reasons. An alternative antibody HPA061075 has been added.
  • HPA026673 has been omitted due to lack of RNA expression in cell line panel.
  • HPA026687 has been omitted due to antibody staining not supported by experimental data.
  • HPA026713 has been omitted due to qualitative reasons.
  • HPA026741 antibody has been omitted due to target gene not found in Ensembl.
  • HPA027024 has been omitted due to antibody staining not supported by experimental data.
  • HPA027110 has been omitted due to qualitative reasons. An alternative antibody HPA027127 has been added.
  • HPA027216 antibody has been omitted due to target gene not found in Ensembl.
  • HPA027277 has been omitted due to qualitative reasons. An alternative antibody HPA028303 has been added.
  • HPA027282 has been omitted due to qualitative reasons.
  • HPA027284 has been omitted due to qualitative reasons.
  • CAB027385 has been omitted due to qualitative reasons.
  • CAB027387 has been omitted due to qualitative reasons. An alternative antibody CAB058698 has been added.
  • HPA027421 has been omitted due to qualitative reasons.
  • HPA027430 has been omitted due to qualitative reasons. An alternative antibody HPA027449 has been added.
  • HPA027478 has been omitted due to antibody staining not supported by experimental data.
  • HPA027728 has been omitted due to antibody staining not supported by experimental data.
  • HPA027769 has been omitted due to lack of RNA expression in cell line panel.
  • HPA027772 has been omitted due to qualitative reasons.
  • HPA027831 has been omitted due to qualitative reasons.
  • HPA027884 has been omitted due to qualitative reasons. An alternative antibody HPA027885 has been added.
  • HPA028020 has been omitted due to qualitative reasons. An alternative antibody HPA028333 has been added.
  • HPA028039 has been omitted due to antibody staining not supported by experimental data.
  • HPA028262 has been omitted due to antibody staining not supported by experimental data.
  • HPA028326 has been omitted due to qualitative reasons.
  • HPA028414 has been omitted due to qualitative reasons. An alternative antibody HPA028412 has been added.
  • HPA028427 has been omitted due to qualitative reasons.
  • HPA028442 has been omitted due to lack of RNA expression in cell line panel.
  • HPA028578 has been omitted due to qualitative reasons. An alternative antibody HPA064660 has been added.
  • HPA028581 has been omitted due to qualitative reasons.
  • HPA028624 antibody has been omitted due to target gene not found in Ensembl.
  • HPA028638 antibody has been omitted due to target gene not found in Ensembl.
  • HPA028654 has been omitted due to qualitative reasons. An alternative antibody HPA028219 has been added.
  • HPA028681 has been omitted due to qualitative reasons.
  • HPA028774 has been omitted due to antibody staining not supported by experimental data.
  • HPA028817 has been omitted due to qualitative reasons.
  • HPA029229 has been omitted due to qualitative reasons.
  • HPA029247 has been omitted due to qualitative reasons.
  • HPA029249 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines. An alternative antibody HPA029250 has been added.
  • HPA029461 has been omitted due to qualitative reasons.
  • HPA029522 has been omitted due to qualitative reasons.
  • HPA029643 has been omitted due to qualitative reasons.
  • HPA029752 has been omitted due to qualitative reasons. An alternative antibody HPA028132 has been added.
  • HPA029839 has been omitted due to qualitative reasons. An alternative antibody HPA066513 has been added.
  • HPA029970 has been omitted due to qualitative reasons.
  • HPA030077 antibody has been omitted due to target gene not found in Ensembl.
  • HPA030166 has been omitted due to qualitative reasons.
  • HPA030265 has been omitted due to antibody staining not supported by experimental data. An alternative antibody HPA028482 has been added.
  • HPA030272 has been omitted due to qualitative reasons.
  • HPA030280 has been omitted due to lack of RNA expression in cell line panel.
  • HPA030719 has been omitted due to antibody staining not supported by experimental data.
  • HPA030737 has been omitted due to antibody staining not supported by experimental data.
  • HPA030786 has been omitted due to antibody staining not supported by experimental data.
  • HPA030887 has been omitted due to qualitative reasons. An alternative antibody HPA063624 has been added.
  • HPA030978 has been omitted due to qualitative reasons.
  • HPA031085 has been omitted due to qualitative reasons.
  • HPA031128 antibody has been omitted due to target gene not found in Ensembl.
  • HPA031263 has been omitted due to qualitative reasons.
  • HPA031314 has been omitted due to qualitative reasons.
  • HPA031642 has been omitted due to qualitative reasons. An alternative antibody HPA028407 has been added.
  • HPA031674 has been omitted due to qualitative reasons. An alternative antibody HPA011940 has been added.
  • HPA031752 has been omitted due to qualitative reasons.
  • HPA031775 has been omitted due to qualitative reasons.
  • HPA031781 has been omitted due to qualitative reasons.
  • HPA031806 has been omitted due to qualitative reasons.
  • HPA031884 has been omitted due to qualitative reasons.
  • HPA031974 has been omitted due to qualitative reasons.
  • HPA032044 has been omitted due to qualitative reasons. An alternative antibody HPA059124 has been added.
  • HPA032117 has been omitted due to antibody staining not supported by experimental data. An alternative antibody HPA060340 has been added.
  • HPA032119 has been omitted due to qualitative reasons.
  • CAB032821 has been omitted due to qualitative reasons. An alternative antibody HPA068456 has been added.
  • CAB033842 has been omitted due to qualitative reasons.
  • HPA034533 has been omitted due to qualitative reasons. An alternative antibody HPA064289 has been added.
  • HPA034571 has been omitted due to qualitative reasons. An alternative antibody HPA034572 has been added.
  • HPA034695 has been omitted due to qualitative reasons.
  • HPA034764 has been omitted due to qualitative reasons. An alternative antibody HPA061405 has been added.
  • HPA034874 has been omitted due to qualitative reasons. An alternative antibody HPA034873 has been added.
  • HPA034959 has been omitted due to lack of RNA expression in cell line panel.
  • HPA034966 has been omitted due to qualitative reasons.
  • HPA035036 has been omitted due to qualitative reasons.
  • HPA035214 has been omitted due to antibody staining not supported by experimental data.
  • HPA035241 has been omitted due to qualitative reasons.
  • HPA035279 has been omitted due to qualitative reasons. An alternative antibody HPA035278 has been added.
  • HPA035336 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA035423 antibody has been omitted due to target gene not found in Ensembl.
  • HPA035437 has been omitted due to qualitative reasons.
  • HPA035513 has been omitted due to qualitative reasons.
  • HPA035557 has been omitted due to qualitative reasons.
  • HPA035715 has been omitted due to qualitative reasons.
  • HPA035719 has been omitted due to qualitative reasons.
  • HPA035731 has been omitted due to lack of RNA expression in cell line panel.
  • HPA035734 has been omitted due to qualitative reasons. An alternative antibody CAB072801 has been added.
  • HPA035736 has been omitted due to qualitative reasons.
  • HPA035849 has been omitted due to qualitative reasons.
  • HPA035874 has been omitted due to qualitative reasons.
  • HPA035944 has been omitted due to qualitative reasons.
  • HPA035951 has been omitted due to antibody staining not supported by experimental data. An alternative antibody HPA066085 has been added.
  • HPA035957 has been omitted due to qualitative reasons.
  • HPA036085 has been omitted due to qualitative reasons.
  • HPA036324 has been omitted due to qualitative reasons.
  • HPA036374 has been omitted due to qualitative reasons. An alternative antibody HPA064759 has been added.
  • HPA036422 has been omitted due to qualitative reasons.
  • HPA036461 has been omitted due to qualitative reasons. An alternative antibody HPA063608 has been added.
  • HPA036472 has been omitted due to qualitative reasons.
  • HPA036479 has been omitted due to qualitative reasons. An alternative antibody HPA036478 has been added.
  • HPA036499 has been omitted due to qualitative reasons.
  • HPA036513 has been omitted due to qualitative reasons. An alternative antibody HPA036512 has been added.
  • HPA036630 has been omitted due to qualitative reasons. An alternative antibody HPA061745 has been added.
  • HPA036652 has been omitted due to qualitative reasons.
  • HPA036711 has been omitted due to qualitative reasons.
  • HPA036712 has been omitted due to qualitative reasons.
  • HPA036742 has been omitted due to qualitative reasons.
  • HPA036791 has been omitted due to qualitative reasons.
  • HPA036794 has been omitted due to qualitative reasons. An alternative antibody HPA036793 has been added.
  • HPA036889 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA036905 has been omitted due to qualitative reasons. An alternative antibody HPA062291 has been added.
  • CAB037158 has been omitted due to qualitative reasons. An alternative antibody HPA067010 has been added.
  • CAB037166 has been omitted due to qualitative reasons.
  • CAB037187 has been omitted due to qualitative reasons.
  • CAB037328 has been omitted due to qualitative reasons.
  • HPA037360 has been omitted due to qualitative reasons.
  • HPA037484 antibody has been omitted due to target gene not found in Ensembl.
  • HPA037536 has been omitted due to qualitative reasons. An alternative antibody HPA003103 has been added.
  • HPA037598 has been omitted due to qualitative reasons.
  • HPA037643 has been omitted due to qualitative reasons.
  • HPA037644 has been omitted due to qualitative reasons.
  • HPA037658 has been omitted due to qualitative reasons.
  • HPA037773 has been omitted due to qualitative reasons. An alternative antibody HPA037772 has been added.
  • HPA037921 has been omitted due to qualitative reasons.
  • HPA038057 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA038172 has been omitted due to antibody staining not supported by experimental data.
  • HPA038224 has been omitted due to qualitative reasons.
  • HPA038245 has been omitted due to qualitative reasons. An alternative antibody HPA064831 has been added.
  • HPA038276 antibody has been omitted due to target gene not found in Ensembl.
  • HPA038404 has been omitted due to qualitative reasons. An alternative antibody HPA057521 has been added.
  • HPA038504 has been omitted due to qualitative reasons.
  • HPA038617 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines. An alternative antibody HPA064831 has been added.
  • HPA038680 has been omitted due to qualitative reasons.
  • HPA038772 has been omitted due to qualitative reasons. An alternative antibody HPA004805 has been added.
  • HPA038778 has been omitted due to qualitative reasons.
  • HPA038860 has been omitted due to qualitative reasons.
  • HPA038884 has been omitted due to qualitative reasons. An alternative antibody HPA038885 has been added.
  • HPA038930 antibody has been omitted due to target gene not found in Ensembl.
  • HPA038966 has been omitted due to qualitative reasons. An alternative antibody HPA058739 has been added.
  • HPA039004 has been omitted due to qualitative reasons. An alternative antibody HPA039003 has been added.
  • HPA039006 has been omitted due to antibody staining not supported by experimental data.
  • HPA039095 has been omitted due to qualitative reasons. An alternative antibody HPA061531 has been added.
  • HPA039165 has been omitted due to antibody staining not supported by experimental data.
  • HPA039176 has been omitted due to qualitative reasons. An alternative antibody CAB072836 has been added.
  • HPA039369 has been omitted due to qualitative reasons. An alternative antibody HPA066144 has been added.
  • HPA039593 has been omitted due to qualitative reasons.
  • HPA039651 antibody has been omitted due to target gene not found in Ensembl.
  • HPA039787 antibody has been omitted due to target gene not found in Ensembl.
  • HPA039883 has been omitted due to qualitative reasons. An alternative antibody CAB072833 has been added.
  • HPA039893 has been omitted due to qualitative reasons. An alternative antibody HPA040214 has been added.
  • HPA039972 has been omitted due to qualitative reasons.
  • HPA039984 has been omitted due to qualitative reasons. An alternative antibody HPA003757 has been added.
  • HPA040053 has been omitted due to qualitative reasons.
  • HPA040325 has been omitted due to qualitative reasons. An alternative antibody HPA061548 has been added.
  • HPA040436 has been omitted due to antibody staining not supported by experimental data. An alternative antibody HPA040407 has been added.
  • CAB040544 has been omitted due to qualitative reasons.
  • HPA040646 antibody has been omitted due to target gene not found in Ensembl.
  • HPA040703 has been omitted due to qualitative reasons. An alternative antibody HPA047801 has been added.
  • HPA040789 has been omitted due to qualitative reasons. An alternative antibody HPA049208 has been added.
  • HPA040867 has been omitted due to qualitative reasons. An alternative antibody HPA066483 has been added.
  • HPA040874 has been omitted due to qualitative reasons.
  • HPA040906 has been omitted due to qualitative reasons. An alternative antibody HPA061872 has been added.
  • HPA041080 has been omitted due to qualitative reasons.
  • HPA041093 has been omitted due to qualitative reasons.
  • HPA041099 has been omitted due to qualitative reasons. An alternative antibody HPA063534 has been added.
  • HPA041120 has been omitted due to qualitative reasons. An alternative antibody HPA053755 has been added.
  • HPA041188 has been omitted due to qualitative reasons.
  • HPA041397 has been omitted due to qualitative reasons. An alternative antibody HPA062142 has been added.
  • HPA041530 has been omitted due to qualitative reasons.
  • HPA041567 has been omitted due to qualitative reasons.
  • HPA041712 has been omitted due to qualitative reasons.
  • HPA041736 has been omitted due to antibody staining not supported by experimental data.
  • HPA041802 has been omitted due to new images pending. An alternative antibody HPA054532 has been added.
  • HPA041875 has been omitted due to antibody staining not supported by experimental data. An alternative antibody HPA043637 has been added.
  • HPA041892 has been omitted due to qualitative reasons. An alternative antibody HPA063027 has been added.
  • HPA041906 has been omitted due to qualitative reasons.
  • HPA041990 has been omitted due to qualitative reasons. An alternative antibody HPA058579 has been added.
  • HPA042037 has been omitted due to qualitative reasons. An alternative antibody HPA040810 has been added.
  • HPA042164 has been omitted due to qualitative reasons.
  • HPA042198 has been omitted due to qualitative reasons.
  • HPA042412 has been omitted due to qualitative reasons.
  • HPA042437 has been omitted due to antibody staining not supported by experimental data. An alternative antibody HPA056359 has been added.
  • HPA042465 has been omitted due to qualitative reasons. An alternative antibody HPA063716 has been added.
  • HPA042733 has been omitted due to qualitative reasons.
  • HPA042745 has been omitted due to qualitative reasons.
  • HPA042870 has been omitted due to qualitative reasons. An alternative antibody HPA063230 has been added.
  • HPA042912 has been omitted due to qualitative reasons.
  • HPA042932 has been omitted due to qualitative reasons. An alternative antibody HPA052205 has been added.
  • HPA042968 has been omitted due to qualitative reasons.
  • HPA043061 has been omitted due to antibody staining not supported by experimental data. An alternative antibody HPA065309 has been added.
  • HPA043073 has been omitted due to qualitative reasons. An alternative antibody HPA035234 has been added.
  • HPA043099 has been omitted due to qualitative reasons. An alternative antibody HPA043563 has been added.
  • HPA043131 has been omitted due to qualitative reasons.
  • HPA043171 has been omitted due to antibody staining not supported by experimental data.
  • HPA043219 has been omitted due to qualitative reasons.
  • HPA043227 has been omitted due to new images pending.
  • HPA043301 has been omitted due to qualitative reasons. An alternative antibody HPA035234 has been added.
  • HPA043388 has been omitted due to antibody staining not supported by experimental data.
  • HPA043500 has been omitted due to qualitative reasons.
  • HPA043552 has been omitted due to qualitative reasons.
  • HPA043594 has been omitted due to qualitative reasons.
  • HPA043627 has been omitted due to qualitative reasons.
  • HPA043639 has been omitted due to qualitative reasons. An alternative antibody HPA043255 has been added.
  • HPA043697 antibody has been omitted due to target gene not found in Ensembl.
  • HPA043709 has been omitted due to qualitative reasons.
  • HPA043793 antibody has been omitted due to target gene not found in Ensembl.
  • HPA043832 has been omitted due to qualitative reasons.
  • HPA043940 has been omitted due to qualitative reasons.
  • HPA043951 has been omitted due to qualitative reasons.
  • HPA043966 has been omitted due to qualitative reasons.
  • HPA044009 has been omitted due to qualitative reasons.
  • HPA044021 antibody has been omitted due to target gene not found in Ensembl.
  • HPA044135 has been omitted due to qualitative reasons.
  • HPA044147 has been omitted due to qualitative reasons.
  • HPA044169 has been omitted due to antibody staining not supported by experimental data.
  • HPA044173 antibody has been omitted due to target gene not found in Ensembl.
  • HPA044206 has been omitted due to qualitative reasons. An alternative antibody HPA066137 has been added.
  • HPA044334 has been omitted due to qualitative reasons. An alternative antibody HPA062997 has been added.
  • HPA044361 has been omitted due to qualitative reasons.
  • HPA044408 has been omitted due to qualitative reasons.
  • HPA044687 antibody has been omitted due to target gene not found in Ensembl.
  • HPA044748 has been omitted due to qualitative reasons. An alternative antibody HPA050397 has been added.
  • HPA044863 has been omitted due to qualitative reasons.
  • HPA044864 has been omitted due to qualitative reasons. An alternative antibody HPA035354 has been added.
  • HPA044870 has been omitted due to qualitative reasons. An alternative antibody HPA037001 has been added.
  • HPA044950 has been omitted due to qualitative reasons. An alternative antibody HPA028382 has been added.
  • HPA044960 has been omitted due to qualitative reasons.
  • HPA045024 has been omitted due to qualitative reasons. An alternative antibody HPA063731 has been added.
  • HPA045192 has been omitted due to antibody staining not supported by experimental data.
  • HPA045252 has been omitted due to qualitative reasons. An alternative antibody HPA066668 has been added.
  • HPA045389 has been omitted due to qualitative reasons.
  • HPA045507 has been omitted due to qualitative reasons.
  • HPA045677 has been omitted due to qualitative reasons. An alternative antibody HPA062853 has been added.
  • HPA045761 has been omitted due to qualitative reasons. An alternative antibody HPA053721 has been added.
  • HPA045845 has been omitted due to qualitative reasons.
  • HPA045939 has been omitted due to qualitative reasons.
  • HPA045958 has been omitted due to qualitative reasons.
  • HPA046053 has been omitted due to qualitative reasons. An alternative antibody HPA057339 has been added.
  • HPA046133 has been omitted due to qualitative reasons.
  • HPA046157 has been omitted due to qualitative reasons. An alternative antibody HPA062290 has been added.
  • HPA046265 has been omitted due to qualitative reasons. An alternative antibody HPA040760 has been added.
  • HPA046343 has been omitted due to qualitative reasons. An alternative antibody HPA037772 has been added.
  • HPA046382 antibody has been omitted due to target gene not found in Ensembl.
  • HPA046403 has been omitted due to qualitative reasons. An alternative antibody HPA039710 has been added.
  • HPA046433 has been omitted due to qualitative reasons. An alternative antibody CAB005261 has been added.
  • HPA046557 has been omitted due to qualitative reasons. An alternative antibody HPA030202 has been added.
  • HPA046577 has been omitted due to qualitative reasons. An alternative antibody HPA049664 has been added.
  • HPA046684 has been omitted due to antibody staining not supported by experimental data.
  • HPA046731 has been omitted due to qualitative reasons. An alternative antibody HPA060089 has been added.
  • HPA046821 has been omitted due to qualitative reasons.
  • HPA046898 has been omitted due to qualitative reasons.
  • HPA046899 has been omitted due to qualitative reasons. An alternative antibody HPA054190 has been added.
  • HPA046967 has been omitted due to qualitative reasons. An alternative antibody HPA062690 has been added.
  • HPA046995 has been omitted due to qualitative reasons.
  • HPA047052 has been omitted due to qualitative reasons.
  • HPA047083 has been omitted due to qualitative reasons.
  • HPA047084 has been omitted due to qualitative reasons. An alternative antibody HPA063542 has been added.
  • HPA047271 has been omitted due to qualitative reasons. An alternative antibody HPA066262 has been added.
  • HPA047275 has been omitted due to qualitative reasons. An alternative antibody HPA065000 has been added.
  • HPA047516 has been omitted due to qualitative reasons. An alternative antibody CAB073543 has been added.
  • HPA047522 has been omitted due to qualitative reasons. An alternative antibody HPA064967 has been added.
  • HPA047537 antibody has been omitted due to target gene not found in Ensembl.
  • HPA047579 has been omitted due to antibody staining not supported by experimental data.
  • HPA047590 has been omitted due to qualitative reasons.
  • HPA047727 antibody has been omitted due to target gene not found in Ensembl.
  • HPA047784 has been omitted due to antibody staining not supported by experimental data.
  • HPA047806 has been omitted due to qualitative reasons. An alternative antibody HPA040140 has been added.
  • HPA047825 has been omitted due to qualitative reasons.
  • HPA048084 has been omitted due to qualitative reasons.
  • HPA048180 has been omitted due to qualitative reasons. An alternative antibody HPA039962 has been added.
  • HPA048213 has been omitted due to qualitative reasons.
  • HPA048223 has been omitted due to qualitative reasons. An alternative antibody HPA059897 has been added.
  • HPA048257 has been omitted due to qualitative reasons.
  • HPA048300 has been omitted due to qualitative reasons.
  • HPA048315 has been omitted due to qualitative reasons. An alternative antibody HPA047893 has been added.
  • HPA048371 has been omitted due to qualitative reasons. An alternative antibody HPA064978 has been added.
  • HPA048610 antibody has been omitted due to target gene not found in Ensembl.
  • HPA048621 has been omitted due to qualitative reasons. An alternative antibody HPA042011 has been added.
  • HPA048682 has been omitted due to qualitative reasons. An alternative antibody HPA053453 has been added.
  • HPA048700 has been omitted due to qualitative reasons.
  • HPA048761 has been omitted due to qualitative reasons.
  • HPA048863 has been omitted due to antibody staining not supported by experimental data. An alternative antibody HPA021183 has been added.
  • HPA048865 has been omitted due to qualitative reasons. An alternative antibody HPA020016 has been added.
  • HPA048994 has been omitted due to qualitative reasons. An alternative antibody HPA039885 has been added.
  • HPA049057 has been omitted due to qualitative reasons. An alternative antibody HPA057379 has been added.
  • HPA049082 has been omitted due to new images pending.
  • HPA049106 has been omitted due to lack of RNA expression in cell line panel.
  • HPA049134 has been omitted due to qualitative reasons. An alternative antibody HPA053283 has been added.
  • HPA049280 has been omitted due to qualitative reasons.
  • HPA049402 has been omitted due to antibody staining not supported by experimental data.
  • HPA049440 has been omitted due to qualitative reasons. An alternative antibody HPA042695 has been added.
  • HPA049460 antibody has been omitted due to target gene not found in Ensembl.
  • HPA049533 has been omitted due to qualitative reasons. An alternative antibody HPA058275 has been added.
  • HPA049603 has been omitted due to qualitative reasons.
  • HPA049726 has been omitted due to qualitative reasons.
  • HPA049779 has been omitted due to antibody staining not supported by experimental data.
  • HPA049866 has been omitted due to qualitative reasons.
  • HPA049873 has been omitted due to qualitative reasons.
  • HPA049875 has been omitted due to qualitative reasons. An alternative antibody HPA057754 has been added.
  • HPA049905 has been omitted due to qualitative reasons.
  • HPA050015 has been omitted due to qualitative reasons.
  • HPA050036 has been omitted due to qualitative reasons.
  • HPA050053 has been omitted due to qualitative reasons.
  • HPA050146 has been omitted due to antibody staining not supported by experimental data.
  • HPA050176 has been omitted due to antibody staining not supported by experimental data.
  • HPA050178 has been omitted due to qualitative reasons.
  • HPA050221 has been omitted due to qualitative reasons. An alternative antibody CAB005261 has been added.
  • HPA050223 has been omitted due to antibody staining not supported by experimental data.
  • HPA050253 has been omitted due to qualitative reasons.
  • HPA050288 has been omitted due to qualitative reasons. An alternative antibody HPA043246 has been added.
  • HPA050405 has been omitted due to qualitative reasons. An alternative antibody HPA043656 has been added.
  • HPA050440 has been omitted due to antibody staining not supported by experimental data.
  • HPA050508 has been omitted due to qualitative reasons. An alternative antibody HPA061214 has been added.
  • HPA050550 has been omitted due to qualitative reasons. An alternative antibody HPA060259 has been added.
  • HPA050625 has been omitted due to qualitative reasons. An alternative antibody HPA064316 has been added.
  • HPA050731 has been omitted due to antibody staining not supported by experimental data. An alternative antibody HPA064925 has been added.
  • HPA050746 has been omitted due to qualitative reasons.
  • HPA050983 has been omitted due to qualitative reasons. An alternative antibody HPA065000 has been added.
  • HPA050995 has been omitted due to qualitative reasons. An alternative antibody HPA060559 has been added.
  • HPA051102 has been omitted due to antibody staining not supported by experimental data.
  • HPA051172 has been omitted due to qualitative reasons.
  • HPA051173 has been omitted due to qualitative reasons. An alternative antibody HPA059934 has been added.
  • HPA051185 has been omitted due to qualitative reasons.
  • HPA051186 has been omitted due to qualitative reasons. An alternative antibody HPA054508 has been added.
  • HPA051303 has been omitted due to qualitative reasons. An alternative antibody HPA059516 has been added.
  • HPA051359 has been omitted due to qualitative reasons.
  • HPA051422 has been omitted due to antibody staining not supported by experimental data.
  • HPA051453 has been omitted due to qualitative reasons. An alternative antibody HPA065012 has been added.
  • HPA051625 has been omitted due to qualitative reasons. An alternative antibody HPA068538 has been added.
  • HPA051651 has been omitted due to qualitative reasons.
  • HPA051652 has been omitted due to qualitative reasons.
  • HPA051663 has been omitted due to qualitative reasons.
  • HPA051788 has been omitted due to qualitative reasons. An alternative antibody HPA072607 has been added.
  • HPA051793 has been omitted due to qualitative reasons.
  • HPA051945 has been omitted due to qualitative reasons. An alternative antibody HPA060259 has been added.
  • HPA052096 has been omitted due to qualitative reasons. An alternative antibody HPA059714 has been added.
  • HPA052098 has been omitted due to antibody staining not supported by experimental data.
  • HPA052241 has been omitted due to qualitative reasons. An alternative antibody HPA053075 has been added.
  • HPA052275 has been omitted due to qualitative reasons.
  • HPA052292 has been omitted due to qualitative reasons. An alternative antibody HPA063050 has been added.
  • HPA052369 has been omitted due to qualitative reasons. An alternative antibody HPA021452 has been added.
  • HPA052371 has been omitted due to qualitative reasons.
  • HPA052398 has been omitted due to new images pending.
  • HPA052409 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines. An alternative antibody HPA057289 has been added.
  • HPA052418 has been omitted due to qualitative reasons.
  • HPA052419 has been omitted due to qualitative reasons. An alternative antibody HPA064316 has been added.
  • HPA052607 has been omitted due to qualitative reasons.
  • HPA052673 has been omitted due to qualitative reasons.
  • HPA052708 has been omitted due to qualitative reasons. An alternative antibody HPA060972 has been added.
  • HPA052718 has been omitted due to qualitative reasons.
  • HPA052796 has been omitted due to qualitative reasons.
  • HPA052805 has been omitted due to qualitative reasons.
  • HPA052844 has been omitted due to qualitative reasons. An alternative antibody HPA055849 has been added.
  • HPA052848 has been omitted due to qualitative reasons.
  • HPA052854 has been omitted due to qualitative reasons.
  • HPA052870 has been omitted due to qualitative reasons.
  • HPA052970 has been omitted due to qualitative reasons.
  • HPA053015 has been omitted due to qualitative reasons.
  • HPA053030 has been omitted due to qualitative reasons.
  • HPA053043 has been omitted due to qualitative reasons. An alternative antibody HPA060022 has been added.
  • HPA053056 has been omitted due to qualitative reasons.
  • HPA053093 has been omitted due to qualitative reasons. An alternative antibody HPA005727 has been added.
  • HPA053169 has been omitted due to lack of RNA expression in cell line panel.
  • HPA053224 has been omitted due to qualitative reasons. An alternative antibody HPA063163 has been added.
  • HPA053255 has been omitted due to qualitative reasons.
  • HPA053256 has been omitted due to qualitative reasons. An alternative antibody HPA058416 has been added.
  • HPA053337 has been omitted due to qualitative reasons.
  • HPA053368 has been omitted due to qualitative reasons.
  • HPA053416 has been omitted due to antibody staining not supported by experimental data.
  • HPA053427 has been omitted due to qualitative reasons. An alternative antibody HPA049139 has been added.
  • HPA053437 has been omitted due to qualitative reasons.
  • HPA053440 has been omitted due to qualitative reasons. An alternative antibody HPA026868 has been added.
  • HPA053550 has been omitted due to qualitative reasons.
  • HPA053562 has been omitted due to new images pending. An alternative antibody HPA004844 has been added.
  • HPA053566 has been omitted due to qualitative reasons. An alternative antibody HPA065012 has been added.
  • HPA053594 has been omitted due to antibody staining not supported by experimental data. An alternative antibody HPA065209 has been added.
  • HPA053693 has been omitted due to qualitative reasons.
  • HPA053717 has been omitted due to qualitative reasons.
  • HPA053734 has been omitted due to qualitative reasons. An alternative antibody HPA063236 has been added.
  • HPA053747 has been omitted due to qualitative reasons. An alternative antibody HPA064495 has been added.
  • HPA053870 has been omitted due to qualitative reasons.
  • HPA053928 has been omitted due to antibody staining not supported by experimental data.
  • HPA054003 has been omitted due to qualitative reasons. An alternative antibody HPA062872 has been added.
  • HPA054088 has been omitted due to qualitative reasons. An alternative antibody HPA066967 has been added.
  • HPA054101 has been omitted due to qualitative reasons. An alternative antibody HPA063742 has been added.
  • HPA054114 has been omitted due to qualitative reasons. An alternative antibody HPA063323 has been added.
  • HPA054136 has been omitted due to qualitative reasons. An alternative antibody HPA062739 has been added.
  • HPA054172 has been omitted due to qualitative reasons.
  • HPA054291 has been omitted due to qualitative reasons. An alternative antibody HPA067133 has been added.
  • HPA054313 has been omitted due to qualitative reasons. An alternative antibody HPA045785 has been added.
  • HPA054358 has been omitted due to qualitative reasons. An alternative antibody HPA027577 has been added.
  • HPA054452 has been omitted due to qualitative reasons. An alternative antibody HPA061934 has been added.
  • HPA054588 has been omitted due to qualitative reasons. An alternative antibody HPA057754 has been added.
  • HPA054600 has been omitted due to qualitative reasons.
  • HPA054654 has been omitted due to qualitative reasons.
  • HPA054763 has been omitted due to qualitative reasons. An alternative antibody HPA051849 has been added.
  • HPA054775 has been omitted due to qualitative reasons. An alternative antibody HPA039003 has been added.
  • HPA054865 antibody has been omitted due to target gene not found in Ensembl.
  • HPA054921 has been omitted due to qualitative reasons. An alternative antibody HPA028729 has been added.
  • HPA054986 has been omitted due to qualitative reasons.
  • HPA055007 has been omitted due to qualitative reasons.
  • HPA055051 has been omitted due to qualitative reasons. An alternative antibody HPA065192 has been added.
  • HPA055056 has been omitted due to qualitative reasons. An alternative antibody HPA053296 has been added.
  • HPA055214 has been omitted due to antibody staining not supported by experimental data.
  • HPA055225 has been omitted due to qualitative reasons.
  • HPA055542 has been omitted due to qualitative reasons.
  • HPA055589 has been omitted due to qualitative reasons.
  • HPA055593 has been omitted due to qualitative reasons.
  • HPA055596 has been omitted due to qualitative reasons.
  • HPA055597 antibody has been omitted due to target gene not found in Ensembl.
  • HPA055606 has been omitted due to qualitative reasons.
  • HPA055647 has been omitted due to qualitative reasons.
  • HPA055897 has been omitted due to qualitative reasons.
  • HPA055953 has been omitted due to qualitative reasons.
  • HPA056190 has been omitted due to antibody staining not supported by experimental data.
  • HPA056270 has been omitted due to qualitative reasons. An alternative antibody HPA062696 has been added.
  • HPA056279 has been omitted due to qualitative reasons.
  • HPA056342 has been omitted due to qualitative reasons. An alternative antibody HPA064527 has been added.
  • HPA056362 has been omitted due to qualitative reasons.
  • HPA056419 has been omitted due to qualitative reasons.
  • HPA056421 has been omitted due to qualitative reasons.
  • HPA056473 has been omitted due to qualitative reasons.
  • HPA056555 has been omitted due to qualitative reasons. An alternative antibody HPA055190 has been added.
  • HPA056559 has been omitted due to qualitative reasons. An alternative antibody HPA053253 has been added.
  • HPA056791 has been omitted due to qualitative reasons.
  • HPA056838 has been omitted due to qualitative reasons. An alternative antibody HPA070212 has been added.
  • HPA057015 has been omitted due to qualitative reasons.
  • HPA057106 has been omitted due to qualitative reasons. An alternative antibody HPA066324 has been added.
  • HPA057176 has been omitted due to qualitative reasons.
  • HPA057187 has been omitted due to antibody staining not supported by experimental data.
  • HPA057272 has been omitted due to qualitative reasons. An alternative antibody HPA070194 has been added.
  • HPA057390 has been omitted due to qualitative reasons.
  • HPA057391 has been omitted due to antibody staining not supported by experimental data.
  • HPA057403 has been omitted due to qualitative reasons.
  • HPA057488 has been omitted due to qualitative reasons. An alternative antibody HPA031599 has been added.
  • HPA057695 has been omitted due to antibody staining not supported by experimental data. An alternative antibody HPA073653 has been added.
  • HPA057795 has been omitted due to antibody staining not supported by experimental data.
  • HPA057808 antibody has been omitted due to target gene not found in Ensembl.
  • HPA058107 has been omitted due to qualitative reasons. An alternative antibody HPA069306 has been added.
  • HPA058206 has been omitted due to qualitative reasons. An alternative antibody HPA037508 has been added.
  • HPA058363 has been omitted due to qualitative reasons. An alternative antibody HPA059577 has been added.
  • HPA058507 has been omitted due to qualitative reasons.
  • HPA058595 has been omitted due to antibody staining not supported by experimental data. An alternative antibody HPA060277 has been added.
  • HPA059028 antibody has been omitted due to target gene not found in Ensembl.
  • HPA059029 has been omitted due to qualitative reasons.
  • HPA059046 has been omitted due to qualitative reasons.
  • HPA059306 has been omitted due to qualitative reasons. An alternative antibody HPA066007 has been added.
  • HPA059335 has been omitted due to qualitative reasons.
  • HPA059795 has been omitted due to qualitative reasons. An alternative antibody HPA021646 has been added.
  • HPA059850 has been omitted due to antibody staining not supported by experimental data. An alternative antibody HPA040856 has been added.
  • HPA060297 has been omitted due to qualitative reasons. An alternative antibody HPA053283 has been added.
  • HPA060520 has been omitted due to qualitative reasons. An alternative antibody HPA058978 has been added.
  • HPA060760 has been omitted due to qualitative reasons. An alternative antibody HPA053966 has been added.
  • HPA060820 has been omitted due to qualitative reasons. An alternative antibody HPA065419 has been added.
  • HPA060847 has been omitted due to antibody staining not supported by experimental data.
  • HPA060959 has been omitted due to qualitative reasons.
  • HPA061232 has been omitted due to qualitative reasons. An alternative antibody HPA069543 has been added.
  • HPA061294 has been omitted due to qualitative reasons. An alternative antibody HPA045165 has been added.
  • HPA061334 has been omitted due to qualitative reasons.
  • HPA061384 has been omitted due to qualitative reasons.
  • HPA061912 has been omitted due to qualitative reasons.
  • HPA062160 has been omitted due to qualitative reasons.
  • HPA062571 has been omitted due to antibody staining not supported by experimental data. An alternative antibody HPA071518 has been added.
  • HPA062609 antibody has been omitted due to target gene not found in Ensembl.
  • HPA062659 has been omitted due to qualitative reasons.
  • HPA062711 has been omitted due to qualitative reasons.
  • HPA062833 has been omitted due to qualitative reasons. An alternative antibody HPA055748 has been added.
  • HPA063078 has been omitted due to qualitative reasons. An alternative antibody HPA046410 has been added.
  • HPA063355 has been omitted due to qualitative reasons.
  • HPA064517 has been omitted due to qualitative reasons. An alternative antibody HPA061357 has been added.
  • HPA064522 has been omitted due to antibody staining not supported by experimental data.
  • HPA064752 has been omitted due to antibody staining not supported by experimental data. An alternative antibody HPA005719 has been added.
  • HPA064810 has been omitted due to qualitative reasons.

Protein Atlas version 13


Release date: 2014.11.06
Ensembl version: 75.37
  • Thirteenth major release of the Human Protein Atlas with more than 24000 antibodies, targeting proteins from more than 16,900 human genes (~83% of the human protein-coding genes).
    Tissue atlas
  • The Xanthine dehydrogenase/oxidase (CAB009518) stained images have been omitted due to selective staining in lactating breast, which is unavailable at the moment.
  • The Prolactin (CAB023353) antibody has been omitted due to selective staining in the anterior lobe of pituitary gland, which is unavailable at the moment.
  • The low affinity sodium-glucose cotransporter (HPA026840) antibody has been omitted due to the lack of selective plasma membrane staining shows instead a nuclear membrane positivity.
  • The SPARC-related modular calcium-binding protein 2 (HPA035430) antibody has been omitted due to the lack of RNA consistency and the selective staining of goblet cells. Instead a majority of epithelial cells should show secretion.
  • The Protein S100-A3 (HPA042674) antibody has been omitted due to selective staining in hair follicles, which is unavailable at the moment.
  • The 24-dehydrocholesterol reductase (CAB037247) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The A kinase (PRKA) anchor protein 5 (CAB004308) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The acid phosphatase 5, tartrate resistant (CAB002584) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The adenosine deaminase, RNA-specific (HPA003890) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The afamin (HPA017006) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The aldo-keto reductase family 1, member B10 (aldose reductase) (HPA020280) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The aldo-keto reductase family 1, member B15 (HPA020280) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The aldo-keto reductase family 1, member E2 (HPA037822) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The allograft inflammatory factor 1-like (HPA020522) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The alpha-1,4-N-acetylglucosaminyltransferase (HPA008017) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The Aminopeptidase Q (HPA053254) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The amyloid beta (A4) precursor-like protein 1 (HPA028971) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The annexin A13 (HPA018535 & HPA019650) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The aquaporin 2 (collecting duct) (HPA046834) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The aquaporin 8 (HPA046259) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The armadillo repeat containing 4 (HPA037829) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The asialoglycoprotein receptor 2 (HPA014899 & HPA015998) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G3 (HPA028701) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The BEN domain containing 2 (HPA009420) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The bleomycin hydrolase (HPA039548) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The BPI fold containing family B, member 2 (HPA049491) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The branched chain amino-acid transaminase 1, cytosolic (HPA048592) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The BTB (POZ) domain containing 17 (HPA025022) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The cadherin-related family member 3 (HPA011218) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The calbindin 1, 28kDa (CAB002138 & HPA023099) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The calcium and integrin binding 1 (calmyrin) (CAB012991) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The calcium channel, voltage-dependent, gamma subunit 8 (HPA041351) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The calcium-sensing receptor (HPA039686) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The calsyntenin 2 (HPA031342) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The CaM kinase-like vesicle-associated (HPA007656) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The carbohydrate (N-acetylglucosamine 6-O) sulfotransferase 4 (HPA021955) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The catenin (cadherin-associated protein), alpha 2 (CAB037175) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The catenin (cadherin-associated protein), delta 2 (HPA015077) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The CCCTC-binding factor (zinc finger protein)-like (HPA001472) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The chemokine (C-X-C motif) receptor 2 (CAB016268) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The cholinergic receptor, muscarinic 1 (HPA014101) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The chromosome 1 open reading frame 167 (HPA039114) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The chromosome 1 open reading frame 194 (HPA031144) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The chromosome 10 open reading frame 67 (HPA038131) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The chromosome 4 open reading frame 40 (HPA036150) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The chromosome 8 open reading frame 47 (HPA025070, HPA025293 & HPA027233) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The chymotrypsin-like (HPA034504) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The claudin 10 (CAB012969) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The coiled-coil domain containing 96 (HPA047546) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The colipase, pancreatic (HPA010512) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The collagen, type VII, alpha 1 (CAB016357) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The collapsin response mediator protein 1 (HPA035640) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The cripto, FRL-1, cryptic family 1 (HPA041773) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The cripto, FRL-1, cryptic family 1B (HPA041773) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7) (HPA021939) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The DEK oncogene (CAB015226) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The deoxynucleotidyltransferase, terminal, interacting protein 2 (HPA044502) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The dihydroxyacetone kinase 2 homolog (S. cerevisiae) (HPA039486) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The distal-less homeobox 5 (HPA005670) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The distal-less homeobox 6 (HPA030608) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The DNA nucleotidylexotransferase (HPA044194) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The DnaJ (Hsp40) homolog, subfamily C, member 6 (HPA031182) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The dual specificity phosphatase 16 (HPA020326) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The dynein, axonemal, heavy chain 12 (HPA037493) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The ELAV like neuron-specific RNA binding protein 2 (CAB022222) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The epoxide hydrolase 1, microsomal (xenobiotic) (HPA020593) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The extracellular matrix protein 1 (HPA027241) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The family with sequence similarity 162, member B (HPA036112) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The family with sequence similarity 168, member A (HPA037580) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The family with sequence similarity 83, member G (HPA023940) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The forkhead box A1 (CAB011595) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The forkhead box J1 (HPA005714) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The galactose mutarotase (aldose 1-epimerase) (HPA035472) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The gamma-aminobutyric acid (GABA) A receptor, alpha 3 (HPA000839) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The gamma-aminobutyric acid (GABA) A receptor, delta (HPA044371) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The gasdermin C (HPA026317) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The GLI pathogenesis-related 1 like 1 (HPA042095) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The glutamate receptor, ionotropic, N-methyl D-aspartate 2A (CAB022725) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The glycine N-methyltransferase (HPA027501) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The GTPase activating protein (SH3 domain) binding protein 1 (HPA004052) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The guanine nucleotide binding protein (G protein), beta polypeptide 2 (CAB010032) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The guanylate binding protein 1, interferon-inducible (CAB015450) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The guanylate binding protein family, member 6 (HPA027744) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The heat shock 70kDa protein 12A (HPA011273) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The histidine rich calcium binding protein (HPA004833) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The homeobox A10 (CAB019384) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The HOP homeobox (CAB018632 & HPA030180) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The inhibin, beta E (HPA016843) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The inositol-trisphosphate 3-kinase A (HPA040454) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The insulin-like growth factor 2 mRNA binding protein 1 (HPA021367) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The insulin-like growth factor binding protein 1 (CAB004445, HPA046972 & HPA050640) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The inter-alpha-trypsin inhibitor heavy chain 2 (HPA059150) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The izumo sperm-egg fusion 1 (HPA038104) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The keratin 78 (HPA039724) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The leucine rich repeat containing 23 (HPA037766) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The leucine rich repeat containing 48 (HPA036040) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The lipase A, lysosomal acid, cholesterol esterase (CAB034892) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The lysine (K)-specific methyltransferase 2A (CAB024270) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The major histocompatibility complex, class I, G (CAB016158) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The megalencephalic leukoencephalopathy with subcortical cysts 1 (HPA003040) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The microtubule-associated protein 1 light chain 3 alpha (HPA007649) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The microtubule-associated protein 1 light chain 3 beta (CAB037216) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The microtubule-associated protein 1A (HPA039063 & HPA039064) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The mitogen-activated protein kinase 14 (CAB040578) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The mitotic spindle positioning (HPA049511) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The MORC family CW-type zinc finger 1 (HPA036413) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The mucin 12, cell surface associated (HPA023835) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The myelin-associated oligodendrocyte basic protein (HPA035152) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The myeloperoxidase (HPA021147) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The myo-inositol oxygenase (HPA039451) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The myomesin 1 (HPA014305) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The myosin, light chain 1, alkali; skeletal, fast (HPA046859) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The myosin, light chain 10, regulatory (HPA019763) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The myosin, light chain 2, regulatory, cardiac, slow (HPA019763) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The myosin, light chain 3, alkali; ventricular, skeletal, slow (HPA046859) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The myosin, light chain 4, alkali; atrial, embryonic (HPA046859 & HPA051884) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The myosin, light chain 6, alkali, smooth muscle and non-muscle (HPA046859) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The myosin, light chain 6B, alkali, smooth muscle and non-muscle (HPA046859) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The Nanog homeobox (CAB019380) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The neurexophilin 2 (HPA034759) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The neurexophilin and PC-esterase domain family, member 1 (HPA049133) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The neurogranin (protein kinase C substrate, RC3) (CAB006908 & HPA038171) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The NHP2 ribonucleoprotein (HPA044171) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The nicastrin (CAB021982) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The nitric oxide synthase 1 (neuronal) adaptor protein (CAB018582) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The nuclear VCP-like (HPA028207) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The nucleolar and coiled-body phosphoprotein 1 (HPA037366) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The pappalysin 2 (HPA018412 & HPA018430) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The peptidase inhibitor 3, skin-derived (CAB009449 & HPA017737) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The peptidyl arginine deiminase, type IV (HPA017007) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The perilipin 4 (HPA044682) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The periplakin (HPA042550) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The phospholipase C, beta 1 (phosphoinositide-specific) (CAB004275 & CAB005334) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The phosphoserine aminotransferase 1 (CAB040567) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The PILR alpha associated neural protein (HPA010631) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The plakophilin 3 (CAB012993) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The plexin A4 (HPA029919) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The polymerase (RNA) III (DNA directed) polypeptide G (32kD) (CAB010109) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The popeye domain containing 2 (HPA024255) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The potassium voltage-gated channel, KQT-like subfamily, member 2 (HPA016642) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The potassium voltage-gated channel, Shab-related subfamily, member 1 (CAB001979) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The potassium voltage-gated channel, subfamily H (eag-related), member 1 (HPA019445) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The PR domain containing 1, with ZNF domain (HPA030033) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The progestagen-associated endometrial protein (CAB016762, HPA020108 & HPA029473) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The proline-rich acidic protein 1 (HPA038713) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The prostaglandin E receptor 3 (subtype EP3) (HPA010689) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The protein phosphatase 1, regulatory (inhibitor) subunit 1A (CAB007811) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The protein phosphatase 1, regulatory subunit 36 (HPA036801) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The protein tyrosine phosphatase, non-receptor type 18 (brain-derived) (CAB012174) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The protein tyrosine phosphatase, non-receptor type 5 (striatum-enriched) (HPA031014) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The protocadherin 9 (HPA015581) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The recombination signal binding protein for immunoglobulin kappa J region-like (CAB006846) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The regulator of microtubule dynamics 3 (HPA009975) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The repetin (HPA030485) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The retinol binding protein 1, cellular (HPA007338) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The Rho GTPase activating protein 26 (HPA035107) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The rhophilin associated tail protein 1-like (HPA039193) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The ring finger protein 186 (HPA034547) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The runt-related transcription factor 3 (CAB025416) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The secreted frizzled-related protein 4 (HPA009712) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The secreted frizzled-related protein 5 (HPA019840) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The secretin receptor (HPA007269) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The sequestosome 1 (CAB004587) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The serpin peptidase inhibitor, clade I (neuroserpin), member 1 (HPA001565) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The sialic acid binding Ig-like lectin 6 (HPA009084 & HPA018198) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The sirtuin 2 (CAB004573 & HPA011165) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The small glutamine-rich tetratricopeptide repeat (TPR)-containing, beta (HPA044689) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The small proline-rich protein 3 (HPA044467) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The smoothelin (CAB001721) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The solute carrier family 20 (phosphate transporter), member 1 (CAB019279) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The solute carrier family 22 (organic anion transporter), member 8 (HPA044174) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The solute carrier family 22 (organic cation/zwitterion transporter), member 4 (CAB015468) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The solute carrier family 24 (sodium/potassium/calcium exchanger), member 1 (HPA039370) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The solute carrier family 34 (type II sodium/phosphate contransporter), member 1 (HPA051255) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The solute carrier family 45, member 3 (HPA019075) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The solute carrier family 5 (sodium/glucose cotransporter), member 2 (HPA041603) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The solute carrier family 6 (neutral amino acid transporter), member 18 (HPA011885) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The sperm acrosome associated 4 (HPA041927) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The sperm flagellar 2 (HPA039606) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The spermidine/spermine N1-acetyltransferase family member 2 (HPA022136) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The sterol O-acyltransferase 1 (CAB009533 & HPA047171) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The surfactant protein D (CAB004578 & HPA044582) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The synaptonemal complex central element protein 2 (HPA042080) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The synaptonemal complex protein 1 (HPA021083) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The synaptoporin (HPA051368) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The T-cell acute lymphocytic leukemia 1 (CAB017805) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The tau tubulin kinase 1 (HPA031736) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The tetratricopeptide repeat domain 23-like (HPA037807) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The tetratricopeptide repeat domain 9B (HPA042496) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The thymocyte selection associated (HPA031425) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The TIMELESS interacting protein (HPA039704) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The TP53 target 5 (HPA041979) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The transglutaminase 1 (CAB015159 & HPA040171) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The transmembrane emp24 protein transport domain containing 6 (HPA012532) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The transmembrane protein 130 (HPA012928) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The transmembrane protein 174 (HPA037975) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The transmembrane protein 27 (HPA048543) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The trefoil factor 1 (HPA003425) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The Uncharacterized protein (HPA012532) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The v-myb avian myeloblastosis viral oncogene homolog-like 1 (HPA008791) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The V-set domain containing T cell activation inhibitor 1 (HPA054200) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The WD repeat domain 54 (HPA043257) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The xeroderma pigmentosum, complementation group C (CAB009932) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The zinc finger protein 511 (HPA038713) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The zinc finger protein 532 (HPA015322) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The zinc finger, B-box domain containing (HPA036327) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The tetratricopeptide repeat domain 29 (HPA037006) antibody has been omitted due to inconsistency with RNA-seq data.
  • The ferredoxin reductase (CAB008597) antibody has been omitted due to inproducubility.
  • The troponin T type 1 (skeletal, slow) (CAB015168) antibody has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
  • The trace amine associated receptor 1 (CAB022754) antibody has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
  • The premelanosome protein (HPA001337) antibody has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • The EPH receptor A4 (CAB004654) antibody has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • The endothelin receptor type B (CAB017842) antibody has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • The regulating synaptic membrane exocytosis 3 (HPA024172) antibody has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • The coiled-coil domain containing 80 (CAB025158) antibody has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • The interleukin 18 binding protein (CAB025980) antibody has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • The leucine rich repeat containing 40 (HPA026553) antibody has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • The peptidyl arginine deiminase, type I (HPA028133) antibody has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • The membrane associated guanylate kinase, WW and PDZ domain containing 1 (HPA031854) antibody has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • The DnaJ (Hsp40) homolog, subfamily C, member 5 gamma (HPA035504) antibody has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • The YTH domain containing 1 (HPA036463) antibody has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • The enolase family member 4 (HPA037937) antibody has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • The SET and MYND domain containing 1 (HPA040790) antibody has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • The interferon-induced protein with tetratricopeptide repeats 1B (HPA041627) antibody has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • The suppressor of variegation 3-9 homolog 2 (Drosophila) (HPA045901) antibody has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • The HMGN2, HMGN4 (HPA048518) antibody has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • The leucine-rich repeat and immunoglobulin-like and transmembrane domains 1 (HPA014296) antibody has been omitted due to inconsistency with gene/protein characterization data.
  • The zinc finger and MYND-type containing 15 (HPA023286) antibody has been omitted due to inconsistency with gene/protein characterization data.
  • The tudor domain containing 6 (HPA035710) antibody has been omitted due to inconsistency with gene/protein characterization data.
  • The membrane protein and palmitoylated 4 (MAGUK p55 subfamily member 4) (HPA036387) antibody has been omitted due to inconsistency with gene/protein characterization data.
  • The small muscle protein and X-linked (HPA044134) antibody has been omitted due to inconsistency with gene/protein characterization data.
  • The adenomatosis polyposis coli 2 (HPA050820) antibody has been omitted due to inconsistency with gene/protein characterization data.
  • The DnaJ (Hsp40) homolog, subfamily C and member 5 beta (HPA052620) antibody has been omitted due to inconsistency with gene/protein characterization data.
  • The sodium channel, voltage-gated, type X, alpha subunit (CAB022171) antibody has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
  • The kallikrein-related peptidase 8 (CAB019393) antibody has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
  • The potassium voltage-gated channel, Isk-related family, member 2 (CAB022640) antibody has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • The ATPase, Na+/K+ transporting, alpha 3 polypeptide (CAB001988) antibody has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • The ATP-binding cassette, sub-family C (CFTR/MRP), member 4 (CAB002751) antibody has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • The desmoglein 3 (CAB002792) antibody has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • The S100 calcium binding protein B (CAB006825) antibody has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • The solute carrier family 18 (vesicular monoamine transporter), member 1 (HPA007210) antibody has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • The angiopoietin-like 4 (HPA007879) antibody has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • The deleted in malignant brain tumors 1 (CAB008386) antibody has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • The Fraser syndrome 1 (HPA011281) antibody has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • The BEN domain containing 2 (HPA012769) antibody has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • The protein kinase, AMP-activated, alpha 2 catalytic subunit (CAB013043) antibody has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • The ATP-binding cassette, sub-family C (CFTR/MRP), member 1 (CAB016097) antibody has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • The phospholipase B domain containing 1 (CAB016798) antibody has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • The ring finger protein 10 (HPA017135) antibody has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • The claudin 16 (HPA018040) antibody has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • The feline Gardner-Rasheed sarcoma viral oncogene homolog (CAB018959) antibody has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • The kallikrein-related peptidase 7 (HPA018994) antibody has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • The dynein, axonemal, heavy chain 9 (HPA020639) antibody has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • The EF-hand domain (C-terminal) containing 1 (CAB020814) antibody has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • The leucine rich repeat containing 6 (HPA021640) antibody has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • The pentraxin 3, long (CAB022226) antibody has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • The cytochrome b-245, beta polypeptide (CAB032510) antibody has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • The phosphatidic acid phosphatase type 2A (CAB033331) antibody has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • The reticulon 2 (HPA034941) antibody has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • The SH3 domain containing ring finger 2 (HPA035903) antibody has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • The mucolipin 3 (CAB037307) antibody has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • The immunoglobulin-like and fibronectin type III domain containing 1 (HPA039566) antibody has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • The acetoacetyl-CoA synthetase (HPA039811) antibody has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • The FK506 binding protein 6, 36kDa (HPA043046) antibody has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • The occludin/ELL domain containing 1 (HPA043223) antibody has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • The translocase of inner mitochondrial membrane 50 homolog (S. cerevisiae) (HPA048843) antibody has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • The hemoglobin, theta 1 (HPA049111) antibody has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • The pyruvate dehydrogenase phosphatase regulatory subunit (HPA049143) antibody has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • The derlin 3 (HPA049306) antibody has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • The ADAM metallopeptidase domain 20 (HPA051096) antibody has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • The Rhox homeobox family, member 1 (HPA052560) antibody has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • The Ca++-dependent secretion activator (HPA053835) antibody has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • The DEAD (Asp-Glu-Ala-Asp) box polypeptide 39A (HPA049769) antibody has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and antibody titration issue.
  • The U2 small nuclear RNA auxiliary factor 1-like 4 (HPA046378) antibody has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • The serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 11 (HPA003066) antibody has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • The G protein-coupled receptor kinase 4 (CAB004421) antibody has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • The kinesin family member 1A (HPA004831) antibody has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • The PCDHA1,PCDHA10,PCDHA11,PCDHA12,PCDHA13,PCDHA2,PCDHA3,PCDHA4,PCDHA5,PCDHA6,PCDHA7,PCDHA8,PCDHA9,PCDHAC1,PCDHAC2 (HPA008712) antibody has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • The SRY (sex determining region Y)-box 11 (CAB009378) antibody has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • The bone morphogenetic protein 10 (HPA010987) antibody has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • The chemokine (C-X-C motif) receptor 4 (CAB011447) antibody has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • The ubiquitin specific peptidase 6 (Tre-2 oncogene) (HPA011742) antibody has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • The doublecortin (CAB012243) antibody has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • The notch 4 (CAB012331) antibody has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • The egl-9 family hypoxia-inducible factor 3 (CAB012351) antibody has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • The zinc and ring finger 4 (HPA012844) antibody has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • The 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 1 (HPA013959) antibody has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • The membrane-associated ring finger (C3HC4) 11 (HPA017603) antibody has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • The chemokine (C-X-C motif) receptor 3 (CAB017820) antibody has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • The BR serine/threonine kinase 1 (HPA021212) antibody has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • The sodium channel, voltage gated, type VIII, alpha subunit (CAB022169) antibody has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • The klotho (HPA023480) antibody has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • The signal peptide peptidase like 2C (HPA024444) antibody has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • The zinc finger, MYND-type containing 15 (HPA024620) antibody has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • The interleukin 22 receptor, alpha 1 (CAB025781) antibody has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • The stathmin-like 2 (HPA026922) antibody has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • The HEN1 methyltransferase homolog 1 (Arabidopsis) (HPA028495) antibody has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • The HEN1 methyltransferase homolog 1 (Arabidopsis) (HPA028497) antibody has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • The cannabinoid receptor 2 (macrophage) (HPA028718) antibody has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • The tyrosine aminotransferase (HPA029316) antibody has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • The piwi-like RNA-mediated gene silencing 2 (HPA029345) antibody has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • The heat shock transcription factor 2 binding protein (HPA031724) antibody has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • The claudin 17 (CAB034279) antibody has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • The cytochrome c oxidase subunit VIb polypeptide 2 (testis) (HPA035014) antibody has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • The solute carrier organic anion transporter family, member 1C1 (HPA035586) antibody has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • The phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma) (HPA035915) antibody has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • The chimerin 1 (HPA036111) antibody has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • The myopalladin (HPA036298) antibody has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • The solute carrier family 39 (zinc transporter), member 12 (HPA036598) antibody has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • The neuregulin 3 (HPA038206) antibody has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • The B-cell translocation gene 4 (HPA038478) antibody has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • The coiled-coil domain containing 33 (HPA038628) antibody has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • The integrin beta 1 binding protein (melusin) 2 (HPA040721) antibody has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • The chromosome 11 open reading frame 89 (HPA040891) antibody has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • The coiled-coil domain containing 11 (HPA041069) antibody has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • The clathrin, heavy chain-like 1 (HPA041110) antibody has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • The G protein-coupled receptor 119 (HPA043747) antibody has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • The fat storage-inducing transmembrane protein 2 (HPA044725) antibody has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • The sperm-tail PG-rich repeat containing 1 (HPA050593) antibody has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • The dynein regulatory complex subunit 1 homolog (Chlamydomonas) (HPA051247) antibody has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • The LY6/PLAUR domain containing 4 (HPA052494) antibody has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • The T-box 15 (HPA053713) antibody has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • The olfactomedin 2 (HPA056442) antibody has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • The 1-acylglycerol-3-phosphate O-acyltransferase 3 (HPA057832) antibody has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • The potassium voltage-gated channel, shaker-related subfamily, member 7 (HPA060229) antibody has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • The IK cytokine and down-regulator of HLA II (HPA019754) antibody has been omitted due to inconsistency with gene/protein characterization data.
  • The component of oligomeric golgi complex 2 (HPA028039) antibody has been omitted due to inconsistency with gene/protein characterization data.
  • The basic helix-loop-helix family and member e40 (HPA028921) antibody has been omitted due to inconsistency with gene/protein characterization data.
  • The DDB1 and CUL4 associated factor 6 (HPA030852) antibody has been omitted due to inconsistency with gene/protein characterization data.
  • The BMS1 ribosome biogenesis factor (HPA036589) antibody has been omitted due to inconsistency with gene/protein characterization data.
  • The zinc finger and BED-type containing 1 (HPA038249) antibody has been omitted due to inconsistency with gene/protein characterization data.
  • The ribonuclease H2 and subunit A (HPA042692) antibody has been omitted due to inconsistency with gene/protein characterization data.
  • The centromere protein C (HPA049740) antibody has been omitted due to inconsistency with gene/protein characterization data.
  • The collagen, type V, alpha 1 (CAB002743) antibody has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
  • The succinate dehydrogenase complex, subunit B, iron sulfur (Ip) (HPA002867) antibody has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
  • The diazepam binding inhibitor (GABA receptor modulator, acyl-CoA binding protein) (CAB008595) antibody has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
  • The TATA box binding protein (CAB009442) antibody has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
  • The insulin-degrading enzyme (CAB012303) antibody has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
  • The NPC1-like 1 (HPA018105) antibody has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
  • The mucin 12, cell surface associated (HPA027769) antibody has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
  • The spindle and centriole associated protein 1 (HPA034832) antibody has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
  • The NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 4, 15kDa (CAB034930) antibody has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
  • The sorbin and SH3 domain containing 1 (HPA036994) antibody has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
  • The BTB (POZ) domain containing 10 (HPA039403) antibody has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
  • The polymerase (DNA-directed), delta 3, accessory subunit (HPA039627) antibody has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
  • The jumonji, AT rich interactive domain 2 (HPA044909) antibody has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
  • The prostaglandin reductase 2 (HPA000695) antibody has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • The tumor necrosis factor (ligand) superfamily, member 10 (CAB002446) antibody has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • The solute carrier family 1 (glutamate/neutral amino acid transporter), member 4 (CAB002757) antibody has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • The ATPase, Ca++ transporting, plasma membrane 3 (CAB005607) antibody has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • The SAP30 binding protein (HPA042382) antibody has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • The solute carrier family 47 (multidrug and toxin extrusion), member 2 (HPA044412) antibody has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • The GINS complex subunit 1 (Psf1 homolog) (HPA054486) antibody has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • The glutamate receptor, ionotropic and AMPA 3 (CAB007799) antibody has been omitted due to inconsistency with gene/protein characterization data.
  • The pleckstrin homology domain containing and family M (with RUN domain) member 1 (HPA021558) antibody has been omitted due to inconsistency with gene/protein characterization data.
  • The Zic family member 4 (CAB022615) antibody has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
  • The peroxisomal biogenesis factor 5-like (HPA040216) antibody has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • The THO complex 3 (HPA045071) antibody has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • The EPH receptor B6 (HPA001351) antibody has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • The zinc finger protein 536 (HPA024525) antibody has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • The prokineticin 1 (CAB026051) antibody has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • The prokineticin 1 (HPA030085) antibody has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • The ubiquitin specific peptidase 39 (HPA034823) antibody has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • The syntaxin binding protein 5-like (HPA035088) antibody has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • The kinesin family member 3C (HPA035755) antibody has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • The solute carrier family 9, subfamily A (NHE4, cation proton antiporter 4), member 4 (HPA036097) antibody has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • The nuclear receptor subfamily 2, group E, member 1 (HPA036954) antibody has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • The chromosome 19 open reading frame 80 (HPA042131) antibody has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • The KIR2DL1 ,KIR2DL2, KIR2DL3, KIR3DL1, KIR3DL2, KIR3DL3 (HPA049255) antibody has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • The homeobox D3 (HPA051831) antibody has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • The transmembrane protease, serine 2 (HPA013182) antibody has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • The eukaryotic translation initiation factor 4B (CAB019440) antibody has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • The dual specificity phosphatase 3 (CAB025265) antibody has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • The neuromedin B receptor (HPA026665) antibody has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • The heterogeneous nuclear ribonucleoprotein H3 (2H9) (HPA038264) antibody has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • The transmembrane and coiled-coil domains 1 (HPA038775) antibody has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • The IQ motif and Sec7 domain 3 (HPA039025) antibody has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • The phospholipase A2, group IVF (HPA042713) antibody has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • The transcription factor 15 (basic helix-loop-helix) (HPA046827) antibody has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • The membrane associated guanylate kinase, WW and PDZ domain containing 1 (HPA031851) antibody has been omitted due to inconsistency with RNA-seq data, antibody titration issue and inconsistency with other antibody targeting the same gene.
  • The heat shock 27kDa protein 3 (HPA038020) antibody has been omitted due to inconsistency with gene/protein characterization data.
  • The Sp7 transcription factor (CAB005874) antibody has been omitted due to inconsistency with RNA-seq data.
  • The transducin (beta)-like 2 (HPA007477) antibody has been omitted due to inconsistency with RNA-seq data.
  • The leucine rich repeat and Ig domain containing 1 (HPA011630) antibody has been omitted due to inconsistency with RNA-seq data.
  • The peptidyl arginine deiminase and type II (CAB012222) antibody has been omitted due to inconsistency with RNA-seq data.
  • The junctophilin 4 (CAB013492) antibody has been omitted due to inconsistency with RNA-seq data.
  • The presenilin 2 (Alzheimer disease 4) (CAB013634) antibody has been omitted due to inconsistency with RNA-seq data.
  • The bromodomain and testis-specific (HPA015283) antibody has been omitted due to inconsistency with RNA-seq data.
  • The chromosome 7 open reading frame 31 (HPA020346) antibody has been omitted due to inconsistency with RNA-seq data.
  • The family with sequence similarity 71 and member F2 (HPA020513) antibody has been omitted due to inconsistency with RNA-seq data.
  • The chromosome 17 open reading frame 105 (HPA026568) antibody has been omitted due to inconsistency with RNA-seq data.
  • The ADAM metallopeptidase domain 18 (HPA027605) antibody has been omitted due to inconsistency with RNA-seq data.
  • The schlafen-like 1 (HPA029931) antibody has been omitted due to inconsistency with RNA-seq data.
  • The serpin peptidase inhibitor, clade I (pancpin) and member 2 (HPA030613) antibody has been omitted due to inconsistency with RNA-seq data.
  • The transcription elongation regulator 1-like (HPA030816) antibody has been omitted due to inconsistency with RNA-seq data.
  • The armadillo repeat containing 12 (HPA030895) antibody has been omitted due to inconsistency with RNA-seq data.
  • The R3H domain containing 1 (HPA030936) antibody has been omitted due to inconsistency with RNA-seq data.
  • The EF-hand domain family and member B (HPA034834) antibody has been omitted due to inconsistency with RNA-seq data.
  • The uridine phosphorylase 2 (HPA035225) antibody has been omitted due to inconsistency with RNA-seq data.
  • The uridine phosphorylase 2 (HPA035226) antibody has been omitted due to inconsistency with RNA-seq data.
  • The MYCBP-associated and testis expressed 1 (HPA035610) antibody has been omitted due to inconsistency with RNA-seq data.
  • The poly (ADP-ribose) polymerase family and member 15 (HPA035757) antibody has been omitted due to inconsistency with RNA-seq data.
  • The androglobin (HPA036341) antibody has been omitted due to inconsistency with RNA-seq data.
  • The BBS5 and RP11-724O16.1 (HPA036416) antibody has been omitted due to inconsistency with RNA-seq data.
  • The PWWP domain containing 2B (HPA038056) antibody has been omitted due to inconsistency with RNA-seq data.
  • The SH3 and cysteine rich domain 3 (HPA039527) antibody has been omitted due to inconsistency with RNA-seq data.
  • The CBWD1, CBWD2, CBWD3, CBWD5 and CBWD6 (HPA042694) antibody has been omitted due to inconsistency with RNA-seq data.
  • The THO complex 3 (HPA042764) antibody has been omitted due to inconsistency with RNA-seq data.
  • The p21 protein (Cdc42/Rac)-activated kinase 3 (HPA044791) antibody has been omitted due to inconsistency with RNA-seq data.
  • The transmembrane protein 30C (HPA045051) antibody has been omitted due to inconsistency with RNA-seq data.
  • The IQ motif containing F1 (HPA046360) antibody has been omitted due to inconsistency with RNA-seq data.
  • The SPANXN2 and SPANXN3 (HPA048303) antibody has been omitted due to inconsistency with RNA-seq data.
  • The pancreatic polypeptide (CAB000069) antibody has been omitted due to product no longer available in provider's catalogue.
  • The proopiomelanocortin (CAB002765) antibody has been omitted due to product no longer available in provider's catalogue.
  • The ras homolog family member C (CAB010821) antibody has been omitted due to product no longer available in provider's catalogue.
  • The v-myb avian myeloblastosis viral oncogene homolog-like 1 (CAB017780) antibody has been omitted due to inconsistency with gene/protein characterization data.
  • The protein phosphatase 1, catalytic subunit and beta isozyme (CAB022558) antibody has been omitted due to inconsistency with gene/protein characterization data.
  • The Sin3A-associated protein and 130kDa (HPA034664) antibody has been omitted due to inconsistency with gene/protein characterization data.
  • The 5'-nucleotidase domain containing 3 (HPA041634) antibody has been omitted due to inconsistency with gene/protein characterization data.
  • The zinc finger RNA binding protein 2 (HPA043390) antibody has been omitted due to inconsistency with gene/protein characterization data.
  • The prion protein 2 (dublet) (CAB032584) antibody has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
  • The APC membrane recruitment protein 2 (HPA039728) antibody has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
  • The solute carrier family 6 (neurotransmitter transporter) and member 2 (HPA004057) antibody has been omitted due to inconsistency with gene/protein characterization data.
  • The protein kinase, AMP-activated and gamma 3 non-catalytic subunit (HPA004909) antibody has been omitted due to inconsistency with gene/protein characterization data.
  • The melanoregulin (CAB006331) antibody has been omitted due to inconsistency with gene/protein characterization data.
  • The melanoma antigen family D and 1 (CAB015165) antibody has been omitted due to inconsistency with gene/protein characterization data.
  • The guanine nucleotide binding protein (G protein) and gamma 7 (CAB018382) antibody has been omitted due to inconsistency with gene/protein characterization data.
  • The meprin A and beta (CAB025850) antibody has been omitted due to inconsistency with gene/protein characterization data.
  • The carboxypeptidase O (HPA040533) antibody has been omitted due to inconsistency with gene/protein characterization data.
  • The coiled-coil domain containing 103 (HPA043131) antibody has been omitted due to inconsistency with gene/protein characterization data.
  • The lactotransferrin (CAB008645) antibody has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
  • The superoxide dismutase 3, extracellular (CAB008671) antibody has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
  • The chromosome 16 open reading frame 71 (HPA041126) antibody has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
  • The drebrin 1 (CAB008367) antibody has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • The sterile alpha motif domain containing 13 (HPA059521) antibody has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
  • The TBC1 domain family, member 4 (CAB011623) antibody has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • The galactose-3-O-sulfotransferase 3 (HPA013570) antibody has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • The small integral membrane protein 21 (CAB034243) antibody has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • The leucine rich repeat containing 24 (HPA037689) antibody has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • The sialic acid binding Ig-like lectin 15 (HPA053509) antibody has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • The upstream binding protein 1 (LBP-1a) (HPA003967) antibody has been omitted due to inconsistency with gene/protein characterization data.
  • The cytochrome P450, family 26, subfamily A and polypeptide 1 (CAB015447) antibody has been omitted due to inconsistency with gene/protein characterization data.
  • The G protein-coupled receptor, family C, group 6 and member A (HPA038428) antibody has been omitted due to inconsistency with gene/protein characterization data.
  • The PWP1 homolog (S. cerevisiae) (HPA038707) antibody has been omitted due to inconsistency with gene/protein characterization data.
  • The INO80 complex subunit B (HPA042717) antibody has been omitted due to inconsistency with gene/protein characterization data.
  • The ribosomal protein L7-like 1 (HPA046049) antibody has been omitted due to inconsistency with gene/protein characterization data.
  • The potassium channel tetramerization domain containing 17 (HPA017602) antibody has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
  • The chordin (CAB020705) antibody has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
  • The plexin B3 (HPA000230) antibody has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • The sterol regulatory element binding transcription factor 1 (CAB005406) antibody has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • The deleted in lung and esophageal cancer 1 (HPA020455) antibody has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • The cholinergic receptor, muscarinic 1 (CAB022366) antibody has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • The gasdermin C (HPA023670) antibody has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • The sperm-tail PG-rich repeat containing 1 (HPA024301) antibody has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • The nuclear GTPase, germinal center associated (HPA025038) antibody has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • The leukocyte cell-derived chemotaxin 2 (CAB026052) antibody has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • The ribonuclease H1 (CAB032715) antibody has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • The RAD54-like 2 (S. cerevisiae) (HPA035004) antibody has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • The cofilin 2 (muscle) (CAB037078) antibody has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
  • The (HPA003212) antibody has been omitted due to target gene not found in Ensembl.
  • The (HPA014660) antibody has been omitted due to target gene not found in Ensembl.
  • The (HPA023395) antibody has been omitted due to target gene not found in Ensembl.
  • The (HPA027920) antibody has been omitted due to target gene not found in Ensembl.
  • The (HPA037968) antibody has been omitted due to target gene not found in Ensembl.
  • The (HPA042445) antibody has been omitted due to target gene not found in Ensembl.
  • The (HPA044992) antibody has been omitted due to target gene not found in Ensembl.
  • The (HPA047747) antibody has been omitted due to target gene not found in Ensembl.
  • The (HPA049093) antibody has been omitted due to target gene not found in Ensembl.
  • The (HPA049323) antibody has been omitted due to target gene not found in Ensembl.
  • The (HPA053005) antibody has been omitted due to target gene not found in Ensembl.
  • The (HPA060063) antibody has been omitted due to target gene not found in Ensembl.
    Subcell atlas
  • CAB000114 has been omitted due to qualitative reasons.
  • CAB000668 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA001168 has been omitted due to antibody staining not supported by experimental data.
  • HPA001906 has been omitted due to qualitative reasons. An alternative antibody HPA064684 has been added.
  • CAB002508 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines. An alternative antibody HPA061418 has been added.
  • HPA002647 has been omitted due to qualitative reasons.
  • HPA002844 has been omitted due to qualitative reasons.
  • HPA003277 has been omitted due to qualitative reasons.
  • CAB003859 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • CAB004004 has been omitted due to antibody staining not supported by experimental data.
  • CAB004027 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • CAB004311 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • CAB004541 has been omitted due to qualitative reasons.
  • CAB004559 has been omitted due to qualitative reasons. An alternative antibody HPA058485 has been added.
  • CAB004596 has been omitted due to qualitative reasons. An alternative antibody HPA062160 has been added.
  • CAB004603 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • CAB004670 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines. An alternative antibody HPA058593 has been added.
  • CAB005044 has been omitted due to qualitative reasons. An alternative antibody CAB009803 has been added.
  • CAB005232 has been omitted due to qualitative reasons. An alternative antibody HPA063683 has been added.
  • HPA005980 has been omitted due to qualitative reasons. An alternative antibody HPA064792 has been added.
  • HPA006007 has been omitted due to qualitative reasons. An alternative antibody HPA064697 has been added.
  • HPA006735 has been omitted due to qualitative reasons.
  • HPA006748 has been omitted due to qualitative reasons. An alternative antibody HPA006581 has been added.
  • HPA006752 has been omitted due to qualitative reasons. An alternative antibody HPA064800 has been added.
  • HPA006914 has been omitted due to qualitative reasons.
  • HPA007042 has been omitted due to qualitative reasons.
  • HPA007644 has been omitted due to qualitative reasons.
  • CAB007781 has been omitted due to qualitative reasons. An alternative antibody HPA050746 has been added.
  • HPA008214 has been omitted due to antibody staining not supported by experimental data.
  • HPA008291 has been omitted due to qualitative reasons.
  • HPA008408 has been omitted due to qualitative reasons.
  • HPA009078 has been omitted due to qualitative reasons.
  • CAB010455 has been omitted due to antibody staining not supported by experimental data.
  • HPA010979 has been omitted due to qualitative reasons.
  • HPA011422 has been omitted due to qualitative reasons. An alternative antibody HPA058656 has been added.
  • CAB011464 has been omitted due to qualitative reasons. An alternative antibody HPA034569 has been added.
  • HPA011762 has been omitted due to qualitative reasons. An alternative antibody HPA017086 has been added.
  • CAB012283 has been omitted due to antibody staining not supported by experimental data. An alternative antibody HPA042344 has been added.
  • CAB012421 has been omitted due to qualitative reasons.
  • HPA012545 has been omitted due to antibody staining not supported by experimental data.
  • HPA013335 has been omitted due to qualitative reasons. An alternative antibody HPA013200 has been added.
  • HPA014757 has been omitted due to qualitative reasons. An alternative antibody HPA056736 has been added.
  • HPA014796 has been omitted due to qualitative reasons.
  • HPA014865 has been omitted due to qualitative reasons.
  • CAB014882 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines. An alternative antibody HPA042924 has been added.
  • CAB014886 has been omitted due to qualitative reasons. An alternative antibody HPA057273 has been added.
  • HPA015315 has been omitted due to qualitative reasons.
  • HPA015673 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA015742 has been omitted due to qualitative reasons. An alternative antibody HPA056855 has been added.
  • CAB016678 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • CAB016787 has been omitted due to qualitative reasons.
  • HPA016894 has been omitted due to qualitative reasons. An alternative antibody HPA008877 has been added.
  • HPA016965 has been omitted due to qualitative reasons.
  • CAB017041 has been omitted due to qualitative reasons.
  • CAB017181 has been omitted due to qualitative reasons.
  • CAB017479 has been omitted due to qualitative reasons. An alternative antibody HPA022012 has been added.
  • CAB017800 has been omitted due to qualitative reasons.
  • HPA017936 has been omitted due to qualitative reasons.
  • HPA018151 has been omitted due to qualitative reasons.
  • HPA018297 has been omitted due to qualitative reasons.
  • HPA018487 has been omitted due to antibody staining not supported by experimental data. An alternative antibody HPA061879 has been added.
  • HPA018503 has been omitted due to antibody staining not supported by experimental data.
  • CAB018625 has been omitted due to antibody staining not supported by experimental data.
  • HPA018841 has been omitted due to qualitative reasons.
  • HPA018843 has been omitted due to qualitative reasons.
  • HPA018862 has been omitted due to qualitative reasons. An alternative antibody HPA019918 has been added.
  • HPA019092 has been omitted due to qualitative reasons.
  • HPA019237 has been omitted due to qualitative reasons. An alternative antibody HPA055309 has been added.
  • HPA019254 has been omitted due to qualitative reasons.
  • HPA019691 has been omitted due to antibody staining not supported by experimental data.
  • HPA019803 has been omitted due to qualitative reasons. An alternative antibody HPA024133 has been added.
  • HPA019806 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines. An alternative antibody HPA024133 has been added.
  • HPA019867 has been omitted due to qualitative reasons. An alternative antibody HPA062933 has been added.
  • HPA020017 has been omitted due to qualitative reasons.
  • HPA020332 has been omitted due to qualitative reasons.
  • HPA020521 has been omitted due to antibody staining not supported by experimental data.
  • CAB020828 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • CAB020833 has been omitted due to qualitative reasons. An alternative antibody HPA039867 has been added.
  • HPA021076 has been omitted due to antibody staining not supported by experimental data.
  • HPA021237 has been omitted due to qualitative reasons. An alternative antibody HPA050448 has been added.
  • HPA021602 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • CAB022079 has been omitted due to qualitative reasons.
  • HPA022119 has been omitted due to antibody staining not supported by experimental data.
  • CAB022682 has been omitted due to qualitative reasons.
  • HPA023067 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA023148 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA023420 has been omitted due to qualitative reasons.
  • HPA023422 has been omitted due to qualitative reasons.
  • HPA023483 has been omitted due to qualitative reasons. An alternative antibody HPA008209 has been added.
  • HPA023559 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA023644 has been omitted due to qualitative reasons.
  • HPA023646 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA023733 has been omitted due to qualitative reasons.
  • HPA024161 has been omitted due to antibody staining not supported by experimental data.
  • HPA024243 has been omitted due to qualitative reasons. An alternative antibody HPA057297 has been added.
  • HPA024334 has been omitted due to qualitative reasons. An alternative antibody HPA014266 has been added.
  • CAB025541 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines. An alternative antibody HPA059381 has been added.
  • HPA026283 has been omitted due to qualitative reasons.
  • CAB026457 has been omitted due to qualitative reasons.
  • HPA026490 has been omitted due to qualitative reasons.
  • HPA026506 has been omitted due to antibody staining not supported by experimental data.
  • HPA026631 has been omitted due to qualitative reasons.
  • HPA026698 has been omitted due to antibody staining not supported by experimental data.
  • HPA026874 has been omitted due to qualitative reasons. An alternative antibody HPA061426 has been added.
  • HPA027144 has been omitted due to qualitative reasons.
  • HPA027318 has been omitted due to qualitative reasons.
  • HPA027366 has been omitted due to antibody staining not supported by experimental data.
  • HPA027412 has been omitted due to qualitative reasons.
  • HPA027760 has been omitted due to qualitative reasons.
  • HPA027920 antibody has been omitted due to target gene not found in Ensembl.
  • HPA028075 has been omitted due to qualitative reasons.
  • HPA028130 has been omitted due to new images pending.
  • HPA028215 has been omitted due to qualitative reasons.
  • HPA028351 has been omitted due to qualitative reasons. An alternative antibody HPA061086 has been added.
  • HPA028795 has been omitted due to qualitative reasons. An alternative antibody HPA060033 has been added.
  • HPA028900 has been omitted due to qualitative reasons. An alternative antibody HPA061418 has been added.
  • HPA029392 has been omitted due to lack of RNA expression in cell line panel.
  • HPA030161 has been omitted due to qualitative reasons.
  • HPA030296 has been omitted due to qualitative reasons. An alternative antibody HPA059090 has been added.
  • HPA030683 has been omitted due to qualitative reasons. An alternative antibody HPA047590 has been added.
  • HPA030917 has been omitted due to qualitative reasons. An alternative antibody HPA049724 has been added.
  • HPA030974 has been omitted due to qualitative reasons. An alternative antibody HPA030976 has been added.
  • HPA030990 has been omitted due to qualitative reasons. An alternative antibody HPA030989 has been added.
  • HPA031020 has been omitted due to qualitative reasons.
  • HPA031097 has been omitted due to qualitative reasons. An alternative antibody HPA031096 has been added.
  • HPA031100 has been omitted due to qualitative reasons.
  • HPA031471 has been omitted due to qualitative reasons. An alternative antibody HPA031470 has been added.
  • HPA031515 has been omitted due to qualitative reasons. An alternative antibody HPA057316 has been added.
  • HPA031844 has been omitted due to qualitative reasons.
  • HPA031845 has been omitted due to qualitative reasons.
  • HPA032060 has been omitted due to antibody staining not supported by experimental data. An alternative antibody HPA032062 has been added.
  • CAB033437 has been omitted due to antibody staining not supported by experimental data.
  • CAB034296 has been omitted due to qualitative reasons. An alternative antibody HPA032113 has been added.
  • HPA034501 has been omitted due to qualitative reasons.
  • HPA034868 has been omitted due to qualitative reasons. An alternative antibody HPA056572 has been added.
  • HPA034873 has been omitted due to qualitative reasons.
  • HPA035027 has been omitted due to qualitative reasons. An alternative antibody HPA035028 has been added.
  • HPA035112 has been omitted due to qualitative reasons. An alternative antibody HPA058387 has been added.
  • HPA035271 has been omitted due to qualitative reasons. An alternative antibody HPA061397 has been added.
  • HPA035303 has been omitted due to qualitative reasons. An alternative antibody HPA056439 has been added.
  • HPA035477 has been omitted due to qualitative reasons. An alternative antibody CAB010189 has been added.
  • HPA035519 has been omitted due to qualitative reasons. An alternative antibody HPA057964 has been added.
  • HPA035608 has been omitted due to antibody staining not supported by experimental data. An alternative antibody HPA063704 has been added.
  • HPA035718 has been omitted due to qualitative reasons. An alternative antibody HPA061866 has been added.
  • HPA035815 has been omitted due to qualitative reasons. An alternative antibody HPA035814 has been added.
  • HPA035830 has been omitted due to qualitative reasons.
  • HPA035863 has been omitted due to qualitative reasons. An alternative antibody HPA058115 has been added.
  • HPA035929 has been omitted due to qualitative reasons. An alternative antibody HPA058122 has been added.
  • HPA036147 has been omitted due to qualitative reasons.
  • HPA036181 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines. An alternative antibody HPA057979 has been added.
  • HPA036182 has been omitted due to antibody staining not supported by experimental data. An alternative antibody HPA057980 has been added.
  • HPA036283 has been omitted due to qualitative reasons. An alternative antibody HPA058159 has been added.
  • HPA036285 has been omitted due to qualitative reasons. An alternative antibody HPA059111 has been added.
  • HPA036401 has been omitted due to antibody staining not supported by experimental data.
  • HPA036488 has been omitted due to qualitative reasons.
  • HPA036508 has been omitted due to qualitative reasons. An alternative antibody HPA058148 has been added.
  • HPA036554 has been omitted due to qualitative reasons.
  • HPA036724 has been omitted due to antibody staining not supported by experimental data.
  • HPA036739 has been omitted due to qualitative reasons. An alternative antibody HPA036738 has been added.
  • HPA036825 has been omitted due to qualitative reasons.
  • HPA036867 has been omitted due to qualitative reasons. An alternative antibody HPA058180 has been added.
  • HPA036888 has been omitted due to qualitative reasons.
  • HPA036943 has been omitted due to qualitative reasons.
  • HPA036977 has been omitted due to qualitative reasons.
  • HPA036994 has been omitted due to antibody staining not supported by experimental data.
  • HPA036996 has been omitted due to qualitative reasons. An alternative antibody HPA044869 has been added.
  • CAB037058 has been omitted due to antibody staining not supported by experimental data. An alternative antibody HPA053198 has been added.
  • CAB037178 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA037410 has been omitted due to qualitative reasons. An alternative antibody HPA061665 has been added.
  • HPA037477 has been omitted due to qualitative reasons.
  • HPA037604 has been omitted due to new images pending.
  • HPA037674 has been omitted due to qualitative reasons. An alternative antibody HPA059332 has been added.
  • HPA037708 has been omitted due to qualitative reasons.
  • HPA037774 has been omitted due to qualitative reasons.
  • HPA037863 has been omitted due to qualitative reasons.
  • HPA037909 has been omitted due to qualitative reasons. An alternative antibody HPA057550 has been added.
  • HPA038042 has been omitted due to qualitative reasons. An alternative antibody HPA061547 has been added.
  • HPA038132 has been omitted due to qualitative reasons. An alternative antibody HPA056807 has been added.
  • HPA038147 has been omitted due to qualitative reasons.
  • HPA038154 has been omitted due to qualitative reasons. An alternative antibody HPA056913 has been added.
  • HPA038312 has been omitted due to qualitative reasons.
  • HPA038397 has been omitted due to antibody staining not supported by experimental data.
  • HPA038499 has been omitted due to qualitative reasons. An alternative antibody HPA057568 has been added.
  • HPA038579 has been omitted due to qualitative reasons. An alternative antibody HPA038578 has been added.
  • HPA038588 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA038605 has been omitted due to qualitative reasons. An alternative antibody HPA038607 has been added.
  • HPA038620 has been omitted due to qualitative reasons. An alternative antibody HPA058232 has been added.
  • HPA038642 has been omitted due to qualitative reasons.
  • HPA038694 has been omitted due to qualitative reasons. An alternative antibody HPA038695 has been added.
  • HPA038730 has been omitted due to antibody staining not supported by experimental data.
  • HPA038779 has been omitted due to antibody staining not supported by experimental data. An alternative antibody HPA062015 has been added.
  • HPA038827 has been omitted due to qualitative reasons. An alternative antibody HPA061763 has been added.
  • HPA038907 has been omitted due to qualitative reasons.
  • HPA039196 has been omitted due to antibody staining not supported by experimental data.
  • HPA039281 has been omitted due to qualitative reasons.
  • HPA039338 has been omitted due to qualitative reasons. An alternative antibody HPA059327 has been added.
  • HPA039353 has been omitted due to qualitative reasons. An alternative antibody HPA061517 has been added.
  • HPA039356 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA039430 has been omitted due to qualitative reasons. An alternative antibody CAB009567 has been added.
  • HPA039434 has been omitted due to qualitative reasons. An alternative antibody HPA059327 has been added.
  • HPA039457 has been omitted due to qualitative reasons. An alternative antibody HPA039801 has been added.
  • HPA039547 has been omitted due to antibody staining not supported by experimental data.
  • HPA039699 has been omitted due to lack of RNA expression in cell line panel.
  • HPA039811 has been omitted due to qualitative reasons. An alternative antibody HPA058815 has been added.
  • HPA039918 has been omitted due to qualitative reasons. An alternative antibody HPA041717 has been added.
  • HPA039985 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA040111 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA040152 has been omitted due to qualitative reasons. An alternative antibody HPA044081 has been added.
  • HPA040166 has been omitted due to qualitative reasons. An alternative antibody HPA064403 has been added.
  • HPA040226 has been omitted due to qualitative reasons. An alternative antibody HPA040205 has been added.
  • HPA040279 has been omitted due to qualitative reasons.
  • HPA040596 has been omitted due to qualitative reasons. An alternative antibody HPA061753 has been added.
  • HPA040697 has been omitted due to qualitative reasons. An alternative antibody HPA059818 has been added.
  • HPA040764 has been omitted due to qualitative reasons. An alternative antibody HPA041091 has been added.
  • HPA040782 has been omitted due to antibody staining not supported by experimental data.
  • HPA040811 has been omitted due to qualitative reasons. An alternative antibody HPA042059 has been added.
  • HPA040827 has been omitted due to lack of RNA expression in cell line panel.
  • HPA041197 has been omitted due to qualitative reasons.
  • HPA041737 has been omitted due to antibody staining not supported by experimental data.
  • HPA041786 has been omitted due to qualitative reasons. An alternative antibody HPA041699 has been added.
  • HPA041801 has been omitted due to qualitative reasons. An alternative antibody HPA058763 has been added.
  • HPA041815 has been omitted due to qualitative reasons.
  • HPA041972 has been omitted due to qualitative reasons.
  • HPA042102 has been omitted due to qualitative reasons. An alternative antibody CAB005268 has been added.
  • HPA042197 has been omitted due to antibody staining not supported by experimental data.
  • HPA042278 has been omitted due to qualitative reasons. An alternative antibody HPA058183 has been added.
  • HPA042445 antibody has been omitted due to target gene not found in Ensembl.
  • HPA042578 has been omitted due to qualitative reasons.
  • HPA042593 has been omitted due to qualitative reasons.
  • HPA042606 has been omitted due to qualitative reasons. An alternative antibody HPA057998 has been added.
  • HPA042620 has been omitted due to qualitative reasons. An alternative antibody HPA057954 has been added.
  • HPA042758 has been omitted due to qualitative reasons. An alternative antibody HPA042839 has been added.
  • HPA042817 has been omitted due to qualitative reasons.
  • HPA043088 has been omitted due to qualitative reasons.
  • HPA043480 has been omitted due to qualitative reasons.
  • HPA043678 has been omitted due to antibody staining not supported by experimental data.
  • HPA043767 has been omitted due to qualitative reasons. An alternative antibody HPA063554 has been added.
  • HPA043887 has been omitted due to qualitative reasons. An alternative antibody HPA041454 has been added.
  • HPA044012 has been omitted due to qualitative reasons. An alternative antibody HPA054615 has been added.
  • HPA044105 has been omitted due to qualitative reasons.
  • HPA044311 has been omitted due to qualitative reasons. An alternative antibody HPA053459 has been added.
  • HPA045095 has been omitted due to qualitative reasons.
  • HPA045498 has been omitted due to qualitative reasons. An alternative antibody HPA058028 has been added.
  • HPA045647 has been omitted due to qualitative reasons. An alternative antibody CAB005389 has been added.
  • HPA045778 has been omitted due to qualitative reasons. An alternative antibody HPA061693 has been added.
  • HPA045784 has been omitted due to qualitative reasons. An alternative antibody HPA064323 has been added.
  • HPA046138 has been omitted due to qualitative reasons. An alternative antibody HPA058368 has been added.
  • HPA046378 has been omitted due to qualitative reasons. An alternative antibody HPA061644 has been added.
  • HPA046558 has been omitted due to antibody staining not supported by experimental data.
  • HPA046634 has been omitted due to qualitative reasons. An alternative antibody HPA029043 has been added.
  • HPA046723 has been omitted due to qualitative reasons.
  • HPA046964 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
  • HPA047175 has been omitted due to antibody staining not supported by experimental data.
  • HPA047205 has been omitted due to qualitative reasons. An alternative antibody HPA057719 has been added.
  • HPA047596 has been omitted due to qualitative reasons. An alternative antibody CAB018762 has been added.
  • HPA047657 has been omitted due to qualitative reasons. An alternative antibody HPA057176 has been added.
  • HPA047658 has been omitted due to qualitative reasons. An alternative antibody HPA058392 has been added.
  • HPA047928 has been omitted due to antibody staining not supported by experimental data.
  • HPA047954 has been omitted due to antibody staining not supported by experimental data.
  • HPA048059 has been omitted due to qualitative reasons. An alternative antibody HPA058036 has been added.
  • HPA048142 has been omitted due to qualitative reasons. An alternative antibody HPA061191 has been added.
  • HPA048457 has been omitted due to qualitative reasons. An alternative antibody HPA060129 has been added.
  • HPA048459 has been omitted due to antibody staining not supported by experimental data.
  • HPA048474 has been omitted due to qualitative reasons.
  • HPA048724 has been omitted due to qualitative reasons. An alternative antibody HPA048289 has been added.
  • HPA048772 has been omitted due to qualitative reasons. An alternative antibody HPA060520 has been added.
  • HPA048921 has been omitted due to qualitative reasons. An alternative antibody HPA058894 has been added.
  • HPA049163 has been omitted due to qualitative reasons. An alternative antibody HPA058265 has been added.
  • HPA049167 has been omitted due to qualitative reasons. An alternative antibody HPA065197 has been added.
  • HPA049250 has been omitted due to antibody staining not supported by experimental data.
  • HPA049307 has been omitted due to qualitative reasons. An alternative antibody HPA056814 has been added.
  • HPA049317 has been omitted due to qualitative reasons. An alternative antibody HPA058381 has been added.
  • HPA049362 has been omitted due to qualitative reasons. An alternative antibody HPA061785 has been added.
  • HPA049528 has been omitted due to qualitative reasons. An alternative antibody HPA059910 has been added.
  • HPA049563 has been omitted due to qualitative reasons. An alternative antibody HPA057768 has been added.
  • HPA049840 has been omitted due to qualitative reasons. An alternative antibody HPA062236 has been added.
  • HPA049957 has been omitted due to qualitative reasons. An alternative antibody HPA057770 has been added.
  • HPA050159 has been omitted due to antibody staining not supported by experimental data. An alternative antibody HPA055007 has been added.
  • HPA050169 has been omitted due to qualitative reasons. An alternative antibody HPA047641 has been added.
  • HPA050392 has been omitted due to antibody staining not supported by experimental data.
  • HPA050404 has been omitted due to antibody staining not supported by experimental data.
  • HPA050547 has been omitted due to qualitative reasons.
  • HPA050590 has been omitted due to qualitative reasons. An alternative antibody HPA045760 has been added.
  • HPA050694 has been omitted due to qualitative reasons. An alternative antibody HPA057676 has been added.
  • HPA050711 has been omitted due to qualitative reasons. An alternative antibody HPA059530 has been added.
  • HPA050726 has been omitted due to qualitative reasons. An alternative antibody HPA019866 has been added.
  • HPA051082 has been omitted due to qualitative reasons. An alternative antibody HPA061678 has been added.
  • HPA051161 has been omitted due to qualitative reasons. An alternative antibody HPA063142 has been added.
  • HPA051230 has been omitted due to qualitative reasons. An alternative antibody HPA059742 has been added.
  • HPA051340 has been omitted due to qualitative reasons. An alternative antibody HPA055387 has been added.
  • HPA051636 has been omitted due to qualitative reasons. An alternative antibody HPA057593 has been added.
  • HPA051861 has been omitted due to qualitative reasons. An alternative antibody HPA061232 has been added.
  • HPA051886 has been omitted due to antibody staining not supported by experimental data. An alternative antibody HPA063748 has been added.
  • HPA051956 has been omitted due to qualitative reasons.
  • HPA052058 has been omitted due to qualitative reasons. An alternative antibody HPA024379 has been added.
  • HPA052140 has been omitted due to qualitative reasons. An alternative antibody HPA020523 has been added.
  • HPA052182 has been omitted due to qualitative reasons.
  • HPA052256 has been omitted due to qualitative reasons. An alternative antibody HPA063044 has been added.
  • HPA052381 has been omitted due to qualitative reasons. An alternative antibody HPA022132 has been added.
  • HPA052408 has been omitted due to qualitative reasons. An alternative antibody HPA054902 has been added.
  • HPA052455 has been omitted due to antibody staining not supported by experimental data. An alternative antibody HPA061391 has been added.
  • HPA052509 has been omitted due to qualitative reasons. An alternative antibody HPA045245 has been added.
  • HPA052910 has been omitted due to qualitative reasons. An alternative antibody HPA020891 has been added.
  • HPA053117 has been omitted due to qualitative reasons. An alternative antibody HPA063344 has been added.
  • HPA053665 has been omitted due to qualitative reasons. An alternative antibody HPA025711 has been added.
  • HPA053700 has been omitted due to qualitative reasons. An alternative antibody HPA007290 has been added.
  • HPA053739 has been omitted due to qualitative reasons. An alternative antibody HPA046109 has been added.
  • HPA053776 has been omitted due to qualitative reasons. An alternative antibody HPA063416 has been added.
  • HPA053875 has been omitted due to qualitative reasons. An alternative antibody HPA060744 has been added.
  • HPA053894 has been omitted due to antibody staining not supported by experimental data.
  • HPA053966 has been omitted due to qualitative reasons. An alternative antibody HPA056028 has been added.
  • HPA053970 has been omitted due to antibody staining not supported by experimental data. An alternative antibody HPA058655 has been added.
  • HPA054000 has been omitted due to qualitative reasons. An alternative antibody HPA061478 has been added.
  • HPA054004 has been omitted due to qualitative reasons. An alternative antibody HPA059601 has been added.
  • HPA054007 has been omitted due to qualitative reasons. An alternative antibody HPA063990 has been added.
  • HPA054519 has been omitted due to qualitative reasons. An alternative antibody HPA059935 has been added.
  • HPA054536 has been omitted due to qualitative reasons. An alternative antibody HPA061199 has been added.
  • HPA054596 has been omitted due to qualitative reasons.
  • HPA054777 has been omitted due to qualitative reasons.
  • HPA054798 has been omitted due to new images pending.
  • HPA054885 has been omitted due to antibody staining not supported by experimental data.
  • HPA054894 has been omitted due to qualitative reasons. An alternative antibody HPA059540 has been added.
  • HPA054903 has been omitted due to qualitative reasons. An alternative antibody HPA057276 has been added.
  • HPA054975 has been omitted due to qualitative reasons. An alternative antibody HPA034569 has been added.
  • HPA055374 has been omitted due to qualitative reasons. An alternative antibody HPA065263 has been added.
  • HPA055545 has been omitted due to qualitative reasons. An alternative antibody HPA064930 has been added.
  • HPA055661 has been omitted due to qualitative reasons. An alternative antibody HPA042449 has been added.
  • HPA055748 has been omitted due to qualitative reasons. An alternative antibody HPA062833 has been added.
  • HPA055853 has been omitted due to qualitative reasons. An alternative antibody HPA030681 has been added.
  • HPA055876 has been omitted due to qualitative reasons.
  • HPA055913 has been omitted due to qualitative reasons.
  • HPA056104 has been omitted due to antibody staining not supported by experimental data.
  • HPA056187 has been omitted due to antibody staining not supported by experimental data.
  • HPA056706 has been omitted due to qualitative reasons. An alternative antibody HPA043051 has been added.
  • HPA056892 has been omitted due to qualitative reasons. An alternative antibody HPA059910 has been added.
  • HPA057178 has been omitted due to qualitative reasons. An alternative antibody HPA015270 has been added.
  • HPA058412 has been omitted due to qualitative reasons. An alternative antibody HPA031949 has been added.

Protein Atlas version 12


Release date: 2013.12.05
Ensembl version: 73.37
  • Twelfth major release of the Human Protein Atlas with more than 21,900 antibodies, targeting proteins from more than 16,600 human genes (~82% of the human protein-coding genes).
  • 27 tissues have been analyzed in the RNAseq assay: adipose tissue, adrenal gland, appendix, bone marrow, cerebral cortex, colon, duodenum, esophagus, gallbladder, heart muscle, kidney, liver, lung, lymph node, ovary, pancreas, placenta, prostate, salivary gland, skin, small intestine, spleen, stomach, testis, thyroid gland, urinary bladder and uterus.
  • 33 new cell lines (total 44) have been analyzed in the RNAseq assay: AN3-CA, BEWO, CAPAN-2, Daudi, EFO-21, HaCaT, HDLM-2, HEL, HL-60, HMC-1, K-562, Karpas-707, MOLT-4, NB-4, NTERA-2, REH, RH-30, RPMI-8226, SCLC-21H, SH-SY5Y, SiHa, SK-BR-3, SK-MEL-30, TIME, THP-1, U-138 MG, U-2197, U-266/70, U-266/84, U-698, U-87 MG, U-937 and WM-115.
  • The identity of cell line KM3 has been adjusted according to information from DSMZ of KM3 being a misidentified cell line. The true identity is given as REH. DSMZ - False leukemia and lymphoma cell lines.
  • Medulla blastoma cell line D341 Med was omitted from the Human Protein Atlas due to an unsatisfactory quality of the cell line images. Both cell number and morphology was considered insufficient for representation on the atlas.
  • The serpin peptidase inhibitor, clade B (ovalbumin), member 3 (CAB036006) antibody has been omitted due to lack of positivity in squamous epithelia. CAB018772 shows positivity in squamous epithelia.
  • The oligodendrocyte transcription factor 1 (CAB025474) antibody has been omitted due to lack of predominant positivity in the brain.
  • The lectin, galactoside-binding, soluble, 13 (HPA046803) antibody has been omitted due to lack of predominant positivity in placenta.
  • The HGF activator (CAB005215) antibody has been omitted due to lack of positivity in plasma. Alternative antibodies (HPA058279 & HPA059076) showing positivity in plasma have been added.
  • The C-type lectin domain family 1, member B (CAB024956) antibody has been omitted due to lack of positivity in liver and leukocytes. An alternative antibody (HPA051108) showing positivity in leukocytes has been added.
  • The inter-alpha-trypsin inhibitor heavy chain 2 (CAB008644) antibody has been omitted due to lack of positivity in plasma. An alternative antibody (HPA059150) showing positivity in plasma has been added.
  • The keratin associated protein 10-1 (CAB034209 & CAB034210) antibodies have been omitted due to lack of predominant positivity in keratin.
  • The apolipoprotein A-V (CAB032848) antibody has been omitted due to lack of positivity in plasma.
  • The ryanodine receptor 1 (skeletal) (CAB006835) antibody has been omitted due to lack of positivity in skeletal muscle and CNS. An alternative antibody (HPA056416) showing positivity in skeletal muscle and CNS has been added.
  • The noggin (CAB011490) antibody has been omitted due to lack of secreted positivity. An alternative antibody (HPA061318) showing secreted positivity has been added.
  • The somatostatin receptor 1 (CAB009773) antibody has been omitted due to lack of membranous positivity. An alternative antibody (HPA031506) showing membranous positivity has been added.
  • The forkhead box O4 (CAB037151) antibody has been omitted due to lack of nuclear positivity. An alternative antibody (HPA040232) showing nuclear positivity has been added.
  • The growth arrest-specific 2 (CAB024194) antibody has been omitted due to weak positivity in liver compared to other tissues. An alternative antibody (HPA058904) showing more specificity towards liver has been added.
  • The cathepsin E (HPA008021) antibody has been omitted due to weak positivity in stomach and intestine compared to other tissues. Alternative antibodies (HPA012940 & CAB032687) showing positivity mainly in stomach and intestine have been added.
  • The phospholipase A2, group IB (pancreas) (CAB022329) antibody has been omitted due to lack of predominant staining in pancreas. Alternative antibodies (HPA060803 & HPA047822) showing predominant staining in pancreas have been added.
  • The nephroblastoma overexpressed (HPA018449) antibody has been omitted due to lack of predominant staining in adrenal gland. HPA019684 shows predominant staining in adrenal gland.
  • The gamma-aminobutyric acid (GABA) A receptor, alpha 1 (CAB001963) antibody has been omitted due to lack of predominant staining in CNS. An alternative antibody (HPA055746) showing predominant staining in CNS has been added.
  • The polycystic kidney and hepatic disease 1 (autosomal recessive) (HPA031229) antibody has been omitted due to lack of predominant staining in kidney. HPA031227 shows positivity predominantly in kidney.
  • The coiled-coil domain containing 62 (HPA039021) antibody has been omitted due to lack of predominant staining in testis. An alternative antibody (HPA058741) showing positivity in testis has been added.
  • The placenta-specific 1-like (HPA039820) antibody has been omitted due to lack of predominant staining in testis. An alternative antibody (HPA050914) showing positivity in testis has been added.
  • The Rho GDP dissociation inhibitor (GDI) alpha (CAB004561) antibody has been omitted due to selective staining in leukocytes when it should stain in many tissues.
  • The aquaporin 2 (collecting duct) (CAB009866) antibody has been omitted due to lack of predominant staining in kidney. An alternative antibody (HPA046834) showing positivity in kidney has been added.
  • The growth hormone releasing hormone receptor (CAB005620) antibody has been omitted due to a general staining pattern when it predominantly should stain pituitary gland.
  • The chromodomain helicase DNA binding protein 8 (HPA000849) antibody has been omitted due to cytoplasmic staining when it should stain nucleus.
  • The neurotensin (CAB022386) antibody has been omitted due to general staining when it predominantly should stain neuroendocrine cells in intestine . An alternative antibody (HPA026664) showing selective staining in neuroendocrine cells has been added.
  • The cytochrome P450, family 1, subfamily A, polypeptide 2 (CAB015446) antibody has been omitted due to lack of predominant staining in liver. CAB016531 shows predominant staining in liver.
  • The capping protein (actin filament) muscle Z-line, alpha 3 (HPA038687) antibody has been omitted due to lack of predominant staining in testis.
  • The golgin A6 family, member A, golgin A6 family, member B, golgin A6 family, member C, golgin A6 family, member D (HPA045056) antibody has been omitted due to lack of predominant staining in testis. An alternative antibody (HPA050087) showing predominant staining in testis has been added.
  • The P antigen family, member 2 (prostate associated), P antigen family, member 2B, P antigen family, member 5 (prostate associated) (HPA045952) antibody has been omitted due to lack of predominant staining in testis. An alternative antibody (HPA052619) showing predominant staining in testis has been added.
  • The myosin binding protein H-like (HPA027623) antibody has been omitted due to lack of predominant staining in heart.
  • The tetratricopeptide repeat domain 21A (HPA035511) antibody has been omitted due to lack of predominant staining in testis. An alternative antibody (HPA035510) showing predominant positivity in testis has been added.
  • The surfactant associated 2 (HPA056272) antibody has been omitted due to lack of predominant staining in lung.
  • The EGF-like-domain, multiple 6 (HPA006003) antibody has been omitted due to overlapping antigen with antibody HPA001838 targeting the same gene (disagreement with the concept of independent antibodies for quality assurance).
  • The von Willebrand factor A domain containing 3B (HPA036701) antibody has been omitted due to lack of predominant positivity in testis, fallopian tube and lung.
  • The paired box 3 (CAB013466) antibody has been omitted due to lack of nuclear staining.
  • The outer dense fiber of sperm tails 4 (HPA016621) antibody has been omitted due to lack of predominant staining in testis.
  • The serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 11 (HPA055433) antibody has been omitted due to lack of secreted positivity or positivity in liver.
  • The secreted phosphoprotein 2, 24kDa (HPA049360) antibody has been omitted due to lack of secreted positivity or positivity in liver.
  • The solute carrier family 22 (organic anion transporter), member 9 (HPA014862) antibody has been omitted due to lack of positivity in liver.
  • The hepatic and glial cell adhesion molecule (HPA017613) antibody has been omitted due to lack of positivity in liver and CNS. CAB025486 shows positivity in liver and CNS.
  • The leiomodin 2 (cardiac) (HPA053789) antibody has been omitted due to lack of predominant positivity in heart and skeletal muscle. An alternative antibody (HPA051039) showing predominant positivity in heart and skeletal muscle has been added.
  • The F-box protein 40 (HPA002884) antibody has been omitted due to lack of predominant positivity in heart and skeletal muscle.
  • The FERM and PDZ domain containing 2 (HPA018872) antibody has been omitted due to nuclear staining when it should stain in the membranes. An alternative antibody (HPA045059) showing positivity in membranes has been added.
  • The troponin I type 3 (cardiac) (CAB018644) antibody has been omitted due to lack of predominant staining in heart muscle. HPA046428 shows predominant staining in heart muscle.
  • The topoisomerase (DNA) III beta (CAB009198) antibody has been omitted due to lack of nuclear staining.
  • The chymotrypsin-like elastase family, member 2B, chymotrypsin-like elastase family, member 2A (HPA047270) antibody has been omitted due to lack of staining in pancreas.
  • The phospholipase A2, group IVE (HPA040329) antibody has been omitted due to lack of predominant staining in squamous epithelia. An alternative antibody (HPA041105) showing predominant positivity in squamous epithelia has been added.
  • The spermatid maturation 1 (HPA017723) antibody has been omitted due to lack of predominant staining in testis.
  • The melanoma antigen family C, 2 (HPA048903) antibody has been omitted due to lack of predominant staining in testis among normal tissues. An alternative antibody (HPA062230) showing specific staining in testis has been added.
  • The phospholipase C, zeta 1 (HPA040732) antibody has been omitted due to lack of predominant staining in testis.
  • The kelch-like family member 32 (HPA043872) antibody has been omitted due to lack of predominant staining in CNS. HPA039150 shows positivity in CNS.
  • The ADP-ribosylhydrolase like 1 (HPA041558 & HPA043951) antibodies have been omitted due to lack of predominant staining in heart muscle.
  • The chemokine (C-C motif) ligand 27 (HPA042918) antibody has been omitted due to lack of predominant staining in skin.
  • The odontogenic, ameloblast asssociated (HPA036543) antibody has been omitted due to lack of positivity in secreted material.
  • The coagulation factor IX (HPA000254) antibody has been omitted due to lack of positivity in plasma.
  • The IGF-like family member 1 (HPA014270) antibody has been omitted and replaced with antibody HPA014001 targeting the same gene (disagreement with the concept of independent antibodies for quality assurance).
  • The kelch-like family member 10 (HPA023853) antibody has been omitted due to lack of positivity in testis.
  • The keratin 2 (HPA006299) antibody has been omitted due to lack of predominant staining in skin. An alternative antibody (CAB037321) showing predominant staining in skin has been added.
  • The submaxillary gland androgen regulated protein 3A (HPA044567) antibody has been omitted due to lack of predominant staining in salivary gland.
  • The cysteine dioxygenase type 1 (HPA036573) antibody has been omitted due to lack of predominant staining in liver. An additional antibody (HPA057503) showing predominant positivity in liver has been added.
  • The calcium channel, voltage-dependent, alpha 2/delta subunit 3 (HPA030850) antibody has been omitted due to lack of predominant staining in brain and heart muscle.
  • The doublecortin domain containing 1 (HPA032083 & HPA039014) antibodies have been omitted due to lack of predominant staining in testis and fallopian tube.
  • The calcitonin-related polypeptide alpha (CAB000005) has been omitted due to negative staining in thyroidea, most likely due to lack of parafollicular cells, the certain cell type that should express the protein in the tested tissue.
  • The gasdermin C (HPA024767) antibody has been omitted due to lack of predominant staining in spleen and esophagus.
  • The neurotrophin 4 (CAB010167) antibody has been omitted due to lack of positivity in secreted material. HPA057435 shows positivity in secreted material.
  • The angiogenin, ribonuclease, RNase A family, 5 (CAB013673) has been omitted since it has been discontinued by the commercial distributor.
  • The mucin 16, cell surface associated (HPA026659 & HPA050015) antibodies have been been omitted due to lack of positivity in uterus and fallopian tube.
  • The calcium channel, voltage-dependent, L type, alpha 1S subunit (CAB009507) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The gasdermin B (CAB013681) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The synaptotagmin binding, cytoplasmic RNA interacting protein (CAB010895) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The Src homology 2 domain containing adaptor protein B (CAB010161) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The ankyrin 3, node of Ranvier (ankyrin G) (CAB015179) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The alcohol dehydrogenase 1A (class I), alpha polypeptide (CAB009562) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The ELOVL fatty acid elongase 5 (CAB017042) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The calsequestrin 2 (cardiac muscle) (HPA027285) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The methylcrotonoyl-CoA carboxylase 1 (alpha) (HPA008310) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The carbonic anhydrase III, muscle specific (HPA026700) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The APOBEC1 complementation factor (HPA037779) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The solute carrier family 6 (neurotransmitter transporter, GABA), member 1 (HPA013341) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The cellular repressor of E1A-stimulated genes 2 (HPA038224) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The etal and adult testis expressed 1 (HPA034604) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The chromosome 2 open reading frame 57 (HPA049917) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The chromosome 9 open reading frame 1 (HPA015504) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The family with sequence similarity 194, member A (HPA048373) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The alpha-2-glycoprotein 1, zinc-binding (HPA012582) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The P antigen family, member 4 (prostate associated) (HPA023880) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The chloride intracellular channel 3 (HPA005963) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The paternally expressed 10 (HPA051038) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The runt-related transcription factor 2 (HPA022040) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The ligodendrocytic myelin paranodal and inner loop protein (HPA014372) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The cystatin E/M (CAB019316) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The S100 calcium binding protein G (CAB017688) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The solute carrier family 5 (sodium/glucose cotransporter), member 1 (CAB015467) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The KiSS-1 metastasis-suppressor (CAB017775) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The lin-28 homolog B (C. elegans) (HPA036630) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The delta-like 1 homolog (Drosophila) (CAB005872) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The surfactant protein A1 (CAB016793) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The polycystic kidney and hepatic disease 1 (autosomal recessive) (HPA031227) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The coiled-coil domain containing 39 (HPA035364) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The insulin-like 5 (HPA030100) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The defensin, alpha 6, Paneth cell-specific (HPA019462) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The gastric inhibitory polypeptide (HPA021612) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The glycoprotein 2 (zymogen granule membrane) (HPA015739 & HPA016668) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The SH3-domain GRB2-like 3 (HPA039381) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The fibronectin type III and SPRY domain containing 1 (HPA043141) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The syntaxin 7 (HPA001467) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The chromogranin A (parathyroid secretory protein 1) (HPA017369) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The carbonic anhydrase XII (HPA008773) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The podocalyxin-like (HPA002110) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The transthyretin (HPA002550) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The ermin, ERM-like protein (HPA038295 & HPA038296) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The major histocompatibility complex, class I, G (CAB016158) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 2 (HPA014963) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The aquaporin 4 (HPA014784 & CAB005079) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The calcyphosine-like (HPA058495) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The phenylethanolamine N-methyltransferase (CAB017029) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The guanylate cyclase activator 2A (guanylin) (HPA018215) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The nephroblastoma overexpressed (HPA019684) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The chromosome 1 open reading frame 222 (HPA028521 & HPA029274) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The ankyrin repeat domain 45 (HPA031655, HPA031656 & HPA031657) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The aquaporin 6, kidney specific (HPA015278) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The coiled-coil domain containing 17 (HPA028338) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The solute carrier family 12 (sodium/chloride transporters), member 3 (HPA028748) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The TGFB-induced factor homeobox 2-like, X-linked (HPA034543) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The calcium channel, voltage-dependent, alpha 2/delta subunit 2 (HPA034771) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The dimethylglycine dehydrogenase (HPA036442) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The fibrinogen alpha chain (CAB016776 & HPA051370) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The tubulin polymerization promoting protein (HPA036575) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The transmembrane protein 174 (HPA037975) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The solute carrier family 34 (type II sodium/phosphate contransporter), member 2 (HPA037989) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The cation channel, sperm associated 4 (HPA045257) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The late cornified envelope 6A (HPA046376) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The chromosome 12 open reading frame 56 (HPA056986) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The centromere protein H (HPA036494) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The cytochrome P450, family 11, subfamily B, polypeptide 1 & 2 (HPA049171) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The hepatoma derived growth factor-like 1 (HPA045679) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G2 (CAB004616) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The MORC family CW-type zinc finger 4 (HPA000395) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The sulfotransferase family, cytosolic, 1B, member 1 (HPA002107) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G2 (CAB004616) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The 5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled (HPA014011) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The troponin T type 2 (cardiac) (HPA015774, HPA017888) stained images have been omitted and replaced with images from a more recent staining with the same antibodies.
  • The cAMP-regulated phosphoprotein, 21kDa (HPA017303) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The fatty acid binding protein 3, muscle and heart (mammary-derived growth inhibitor) (CAB017830) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The G protein-coupled receptor 182 (HPA027037) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The G protein-coupled receptor 32 (HPA030330) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The SHC SH2-domain binding protein 1-like (HPA036125) stained images have been omitted and replaced with images from a more recent staining with the same antibodies.
  • The spermatogenesis associated 16 (HPA037884) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The chromosome 10 open reading frame 53 (HPA037951) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The leucine rich repeat containing 38 (HPA038778) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The spermatid associated (HPA040046 & HPA039359) stained images have been omitted and replaced with images from a more recent staining with the same antibodies.
  • The trehalase (brush-border membrane glycoprotein) (HPA039913) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The zymogen granule protein 16B (HPA041125) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The sarcalumenin (HPA041535) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The proline rich 4 (lacrimal) (HPA042133) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The collagen, type XVII, alpha 1 (HPA043673) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The BPI fold containing family A, member 2 (HPA044006) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The lactate dehydrogenase C (HPA045442) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The gastrokine 1 (HPA047684) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The testis specific protein, Y-linked 1, testis specific protein, Y-linked 2, testis specific protein, Y-linked 3, testis specific protein, Y-linked 4, testis specific protein, Y-linked 6, pseudogene, testis specific protein, Y-linked 8, testis specific protein, Y-linked 10 stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The insulin-like 5 (HPA030100 & CAB033849) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The actin-related protein T2 (HPA006480) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The phospholipase C, beta 3 (phosphatidylinositol-specific) (CAB009257) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The leucine rich repeat containing 38 (HPA038778) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The defensin, alpha 5, Paneth cell-specific (HPA015775) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The chromosome 1 open reading frame 170 (HPA031711) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The transglutaminase 3 (HPA004728) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The isthmin 2 (HPA039314) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The actin-related protein T3 (HPA035817) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The secretagogin, EF-hand calcium binding protein (HPA006641) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The interleukin 1 receptor antagonist (CAB009633) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The caspase 14, apoptosis-related cysteine peptidase (CAB010059) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The diffuse panbronchiolitis critical region 1 (HPA014036) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The proteasome (prosome, macropain) subunit, beta type, 9 (CAB015180) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The doublecortin-like kinase 2 (HPA015770) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The G protein-coupled receptor 17 (HPA029766) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The cytochrome P450, family 17, subfamily A, polypeptide 1 stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The low density lipoprotein receptor class A domain containing 1 (HPA052489) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The endoplasmic reticulum protein 27 (HPA039636) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The ArfGAP with FG repeats 2 (HPA019689) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The emerin (HPA000609) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The fms-related tyrosine kinase 1 (HPA014290 & HPA011740) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The POU class 2 homeobox 3 (HPA019652) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The growth differentiation factor 2 (CAB023357) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The isocitrate dehydrogenase 1 (NADP+), soluble (HPA035248) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The erythrocyte membrane protein band 4.2 (HPA040261) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The hyaluronan and proteoglycan link protein 2 (HPA045765) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The myosin, light chain 7, regulatory (HPA013331) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The family with sequence similarity 92, member B (HPA041022) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The retinol dehydrogenase 11 (all-trans/9-cis/11-cis) (CAB046011) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The leiomodin 2 (cardiac) (HPA051039) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The tumor protein p73 (CAB002514) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The annexin A10 (HPA005469) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The MORC family CW-type zinc finger 4 antibody (HPA001017) has been omitted and replaced by another antibody (HPA000395) originated from identical PrEST since HPA000395 shows a more distinct staining pattern.
  • The CAB020711 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA056305 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA048324 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA053500 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA052039 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA047665 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA047717 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA047525 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA045742 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA046349 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA048897 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA045040 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA043677 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA045315 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA043842 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA045953 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA045048 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA053779 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA045443 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA046401 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA050866 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA043695 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA045630 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA044973 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA043101 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA042624 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA044018 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA047711 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA052349 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA042724 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA042693 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA047391 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA042086 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA043291 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA042104 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA038365 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA037405 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA041389 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA039604 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA036454 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA044091 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA036644 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA047689 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA037610 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA030240 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA030157 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA027116 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA022857 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA023055 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA022890 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA044320 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA042423 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA016895 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA016715 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA012541 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA030441 antibody has been omitted due to target gene not found in Ensembl.

Protein Atlas version 11


Release date: 2013.03.11
Ensembl version: 69.37
  • Eleventh major release of the Human Protein Atlas with more than 18,000 antibodies, targeting proteins from more than 15,000 human genes (~75% of the human protein-coding genes).
  • Protein evidence for all 20.083 predicted genes based on manual annotation from literature (UniProt), antibody-based profiling in cells, tissues and organs and analysis of transcripts using next generation sequencing.
  • Eight new cell lines: A-549, CACO-2, HEK 293, HeLA, Hep-G2, MCF-7, PC-3 and RT-4, have been analyzed in the RNAseq assay.
  • Neuropil (in cerebral cortex) has been annotated and added in the normal tissue immunohistochemistry assay.
  • The guanine nucleotide binding protein (G protein), beta polypeptide 3 antibody (HPA005645) has been omitted due to nuclear positivity.
  • The protocadherin 19 antibody (HPA001461) has been omitted due to lack of membranous positivity.
  • The SAM domain and HD domain 1 antibody (CAB002004) has been omitted due to lack of nuclear positivity. An alternative antibody (HPA047072) showing nuclear positivity has been added.
  • The orthodenticle homeobox 1 antibody (CAB012341) has been omitted due to lack of positivity in brain. An alternative antibody (HPA052122) showing positivity in brain has been added.
  • The interleukin 1, alpha antibody (CAB004449) has been omitted due to lack of secreted staining.
  • The TNF receptor-associated protein 1 antibody (CAB004281) has been omitted due to lack of general granular positivity. Alternative antibodies (HPA041082 & HPA044227) showing general granular positivity have been added.
  • The protease, serine, 57 antibody (HPA006099) has been omitted due to disconcordant staining.
  • The ATPase, Ca++ transporting, cardiac muscle, fast twitch 1 antibody (CAB002310) has been omitted since it has been discontinued by the commercial distributor. An alternative antibody (CAB032706) targeting the same gene has been added.
  • The chromogranin A (parathyroid secretory protein 1) antibody (CAB000023) has been omitted since it has been discontinued by the commercial distributor. An alternative antibody (CAB055506) targeting the same gene has been added.
  • The regulatory factor X, 6 antibody (HPA037697) has been omitted due to lack of positivity in endocrine pancreas. An alternative antibody (HPA037696) showing positivity in endocrine pancreas has been added.
  • The KRIT1, ankyrin repeat containing antibody (HPA022155) has been omitted due to lack of positivity in endothelial cells. An alternative antibody (HPA049606) showing positivity in endothelial cells has been added.
  • The BCL2-related protein A1 antibody (CAB010382) has been omitted due to lack of positivity in lymphoid tissues.
  • The dipeptidyl-peptidase 6 antibody (CAB025851) has been omitted due to lack of positivity in brain. An alternative antibody (HPA050509) showing positivity in brain has been added.
  • The adiponectin receptor 1 antibody (CAB015935) has been omitted due to lack of plasma membrane positivity.
  • The structural maintenance of chromosomes 4 antibody (HPA018259) has been omitted due to a selective staining pattern when it should stain ubiquitous. An alternative antibody (CAB055509) showing general positivity has been added.
  • The cytochrome c oxidase subunit VIa polypeptide 2 antibody (HPA044591) has been omitted due to lack of mitochondrial positivity.
  • The nuclear receptor subfamily 2, group C, member 1 antibody (CAB010395) has been omitted due to lack of nuclear positivity.
  • The suppression of tumorigenicity 13 (colon carcinoma) (Hsp70 interacting protein) antibody (CAB017443) has been omitted due to nuclear staining. Alternative antibodies (HPA043233, HPA046412, HPA047114 & HPA047116) showing cytoplasmic positivity have been added
  • The somatostatin receptor 5 antibody (CAB005615) has been omitted due to nuclear positivity.
  • The discoidin domain receptor tyrosine kinase 2 antibody (CAB010432) has been omitted due to a selective staining pattern when it should stain more general.
  • The hydroxysteroid (11-beta) dehydrogenase 1 antibody (CAB003788) has been omitted due to low positivity in liver compared to many other tissues. An alternative antibody (HPA047729) showing strong positivity in liver has been added.
  • The chemokine (C-X-C motif) receptor 1 antibody (CAB016267) has been omitted due to lack of positivity in neutrophils.
  • The thyroid hormone receptor interactor 10 antibody (CAB035547) has been omitted due to a selective staining pattern when it should stain ubiquitous.
  • The solute carrier family 11 (proton-coupled divalent metal ion transporters), member 1 antibody (CAB009393) has been omitted due to lack of positivity in lymphoid tissues.
  • The activin A receptor, type IB antibody (CAB026126) has been omitted due to lack of membranous positivity.
  • The acetylserotonin O-methyltransferase-like antibody (HPA021865) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The kallikrein-related peptidase 7 antibody (HPA018994) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The profilin 1 antibody (CAB037140) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The 2',3'-cyclic nucleotide 3' phosphodiesterase antibodies (HPA023278, HPA023280 and HPA023338) stained images have been omitted and replaced with images from a more recent staining with the same antibodies.
  • The dickkopf-like 1 antibody (CAB025410) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The ELAV (embryonic lethal, abnormal vision, Drosophila)-like 3 (Hu antigen C) antibody (CAB013066) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The Rac GTPase activating protein 1 antibody (CAB025859) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The guanine nucleotide binding protein (G protein), q polypeptide antibody (CAB010036) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The myosin, light chain 12A, regulatory, non-sarcomeric antibody (CAB004503) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The charged multivesicular body protein 5 antibody (CAB033874) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The developmental pluripotency associated 4 antibody (CAB020678) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The derlin 2 antibody (CAB037287) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The sialidase 2 (cytosolic sialidase) antibody (CAB022336) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The dopey family member 2 antibody (CAB034922) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The testis expressed 33 antibody (HPA005998) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The lipase, hormone-sensitive antibody (CAB017700) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The glycoprotein (transmembrane) nmb antibody (CAB026224) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The retinoblastoma binding protein 6 antibody (CAB032866) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The tenomodulin antibody (HPA034961) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The stromal cell derived factor 4 antibody (CAB015227) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The myomesin (M-protein) 2, 165kDa antibody (HPA005953) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The methylmalonic aciduria (cobalamin deficiency) cblC type, with homocystinuria antibody (HPA027394) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The mediator complex subunit 19 antibodies (HPA039912 and HPA040860) stained images have been omitted and replaced with images from a more recent staining with the same antibodies.
  • The melanoma associated antigen (mutated) 1-like 1 antibodies (HPA020464 and HPA000168) stained images have been omitted and replaced with images from a more recent staining with the same antibodies.
  • The coiled-coil domain containing 144A antibody (HPA022996) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The cathelicidin antimicrobial peptide antibodies (CAB015949 and CAB016522) stained images have been omitted and replaced with images from a more recent staining with the same antibodies.
  • The dopamine receptor D2 antibody (HPA015691) stained images have been omitted and replaced with images from a more recent staining with the same antibodies.
  • The kinesin family member 1C antibody (HPA021831) has been omitted due to overlapping antigen with antibody HPA045020 targeting the same gene (disagreement with the concept of independent antibodies for quality assurance).
  • The CAB004518 antibody has been omitted due to target gene not found in Ensembl.
  • The CAB005592 antibody has been omitted due to target gene not found in Ensembl.
  • The CAB034205 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA003446 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA019858 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA021630 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA022139 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA023076 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA023495 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA023862 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA023908 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA024416 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA024633 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA025700 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA027269 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA027270 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA029425 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA035687 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA036919 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA038358 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA038835 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA039741 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA041046 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA041864 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA043465 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA043733 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA043776 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA044027 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA044152 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA044162 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA044381 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA044447 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA045320 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA045533 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA045566 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA047080 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA047197 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA047528 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA048357 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA048611 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA049408 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA049804 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA051106 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA051139 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA052092 antibody has been omitted due to target gene not found in Ensembl.

Protein Atlas version 10


Release date: 2012.09.12
Ensembl version: 67.37
  • Tenth major release of the Human Protein Atlas with more than 17,000 antibodies, targeting proteins from more than 14,000 human genes (~70% of the human protein-coding genes).
  • The chromatin assembly factor 1, subunit B (p60) antibodies (HPA016698 and HPA029538) have been omitted due to cytoplasmic positivity and lack of nuclear staining. An alternative antibody (CAB033604) showing nuclear staining in dividing cells has been added.
  • The purinergic receptor P2X, ligand-gated ion channel, 7 antibody (HPA034967) has been omitted due to a selective staining pattern.
  • The heat shock 27 kDa protein 1 antibody (CAB002061) has been omitted due to a selective staining pattern. HPA000497, CAB004439 and CAB047331 show a more general staining pattern.
  • The heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) antibody (CAB019420) has been omitted due to a selective staining pattern. HPA038845, HPA038846 and CAB005221 show a general staining pattern.
  • The Cbl proto-oncogene, E3 ubiquitin protein ligase B antibody (HPA016864) has been omitted due to nuclear staining. HPA018327 and HPA019880 show cytoplasmic staining.
  • The BCL2-like 2 antibody (CAB002048) has been omitted due to a selective staining pattern. CAB040539 shows a general staining pattern.
  • The chloride intracellular channel 1 antibody (HPA008917) has been omitted due to unspecific staining. CAB020825 and CAB040557 show a more reliable staining pattern.
  • The insulin receptor antibody (CAB013113) has been omitted due to lack of staining in liver and muscle.
  • The cytochrome P450, family 7, subfamily A, polypeptide 1 antibody (HPA010970) has been omitted due to lack of staining in liver.
  • The 24-dehydrocholesterol reductase antibody (HPA028826) has been omitted due to lack of staining in liver. An alternative antibody (CAB037247) showing positivity in liver has been added.
  • The phosphoinositide-3-kinase, catalytic, gamma polypeptide antibody (CAB010283) has been omitted due to nuclear staining.
  • The vitamin D (1,25- dihydroxyvitamin D3) receptor antibody (CAB004617) has been omitted due to cytoplasmic staining.
  • The G elongation factor, mitochondrial 2 antibody (HPA036864) has been omitted due to lack of staining in liver. An alternative antibody (HPA036863) showing positivity in liver has been added.
  • The bile acid CoA: amino acid N-acyltransferase (glycine N-choloyltransferase) antibody (HPA021251) has been omitted due to lack of staining in liver. An alternative antibody (HPA021330) showing positivity in liver has been added.
  • The caspase 8, apoptosis-related cysteine peptidase antibody (HPA008936) has been omitted due to a selective staining pattern. HPA001302, CAB002047 and HPA005688 show a more general staining pattern.
  • The latent-transforming growth factor beta-binding protein 1 antibody (HPA005707) has been omitted due to lack of extracellular staining. CAB025428 shows extracellular positivity.
  • The geminin, DNA replication inhibitor antibody (CAB047328) has been omitted due to a general nuclear staining pattern when it should only stain proliferating cells. An alternative antibody (CAB047327) showing nuclear positivity in dividing cells has been added.
  • The serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 antibody (CAB002516) has been omitted due to lack of extracellular staining or staining of endothelial cells. An alternative antibody (HPA050039) showing positivity in endothelial cells has been added.
  • The NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 9, 39kDa antibody (CAB034893) has been omitted due to selective staining. An alternative antibody (HPA042268) showing a general staining pattern has been added.
  • The aldo-keto reductase family 1, member C4 (chlordecone reductase; 3-alphahydroxysteroid dehydrogenase, type I; dihydrodiol dehydrogenase 4) antibody (CAB006258) has been omitted due to a general staining pattern when it should be liver specific. An alternative antibody (HPA044720) showing a more selective staining and positivity in liver has been added.
  • The pyruvate kinase, liver and RBC antibody (HPA011991) has been omitted due to lack of positivity in liver. Alternative antibodies (CAB034376 and CAB034378) showing positivity in liver have been added.
  • The myostatin antibodies (HPA018534 and HPA021681) have been omitted due to lack of extracellular positivity. CAB009963 shows extracellular positivity.
  • The TYRO3 protein tyrosine kinase antibody (HPA007654) has been omitted due to lack of cell membranous positivity.
  • The neuregulin 1 antibody (CAB002304) has been omitted since it has been discontinued by the commercial distributor.
  • The mucin 16, cell surface associated antibody (CAB000004) has been omitted since it has been discontinued by the commercial distributor. An alternative antibody (CAB055170) targeting the same gene has been added.
  • The KIAA2022 antibody (HPA000404) has been been omitted and replaced by another antibody (HPA000407) originating from identical PrEST since HPA000407 shows a more distinct staining pattern.
  • The troponin T type 3 (skeletal, fast) antibody (CAB000472) has been been omitted due to overlapping antigen with antibody CAB002451 targeting the same gene (disagreement with the concept of independent antibodies for quality assurance).
  • The mitochondrial ribosomal protein L40 antibody (CAB010069) has been omitted since it has been discontinued by the commercial distributor. The antibody HPA006181 targeting the same gene has been added.
  • The PHD finger protein 20 antibody (HPA029620) has been omitted due to cytoplasmic positivity and lack of nuclear staining. HPA029619 shows nuclear positivity.
  • The terminal uridylyl transferase 1, U6 snRNA-specific antibody (CAB004969) has been omitted due to cytoplasmic positivity and lack of nuclear staining.
  • The fms-related tyrosine kinase 4 antibody (CAB000099) has been omitted due to lack of positivity in vessels.
  • The adenylate kinase 1 antibody (HPA006456) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The moesin antibody (CAB047338) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The 8-oxoguanine DNA glycosylase antibody (CAB047301) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The WW domain containing transcription regulator 1 antibody (CAB017483) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The chromosome X open reading frame 57 antibody (HPA000896) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The carbonic anhydrase IX antibody (CAB005100) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The Insulin antibody (HPA004932) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The serine/threonine kinase 4 antibody (HPA015270) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The oligodendrocyte myelin glycoprotein antibodies (HPA008206 and HPA012693) stained images have been omitted and replaced with images from a more recent staining with the same antibodies.
  • The ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D antibody (HPA031515) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The Chloride intracellular channel protein 1 antibodies (CAB020825 and CAB040557) stained images have been omitted and replaced with images from a more recent staining with the same antibodies.
  • The HEAT repeat containing 4 antibodies (HPA003642 and HPA019767) stained images have been omitted and replaced with images from a more recent staining with the same antibodies.
  • The keratin 83 antibody (CAB004987) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The membrane protein, palmitoylated 6 (MAGUK p55 subfamily member 6) antibodies (HPA020456 and HPA019085) stained images have been omitted and replaced with images from more recent stainings with the same antibodies.
  • The small proline-rich protein 1A antibody (CAB011237) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The ankyrin repeat and SOCS box containing 1 antibody (HPA003508) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The chordin-like 1 antibody (HPA000250) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The scinderin antibody (HPA020518) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The CAB008594 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA041886 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA040799 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA041926 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA042108 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA028677 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA010786 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA019112 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA022521 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA043690 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA045651 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA041320 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA041181 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA041526 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA009028 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA017993 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA027338 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA042153 antibody has been omitted due to target gene not found in Ensembl.

Protein Atlas version 9


Release date: 2011.11.11
Ensembl version: 64.37
  • Ninth major release of the Human Protein Atlas with more than 15,500 antibodies, targeting proteins from more than 12,200 human genes (~61% of the human protein-coding genes).
  • The DNA-damage-inducible transcript 3 antibody (CAB008969) has been omitted due to unspecific staining.
  • The chromosome 1 open reading frame 222 antibody (HPA028491) has been omitted due to nuclear staining.
  • The ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1 antibody (HPA024243) has been omitted due to indistinct staining.
  • The ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1 antibody (CAB009525) has been omitted due to nuclear staining.
  • The S100 calcium binding protein A4 antibody (CAB027387) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The S100 calcium binding protein A4 antibody (HPA007973) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The YY1 associated protein 1 antibody (HPA006986) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The tropomyosin 1 (alpha) antibody (CAB017698) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The solute carrier family 7 (cationic amino acid transporter, y+ system), member 9 antibody (HPA042591) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The glutamate decarboxylase 2 (pancreatic islets and brain, 65kDa) antibody (CAB002682) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The choroideremia (Rab escort protein 1) antibody (CAB016171) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The gamma-aminobutyric acid (GABA) A receptor, alpha 1 antibody (CAB022502) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The insulin-like growth factor binding protein 7 antibody (HPA002196) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The kinesin family member 7 antibody (HPA043145) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The RAD23 homolog B antibody (HPA029719) has been omitted due to a staining pattern deviating from that of the sibling antibodies.
  • The keratin 18 antibody (CAB000092) has been omitted due to specific staining of caspase cleaved keratin 18.
  • The glutathione S-transferase mu 1 antibody (CAB027393) has been omitted due to addition of an alternative and more specific antibody to the Protein Atlas.
  • The HPA000519 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA003232 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA003553 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA003644 antibody has been omitted due to target gene not found in Ensembl.
  • The CAB010396 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA014347 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA014850 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA018452 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA023262 antibody has been omitted due to target gene not found in Ensembl.
  • The CAB025805 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA025821 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA026562 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA027480 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA028260 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA030710 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA030809 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA030810 antibody has been omitted due to target gene not found in Ensembl.
  • The CAB033804 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA038584 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA039525 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA040714 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA041033 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA041543 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA041980 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA042002 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA043385 antibody has been omitted due to target gene not found in Ensembl.

Protein Atlas version 8


Release date: 2011.05.16
Ensembl version: 62.37
  • Eigth major release of the Human Protein Atlas with more than 14,500 antibodies, targeting proteins from more than 11,250 human genes (~56% of the human protein-coding genes).
  • The transcription factor 21, TCF21 antibody (HPA012792) has been omitted due to publication of two antibodies produced against the same PrEST.
  • The tumor necrosis factor (ligand) superfamily, member 14 antibody (HPA026919) has been omitted due to publication of two antibodies produced against the same PrEST.
  • The surfactant protein C antibody (HPA011644) has been omitted due to publication of two antibodies produced against the same PrEST.
  • The family with sequence similarity 26, member D antibody (HPA014524) has been omitted due to publication of two antibodies produced against the same PrEST.
  • The glial fibrillary acidic protein antibody (CAB000039) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The amylase, alpha 1A (salivary) antibody (CAB004310) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The tripartite motif containing 22 antibody (HPA003575) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The BCDIN3 domain containing protein antibody (HPA039911) stained images have been omitted and replaced with images from a more recent scanning of the same stained TMA slides.
  • The pleiomorphic adenoma gene 1 antibody (HPA005462) has been omitted due to lack of nuclear staining.
  • The SH2 domain containing 2A, SH2D2A antibody (HPA019483) has been omitted due to lack of staining in T cells.
  • The Fas ligand (TNF superfamily, member 6) antibody (HPA030524) has been omitted due to lack of staining in T and NK cells.
  • The signal transducer and activator of transcription 6, interleukin-4 induced, STAT6 antibody (CAB002613) has been omitted due to lack of nuclear staining.
  • The calcium channel, voltage-dependent, L type, alpha 1D subunit, CACNA1D antibody (CAB009777) has been omitted due to nuclear staining.
  • The potassium inwardly-rectifying channel, subfamily J member 10, KCNJ10 antibody (HPA011992) has been omitted due to nuclear membrane staining.
  • The interleukin 1 receptor, type I, IL1R1 antibody (HPA029559) has been omitted due to nucleolar staining.
  • The Kv channel interacting protein 3, calsenilin, KCNIP3 antibody (CAB010450) has been omitted due to lack of staining in the CNS.
  • The crystallin, zeta (quinone reductase), CRYZ, antibody (HPA021919) has been omitted due to overlapping antigen with other antibody targeting the same gene.
  • The pumilio homolog 1 (Drosophila), PUM1, antibody (HPA027430) has been omitted due to overlapping antigen with other antibody targeting the same gene.
  • The protein prenyltransferase alpha subunit repeat containing 1, PTAR1, antibody (HPA022781) has been omitted due to overlapping antigen with other antibody targeting the same gene.
  • The transketolase-like 1, TKTL1, antibody (HPA029155) has been omitted due to overlapping antigen with other antibody targeting the same gene.
  • The secreted phosphoprotein 1, SPP1, antibody (HPA027540) has been omitted due to overlapping antigen with other antibody targeting the same gene.
  • The PTK2 protein tyrosine kinase 2, PTK2, antibody (HPA029671) has been omitted due to overlapping antigen with other antibody targeting the same gene.
  • The ring finger protein 24, RNF24, antibody (HPA036637) has been omitted due to overlapping antigen with other antibody targeting the same gene.
  • The aspartyl-tRNA synthetase, DARS, antibody (HPA024079) has been omitted due to overlapping antigen with other antibody targeting the same gene.
  • The filaggrin, FLG, antibody (HPA027505) has been omitted due to overlapping antigen with other antibody targeting the same gene.
  • The SKI-like oncogene, SKIL, antibody (HPA013920) has been omitted due to overlapping antigen with other antibody targeting the same gene.
  • The CAB010763 antibody has been omitted due to target gene not found in Ensembl.
  • The CAB017481 antibody has been omitted due to target gene not found in Ensembl.
  • The CAB017800 antibody has been omitted due to target gene not found in Ensembl.
  • The CAB020836 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA001187 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA011085 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA012131 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA012167 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA013202 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA014078 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA014103 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA014441 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA014911 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA015527 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA015978 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA016828 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA017431 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA017725 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA019155 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA021040 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA021078 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA021544 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA021644 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA021847 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA024095 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA024257 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA025759 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA026879 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA027059 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA027313 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA027324 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA027561 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA027571 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA027633 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA027828 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA027953 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA028902 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA029050 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA029512 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA030365 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA030366 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA030597 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA034601 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA035579 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA035673 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA036477 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA036625 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA036666 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA036673 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA037887 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA038210 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA038365 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA038651 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA039020 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA039142 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA039524 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA039666 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA040085 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA040334 antibody has been omitted due to target gene not found in Ensembl.

Protein Atlas version 7.1


Release date: 2011.01.14
Ensembl version: 59.37
  • Erroneous RNA RPKM values for 944 genes (listed here) have been corrected.
  • The annotated protein expression values (IH) for MLLT4 (ENSG00000130396) and NR3C1 (ENSG00000113580) have been updated.

Protein Atlas version 7


Release date: 2010.11.15
Ensembl version: 59.37
  • Seventh major release of the Human Protein Atlas with more than 13,150 antibodies, targeting proteins from more than 10,100 human genes (~50% of the human protein-coding genes).
  • Major redesign of the Human Protein Atlas web portal.
  • Knowledge-based annotated protein expression added.
  • The ras-related C3 botulinum toxin substrate 1 antibody (CAB002002) has been omitted due to nuclear staining. An alternative antibody (CAB035994) showing cytoplasmic staining has been added.
  • The TAF9 RNA polymerase II, TATA box binding protein (TBP)-associated factor antibody (HPA031968) has been omitted due to ubiquitous cytoplasmic staining.
  • The serine/threonine kinase 4 antibody (CAB004965) has been omitted due to staining mainly in goblet cells.
  • The nitric oxide synthase 1 (neuronal) adaptor protein antibody (HPA027712) has been omitted due to ubiquitous nuclear staining.
  • The RPA interacting protein antibody (HPA022478) has been omitted due to technical difficulties.
  • The egl nine homolog 2 antibody (HPA001624) has been omitted due to technical difficulties.
  • The CAB009738 antibody has been omitted due to target gene not found in Ensembl.
  • The CAB022461 antibody has been omitted due to target gene not found in Ensembl.
  • The CAB034119 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA001206 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA003181 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA003209 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA003285 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA003550 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA004739 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA010516 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA010818 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA011010 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA011229 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA013760 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA015241 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA015970 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA017238 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA017595 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA018938 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA019677 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA019833 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA019856 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA021614 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA021733 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA023077 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA023156 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA023262 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA023264 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA023460 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA024025 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA025719 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA027071 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA027600 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA027912 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA029815 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA029817 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA030157 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA030375 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA030651 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA030809 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA030810 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA035002 antibody has been omitted due to target gene not found in Ensembl.

Protein Atlas version 6


Release date: 2010.03.26
Ensembl version: 57.37
  • Sixth major release of the Human Protein Atlas with more than 11,200 antibodies and more than 9,100,000 images.
  • Membrane protein related protein classes have been added.
  • New membrane protein topology prediction methods have been added to the protein view.
  • The Two pore calcium channel protein 2 antibody (HPA0016561) has been omitted due to lack of membranous staining. An alternative antibody (HPA0027080), showing a membranous positivity, has been added to the Protein Atlas.
  • The Serine/threonine-protein kinase TNNI3K antibody (HPA013188) has been omitted due to lack of staining in heart muscle.
  • The Mitogen-activated protein kinase 12 antibody (HPA018841) has been omitted due to negative skeletal muscle. An alternative antibody (CAB025483), showing distinct staining in skeletal muscle, has been added to the protein atlas.
  • The Thyrotropin receptor Precursor antibody (CAB000473) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The Serotonin antibody (CAB000074) has been omitted due to wrong ensg id.
  • The Neurotensin receptor type 1 antibody (HPA009132) has been omitted due to nuclear positivity and lack of staining in neurons.
  • The Neurexin-2-beta Precursor antibody (CAB012472) has been omitted due to ubiquitous granular cytoplasmic staining.
  • The Focal adhesion kinase 1 antibody (HPA001842) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The Tumor necrosis factor receptor superfamily member 6 Precursor antibody (CAB000124) has been omitted due to weak staining. An alternative antibody (HPA027444), showing staining in inflammatory cells, has been added to the protein atlas.
  • The La-related protein 7 antibody (HPA017600) has been omitted due to cytoplasmic staining. Alternative antibodies (HPA026842 and HPA027930), showing mostly nuclear staining, have been added to the protein atlas.
  • The Tensin-3 antibody (HPA005547) has been omitted due to non-reliable protein expression patterns (IHC).
  • The ATP-sensitive inward rectifier potassium channel 8 (CAB009504) has been omitted due to lack of membranous staining. An alternative antibody (HPA0031066), showing a membranous positivity, has been added to the Protein Atlas.
  • The Pogo transposable element with KRAB domain antibody (HPA007838) has been omitted due to ubiquitous cytoplasmic and extracellular staining. An alternative antibody (HPA0031630) showing nuclear staining have been added to the protein atlas.
  • The Hepatocyte cell adhesion molecule Precursor antibody (HPA0017613) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The Transketolase-like protein 1 antibody (HPA000505) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The Laminin, alpha 2 antibody (HPA005537) has been omitted due to lack of staining in basement membranes.
  • The HPA000429 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA000523 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA001942 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA003249 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA003533 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA003535 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA003553 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA003721 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA004690 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA008331 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA009072 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA010930 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA011369 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA012133 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA013207 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA013788 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA014079 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA014207 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA014347 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA014904 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA014916 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA015796 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA017597 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA017657 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA018521 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA019064 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA019164 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA019546 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA020458 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA020854 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA020946 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA020953 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA021259 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA021268 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA021271 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA021324 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA021495 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA021642 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA021772 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA021782 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA022024 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA022247 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA022954 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA023061 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA023101 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA023105 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA023133 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA023538 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA023540 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA023931 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA024419 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA024454 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA024461 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA024799 antibody has been omitted due to target gene not found in Ensembl.
  • The HPA027245 antibody has been omitted due to target gene not found in Ensembl.
  • The CAB000074 antibody has been omitted due to target gene not found in Ensembl.
  • The CAB000017 antibody has been omitted due to target gene not found in Ensembl.
  • The CAB002774 antibody has been omitted due to target gene not found in Ensembl.
  • The CAB008668 antibody has been omitted due to target gene not found in Ensembl.
  • The CAB009395 antibody has been omitted due to target gene not found in Ensembl.
  • The CAB016176 antibody has been omitted due to target gene not found in Ensembl.

Protein Atlas version 5


Release date: 2009.06.16
Ensembl version: 54.36
  • Fifth major release of the Human Protein Atlas with more than 8,800 antibodies and more than 7,300,000 images.
  • A new protein class group, Voltage-gated ion channels, has been added.
  • The Receptor tyrosine-protein kinase erbB-3 Precursor antibody (CAB000088) has been omitted due to lack of membrane positivity.
  • The Ubiquitin carboxyl-terminal hydrolase 26 antibody (HPA000424) has been omitted due to general positivity.
  • The Cleavage and polyadenylation specificity factor subunit 2 antibody (HPA000870) have been omitted due to cytoplasmic positivity. An alternative antibody (HPA024238), showing nuclear immunostaining pattern, has been added to the Protein Atlas.
  • The Paired box protein Pax-5 antibody (CAB001449) has been removed from the protein atlas since it has been discontinued by the commercial distributor. Two alternative antibodies (CAB026269 and CAB026869) have been added to the Protein Atlas.
  • The Serotonin N-acetyltransferase antibody (CAB001705) has been omitted due to general positivity.
  • The Monocyte differentiation antigen CD14 antibody (HPA002127) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The Bcl-2-like protein 11 antibody (CAB002616) has been omitted due to nuclear positivity.
  • The AT-rich interactive domain-containing protein 5A antibody (HPA002860) has been omitted due to cytoplasmic positivity. An alternative antibody (CAB023879), showing a nuclear immunostaining pattern, has been added to the Protein Atlas.
  • The 2'-5'-oligoadenylate synthetase 2 antibody (HPA003320) has been omitted due to cytoplasmic positivity. An alternative antibody (CAB024984), showing a distinct nuclear immunostaining pattern, has been added to the Protein Atlas.
  • The Runt-related transcription factor 3 antibody (HPA004195) has been omitted due to cytoplasmic positivity. An alternative antibody (CAB025416), showing a nuclear immunostaining pattern, has been added to the Protein Atlas.
  • The Mitogen-activated protein kinase kinase 1-interacting protein 1 antibody (CAB004263) has been omitted due to nuclear positivity. An alternative antibody (HPA026858), showing a cytoplasmatic immunostaining pattern, has been added to the Protein Atlas.
  • The Moesin antibody (CAB004505) has been omitted due to positivity in nuclear membranes.
  • The Glutamate [NMDA] receptor subunit epsilon-1 Precursor antibody (HPA004692) has been omitted due to general positivity. An alternative antibody (CAB0022725), showing a more distinct immunostaining pattern in cns, has been added to the Protein Atlas.
  • The Guanine nucleotide-binding protein subunit beta-2-like 1 antibody (CAB004288) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The Cardiac phospholamban antibody (CAB005597) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The Zinc finger homeobox protein 4 antibody (HPA006176) has been omitted due to cytoplasmic positivity. An alternative antibody (HPA023837), showing a nuclear immunostaining pattern, has been added to the Protein Atlas.
  • The FK506-binding protein 8 antibody (HPA007054) has been omitted due to nuclear positivity. An alternative antibody (CAB025346), showing a cytoplasmic immunostaining pattern, has been added to the Protein Atlas.
  • The Hepatitis A virus cellular receptor 1 Precursor antibody (HPA007173) has been omitted due to lack of positivity in T-cells.
  • The Zinc finger and SCAN domain-containing protein 2 antibody (HPA007296) has been omitted due to cytoplasmic positivity. An alternative antibody (HPA024331), showing nuclear immunostaining pattern, has been added to the Protein Atlas.
  • The Tumor necrosis factor-inducible gene 6 protein Precursor antibody (HPA007896) has been omitted due to nuclear positivity.
  • The Endonuclease III-like protein 1 antibody (HPA008299) has been omitted due to cytoplasmic positivity. An alternative antibody (CAB025152), showing a nuclear immunostaining pattern, has been added to the Protein Atlas.
  • The Breast cancer metastasis-suppressor 1 antibody (CAB010824) has been omitted due to general positivity. An alternative antibody (HPA019637), showing a more distinct immunostaining pattern in placenta, has been added to the Protein Atlas.
  • The Neurofilament medium polypeptide antibody (HPA010900) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The Gastrotropin antibody (HPA012601) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The Neurofilament medium polypeptide antibody (HPA012976) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The Dual specificity protein phosphatase 2 antibody (CAB016341) has been omitted due to cytoplasmic positivity.
  • The Zinc finger and SCAN domain-containing protein 21 antibody (HPA016948) has been omitted due to cytoplasmic positivity. An alternative antibody (HPA023591), showing a nuclear immunostaining pattern, has been added to the Protein Atlas.
  • The Group 3 secretory phospholipase A2 Precursor antibody (HPA018314) has been omitted due to rare positivity. An alternative antibody (HPA021016), showing a more ubiquitous immunostaining pattern, has been added to the Protein Atlas.
  • The Cyclin-A1 antibody (CAB019372) has been omitted due to diffuse cytoplasmic positivity.
  • The Forkhead box protein P3 antibody (HPA003191 and HPA008383) have been omitted due to cytoplasmic positivity. An alternative antibody (CAB026301), showing nuclear immunostaining pattern, has been added to the Protein Atlas.
  • The CD63 antigen antibody (CAB000062) has been removed from the protein atlas since it has been discontinued by the commercial distributor.
  • The Alkaline phosphatase, placental type Precursor antibody (CAB000067) has been removed from the protein atlas since it has been discontinued by the commercial distributor.
  • The Large Intestine Mucinous Antigen antibody (CAB000358) has been removed from the protein atlas since it has been discontinued by the commercial distributor.
  • The Proto-oncogene protein c-fos antibody (CAB000461) has been removed from the protein atlas since it has been discontinued by the commercial distributor.
  • The Kallikrein-6 Precursor antibody (CAB000463) has been removed from the protein atlas since it has been discontinued by the commercial distributor.
  • The SIMA antibody (CAB000468) has been removed from the protein atlas since it has been discontinued by the commercial distributor.
  • The Cystatin-B antibody (CAB000470) has been removed from the protein atlas since it has been discontinued by the commercial distributor.
  • The Hepatocyte nuclear factor 4-alpha antibody (CAB001387) has been removed from the protein atlas since it has been discontinued by the commercial distributor.
  • The Mitochondria antibody (CAB001516) has been removed from the protein atlas since it has been discontinued by the commercial distributor.
  • The Prohibitin antibody (CAB001517) has been removed from the protein atlas since it has been discontinued by the commercial distributor.
  • The Tubulin antibody (CAB001518) has been removed from the protein atlas since it has been discontinued by the commercial distributor.
  • The GRB2-associated-binding protein 1 antibody (CAB002605) has been removed from the protein atlas since it has been discontinued by the commercial distributor.
  • The CAB000026 antibody has been removed from the protein atlas due to target gene not found in Ensembl.
  • The CAB000033 antibody has been removed from the protein atlas due to target gene not found in Ensembl.
  • The CAB000044 antibody has been removed from the protein atlas due to target gene not found in Ensembl.
  • The CAB000046 antibody has been removed from the protein atlas due to target gene not found in Ensembl.
  • The CAB000049 antibody has been removed from the protein atlas due to target gene not found in Ensembl.
  • The CAB000050 antibody has been removed from the protein atlas due to target gene not found in Ensembl.
  • The CAB000056 antibody has been removed from the protein atlas due to target gene not found in Ensembl.
  • The CAB000061 antibody has been removed from the protein atlas due to target gene not found in Ensembl.
  • The CAB000138 antibody has been removed from the protein atlas due to target gene not found in Ensembl.
  • The CAB000302 antibody has been removed from the protein atlas due to target gene not found in Ensembl.
  • The HPA000519 antibody has been removed from the protein atlas due to target gene not found in Ensembl.
  • The HPA000639 antibody has been removed from the protein atlas due to target gene not found in Ensembl.
  • The HPA000754 antibody has been removed from the protein atlas due to target gene not found in Ensembl.
  • The HPA001217 antibody has been removed from the protein atlas due to target gene not found in Ensembl.
  • The HPA001245 antibody has been removed from the protein atlas due to target gene not found in Ensembl.
  • The CAB001717 antibody has been removed from the protein atlas due to target gene not found in Ensembl.
  • The CAB001810 antibody has been removed from the protein atlas due to target gene not found in Ensembl.
  • The HPA001839 antibody has been removed from the protein atlas due to target gene not found in Ensembl.
  • The CAB001997 antibody has been removed from the protein atlas due to target gene not found in Ensembl.
  • The HPA002357 antibody has been removed from the protein atlas due to target gene not found in Ensembl.
  • The HPA002539 antibody has been removed from the protein atlas due to target gene not found in Ensembl.
  • The HPA003009 antibody has been removed from the protein atlas due to target gene not found in Ensembl.
  • The HPA003034 antibody has been removed from the protein atlas due to target gene not found in Ensembl.
  • The HPA003052 antibody has been removed from the protein atlas due to target gene not found in Ensembl.
  • The HPA003065 antibody has been removed from the protein atlas due to target gene not found in Ensembl.
  • The HPA003181 antibody has been removed from the protein atlas due to target gene not found in Ensembl.
  • The HPA003182 antibody has been removed from the protein atlas due to target gene not found in Ensembl.
  • The HPA003212 antibody has been removed from the protein atlas due to target gene not found in Ensembl.
  • The HPA003214 antibody has been removed from the protein atlas due to target gene not found in Ensembl.
  • The HPA003285 antibody has been removed from the protein atlas due to target gene not found in Ensembl.
  • The HPA003532 antibody has been removed from the protein atlas due to target gene not found in Ensembl.
  • The HPA003540 antibody has been removed from the protein atlas due to target gene not found in Ensembl.
  • The HPA003550 antibody has been removed from the protein atlas due to target gene not found in Ensembl.
  • The HPA003644 antibody has been removed from the protein atlas due to target gene not found in Ensembl.
  • The HPA003652 antibody has been removed from the protein atlas due to target gene not found in Ensembl.
  • The HPA004008 antibody has been removed from the protein atlas due to target gene not found in Ensembl.
  • The CAB004085 antibody has been removed from the protein atlas due to target gene not found in Ensembl.
  • The HPA004110 antibody has been removed from the protein atlas due to target gene not found in Ensembl.
  • The HPA004115 antibody has been removed from the protein atlas due to target gene not found in Ensembl.
  • The CAB004271 antibody has been removed from the protein atlas due to target gene not found in Ensembl.
  • The HPA004709 antibody has been removed from the protein atlas due to target gene not found in Ensembl.
  • The HPA005736 antibody has been removed from the protein atlas due to target gene not found in Ensembl.
  • The HPA006013 antibody has been removed from the protein atlas due to target gene not found in Ensembl.
  • The HPA006766 antibody has been removed from the protein atlas due to target gene not found in Ensembl.
  • The HPA007969 antibody has been removed from the protein atlas due to target gene not found in Ensembl.
  • The CAB008641 antibody has been removed from the protein atlas due to target gene not found in Ensembl.
  • The CAB008642 antibody has been removed from the protein atlas due to target gene not found in Ensembl.
  • The CAB008643 antibody has been removed from the protein atlas due to target gene not found in Ensembl.
  • The HPA009419 antibody has been removed from the protein atlas due to target gene not found in Ensembl.
  • The CAB010402 antibody has been removed from the protein atlas due to target gene not found in Ensembl.
  • The HPA011072 antibody has been removed from the protein atlas due to target gene not found in Ensembl.
  • The CAB011453 antibody has been removed from the protein atlas due to target gene not found in Ensembl.
  • The HPA012158 antibody has been removed from the protein atlas due to target gene not found in Ensembl.
  • The CAB012703 antibody has been removed from the protein atlas due to target gene not found in Ensembl.
  • The CAB012908 antibody has been removed from the protein atlas due to target gene not found in Ensembl.
  • The HPA013409 antibody has been removed from the protein atlas due to target gene not found in Ensembl.
  • The HPA013767 antibody has been removed from the protein atlas due to target gene not found in Ensembl.
  • The HPA014796 antibody has been removed from the protein atlas due to target gene not found in Ensembl.
  • The CAB014879 antibody has been removed from the protein atlas due to target gene not found in Ensembl.
  • The HPA015013 antibody has been removed from the protein atlas due to target gene not found in Ensembl.
  • The CAB015367 antibody has been removed from the protein atlas due to target gene not found in Ensembl.
  • The CAB015377 antibody has been removed from the protein atlas due to target gene not found in Ensembl.
  • The CAB015395 antibody has been removed from the protein atlas due to target gene not found in Ensembl.
  • The HPA015509 antibody has been removed from the protein atlas due to target gene not found in Ensembl.
  • The CAB016533 antibody has been removed from the protein atlas due to target gene not found in Ensembl.
  • The CAB016726 antibody has been removed from the protein atlas due to target gene not found in Ensembl.
  • The CAB016789 antibody has been removed from the protein atlas due to target gene not found in Ensembl.
  • The HPA017390 antibody has been removed from the protein atlas due to target gene not found in Ensembl.
  • The HPA017595 antibody has been removed from the protein atlas due to target gene not found in Ensembl.
  • The HPA018452 antibody has been removed from the protein atlas due to target gene not found in Ensembl.
  • The HPA018827 antibody has been removed from the protein atlas due to target gene not found in Ensembl.

Protein Atlas version 4.1


Release date: 2008.12.03
Ensembl version: 51.36
  • Gene synonyms are now included in the database. The synonyms are searchable and displayed on the gene/protein-page. The gene synonyms are derived from Ensembl.
  • Western blot results with the validation score 3 (Single band larger than predicted size in kDa (+20%) but partly supported by predicted transmembrane region, signal peptide or by other available data.) have been moved from the validation category supportive (displayed as green) to the validation category uncertain (displayed as yellow).
  • The A-kinase anchor protein 4 precursor antibody (HPA005949) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The Fructose-bisphosphate aldolase C antibody (HPA003282) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The Solute carrier family 40 member 1 antibody (HPA011124) was removed from the Protein Atlas due to lack of positivity in entercytes.
  • The Synaptotagmin-like protein 4 antibodies (HPA001475 and HPA001589) were removed from the Protein Atlas due to lack of positivity in islet cells.
  • The Tyrosine-protein phosphatase non-receptor type 7 antibody (CAB0009530) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The Bile salt export pump antibody (HPA0019035) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The Collagen alpha-3(VI) chain precursor antibody (CAB002307) has been omitted due to immunostaining in most tissues including epithelial cells.
  • The NKG2-D type II integral membrane protein antibody (HPA001043) has been omitted due to diffuse cytoplasmic immunostaining.
  • The Catenin alpha-1 antibody (CAB000107) has been omitted due to nuclear staining.
  • The Cytokeratin AE1/AE3 antibody (CAB000025) has been omitted from the Protein Atlas due to representation of more than one gene.
  • The E3 ubiquitin-protein ligase UBR4 antibody (HPA013394) has been omitted due to nuclear staining.
  • The VIP peptides precursor antibody (CAB000573) was removed from the Protein Atlas due to lack of positivity in islet cells and periferial nerves.
  • The NGFI-A-binding protein 1 antibody (HPA002738) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The Plexin-B2 precursor antibody (HPA003100) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • The Major prion protein precursor antibody (CAB005591) has been omitted from the Protein Atlas due to positivity in HEK293 cells.
  • The Pericentrin antibody (CAB005888) has been omitted from the Protein Atlas due to nuclear staining.
  • The Ephrin-B1 precursor antibody (CAB013501) has been omitted from the Protein Atlas due to nuclear staining.
  • The Argininosuccinate synthase antibody (CAB001953) has been omitted from the Protein Atlas due to weak and sparse cytoplasmic staining.
  • The DNA-binding protein inhibitor ID-3 antibody (CAB017119) has been omitted from the Protein Atlas due to cytoplasmic staining.
  • The Mitogen-activated protein kinase kinase kinase kinase 2 antibody (HPA012120) has been omitted from the Protein Atlas due to lack of positivity in B cells.
  • The Lysosomal-associated transmembrane protein 4B antibody (HPA014996) has been omitted from the Protein Atlas due to nuclear staining.
  • The Transmembrane protein 70 antibody (HPA014446) has been omitted due to diffuse cytoplasmic positivity.

Protein Atlas version 4


Release date: 2008.08.18
Ensembl version: 51.36
  • [New] Fourth major release of the Human Protein Atlas with more than 6,000 antibodies and more than 5,700,000 images.
  • [New] All human protein-coding genes (Ensembl v50.36) have been included in the protein atlas.
  • [New] The proteins have now been classified according to a collection of protein classes.
  • [New] The antigen sequence for all HPA antibodies is now disclosed and visualized on the target protein sequence.
  • [Update] The search has been updated to make it possible to search for specific chromosomes, protein classes or protein expression patterns in cells.
  • [Change] The CDC25A antibody (CAB002674) has been omitted due to weak immunostaining. An alternative antibody (HPA005855), showing a more distinct immunostaining pattern, has been added to the Protein Atlas.
  • [Change] The E3 SUMO-protein ligase PIAS1 antibody (HPA005743) has been omitted due to diffuse cytoplasmic and sparse nuclear immunostaining. An alternative antibody (CAB012304), showing a more distinct nuclear immunostaining pattern, has been added to the Protein Atlas.
  • [Change] The Protein CASP antibody (HPA003277) has been omitted due to non-reliable protein expression patterns (IHC).
  • [Change] The Phosphatidylinositol 3-kinase regulatory subunit alpha antibody (HPA001569) has been omitted due to non-reliable protein expression patterns (IHC).
  • [Change] The Neurogenic locus notch homolog protein 4 precursor antibody (CAB010183) has been omitted due to negative or weak cytoplasmic staining. An alternative antibody (CAB012331), showing a more distinct and ubiquitous immunostaining pattern, has been added to the Protein Atlas.
  • [Change] The Sequestosome-1 antibody (HPA003196) has been omitted due to weak and diffuse staining in some cells. An alternative antibody (CAB004587), showing a more distinct and ubiquitous immunostaining pattern, has been added to the Protein Atlas.
  • [Change] The Beta crystallin B1 antibody (HPA003101) has been omitted due to ubiquitous expression in most cells. The antibody should be eye specific.
  • [Change] The Transcription factor E2F1 antibody (CAB000120) has been omitted due to negative or weak staining in most cells. An alternative antibody (CAB000329), showing a more distinct nuclear immunostaining pattern, has been added to the Protein Atlas.
  • [Change] The T-cell surface glycoprotein CD3 zeta chain precursor antibody (CAB002721) has been omitted due to ubiquitous staining in most cells. Alternative antibodies (CAB004651 and HPA008750), showing a more distinct immunostaining pattern in inflammatory cells, have been added to the Protein Atlas.
  • [Change] The Protein numb homolog (HPA002874) has been omitted due to lack of membranous staining in most cells. An alternative antibody (CAB011478), showing a more distinct membranous immunostaining pattern in most cells, has been added to the Protein Atlas.
  • [Change] The Major histocompatibility complex, class II, DM beta antibody (HPA007113) has been omitted due to ubiquitous staining in most cells. Alternative antibody (HPA012298), showing a more distinct immunostaining pattern in inflammatory cells, has been added to the Protein Atlas.
  • [Change] The Ephrin type-A receptor 7 precursor antibody (HPA000858) has been omitted due to negative or weak staining. An alternative antibody (CAB010496), showing a more distinct membranous immunostaining pattern, has been added to the Protein Atlas.
  • [Change] The Sodium/potassium-transporting ATPase subunit beta-1 antibody (CAB001989) has been omitted due to cytoplasmic staining. An alternative antibody (HPA012911), showing a more distinct membranous immunostaining pattern, has been added to the Protein Atlas.
  • [Change] The Nucleobindin-1 precursor antibody (CAB004677) has been omitted due to negative or weak staining. An alternative antibody (HPA008176), showing a more distinct ubiquitous cytoplasmic immunostaining pattern, has been added to the Protein Atlas.
  • [Change] The Cullin-4B antibody (HPA003046) has been omitted due to cytoplasmic positivity. Other alternative antibodies (CAB017786 and HPA011880), showing a more distinct nuclear immunostaining pattern, has been added to the Protein Atlas.
  • [Change] The Coagulation factor VIII precursor antibody (HPA001108) has been omitted due to absence of extra-cellular positivity. An alternative antibody (CAB018777), showing a more reliable immunostaining pattern, has been added to the Protein Atlas.
  • [Change] The UDP-N-acetylhexosamine pyrophosphorylase antibody (HPA005897) has been omitted due to diffuse immunostaining pattern. An alternative antibody (HPA014659), showing a more reliable positivity, has been added to the Protein Atlas.
  • [Change] The Caspase-2 precursor antibody (CAB002046) has been omitted due to nuclear and cytoplasmic positivity. An alternative antibody (CAB012175), showing cytoplasmic immunostaining pattern, has been added to the Protein Atlas.
  • [Change] The Formimidoyltransferase-cyclodeaminase antibody (CAB001519) has been omitted due to diffuse and general cytoplasmic positivity. An alternative antibody (CAB016409), showing a more distinct cytoplasmic immunostaining pattern, has been added to the Protein Atlas.
  • [Change] The Glycogen synthase kinase-3 beta antibody (CAB005033) has been omitted due to diffuse cytoplasmic positivity. An alternative antibody (CAB016263), showing a more distinct cytoplasmic immunostaining pattern in eg neuronal tissues, has been added to the Protein Atlas.
  • [Change] The NF-kappa-B-repressing factor antibody (HPA001136) has been omitted due to the excistence of other redundant antibody (HPA001476).
  • [Change] The Zinc finger Y-chromosomal protein antibody (HPA000723) has been omitted due to diffuse cytoplasmic positivity. An alternative antibody (HPA001748), showing nuclear immunostaining pattern, has been added to the Protein Atlas.
  • [Change] The HPA000629 antibody has been omitted from the protein atlas due to overlapping antigen with antibody HPA0001862 (disagreement with the concept of independent antibodies for quality assurance).
  • [Change] The HPA005694 antibody has been omitted from the protein atlas due to overlapping antigen with antibody HPA000634 (disagreement with the concept of independent antibodies for quality assurance).
  • [Change] The HPA000403 antibody has been omitted from the protein atlas due to overlapping antigen with antibody HPA003060 (disagreement with the concept of independent antibodies for quality assurance).
  • [Change] The HPA007983 antibody has been omitted from the protein atlas due to overlapping antigen with antibody HPA001383 (disagreement with the concept of independent antibodies for quality assurance).
  • [Change] The HPA006077 antibody has been omitted from the protein atlas due to overlapping antigen with antibody HPA010873 (disagreement with the concept of independent antibodies for quality assurance).
  • [Change] The HPA002035 antibody has been omitted from the protein atlas due to overlapping antigen with antibody HPA002127 (disagreement with the concept of independent antibodies for quality assurance).
  • [Change] The HPA000829 antibody has been omitted from the protein atlas due to overlapping antigen with antibody HPA000764 (disagreement with the concept of independent antibodies for quality assurance).
  • [Change] The HPA000539 antibody has been omitted from the protein atlas due to overlapping antigen with antibody HPA000452 (disagreement with the concept of independent antibodies for quality assurance).
  • [Change] The HPA001506 antibody has been omitted from the protein atlas due to overlapping antigen with antibody HPA000289 (disagreement with the concept of independent antibodies for quality assurance).
  • [Change] The HPA001006 antibody has been omitted from the protein atlas due to overlapping antigen with antibody HPA005552 (disagreement with the concept of independent antibodies for quality assurance).
  • [Change] The HPA002034 antibody has been omitted from the protein atlas due to overlapping antigen with antibody HPA002192 (disagreement with the concept of independent antibodies for quality assurance).
  • [Change] The HPA000368 antibody has been omitted from the protein atlas due to overlapping antigen with antibody HPA002925 (disagreement with the concept of independent antibodies for quality assurance).
  • [Change] The HPA001230 antibody has been omitted from the protein atlas due to overlapping antigen with antibody HPA001625 (disagreement with the concept of independent antibodies for quality assurance).
  • [Change] The HPA000951 and HPA000952 antibody has been omitted from the protein atlas due to overlapping antigen with antibody HPA001817 and HPA001832 (disagreement with the concept of independent antibodies for quality assurance).
  • [Change] The Adenomatous polyposis coli protein antibody (CAB002211) has been omitted due to sparse cytoplasmic positivity in goblet cells. An alternative antibody (HPA013349), showing a more general distinct cytoplasmic immunostaining pattern, has been added to the Protein Atlas.
  • [Change] The Alpha-type platelet-derived growth factor receptor precursor antibody (HPA004947) has been omitted due to unexpected positivity in some tissues. An alternative antibody (CAB018143), showing a more reliable immunostaining pattern, has been added to the Protein Atlas.
  • [Change] The Sulfotransferase family cytosolic 1B member 1 antibody (HPA002107) images have been omitted and replaced with images from a more recent staining with the same antibody.
  • [Change] The Interleukin-1 beta precursor antibody (HPA001410) has been omitted due to non-reliable nucleolar immunostaining pattern.
  • [Change] The prothrombin precursor antibody (HPA002970) has been omitted due to unexpected positivity in leukocytes. Two alternative antibodies (CAB016780 and CAB018650), showing a more distinct immunostaining pattern in serum, have been added to the Protein Atlas.
  • [Change] The C-X-C chemokine receptor type 3 antibody (HPA003189) has been omitted due diffuse nuclear staining. An alternative antibody (CAB017820), displaying a more reliable immunostaining pattern, has been added to the Protein Atlas.
  • [Change] The Carcinoembryonic antigen-related cell adhesion molecule 5 precursor antibody (CAB000022) images have been omitted and replaced with images from a more recent staining with the same antibody.
  • [Change] The Myeloperoxidase precursor antibody (CAB000059) images have been omitted and replaced with images from a more recent staining with the same antibody.
  • [Change] The CAMP-responsive element modulator antibody (HPA001818) images have been omitted and replaced with images from a more recent staining with the same antibody.
  • [Change] The Collagen alpha-1(III) chain precursor antibody (HPA007583) images have been omitted and replaced with images from a more recent staining with the same antibody.

Protein Atlas version 3.1


Release date: 2008.02.15
Ensembl version: 48.36
  • [New] A FAQ document (Frequently Asked Questions) has been added and is available as a link on the bottom of each page.
  • [New] Each image has now been complemented with more tissue information such as T-number and M-number as defined by SNOMED.
  • [Change] The term Staining intensity has been changed to Protein expression on several pages.
  • [Change] The ETS1-associated protein 1 (EAP1) antibody HPA008797 has been removed due to weak and unspecific staining. An alternative antibody HPA008736 is available on the Protein Atlas.
  • [Change] The Myeloid zinc finger 1 antibody (HPA001757) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • [Change] The E3 ubiquitin-protein ligase Praja1 antibody (HPA000595) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
  • [Change] The WD repeat protein 13 antibody (HPA000239) has been omitted due to non-reliable protein expression patterns (IHC), showing mainly cytoplasmic positivity. An alternative antibody (HPA000913), displaying distinct nuclear staining, has been added to the Protein Atlas.
  • [Change] Medullar cells has been removed for adrenal gland.
  • [Change] Lymphoid tissue has been renamed to lymphoid cells in appendix.
  • [Change] Bone marrow poetic cells has been renamed to bone marrow poietic cells.
  • [Change] Surface epithelial cells has been renamed to respiratory epithelial cells in bronchus.
  • [Change] Non-neuronal cells has been renamed to glial cells in cerebral cortex.
  • [Change] Surface epithelial cells (squamous) has been renamed to squamous epithelial cells in cervix, uterine.
  • [Change] Endometrium has been renamed to corpus, uterine.
  • [Change] Cells in endometrial stroma/ECM has been renamed to cells in endometrial stroma in corpus, uterine.
  • [Change] Cells in myometrium/ECM has been removed for corpus, uterine.
  • [Change] Surface epithelial cells has been renamed to squamous epithelial cells in esophagus.
  • [Change] Non-neuronal cells has been renamed to glial cells in hippo campus.
  • [Change] Cells in tubuli has been renamed to cells in tubules in kidney.
  • [Change] Non-neuronal cells has been renamed to glial cells in lateral ventricle.
  • [Change] Follicle cells (cortex) has been renamed to reaction center cells in lymph node.
  • [Change] Non-follicle cells (paracortex) has been renamed to lymphoid cells outside reaction centra in lymph node.
  • [Change] Surface epithelial cells has been renamed to respiratory epithelial cells in nasopharynx.
  • [Change] Surface epithelial cells has been renamed to squamous epithelial cells in oral mucosa.
  • [Change] Exocrine pancreas has been renamed to exocrine glandular cells in pancreas.
  • [Change] Cells in ductus seminiferus has been renamed to cells in seminiferus ducts in testis.
  • [Change] Follicle cells (cortex) has been renamed to reaction center cells in tonsil.
  • [Change] Non-follicle cells (paracortex) has been renamed to lymphoid cells outside reaction centra in tonsil.
  • [Change] Surface epithelial cells has been renamed to squamous epithelial cells in tonsil.
  • [Change] Surface epithelial cells has been renamed to urothelial cells in urinary bladder.
  • [Change] Surface epithelial cells has been renamed to squamous epithelial cells in vagina.
  • [Change] Surface epithelial cells has been renamed to squamous epithelial cells in vulva/anal skin.
  • [Change] Colo-rectal cancer has been renamed to colorectal cancer.

Protein Atlas version 3


Release date: 2007.10.09
Ensembl version: 48.36
  • [New] Third major release of the Human Protein Atlas with more than 3.000 antibodies and more than 2.800.000 images.
  • [New] Section for immunoflourescence staining of cell lines and confocal scanned images.
  • [New] Advanced search functionality enabling expression pattern search.
  • [New] Sort IHC tissues by alphabetic or histogenic order.
  • [New] Antibody specifility diagrams are now available for each HPA antibody based on array experiments. The diagrams can be found on the antibody info page.
  • [New] Western blot images are showed on selected antibodies on the antibody info page.
  • [Change] The SMC1 alpha protein antibody (HPA002855) has been omitted due to weak immunostaining. An alternative antibody (HPA005499), showing a more distinct immunostaining pattern, has been added to the Protein Atlas.
  • [Change] The TNF-R2 antibody (CAB002614) has been omitted due to a nuclear staining pattern. An alternative antibody (HPA004796), showing cytoplasmic and membranous positivity, has been added to the Protein Atlas.
  • [Change] The IL-1R-1 antibody (HPA001237) has been omitted due to a nuclear staining pattern. An alternative antibody (CAB007779) has been added to the Protein Atlas.
  • [Change] The LTF antibody (HPA001833) has been omitted due to deficient immunostaing with expected extra-cellular positivity. An alternative antibody (CAB008645) has been added to the Protein Atlas.
  • [Change] The FERM and PDZ domain-containing protein 3 antibody (HPA000830) has been omitted due to unspecific staining pattern.
  • [Change] The MMP-3 antibody (CAB002747) has been omitted due to low quality immunostaining pattern with only sparse positivity in mucous producing cells.
  • [Change] The AMOT antibody (CAB003708) has been omitted due to lack of expected positivity in endothelial cells.

Protein Atlas version 2


Release date: 2006.10.30
Ensembl version: 41.36
  • [New] Second major release of the Human Protein Atlas with more than 1.500 antibodies and 1.000.000 images.
  • [New] Cell profiles have been added to complement the tissue profiles. The new profiles consist of 47 cell lines and 12 primary cells that have been stained with HPA antibodies and evaluated using automated image analysis. The results are presented at the bottom of the expression profile-page for almost every antibody.
  • [Change] Due to late finding of an incorrect molecular weight of the antigens for HPA001340 and HPA001660, these antibodies were removed.
  • [Change] Due to weak and unspecific staining using the CDC2 antibody, CAB002435, a new immunostaining and subsequent annotation has been performed using the alternative antibody, CAB003799.

Protein Atlas version 1.2


Release date: 2006.03.13
Ensembl version: 35.35
  • [Change] The underlying algorithms for color code representation of negative, weak, moderate and strong staining has been modified. In the updated version, an immunostaining of less than 25% of the recorded cell type has been given less weight compared to the previous version. The result provides a more accurate display of the represented immunostained cell population.
  • [Change] In the previous version, tissues with one or several cell types missing were shown as a negative (white) color code. In the present version, this has been changed so that all cell types now displayed as negative (white) correctly represent existing cell types that lack immunohistochemical staining. The color code black (Not representative) has now been extended to include both not representative images as well as images where cell types are missing. The overall result will be an increase of displayed cell types as "Not representative" (black).
  • [Change] The explanation for a black color code on the summary page has been changed from "No images" to "Not representative".
  • [Change] A new design of the table displaying the splice variants for each gene.
  • [Update] Due to a weak and unspecific staining of the Integrin antibody, CAB003434, a new immunostaining has been performed using the same antibody. Images and annotation has been updated and the old version, CAB000127, has been removed.

Protein Atlas version 1.1


Release date: 2005.11.11
Ensembl version: 35.35
  • [Change] Changes have been made in the presentation of annotated localization patterns. Previous version included 4 different parameters for describing subcellular localization of protein expression: i) nuclear, ii) cytoplasmic, iii) membrane and iv) extra cellular. In the present version cytoplasmic and membraneous localization have been merged so that the output parameters now are i) nuclear, ii) cytoplasmic and/or membraneous. Due to the level of resolution using enzyme-based immunohistochemistry it is not possible to distinguish between cytoplasmic and membraneous localization in cells with a small cytoplasm. Cytoplasmic and membraneous localization has consequently been changed to one shared output parameter. Extra cellular localization has been omitted as a localization parameter given for a cell type. Corresponding text concerning annotation in “about protein atlas” has been modified accordingly.
  • [Change] A new summary page has been created. Previous version included two different summary pages, one for normal tissues and one for cancer tissues as well as a summary page containing all antibody information. In the present version the summary page contains a short gene description and a summary of both normal and cancer tissues.
  • [New] A new tab on the start page has been inserted. The new tab represents a “submission of antibodies” and contains a call for antibodies, information and an application form. Previous version included a tab “collaborations” which has been omitted.
  • [Update] Reliabilty scores have been curated for a subset of antibodies in the protein atlas since new data has allowed for detailed validation. A validation comment text has been added in these cases.
  • [New] The possibility to reference or link into a particular antibody in the Protein Atlas has now been simplified. The Protein Atlas now supports links in the following two new formats: HUGO ID and Ensembl gene ID. Examples of the new URLs:
    http://www.proteinatlas.org/tissue_profile.php?hugo_id=bmx
    or
    http://www.proteinatlas.org/tissue_profile.php?ensembl_gene_id=ENSG00000102010
  • [New] Version history (this text) has been added as text under the tab “about protein atlas”.

Protein Atlas version 1


Release date: 2005.08.29
Ensembl version: 35.35
  • First release of the Protein Atlas. Atlas content: 718 antibodies and 413,568 images